THERMOSTABLE POLYMERASES HAVING ALTERED FIDELITY

Abstract: The present invention relates to novel genes located in two chromosomal regions within uropathogenic E. coli that are associated with virulence. These chromosomal regions are known as pathogenicity islands (PAIs). In particular, the present application discloses 142 sequenced fragments (contigs) of DNA from two pools of cosmids covering pathogenicity islands PAI IV and PAI V located on the chromosome of the uropathogenic Escherichia coli J96. Further disclosed are 351 predicted protein-coding open reading frames within the sequenced fragments.

Description: Nucleotide Sequence of Escherichia coli Pathogenicity Islands Background of the Invention Field of the Invention The present invention relates to novel genes located in two chromosomal regions within E. coli that are associated with virulence. These chromosomal regions are known as pathogenicity islands (PAIs). Related Background Art Escherichia coli (E. coli) is a normal inhabitant of the intestine of humans and various animals. Pathogenic E. coli strains are able to cause infections of the intestine (intestinal E. coli strains) and of other organs such as the urinary tract (uropathogenic E. coli) or the brain (extraintestinal E. coli). Intestinal pathogenic E. coli are a well established and leading cause of severe infantile diarrhea in the developing world. Additionally, cases of newborn meningitis and sepsis have been attributed to E. coli pathogens. In contrast to non-pathogenic isolates, pathogenic E. coli produce pathogenicity factors which contribute to the ability of strains to cause infectious diseases (Muhldorfer, I. and Hacker, J., Microb. Pathogen. 16:171-181 1994). Adhesions facilitate binding of pathogenic bacteria to host tissues. Pathogenic E. coli strains also express toxins including haemolysins, which are involved in the destruction of host cells, and surface structures such as O-antigens, capsules or membrane proteins, which protect the bacteria from the action of phagocytes or the complement system (Ritter, et al., Mol. Microbiol. 17:109-212 1995). The genes coding for pathogenicity factors of intestinal E. coli are located on large plasmids. phage genomes or on the chromosome. In contrast to intestinal E. coli, pathogenicity determinants of uropathogenic and other extraintestinal E. coli are, in most cases, located on the chromosome. Id. Large chromosomal regions in pathogenic bacteria that encode adjacently located virulence genes have been termed pathogenicity islands ("PAIs"). PAIs are indicative of large fragments of DNA which comprise a group of virulence genes behaving as a distinct molecular and functional unit much like an island within the bacterial chromosome. For example, intact PAIs appear to transfer between organisms and confer complex virulence properties to the recipient bacteria. Chromosomal PAIs in bacterial cells have been described in increasing detail over recent years. For example, J. Hacker and co-workers described two large, unstable regions in the chromosome of uropathogenic Escherichia coli strain 536 as PAI-I and PAI-II (Hacker J., et al, Microbiol Pathog. 8:213-25 1990). Hacker found that PAI-I and PAI-II containing virulence regions can be lost by spontaneous deletion due to recombination events. Both of these PAIs were found to encode multiple virulence genes, and their loss resulted in reduced hemolytic activity, serum resistance, mannose-resistant hemagglutination, uroepithelial cell binding, and mouse virulence of the E. coli. (Knapp, S et al, J. Bacterial 168:22-30 1986). Therefore, pathogenicity islands are characterized by their ability to confer complex virulence phenotypes to bacterial cells. In addition to E. coli, specific deletion of large virulence regions has been observed in other bacteria such as Yersinia pestis. For example, Fetherston and co-workers found that a 102-kb region of the Y. pestis chromosome lost by spontaneous deletion resulted in the loss of many Y. pestis virulence phenotypes. (Fetherston, J.D. and Perry, R.D., Mol. Microbiol 13:697-708 1994, Fetherston, et al, Mol Microbiol. 6:2693-704 1992). In this instance, the deletion appeared to be due to recombination within 2.2-kb repetitive elements at both ends of the 102-kb region. It is possible that deletion of PAIs may benefit the organism by modulating bacterial virulence or genome size during infection. PAIs may also represent foreign DNA segments that were acquired during bacterial evolution that conferred important pathogenic properties to the bacteria. Observed flanking repeats, as observed in Y. pestis for example, may suggest a common mechanism by which these virulence genes were integrated into the bacterial chromosomes. Integration of the virulence genes into bacterial chromosomes was further elucidated by the discovery and characterization of a locus of enterocyte effacement (the LEE locus) in enteropathogenic E. coli (McDaniel, et al, Proc. Natl Acad. Sci. (USA) 92:1664-8 1995). The LEE locus comprises 35-kb and encodes many genes required for these bacteria to "invade" and degrade the apical structure of enerocytes causing diarrhea. Although the LEE and PAI-I loci encode different virulence genes, these elements are located at the exact same site in the E. coli genome and contain the same DNA sequence within their right-hand ends, thus suggesting a common mechanism for their insertion. Besides being found in enteropathogenic E. coli, the LEE element is also present in rabbit diarrheal E. coli, Hafhia alvei, and Citrobacter freundii biotype 4280, all of which induce attaching and effacing lesions on the apical face of enterocytes. The LEE locus appears to be inserted in the bacterial chromosome as a discrete molecular and functional virulence unit in the same fashion as PAI-I, PAI-II, and Yersinia PAI. Along these same lines, a 40-kb Salmonella typhimurium PAI was characterized on the bacterial chromosome which encodes genes required for Salmonella entry into nonphagocytic epithelial cells of the intestine (Mills, D.M., et al, Mol Microbiol. 15:749-59 1995). Like the LEE element, this PAI confers to Salmonella the ability to invade intestinal cells, and hence may likewise be characterized as an "invasion" PAI. The pathogenicity islands described above all possess the common feature of conferring complex virulence properties to the recipient bacteria. However, they may be separated into two types by their respective contributions to virulence. PAI-I, PAI-II, and the Y. pestis PAI confer multiple virulence phenotypes, while the LEE and the S. typhimurium "invasion" PAI encode many genes specifying a single, complex virulence process. It is advantageous to characterize closely-related bacteria that contain or do not contain the PAI by the isolation of a discrete molecular and functional unit on the bacterial chromosome. Since the presence versus the absence of essential virulence genes can often distinguish closely-related virulent versus avirulent bacterial strains or species, experiments have been conducted to identify virulence loci and potential PAIs by isolating DNA sequences that are unique to virulent bacteria (Bloch, C.A., et al, J Bacteriol 176:7121-5 1994, Groisman, E.A., EMBO J. 12:3779-87 1993). At least two PAIs are present in E. coli J96. These PAIs, PAI IV and PAI V are linked to tRNA loci but at sites different from those occupied by other known E. coli PAIs. Swenson et al, Infect, and Immun. 64:3136-3143 (1996). The era of true comparative genomics has been ushered in by high through-put genomic sequencing and analysis. The first two complete bacterial genome sequences, those of Haemophilus influenzae and Mycoplasma genitalium were recently described (Fleischmann, R.D., et al, Science 269:496 (1995); Fraser, CM., et al, Science 270:391 (1995)). Large scale DNA sequencing efforts also have produced an extensive collection of sequence data from eukaryotes, including Homo sapiens (Adams, M.D., et al, Nature 377:3 (1995)) and Saccharomyces cerevisiae (Levy, J., Yeast 70: 1689 (1994)). The need continues to exist for the application of high through-put sequencing and analysis to study genomes and subgenomes of infectious organisms. Further, a need exists for genetic markers that can be employed to distinguish closely-related virulent and avirulent strains of a given bacteria. Summary of the Invention The present invention is based on the high through-put, random sequencing of cosmid clones covering two pathogenic islands (PAIs) of uropathogenic Escherichia coli strain J96 (O4:K6; E. coli J96). PAIs are large fragments of DNA which comprise pathogenicity determinants. PAI IV is located approximately at 64 min (near pheV) on the E. coli chromosome and is greater than 170 kilobases in size. PAI V is located at approximately 94 min (at /zeR) on the E. coli chromosome and is approximately 106 kb in size. These PAIs differ in location from the PAIs described by Hacker and colleagues for uropathogenic strain 536 (PAI I, 82 minutes {selC} and PAI II, 97 minutes {leuX}). The location of the PAIs relative to one another and the cosmid clones covering the J96 PAIs is shown in Figure 1. The present invention relates to the nucleotide sequences of 142 fragments of DNA (contigs) covering the PAI IV and PAI V regions of the E. coli J96 chromosome. The nucleotide sequences shown in SΕQ ID NOs: 1 through 142 were obtained by shotgun sequencing eleven E. coli J96 subclones, which were deposited in two pools on September 23, 1996 at the American Type Culture Collection, 12301 Park Lawn Drive, Rockville, Maryland 20852, and given accession numbers 97726 (includes 7 cosmid clones covering PAI (IV) and 97727 (includes 4 cosmid clones covering PAI V). The deposited sets or "pools" of clones are more fully described in Example 1. In addition, E. coli strain J96 was also deposited at the American Type Culture Collection on September 23, 1996, and given accession number 98176. Three hundred fifty-one open reading frames have been thus far identified in the 142 contigs described by SEQ ID NOs: 1 through 142. Thus, the present invention is directed to isolated nucleic acid molecules comprising open reading frames (ORFs) encoding E. coli J96 PAI proteins, and fragments of said nucleic acid molecules. The present invention also relates to variants of the nucleic acid molecules of the present invention, which encode portions, analogs or derivatives of E. coli J96 PAI proteins. Further embodiments include isolated nucleic acid molecules comprising a polynucleotide having a nucleotide sequence at least 90% identical, and more preferably at least 95%, 96%, 97%, 98% or 99% identical, to the nucleotide sequence of an E. coli J96 PAI ORF described herein, and fragments of said nucleic acid molecules. The present invention also relates to recombinant vectors, which include the isolated nucleic acid molecules of the present invention and fragments thereof, host cells containing the recombinant vectors, as well as methods for making such vectors and host cells for E. coli J96 PAI protein production by recombinant techniques. The invention further provides isolated polypeptides encoded by the E. coli J96 PAI ORFs or fragments of said ORFs. It will be recognized that some amino acid sequences of the polypeptides described herein can be varied without significant effect on the structure or function of the protein. If such differences in sequence are contemplated, it should be remembered that there will be critical areas on the protein which determine activity. In general, it is possible to replace residues which form the tertiary structure, provided that residues performing a similar function are used. In other instances, the type of residue may be completely unimportant if the alteration occurs at a non-critical region of the protein. In another aspect, the invention provides a peptide or polypeptide comprising an epitope-bearing portion of a polypeptide of the invention. The epitope-bearing portion is an immunogenic or antigenic epitope useful for raising antibodies. The invention further provides a vaccine comprising one or more E. coli J96 PAI antigens together with a pharmaceutically acceptable diluent, carrier, or excipient, wherein the one or more antigens are present in an amount effective to elicit protective antibodies in an animal to pathogenic E. coli, such as strain J96. The invention also provides a method of eliciting a protective immune response in an animal comprising administering to the animal the above- described vaccine. The invention further provides a method for identifying pathogenic E. coli in an animal comprising analyzing tissue or body fluid from the animal for one or more of: (a) polynucleic acids encoding an open reading frame listed in Tables 1-4 or a fragment of said polynucleic acid; (b) full length or mature polypeptides encoded for by an open reading frame listed in Tables 1-4; or (c) antibodies specific to polypeptides encoded for by an open reading frame listed in Tables 1-4. The invention further provides a nucleic acid probe for the detection of the presence of one or more E. coli PAI nucleic acids (nucleic acids encoding one or more ORFs as listed in Tables 1-4) in a sample from an individual comprising one or more nucleic acid molecules sufficient to specifically detect under stringent hybridization conditions the presence of the above-described molecule in the sample. The invention also provides a method of detecting E. coli PAI nucleic acids in a sample comprising: a) contacting the sample with the above-described nucleic acid probe, under conditions such that hybridization occurs, and b) detecting the presence of the probe bound to an E. coli PAI nucleic acid. The invention further provides a kit for detecting the presence of one or more E. coli PAI nucleic acids in a sample comprising at least one container means having disposed therein the above-described nucleic acid probe. The invention also provides a diagnostic kit for detecting the presence of pathogenic E. coli in a sample comprising at least one container means having disposed therein one or more of the above-described antibodies. The invention also provides a diagnostic kit for detecting the presence of antibodies to pathogenic E. coli in a sample comprising at least one container means having disposed therein one or more of the above-described antigens. Brief Description of the Figures Figure 1 is a schematic diagram of cosmid clones derived from E. coli J96 pathogenicity island and map positions of known E. coli PAIs (not drawn to scale). The gray bar represents the E. coli K-12 chromosome with minute demarcations of PAI junction points located above the bar. E. coli J96 overlapping cosmid clones are represented by hatched bars (overlap not drawn to scale) with positions of hly, pap, and prs operons indicated above bar. The PAIs and estimated sizes are shown above and below the K-12 chromosome map. Figure 2 is a block diagram of a computer system 102 that can be used to implement the computer-based systems of present invention. Detailed Description of the Invention The present invention is based on high through-put, random sequencing of a uropathogenic strain of Escherichia coli. The DNA sequences of contiguous DNA fragments covering the pathogenicity islands, PAI IV (also referred to as PAI J96(pheV) ) and PAI V (also referred to as PAI J96(pheU) ) from the chromosome of the E. coli uropathogenic strain, J96 (04:K6) were determined. The sequences were used for DNA and protein sequence similarity searches of the database. The primary nucleotide sequences generated by shotgun sequencing cosmid clones of the PAI IV and PAI V regions of the E. coli chromosome are provided in SΕQ ID NOs:l through 142. These sequences represent contiguous fragments of the PAI DNA. As used herein, the "primary sequence" refers to the nucleotide sequence represented by the IUPAC nomenclature system. The present invention provides the nucleotide sequences of SΕQ ID NOs:l through 142, or representative fragments thereof, in a form that can be readily used, analyzed, and interpreted by a skilled artisan. Within these 142 sequences, there have been thus far identified 351 open reading frames (ORFs) that are described in greater detail below. As used herein, a "representative fragment" refers to E. coli J96 PAI protein-encoding regions (also referred to herein as open reading frames or ORFs), expression modulating fragments, and fragments that can be used to diagnose the presence of E. coli in a sample. A non-limiting identification of such representative fragments is provided in Tables 1 through 6, preferably in Tables 1 through 4. As described in detail below, representative fragments of the present invention further include nucleic acid molecules having a nucleotide sequence at least 95% identical, preferably at least 96%, 97%, 98%, or 99% identical, to an ORF identified in Tables 1 through 6, or more preferably Tables 1 through 4. As indicated above, the nucleotide sequence information provided in SEQ ID NOs:l through 142 was obtained by sequencing cosmid clones covering the PAIs located on the chromosome of E. coli J96 using a megabase shotgun sequencing method. The sequences provided in SEQ ID NOs:l through 142 are highly accurate, although not necessarily a 100%) perfect, representation of the nucleotide sequences of contiguous stretches of DNA (contigs) which include the ORFs located on the two pathogenicity islands of E. coli J96. As discussed in detail below, using the information provided in SEQ ID NOs: 1 through 142 and in Tables 1 through 6 together with routine cloning and sequencing methods, one of ordinary skill in the art would be able to clone and sequence all "representative fragments" of interest including open reading frames (ORFs) encoding a large variety of E. coli J96 PAI proteins. In rare instances, this may reveal a nucleotide sequence error present in the nucleotide sequences disclosed in SEQ ID NOs: 1 through 142. Thus, once the present invention is made available (i.e., once the information in SEQ ID NOs: 1 through 142 and in Tables 1 through 6 is made available), resolving a rare sequencing error would be well within the skill of the art. Nucleotide sequence editing software is publicly available. For example, Applied Biosystem's (AB) AutoAssembler™ can be used as an aid during visual inspection of nucleotide sequences. Even if all of the rare sequencing errors were corrected, it is predicted that the resulting nucleotide sequences would still be at least about 99.9% identical to the reference nucleotide sequences in SEQ ID NOs: 1 through 142. Thus, the present invention further provides nucleotide sequences that are at least 99.9% identical to the nucleotide sequence of SEQ ID NOs: 1 through 142 in a form which can be readily used, analyzed and interpreted by the skilled artisan. Methods for determining whether a nucleotide sequence is at least 99.9% identical to a reference nucleotide sequence of the present invention are described below. Nucleic Acid Molecules The present invention is directed to isolated nucleic acid fragments of the PAIs of E. coli J96. Such fragments include, but are not limited to, nucleic acid molecules encoding polypeptides, nucleic acid molecules that modulate the expression of an operably linked ORF (hereinafter expression modulating fragments (ΕMFs)), and nucleic acid molecules that can be used to diagnose the presence of E. coli in a sample (hereinafter diagnostic fragments (DFs)). By "isolated nucleic acid molecule(s)" is intended a nucleic acid molecule, DNA or RNA, that has been removed from its native environment. For example, recombinant DNA molecules contained in a vector are considered isolated for the purposes of the present invention. Further examples of isolated DNA molecules include recombinant DNA molecules maintained in heterologous host cells, purified (partially or substantially) DNA molecules in solution, and nucleic acid molecules produced synthetically. Isolated RNA molecules include in vitro RNA transcripts of the DNA molecules of the present invention. In one embodiment, E. coli J96 PAI DNA can be mechanically sheared to produce fragments about 15-20 kb in length, which can be used to generate an E. coli J96 PAI DNA library by insertion into lambda clones as described in Example 1 below. Primers flanking an ORF described in Tables 1 through 6 can then be generated using the nucleotide sequence information provided in SEQ ID NOs: 1 through 142. The polymerase chain reaction (PCR) is then used to amplify and isolate the ORF from the lambda DNA library. PCR cloning is well known in the art. Thus, given SEQ ID NOs: 1 through 142, and Tables 1 through 6, it would be routine to isolate any ORF or other representative fragment of the E. coli J96 PAI subgenomes. Isolated nucleic acid molecules of the present invention include, but are not limited to. single stranded and double stranded DNA, and single stranded RNA, and complements thereof. Tables 1 through 6 herein describe ORFs in the E. coli J96 PAI cosmid clone library. Tables 1 and 3 list, for PAI IV and PAI V, respectively, a number of ORFs that putatively encode a recited protein based on homology matching with protein sequences from an organism listed in the Table. Tables 1 and 3 indicate the location of ORFs (i.e., the position) by reference to its position within the one of the 142 E. coli J96 contigs described in SΕQ ID NOs: 1 through 142. Column 1 of Tables 1 and 3 provides the Sequence ID Number (SΕQ ID NO) of the contig in which a particular open reading frame is located. Column 2 numerically identifies a particular ORF on a particular contig (SΕQ ID NO) since many contigs comprise a plurality of ORFs. Columns 3 and 4 indicate an ORF's position in the nucleotide sequence (contig) provided in SΕQ ID NOs: 1 through 142 by referring to start and stop positions in the contig sequence. One of ordinary skill in the art will appreciate that the ORFs may be oriented in opposite directions in the E. coli chromosome. This is reflected in columns 3 and 4. For these ORFs, the sense strand is complementary to the actual sequence given. The corresponding sense-strand of the ORF must be read as the 5'-3' complement of the antisense strand actually shown in the Sequence Listing, wherein the location is specified 3'-5'. Column 5 provides a database accession number to a homologous protein identified by a similarity search of public sequence databases (see, infra). Column 6 describes the matching protein sequence and the source organism is identified in brackets. Column 7 of Tables 1 and 3 indicates the percent similarity of the protein sequence encoded by an ORF to the corresponding protein sequence from the organism appearing in parentheses in the sixth column. Column 8 of Tables 1 and 3 indicates the percent identity of the protein sequence encoded by an ORF to the corresponding protein sequence from the organism appearing in parentheses in the sixth column. The concepts of percent identity and percent similarity of two polypeptide sequences are well understood in the art and are described in more detail below. Identified genes can frequently be assigned a putative cellular role category adapted from Riley (see, Riley, M., Microbiol. Rev. 57:862 (1993)). Column 9 of Tables 1 and 3 provides the nucleotide length of the open reading frame. Tables 2 and 4, below, provide ORFs of E. coli J96 PAI IV and PAI V, respectively, that did not elicit a homology match with a known sequence from either E. coli or another organism. As above, the first column in Tables 2 and 4 provides the contig in which the ORF is located and the second column numerically identifies a particular ORF in a particular contig. Columns 3 and 4 identify an ORF's position in one of SΕQ ID NOs: 1 through 142 by reference to start and stop nucleotides. Tables 5 and 6, below, provide the E. coli J96 PAI IV ORFs and PAI V ORFs, respectively, identified by the present inventors that provided a significant match to a previously published E. coli protein. Columns 1-6 correspond to columns 1-6 appearing in Tables 1 and 3. Column 7 indicates the percent identity of the protein sequence encoded by an ORF to the corresponding protein sequence from the organism appearing in parentheses in the sixth column. Column 8 indicates the length of the high-scoring segment pair (HSP). Column 9 provides the nucleotide length of the open reading frame. As used herein, "open reading frame" or "ORF" refers to the nucleotide sequences as described in Tables 1 through 6. In Tables 1 through 6, each ORF is designated by a nucleotide sequence start position and stop position according to numbering of contig nucleotides in the Sequence Listing provided (Contig ID = SΕQ ID NO). In a first embodiment, the invention comprises a nucleotide sequence described in Tables 1 through 4 which begins with the nucleotide following the last nucleotide of an upstream stop codon (first nucleotide of the "ORF"), an initiation codon, in-frame putative polypeptide-encoding sequence, and nucleotides of an in-frame stop codon. In a second embodiment, the invention comprises a nucleotide sequence of Tables 1 through 4 which contains an initiation codon (e.g. a methionine or valine codon) on their 5' end and a stop codon on their 3' end. The sequences of this embodiment are present within the nucleotide sequence described in Tables 1 through 4 by start and stop position as numbered in the Sequence Listing. To determine the 5' start position of this embodiment, one simply reads 5' to 3' from the designated 5' end position until an initiation codon is found. In a third embodiment, the invention comprises a nucleotide sequence of the second embodiment, except that the 3' stop codon is not present. In a fourth embodiment, the invention comprises a nucleotide sequence encoding a putative protein which is a sequence of Tables 1 through 4 excluding sequence encoding amino acids subject to removal by post-translational processing and sequences 3' of the last codon coding for an amino acid present in the putative polypeptide (e.g., sequences not containing the stop codon and encoding the mature form of the polypeptide). Certain embodiments of the invention may therefore either include or exclude initiation codons for methionine or valine and either include or exclude the stop codon. Further details concerning the algorithms and criteria used for homology searches are provided in the Examples below. A skilled artisan can readily identify ORFs in the Escherichia coli J96 cosmid library other than those listed in Tables 1 through 6, such as ORFs that are overlapping or encoded by the opposite strand of an identified ORF in addition to those ascertainable using the computer-based systems of the present invention. Isolated nucleic acid molecules of the present invention include DNA molecules having a nucleotide sequence substantially different than the nucleotide sequence of an ORF described in Tables 1 through 4, but which, due to the degeneracy of the genetic code, still encode a E. coli J96 PAI protein. The genetic code is well known in the art. Thus, it would be routine to generate such degenerate variants. The present invention further relates to variants of the nucleic acid molecules of the present invention, which encode portions, analogs or derivatives of an E. coli protein encoded by an ORF described in Table 1 through 4. Non-naturally occurring variants may be produced using art-known mutagenesis techniques and include those produced by nucleotide substitutions, deletions or additions. The substitutions, deletions or additions may involve one or more nucleotides. The variants may be altered in coding regions, non-coding regions, or both. Alterations in the coding regions may produce conservative or non-conservative amino acid substitutions, deletions or additions. Especially preferred among these are silent substitutions, additions and deletions, which do not alter the properties and activities of the E. coli protein or portions thereof. Also especially preferred in this regard are conservative substitutions. Further embodiments of the invention include isolated nucleic acid molecules comprising a polynucleotide having a nucleotide sequence at least 90% identical, and more preferably at least 95%, 96%, 97%, 98% or 99% identical, to the nucleotide sequence of an ORF described in Tables 1 through 6, preferably 1 through 4. By a polynucleotide having a nucleotide sequence at least, for example, 95% identical to the reference E. coli ORF nucleotide sequence is intended that the nucleotide sequence of the polynucleotide is identical to the reference sequence except that the polynucleotide sequence may include up to five point mutations per each 100 nucleotides of the ORF sequence. In other words, to obtain a polynucleotide having a nucleotide sequence at least 95% identical to a reference ORF nucleotide sequence, up to 5% of the nucleotides in the reference sequence may be deleted or substituted with another nucleotide, or a number of nucleotides up to 5% of the total nucleotides in the reference sequence may be inserted into the reference sequence. These mutations of the reference sequence may occur at the 5 ' or 3 ' terminal positions of the reference nucleotide sequence or anywhere between those terminal positions, interspersed either individually among nucleotides in the reference sequence or in one or more contiguous groups within the reference sequence. As a practical matter, whether any particular nucleic acid molecule is at least 90%, 95%, 96%, 97%, 98% or 99% identical to the nucleotide sequence of an E. coli J96 PAI ORF can be determined conventionally using known computer programs such as the Bestfit program (Wisconsin Sequence Analysis Package, Version 8 for Unix, Genetics Computer Group, University Research Park, 575 Science Drive, Madison, WI 5371 1). Bestfit uses the local homology algorithm of Smith and Waterman, Advances in Applied Mathematics 2: 482-489 (1981), to find the best segment of homology between two sequences. When using Bestfit or any other sequence alignment program to determine whether a particular sequence is, for instance, 95% identical to a reference sequence according to the present invention, the parameters are set, of course, such that the percentage of identity is calculated over the full length of the reference nucleotide sequence and that gaps in homology of up to 5% of the total number of nucleotides in the reference sequence are allowed. Preferred are nucleic acid molecules having sequences at least 90%, 95%, 96%, 91%, 98% or 99% identical to the nucleic acid sequence of an E. coli J96 PAI ORF that encode a functional polypeptide. By a "functional polypeptide" is intended a polypeptide exhibiting activity similar, but not necessarily identical, to an activity of the protein encoded by the E. coli J96 PAI ORF. For example, the E. coli ORF [Contig ID 84, ORF ID 3 (84/3)] encodes a hemolysin. Thus, a "functional polypeptide" encoded by a nucleic acid molecule having a nucleotide sequence, for example, 95% identical to the nucleotide sequence of 84/3, will also possess hemolytic activity. As the skilled artisan will appreciate, assays for determining whether a particular polypeptide is "functional" will depend on which ORF is used as the reference sequence. Depending on the reference ORF, the assay chosen for measuring polypeptide activity will be readily apparent in light of the role categories provided in Tables 1, 3, 5 and 6. Of course, due to the degeneracy of the genetic code, one of ordinary skill in the art will immediately recognize that a large number of the nucleic acid molecules having a sequence at least 90%, 95%, 96%, 97%, 98%, or 99% identical to the nucleic acid sequence of a reference ORF will encode a functional polypeptide. In fact, since degenerate variants all encode the same amino acid sequence, this will be clear to the skilled artisan even without performing a comparison assay for protein activity. It will be further recognized in the art that, for such nucleic acid molecules that are not degenerate variants, a reasonable number will also encode a functional polypeptide. This is because the skilled artisan is fully aware of amino acid substitutions that are either less likely or not likely to significantly affect protein function (e.g.. replacing one aliphatic amino acid with a second aliphatic amino acid). For example, guidance concerning how to make phenotypically silent amino acid substitutions is provided in Bowie, J. U. et al, "Deciphering the Message in Protein Sequences: Tolerance to Amino Acid Substitutions," Science 2 7. 1306-1310 (1990), wherein the authors indicate that there are two main approaches for studying the tolerance of an amino acid sequence to change. The first method relies on the process of evolution, in which mutations are either accepted or rejected by natural selection. The second approach uses genetic engineering to introduce amino acid changes at specific positions of a cloned gene and selections or screens to identify sequences that maintain functionality. As the authors state, these studies have revealed that proteins are surprisingly tolerant of amino acid substitutions. The authors further indicate which amino acid changes are likely to be permissive at a certain position of the protein. For example, most buried amino acid residues require nonpolar side chains, whereas few features of surface side chains are generally conserved. Other such phenotypically silent substitutions are described in Bowie, J.U. et al, supra, and the references cited therein. The present invention is further directed to fragments of the isolated nucleic acid molecules described herein. By a fragment of an isolated nucleic acid molecule having the nucleotide sequence of an E. coli J96 PAI ORF is intended fragments at least about 15 nt, and more preferably at least about 20 nt, still more preferably at least about 30 nt, and even more preferably, at least about 40 nt in length that are useful as diagnostic probes and primers as discussed herein. Of course, larger fragments 50-500 nt in length are also useful according to the present invention as are fragments corresponding to most, if not all, of the nucleotide sequence of an E. coli J96 PAI ORF. By a fragment at least 20 nt in length, for example, is intended fragments that include 20 or more contiguous bases from the nucleotide sequence of an E. coli J96 PAI ORF. Since E coli ORFs are listed in Tables 1 through 6 and the sequences of the ORFs have been provided within the contig sequences of SΕQ ID NOs: 1 through 142, generating such DNA fragments would be routine to the skilled artisan. For example, restriction endonuclease cleavage or shearing by sonication could easily be used to generate fragments of various sizes from the PAI DNA that is incorporated into the deposited pools of cosmid clones. Alternatively, such fragments could be generated synthetically. Preferred nucleic acid fragments of the present invention include nucleic acid molecules encoding epitope-bearing portions of an E. coli J96 PAI protein. Methods for determining such epitope-bearing portions are described in detail below. In another aspect, the invention provides an isolated nucleic acid molecule comprising a polynucleotide that hybridizes under stringent hybridization conditions to a portion of the polynucleotide in a nucleic acid molecule of the invention described above, for instance, an ORF described in Tables 1 through 6, preferably an ORF described in Tables 1, 2, 3 or 4. By "stringent hybridization conditions" is intended overnight incubation at 42° C in a solution comprising: 50%> formamide, 5 x SSC (150 mM NaCl, 15mM trisodium citrate), 50 mM sodium phosphate (pFI 7.6), 5 x Denhardt's solution, 10% dextran sulfate, and 20 g/ml denatured, sheared salmon sperm DNA, followed by washing the filters in 0.1 x SSC at about 65 °C. By a polynucleotide that hybridizes to a "portion" of a polynucleotide is intended a polynucleotide (either DNA or RNA) hybridizing to at least about 15 nucleotides (nt), and more preferably at least about 20 nt, still more preferably at least about 30 nt, and even more preferably about 30-70 nt of the reference polynucleotide. These are useful as diagnostic probes and primers as discussed above and in more detail below. Of course, polynucleotides hybridizing to a larger portion of the reference polynucleotide (e.g., a E. coli ORF), for instance, a portion 50-500 nt in length, or even to the entire length of the reference polynucleotide, are also useful as probes according to the present invention, as are polynucleotides corresponding to most, if not all, of an E. coli J96 PAI ORF. By "expression modulating fragment" (EMF), is intended a series of nucleotides that modulate the expression of an operably linked, putative polypeptide-encoding region (encoding region). A sequence is said to "modulate the expression of an operably linked sequence" when the expression of the sequence is altered by the presence of the EMF. EMFs include, but are not limited to, promoters, and promoter modulating sequences (inducible elements). One class of EMFs are fragments that induce the expression of an operably linked encoding region in response to a specific regulatory factor or physiological event. EMF sequences can be identified within the E. coli genome by their proximity to the encoding regions within ORFs described in Tables 1 through 6. An intergenic segment, or a fragment of the intergenic segment, from about 10 to 200 nucleotides in length, taken 5' from any one of the encoding regions of ORFs of Tables 1 through 6 will modulate the expression of an operably linked 3' encoding region in a fashion similar to that found within the naturally linked ORF sequence. As used herein, an "intergenic segment" refers to the fragments of the E. coli J96 PAI subgenome that are between two encoding regions herein described. Alternatively, ΕMFs can be identified using known ΕMFs as a target sequence or target motif in the computer-based systems of the present invention. The presence and activity of an ΕMF can be confirmed using an ΕMF trap vector. An ΕMF trap vector contains a cloning site 5 ' to a marker sequence. A marker sequence encodes an identifiable phenotype, such as antibiotic resistance or a complementing nutrition auxotrophic factor, which can be identified or assayed when the ΕMF trap vector is placed within an appropriate host under appropriate conditions. As described above, an ΕMF will modulate the expression of an operably linked marker sequence. A more detailed discussion of various marker sequences is provided below. A sequence that is suspected as being an ΕMF is cloned in all three reading frames in one or more restriction sites upstream from the marker sequence in the ΕMF trap vector. The vector is then transformed into an appropriate host using known procedures and the phenotype of the transformed host in examined under appropriate conditions. As described above, an EMF will modulate the expression of an operably linked marker sequence. By a "diagnostic fragment" (DF), is intended a series of nucleotides that selectively hybridize to E. coli sequences. DFs can be readily identified by identifying unique sequences within the E. coli J96 PAI subgenome, or by generating and testing probes or amplification primers consisting of the DF sequence in an appropriate diagnostic format for amplification or hybridization selectivity. Each of the ORFs of the E. coli J96 PAI subgenome disclosed in Tables 1 through 4, and EMFs found 5 ' to the encoding regions of the ORFs, can be used in numerous ways as polynucleotide reagents. The sequences can be used as diagnostic probes or diagnostic amplification primers to detect the presence of uropathogenic E. coli in a sample. This is especially the case with the fragments or ORFs of Table 2 and 4 which will be highly selective for uropathogenic E. coli J96, and perhaps other uropathogenic or extraintestinal strains that include one or more PAIs. In addition, the fragments of the present invention, as broadly described, can be used to control gene expression through triple helix formation or antisense DNA or RNA, both of which methods are based on the binding of a polynucleotide sequence to DNA or RNA. Polynucleotides suitable for use in these methods are usually 20 to 40 bases in length and are designed to be complementary to a region of the gene involved in transcription (triple helix - see Lee et al, Nuc Acids Res. 6:3013 (1979); Cooney et al, Science 241:456 (1988); and Dervan et al, Science 257:1360 (1991)) or to the mRNA itself (antisense - Okano, J. Neurochem. 56:560 (1991); Oligodeoxynucleotides as Antisense Inhibitors of Gene Expression, CRC Press, Boca Raton, FL (1988)). Triple helix- formation optimally results in a shut-off of RNA transcription from DNA, while antisense RNA hybridization blocks translation of an mRNA molecule into polypeptide. Both techniques have been demonstrated to be effective in model systems. Information contained in the sequences of the present invention is necessary for the design of an antisense or triple helix oligonucleotide. Vectors and Host Cells The present invention further provides recombinant constructs comprising one or more fragments of the E coli J96 PAIs. The recombinant constructs of the present invention comprise a vector, such as a plasmid or viral vector, into which, for example, an E. coli J96 PAI ORF is inserted. The vector may further comprise regulatory sequences, including for example, a promoter, operably linked to the encoding region of an ORF. For vectors comprising the ΕMFs of the present invention, the vector may further comprise a marker sequence or heterologous ORF operably linked to the ΕMF. Large numbers of suitable vectors and promoters are known to those of skill in the art and are commercially available for generating the recombinant constructs of the present invention. The following vectors are provided by way of example. Bacterial: pBs, phagescript, PsiX174, pBluescript SK, pBs KS, pNH8a, pNHlόa, pNH18a, pNH46a (Stratagene); P Trc99A, pKK223-3, pKK233-3, pDR540, pRIT5 (Pharmacia). Eukaryotic: pWLneo, pSV2cat, pOG44, pXTl, pSG (Stratagene) pSVK3, pBPV, pMSG, pSVL (Pharmacia). Promoter regions can be selected from any desired gene using CAT (chloramphenicol transferase) vectors or other vectors with selectable markers. Two appropriate vectors are pKK232-8 and pCM7. Particular named bacterial promoters include lad, lacZ, T3, T7, gpt, lambda P R , and trc. Eukaryotic promoters include CMV immediate early, HSV thymidine kinase, early and late SV40, LTRs from retrovirus, and mouse metallothionein-I. Selection of the appropriate vector and promoter is well within the level of ordinary skill in the art. The present invention further provides host cells containing any one of the isolated fragments (preferably an ORF) of the E. coli J96 PAIs described herein. The host cell can be a higher eukaryotic host cell, such as a mammalian cell, a lower eukaryotic host cell, such as a yeast cell, or the host cell can be a procaryotic cell, such as a bacterial cell. Introduction of the recombinant construct into the host cell can be effected by calcium phosphate transfection, DEAE, dextran mediated transfection, or electroporation (Davis, L. et al, Basic Methods in Molecular Biology (1986)). Host cells containing, for example, an E. coli J96 PAI ORF can be used conventionally to produce the encoded protein. Polypeptides and Fragments The invention further provides isolated polypeptides having the amino acid sequence encoded by an E coli PAI ORF described in Tables 1 through 6, preferably Tables 1 through 4, or a peptide or polypeptide comprising a portion of the above polypeptides. The terms "peptide" and "oligopeptide" are considered synonymous (as is commonly recognized) and each term can be used interchangeably as the context requires to indicate a chain of at least two amino acids coupled by peptidyl linkages. The word "polypeptide" is used herein for chains containing more than ten amino acid residues. All oligopeptide and polypeptide formulas or sequences herein are written from left to right and in the direction from amino terminus to carboxy terminus. It will be recognized in the art that some amino acid sequences of E. coli polypeptides can be varied without significant effect of the structure or function of the protein. If such differences in sequence are contemplated, it should be remembered that there will be critical areas on the protein which determine activity. In general, it is possible to replace residues which form the tertiary structure, provided that residues performing a similar function are used. In other instances, the type of residue may be completely unimportant if the alteration occurs at a non-critical region of the protein. Thus, the invention further includes variations of polypeptides encoded for by ORFs listed in Tables 1 through 6 which show substantial pathogenic activity or which include regions of particular E. coli PAI proteins such as the protein portions discussed below. Such mutants include deletions, insertions, inversions, repeats, and type substitutions (for example, substituting one hydrophilic residue for another, but not strongly hydrophilic for strongly hydrophobic as a rule). Small changes or such "neutral" amino acid substitutions will generally have little effect on activity. Typically seen as conservative substitutions are the replacements, one for another, among the aliphatic amino acids Ala, Val, Leu and He; interchange of the hydroxyl residues Ser and Thr, exchange of the acidic residues Asp and Glu, substitution between the amide residues Asn and Gin, exchange of the basic residues Lys and Arg and replacements among the aromatic residues Phe, Tyr. As indicated in detail above, further guidance concerning which amino acid changes are likely to be phenotypically silent (i.e., are not likely to have a significant deleterious effect on a function) can be found in Bowie, J.U., et al, "Deciphering the Message in Protein Sequences: Tolerance to Amino Acid Substitutions," Science 247. 1306-1310 (1990). Thus, the fragment, derivative or analog of a polypeptide encoded by an ORF described in one of Tables 1 through 6, may be (i) one in which one or more of the amino acid residues are substituted with a conserved or non-conserved amino acid residue (preferably a conserved amino acid residue) and such substituted amino acid residue may or may not be one encoded by the genetic code, or (ii) one in which one or more of the amino acid residues includes a substituent group, or (iii) one in which the mature polypeptide is fused with another compound, such as a compound to increase the half-life of the polypeptide (for example, polyethylene glycol), or (iv) one in which the additional amino acids are fused to the mature polypeptide, such as an IgG Fc fusion region peptide or leader or secretory sequence or a sequence which is employed for purification of the mature polypeptide or a proprotein sequence. Such fragments, derivatives and analogs are deemed to be within the scope of those skilled in the art from the teachings herein. Of particular interest are substitutions of charged amino acids with another charged amino acid and with neutral or negatively charged amino acids. The latter results in proteins with reduced positive charge to improve the characteristics of said proteins. The prevention of aggregation is highly desirable. Aggregation of proteins not only results in a loss of activity but can also be problematic when preparing pharmaceutical formulations, because they can be imrnunogenic. (Pinckard et al, Clin Exp. Immunol. 2:331-340 (1967); Robbins et al, Diabetes 56:838-845 (1987); Cleland et al. Crit. Rev. Therapeutic Drug Carrier Systems 10:301-311 (1993)). The replacement of amino acids can also change the selectivity of binding to cell surface receptors. Ostade et al, Nature 361 :266-268 (1993) describes certain mutations resulting in selective binding of TNF-α to only one of the two known types of TNF receptors. Thus, proteins encoded for by the ORFs listed in Tables 1, 2, 3, 4, 5, or 6, and that bind to a cell surface receptor, may include one or more amino acid substitutions, deletions or additions, either from natural mutations or human manipulation. As indicated, changes are preferably of a minor nature, such as conservative amino acid substitutions that do not significantly affect the folding or activity of the protein (see Table 7). TABLE 7. Conservative Amino A cid Substitutions Amino acids in the proteins encoded by ORFs of the present invention that are essential for function can be identified by methods known in the art, such as site-directed mutagenesis or alanine-scanning mutagenesis (Cunningham and Wells, Science 244:1081-1085 (1989)). The latter procedure introduces single alanine mutations at every residue in the molecule. The resulting mutant molecules are then tested for biological activity such as receptor binding or in vitro, or in vitro proliferative activity. Sites that are critical for ligand-receptor binding can also be determined by structural analysis such as crystallization, nuclear magnetic resonance or photoaffinity labeling (Smith et al, J. Mol. Biol. 224:899-904 (1992) and de Vos et al. Science 255:306-312 (1992)). The polypeptides of the present invention are preferably provided in an isolated form, and preferably are substantially purified. A recombinantly produced version of the polypeptides can be substantially purified by the one-step method described in Smith and Johnson, Gene 57:31-40 (1988). The polypeptides of the present invention include the polypeptide encoded by the ORFs listed in Tables 1-6, preferably Tables 1-4, as well as polypeptides which have at least 90% similarity, more preferably at least 95%) similarity, and still more preferably at least 96%, 91%, 98% or 99%) similarity to those described above, and also include portions of such polypeptides with at least 30 amino acids and more preferably at least 50 amino acids. By "% similarity" for two polypeptides is intended a similarity score produced by comparing the amino acid sequences of the two polypeptides using the Bestfit program (Wisconsin Sequence Analysis Package, Version 8 for Unix, Genetics Computer Group, University Research Park, 575 Science Drive, Madison, WI 5371 1) and the default settings for determining similarity. Bestfit uses the local homology algorithm of Smith and Waterman (Advances in Applied Mathematics 2:482-489, 1981 ) to find the best segment of similarity between two sequences. By a polypeptide having an amino acid sequence at least, for example, 95% "identical" to a reference amino acid sequence of a polypeptide is intended that the amino acid sequence of the polypeptide is identical to the reference sequence except that the polypeptide sequence may include up to five amino acid alterations per each 100 amino acids of the reference amino acid of said polypeptide. In other words, to obtain a polypeptide having an amino acid sequence at least 95% identical to a reference amino acid sequence, up to 5% of the amino acid residues in the reference sequence may be deleted or substituted with another amino acid, or a number of amino acids up to 5% of the total amino acid residues in the reference sequence may be inserted into the reference sequence. These alterations of the reference sequence may occur at the amino or carboxy terminal positions of the reference amino acid sequence or anywhere between those terminal positions, interspersed either individually among residues in the reference sequence or in one or more contiguous groups within the reference sequence. As a practical matter, whether any particular polypeptide is at least 90%, 95%, 96%), 97%), 98%> or 99%) identical to, for instance, the amino acid sequence encoded by the ORFs listed in Tables 1, 2, 3, 4, 5, or 6 can be determined conventionally using known computer programs such the Bestfit program (Wisconsin Sequence Analysis Package, Version 8 for Unix, Genetics Computer Group, University Research Park, 575 Science Drive, Madison, WI 5371 1. When using Bestfit or any other sequence alignment program to determine whether a particular sequence is, for instance, 95% identical to a reference sequence according to the present invention, the parameters are set, of course, such that the percentage of identity is calculated over the full length of the reference amino acid sequence and that gaps in homology of up to 5% of the total number of amino acid residues in the reference sequence are allowed. The polypeptide of the present invention could be used as a molecular weight marker on SDS-PAGE gels or on molecular sieve gel filtration columns using methods well known to those of skill in the art. As described in detail below, the polypeptides of the present invention can also be used to raise polyclonal and monoclonal antibodies, which are useful in assays for detecting pathogenic protein expression as described below or as agonists and antagonists capable of enhancing or inhibiting protein function of important proteins encoded by the ORFs of the present invention. Further, such polypeptides can be used in the yeast two-hybrid system to "capture" protein binding proteins which are also candidate agonist and antagonist according to the present invention. The yeast two hybrid system is described in Fields and Song, Nature 340:245-246 (1989). In another aspect, the invention provides a peptide or polypeptide comprising an epitope-bearing portion of a polypeptide of the invention. The epitope of this polypeptide portion is an immunogenic or antigenic epitope of a polypeptide of the invention. An "immunogenic epitope" is defined as a part of a protein that elicits an antibody response when the whole protein is the immunogen. These immunogenic epitopes are believed to be confined to a few loci on the molecule. On the other hand, a region of a protein molecule to which an antibody can bind is defined as an "antigenic epitope." The number of immunogenic epitopes of a protein generally is less than the number of antigenic epitopes. See, for instance, Geysen et al, Proc. Natl. Acad. Sci. USA 81:3998- 4002 (1983). As to the selection of peptides or polypeptides bearing an antigenic epitope (i.e., that contain a region of a protein molecule to which an antibody can bind), it is well known in that art that relatively short synthetic peptides that mimic part of a protein sequence are routinely capable of eliciting an antiserum that reacts with the partially mimicked protein. See, for instance, Sutcliffe, J. G., Shinnick, T. M., Green, N. and Learner, R.A. (1983) Antibodies that react with predetermined sites on proteins. Science 219:660-666. Peptides capable of eliciting protein-reactive sera are frequently represented in the primary sequence of a protein, can be characterized by a set of simple chemical rules, and are confined neither to immunodominant regions of intact proteins (i.e., immunogenic epitopes) nor to the amino or carboxyl terminals. Peptides that are extremely hydrophobic and those of six or fewer residues generally are ineffective at inducing antibodies that bind to the mimicked protein; longer, peptides, especially those containing proline residues, usually are effective. Sutcliffe et al. , supra, at 661. For instance, 18 of 20 peptides designed according to these guidelines, containing 8-39 residues covering 75% of the sequence of the influenza virus hemagglutinin HA1 polypeptide chain, induced antibodies that reacted with the HA1 protein or intact virus; and 12/12 peptides from the MuLV polymerase and 18/18 from the rabies glycoprotein induced antibodies that precipitated the respective proteins. Antigenic epitope-bearing peptides and polypeptides of the invention are therefore useful to raise antibodies, including monoclonal antibodies, that bind specifically to a polypeptide of the invention. Thus, a high proportion of hybridomas obtained by fusion of spleen cells from donors immunized with an antigen epitope-bearing peptide generally secrete antibody reactive with the native protein. Sutcliffe et al, supra, at 663. The antibodies raised by antigenic epitope-bearing peptides or polypeptides are useful to detect the mimicked protein, and antibodies to different peptides may be used for tracking the fate of various regions of a protein precursor which undergoes post-translational processing. The peptides and anti-peptide antibodies may be used in a variety of qualitative or quantitative assays for the mimicked protein, for instance in competition assays since it has been shown that even short peptides (e.g., about 9 amino acids) can bind and displace the larger peptides in immunoprecipitation assays. See, for instance, Wilson et al, Cell 37:161-11% (1984) at 777. The anti- peptide antibodies of the invention also are useful for purification of the mimicked protein, for instance, by adsorption chromatography using methods well known in the art. Antigenic epitope-bearing peptides and polypeptides of the invention designed according to the above guidelines preferably contain a sequence of at least seven, more preferably at least nine and most preferably between about 15 to about 30 amino acids contained within the amino acid sequence of a polypeptide of the invention. However, peptides or polypeptides comprising a larger portion of an amino acid sequence of a polypeptide of the invention, containing about 30 to about 50 amino acids, or any length up to and including the entire amino acid sequence of a polypeptide of the invention, also are considered epitope-bearing peptides or polypeptides of the invention and also are useful for inducing antibodies that react with the mimicked protein. Preferably, the amino acid sequence of the epitope-bearing peptide is selected to provide substantial solubility in aqueous solvents (i.e., the sequence includes relatively hydrophilic residues and highly hydrophobic sequences are preferably avoided); and sequences containing proline residues are particularly preferred. The epitope-bearing peptides and polypeptides of the invention may be produced by any conventional means for making peptides or polypeptides including recombinant means using nucleic acid molecules of the invention. For instance, a short epitope-bearing amino acid sequence may be fused to a larger polypeptide which acts as a carrier during recombinant production and purification, as well as during immunization to produce anti-peptide antibodies. Epitope-bearing peptides also may be synthesized using known methods of chemical synthesis. For instance, Houghten has described a simple method for synthesis of large numbers of peptides, such as 10-20 mg of 248 different 13 residue peptides representing single amino acid variants of a segment of the HA1 polypeptide which were prepared and characterized (by ELISA-type binding studies) in less than four weeks. Houghten, R. A. (1985) General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids. Proc. Natl. Acad. Sci. USA 52:5131-5135. This "Simultaneous Multiple Peptide Synthesis (SMPS)" process is further described in U.S. Patent No. 4,631,211 to Houghten et al. (1986). In this procedure the individual resins for the solid-phase synthesis of various peptides are contained in separate solvent-permeable packets, enabling the optimal use of the many identical repetitive steps involved in solid-phase methods. A completely manual procedure allows 500-1000 or more syntheses to be conducted simultaneously. Houghten et al, supra, at 5134. Epitope-bearing peptides and polypeptides of the invention are used to induce antibodies according to methods well known in the art. See, for instance, Sutcliffe et al, supra; Wilson et al, supra; Chow, M. et al, Proc. Natl Acad. Sci. USA 52:910-914; and Bittle, F. J. et al, J. Gen. Virol. 66:2341-2354 (1985). Generally, animals may be immunized with free peptide; however, anti-peptide antibody titer may be boosted by coupling of the peptide to a macromolecular carrier, such as keyhole limpet hemacyanin (KLH) or tetanus toxoid. For instance, peptides containing cysteine may be coupled to carrier using a linker such as m-maleimidobenzoyl-N-hydroxysuccinimide ester (MBS), while other peptides may be coupled to carrier using a more general linking agent such as glutaraldehyde. Animals such as rabbits, rats and mice are immunized with either free or carrier-coupled peptides, for instance, by intraperitoneal and/or intradermal injection of emulsions containing about 100 μg peptide or carrier protein and Freund's adjuvant. Several booster injections may be needed, for instance, at intervals of about two weeks, to provide a useful titer of anti-peptide antibody which can be detected, for example, by ELISA assay using free peptide adsorbed to a solid surface. The titer of anti-peptide antibodies in serum from an immunized animal may be increased by selection of anti-peptide antibodies, for instance, by adsorption to the peptide on a solid support and elution of the selected antibodies according to methods well known in the art. Immunogenic epitope-bearing peptides of the invention, i.e., those parts of a protein that elicit an antibody response when the whole protein is the immunogen, are identified according to methods known in the art. For instance, Geysen et al. , supra, discloses a procedure for rapid concurrent synthesis on solid supports of hundreds of peptides of sufficient purity to react in an enzyme-linked immunosorbent assay. Interaction of synthesized peptides with antibodies is then easily detected without removing them from the support. In this manner a peptide bearing an immunogenic epitope of a desired protein may be identified routinely by one of ordinary skill in the art. For instance, the immunologically important epitope in the coat protein of foot-and-mouth disease virus was located by Geysen et al. supra with a resolution of seven amino acids by synthesis of an overlapping set of all 208 possible hexapeptides covering the entire 213 amino acid sequence of the protein. Then, a complete replacement set of peptides in which all 20 amino acids were substituted in turn at every position within the epitope were synthesized, and the particular amino acids conferring specificity for the reaction with antibody were determined. Thus, peptide analogs of the epitope-bearing peptides of the invention can be made routinely by this method. U.S. Patent No. 4,708,781 to Geysen (1987) further describes this method of identifying a peptide bearing an immunogenic epitope of a desired protein. Further still, U.S. Patent No. 5,194,392 to Geysen (1990) describes a general method of detecting or determining the sequence of monomers (amino acids or other compounds) which is a topological equivalent of the epitope (i.e., a "mimotope") which is complementary to a particular paratope (antigen binding site) of an antibody of interest. More generally, U.S. Patent No. 4,433,092 to Geysen (1989) describes a method of detecting or determining a sequence of monomers which is a topographical equivalent of a ligand which is complementary to the ligand binding site of a particular receptor of interest. Similarly, U.S. Patent No. 5,480,971 to Houghten, R. A. et al. (1996) on Peralkylated Oligopeptide Mixtures discloses linear C,-C 7 -alkyl peralkylated oligopeptides and sets and libraries of such peptides, as well as methods for using such oligopeptide sets and libraries for determining the sequence of a peralkylated oligopeptide that preferentially binds to an acceptor molecule of interest. Thus, non-peptide analogs of the epitope-bearing peptides of the invention also can be made routinely by these methods. The entire disclosure of each document cited in this section on "Polypeptides and Peptides" is hereby incorporated herein by reference. As one of skill in the art will appreciate, E. coli PAI polypeptides of the present invention and the epitope-bearing fragments thereof described above can be combined with parts of the constant domain of immunoglobulins (IgG), resulting in chimeric polypeptides. These fusion proteins facilitate purification and show an increased half-life in vivo. This has been shown, e.g., for chimeric proteins consisting of the first two domains of the human CD4-polypeptide and various domains of the constant regions of the heavy or light chains of mammalian immunoglobulins (ΕP A 394,827; Traunecker et al, Nature 33J:84- 86 (1988)). Fusion proteins that have a disulfide-linked dimeric structure due to the IgG part can also be more efficient in binding and neutralizing other molecules than the monomeric E. coli J96 PAI proteins or protein fragments alone (Fountoulakis et al, J. Biochem 270:3958-3964 (1995)). Vaccines In another embodiment, the present invention relates to a vaccine, preferably in unit dosage form, comprising one or more E. coli J96 PAI antigens together with a pharmaceutically acceptable diluent, carrier, or excipient, wherein the one or more antigens are present in an amount effective to elicit a protective immune response in an animal to pathogenic E. coli. Antigens of E coli J96 PAI IV and V may be obtained from polypeptides encoded for by the ORFs listed in Tables 1 -6, particularly Tables 1-4, using methods well known in the art. In a preferred embodiment, the antigens are E. coli J96 PAI IV or PAI V proteins that are present on the surface of pathogenic E coli. In another preferred embodiment, the pathogenic E. coli J96 PAI IV or PAI V protein-antigen is conjugated to an E. coli capsular polysaccharide (CP), particularly to capsular polypeptides that are more prevalent in pathogenic strains, to produce a double vaccine. CPs, in general, may be prepared or synthesized as described in Schneerson et al. J. Exp. Med. 752:361-376 (1980); Marburg et al. J. Am. Chem. Soc. 108:5282 (1986); Jennings et al, J. Immunol. 727:101 1-1018 (1981); and Beuvery et al, Infect. Immunol. 40:39-45 (1983). In a further preferred embodiment, the present invention relates to a method of preparing a polysaccharide conjugate comprising: obtaining the above-described E. coli J96 PAI antigen; obtaining a CP or fragment from pathogenic E coli; and conjugating the antigen to the CP or CP fragment. In a preferred embodiment, the animal to be protected is selected from the group consisting of humans, horses, deer, cattle, pigs, sheep, dogs, and chickens. In a more preferred embodiment, the animal is a human or a dog. In a further embodiment, the present invention relates to a prophylactic method whereby the incidence of pathogenic E. co/z ' -induced symptoms are decreased in an animal, comprising administering to the animal the above- described vaccine, wherein the vaccine is administered in an amount effective to elicit protective antibodies in an animal to pathogenic E. coli. This vaccination method is contemplated to be useful in protecting against severe diarrhea (pathogenic intestinal E. coli strains), urinary tract infections (uropathogenic E. coli) and infections of the brain (extraintestinal E. coli). The vaccine of the invention is used in an effective amount depending on the route of administration. Although intra-nasal, subcutaneous or intramuscular routes of administration are preferred, the vaccine of the present invention can also be administered by an oral, intraperitoneal or intravenous route. One skilled in the art will appreciate that the amounts to be administered for any particular treatment protocol can be readily determined without undue experimentation. Suitable amounts are within the range of 2 micrograms of the protein per kg body weight to 100 micrograms per kg body weight. The vaccine can be delivered through a vector such as BCG. The vaccine can also be delivered as naked DNA coding for target antigens. The vaccine of the present invention may be employed in such dosage forms as capsules, liquid solutions, suspensions or elixirs for oral administration, or sterile liquid forms such as solutions or suspensions. Any inert carrier is preferably used, such as saline, phosphate-buffered saline, or any such carrier in which the vaccine has suitable solubility properties. The vaccines may be in the form of single dose preparations or in multi-dose flasks which can be used for mass vaccination programs. Reference is made to Remington's Pharmaceutical Sciences, Mack Publishing Co., Εaston, PA, Osol (ed.) (1980); and New Trends and Developments in Vaccines, Voller et al. (eds.), University Park Press, Baltimore, MD (1978), for methods of preparing and using vaccines. The vaccines of the present invention may further comprise adjuvants which enhance production of antibodies and immune cells. Such adjuvants include, but are not limited to, various oil formulations such as Freund's complete adjuvant (CFA), the dipeptide known as MDP, saponins (ex. Quillajasaponin fraction QA-21, U.S. Patent No. 5,047,540), aluminum hydroxide, or lymphatic cytokines. Freund's adjuvant is an emulsion of mineral oil and water which is mixed with the immunogenic substance. Although Freund's adjuvant is powerful, it is usually not administered to humans. Instead, the adjuvant alum (aluminum hydroxide) may be used for administration to a human. Vaccine may be absorbed onto the aluminum hydroxide from which it is slowly released after injection. The vaccine may also be encapsulated within liposomes according to Fullerton, U.S. Patent No. 4,235,877. Protein Function Each ORF described in Tables 1 and 3 possesses a biological role similar to the role associated with the identified homologous protein. This allows the skilled artisan to determine a function for each identified coding sequence. For example, a partial list of the E. coli protein functions provided in Tables 1 and 3 includes many of the functions associated with virulence of pathogenic bacterial strains. These include, but are not limited to adhesins, excretion pathway proteins, O-antigen/carbohydrate modification, cytotoxins and regulators. A more detailed description of several of these functions is provided in Example 1 below. Diagnostic Assays In another preferred embodiment, the present invention relates to a method of detecting pathogenic E. coli nucleic acid in a sample comprising: a) contacting the sample with the above-described nucleic acid probe, under conditions such that hybridization occurs, and b) detecting the presence of the probe bound to pathogenic E. coli nucleic acid. In another preferred embodiment, the present invention relates to a diagnostic kit for detecting the presence of pathogenic E. coli nucleic acid in a sample comprising at least one container means having disposed therein the above-described nucleic acid probe. In another preferred embodiment, the present invention relates to a diagnostic kit for detecting the presence of pathogenic E. coli antigens in a sample comprising at least one container means having disposed therein the above- described antibodies. In another preferred embodiment, the present invention relates to a diagnostic kit for detecting the presence of antibodies to pathogenic E. coli antigens in a sample comprising at least one container means having disposed therein the above-described antigens. The present invention provides methods to identify the expression of an ORF of the present invention, or homolog thereof, in a test sample, using one of the antibodies of the present invention. Such methods involve incubating a test sample with one or more of the antibodies of the present invention and assaying for binding of the antibodies to components within the test sample. In a further embodiment, the present invention relates to a method for identifying pathogenic E. coli in an animal comprising analyzing tissue or body fluid from the animal for a nucleic acid, protein, polypeptide-antigen or antibody specific to one of the ORFs described in Tables 1-4 herein from E. coli J96 PAI IV or V. Analysis of nucleic acid specific to pathogenic E. coli can be by PCR techniques or hybridization techniques (cf. Molecular Cloning: A Laboratory Manual, second edition, edited by Sambrook, Fritsch, & Maniatis, Cold Spring Harbor Laboratory, 1989; Εremeeva et al, J. Clin. Microbiol. 32:803-810 (1994) which describes differentiation among spotted fever group Rickettsiae species by analysis of restriction fragment length polymorphism of PCR-amplified DNA). Proteins or antibodies specific to pathogenic E. coli may be identified as described in Molecular Cloning: A Laboratory Manual, second edition, Sambrook et al, eds., Cold Spring Harbor Laboratory (1989). More specifically, antibodies may be raised to E. coli J96 PAI proteins as generally described in Antibodies: A Laboratory Manual, Harlow and Lane, eds.. Cold Spring Harbor Laboratory (1988). E. coli J96 PAI-specific antibodies can also be obtained from infected animals (Mather, T. et al. AMA 205:186-188 (1994)). In another embodiment, the present invention relates to an antibody having binding affinity specifically to an E coli J96 PAI antigen as described above. The E coli J96 PAI antigens of the present invention can be used to produce antibodies or hybridomas. One skilled in the art will recognize that if an antibody is desired, a peptide can be generated as described herein and used as an immunogen. The antibodies of the present invention include monoclonal and polyclonal antibodies, as well as fragments of these antibodies. The invention further includes single chain antibodies. Antibody fragments which contain the idiotype of the molecule can be generated by known techniques, for example, such fragments include but are not limited to: the F(ab') 2 fragment; the Fab' fragments, Fab fragments, and Fv fragments. Of special interest to the present invention are antibodies to pathogenic E. coli antigens which are produced in humans, or are "humanized" (i.e. non- immunogenic in a human) by recombinant or other technology. Humanized antibodies may be produced, for example by replacing an immunogenic portion of an antibody with a corresponding, but non-immunogenic portion (i.e. chimeric antibodies) (Robinson, R.R. et al, International Patent Publication PCT/US86/02269; Akira, K. et al, European Patent Application 184,187; Taniguchi, M., European Patent Application 171 ,496; Morrison, S.L. et al, European Patent Application 173,494; Neuberger, M.S. et al., PCT Application WO 86/01533; Cabilly, S. et al, European Patent Application 125,023; Better, M. et al, Science 240:1041-1043 (1988); Liu, A.Y. et al, Proc. Nat Acad. Sci. USA 54:3439-3443 (1987); Liu, A.Y. et l, J. Immunol. 139:3521-3526 (1987); Sun, L.K. et al, Proc. Natl. Acad. Sci. USA 54:214-218 (1987); Nishimura, Y. et al, Cane. Res. 47:999-1005 (1987); Wood, C.R. et al, Nature 314:446-449 (1985)); Shaw et al, J. Natl. Cancer Inst. 50:1553-1559 (1988). General reviews of "humanized" chimeric antibodies are provided by Morrison, S.L. (Science, 229: 1202-1207 (1985)) and by Oi, V.T. et al, BioTechniqucs 4:214 (1986)). Suitable "humanized" antibodies can be alternatively produced by CDR or CEA substitution (Jones, P.T. et al, Nature 321:552-525 (1986); Verhoeyan et al, Science 2 9:1534 (1988); Beidler, C.B. et al, J. Immunol. 747:4053-4060 (1988)). In another embodiment, the present invention relates to a hybridoma which produces the above-described monoclonal antibody. A hybridoma is an immortalized cell line which is capable of secreting a specific monoclonal antibody. In general, techniques for preparing monoclonal antibodies and hybridomas are well known in the art (Campbell, "Monoclonal Antibody Technology: Laboratory Techniques in Biochemistry and Molecular Biology," Elsevier Science Publishers, Amsterdam, The Netherlands (1984); St. Groth et al, J. Immunol. Methods 35:1-21 (1980)). In another embodiment, the present invention relates to a method of detecting a pathogenic E. coli antigen in a sample, comprising: a) contacting the sample with an above-described antibody, under conditions such that immunocomplexes form, and b) detecting the presence of said antibody bound to the antigen. In detail, the methods comprise incubating a test sample with one or more of the antibodies of the present invention and assaying whether the antibody binds to the test sample. Conditions for incubating an antibody with a test sample vary. Incubation conditions depend on the format employed in the assay, the detection methods employed, and the type and nature of the antibody used in the assay. One skilled in the art will recognize that any one of the commonly available immunological assay formats (such as radioimmunoassays, enzyme-linked immunosorbent assays, diffusion based Ouchterlony, or rocket immunofluorescent assays) can readily be adapted to employ the antibodies of the present invention. Examples of such assays can be found in Chard, An Introduction to Radioimmunoassay and Related Techniques, Elsevier Science Publishers, Amsterdam, The Netherlands (1986); Bullock et al, Techniques in Immunocytochemistry, Academic Press, Orlando, FL Vol. 1 (1982), Vol. 2 (1983), Vol. 3 (1985); Tijssen, Practice and Theory of Enzyme Immunoassays: Laboratory Techniques in Biochemistry and Molecular Biology, Elsevier Science Publishers, Amsterdam, The Netherlands (1985); and Antibodies: A Laboratory Manual Harlow and Lane, eds., Cold Spring Harbor Laboratory (1988). The immunological assay test samples of the present invention include cells, protein or membrane extracts of cells, or biological fluids such as blood, serum, plasma, or urine. The test sample used in the above-described method will vary based on the assay format, nature of the detection method and the tissues, cells or extracts used as the sample to be assayed. Methods for preparing protein extracts or membrane extracts of cells are well known in the art and can be readily be adapted in order to obtain a sample which is capable with the system utilized. In another embodiment, the present invention relates to a method of detecting the presence of antibodies to pathogenic E coli in a sample, comprising: a) contacting the sample with an above-described antigen, under conditions such that immunocomplexes form, and b) detecting the presence of said antigen bound to the antibody. In detail, the methods comprise incubating a test sample with one or more of the antigens of the present invention and assaying whether the antigen binds to the test sample. In another embodiment of the present invention, a kit is provided which contains all the necessary reagents to carry out the previously described methods of detection. The kit may comprise: i) a first container means containing an above-described antibody, and ii) second container means containing a conjugate comprising a binding partner of the antibody and a label. In another preferred embodiment, the kit further comprises one or more other containers comprising one or more of the following: wash reagents and reagents capable of detecting the presence of bound antibodies. Examples of detection reagents include, but are not limited to, labeled secondary antibodies, or in the alternative, if the primary antibody is labeled, the chromophoric. enzymatic, or antibody binding reagents which are capable of reacting with the labeled antibody. The compartmentalized kit may be as described above for nucleic acid probe kits. One skilled in the art will readily recognize that the antibodies described in the present invention can readily be incorporated into one of the established kit formats which are well known in the art. Screening Assay for Binding Agents Using the isolated proteins described herein, the present invention further provides methods of obtaining and identifying agents that bind to a protein encoded by an E coli J96 PAI ORF or to a fragment thereof. The method involves: (a) contacting an agent with an isolated protein encoded by a E. coli J96 PAI ORF, or an isolated fragment thereof; and (b) determining whether the agent binds to said protein or said fragment. The agents screened in the above assay can be, but are not limited to, peptides, carbohydrates, vitamin derivatives, or other pharmaceutical agents. The agents can be selected and screened at random or rationally selected or designed using protein modeling techniques. For random screening, agents such as peptides, carbohydrates, pharmaceutical agents and the like are selected at random and are assayed for their ability to bind to the protein encoded by an ORF of the present invention. Alternatively, agents may be rationally selected or designed. As used herein, an agent is said to be "rationally selected or designed" when the agent is chosen based on the configuration of the particular protein. For example, one skilled in the art can readily adapt currently available procedures to generate peptides, pharmaceutical agents and the like capable of binding to a specific peptide sequence in order to generate rationally designed antipeptide ligands, for example see Hurby et al, Application of Synthetic Peptides: Antisense Peptides, In Synthetic Peptides, A User's Guide, W.H. Freeman, NY (1992), pp. 289-307, and Kaspczak et al, Biochemistry 25:9230-8 (1989). In addition to the foregoing, one class of agents of the present invention, can be used to control gene expression through binding to one of the ORF encoding regions or EMFs of the present invention. As described above, such agents can be randomly screened or rationally designed and selected. Targeting the encoding region or EMF allows a skilled artisan to design sequence specific or element specific agents, modulating the expression of either a single ORF encoding region or multiple encoding regions that rely on the same EMF for expression control. One class of DNA binding agents are those that contain nucleotide base residues that hybridize or form a triple helix by binding to DNA or RNA. Such agents can be based on the classic phosphodiester, ribonucleic acid backbone, or can be a variety of sulfhydryl or polymeric derivatives having base attachment capacity. Agents suitable for use in these methods usually contain 20 to 40 bases and are designed to be complementary to a region of the gene involved in transcription (triple helix - see Lee et al, Nucl. Acids Res. 6:3013 (1979); Cooney et al, Science 247:456 (1988); and Dervan et al, Science 251: 1360 (1991)) or to the mRNA itself (antisense - Okano, J. Neurochem. 56:560 (1991); Oligodeoxynucleotides as Antisense Inhibitors of Gene Expression, CRC Press, Boca Raton, FL (1988)). Triple helix-formation optimally results in a shut-off of RNA transcription from DNA, while antisense RNA hybridization blocks translation of an mRNA molecule into polypeptide. Both techniques have been demonstrated to be effective in model systems. Information contained in the sequences of the present invention is necessary for the design of an antisense or triple helix oligonucleotide and other DNA binding agents. Computer Related Embodiments The nucleotide sequence provided in SEQ ID NOs: 1 through 142, representative fragments thereof, or nucleotide sequences at least 99.9% identical to the sequences provided in SEQ ID NOs: 1 through 142, can be "provided" in a variety of media to facilitate use thereof. As used herein, "provided" refers to a manufacture, other than an isolated nucleic acid molecule, that contains a nucleotide sequence of the present invention, i.e., the nucleotide sequence provided in SEQ ID NOs: 1 through 142, a representative fragment thereof, or a nucleotide sequence at least 99.9% identical to SEQ ID NOs: 1 through 142. Such a manufacture provides the E. coli J96 PAI subgenomes or a subset thereof (e.g., one or more E. coli J96 PAI open reading frame (ORF)) in a form that allows a skilled artisan to examine the manufacture using means not directly applicable to examining the E. coli J96 PAI subgenome or a subset thereof as it exists in nature or in purified form. In one application of this embodiment, one or more nucleotide sequences of the present invention can be recorded on computer readable media. As used herein, "computer readable media" refers to any medium that can be read and accessed directly by a computer. Such media include, but are not limited to: magnetic storage media, such as floppy discs, hard disc storage medium, and magnetic tape; optical storage media such as CD-ROM; electrical storage media such as RAM and ROM; and hybrids of these categories such as magnetic/optical storage media. A skilled artisan can readily appreciate how any of the presently known computer readable mediums can be used to create a manufacture comprising computer readable medium having recorded thereon a nucleotide sequence of the present invention. As used herein, "recorded" refers to a process for storing information on computer readable medium. A skilled artisan can readily adopt any of the presently know methods for recording information on computer readable medium to generate manufactures comprising the nucleotide sequence information of the present invention. A variety of data storage structures are available to a skilled artisan for creating a computer readable medium having recorded thereon a nucleotide sequence of the present invention. The choice of the data storage structure will generally be based on the means chosen to access the stored information. In addition, a variety of data processor programs and formats can be used to store the nucleotide sequence information of the present invention on computer readable medium. The sequence information can be represented in a word processing text file, formatted in commercially-available software such as WordPerfect and MicroSoft Word, or represented in the form of an ASCII file, stored in a database application, such as DB2, Sybase, Oracle, or the like. A skilled artisan can readily adapt any number of dataprocessor structuring formats (e.g. text file or database) in order to obtain computer readable medium having recorded thereon the nucleotide sequence information of the present invention. By providing the nucleotide sequence of SEQ ID NOs: 1 through 142, representative fragments thereof, or nucleotide sequences at least 99.9% identical to SEQ ID NOs: 1 through 142, in computer readable form, a skilled artisan can routinely access the sequence information for a variety of purposes. Computer software is publicly available which allows a skilled artisan to access sequence information provided in a computer readable medium. The examples which follow demonstrate how software which implements the BLAST (Altschul et al. , J. Mol Biol. 275:403-410 (1990)) and BLAZE (Brutlag et al, Comp. Chem. 77:203-207 (1993)) search algorithms on a Sybase system can be used to identify open reading frames (ORFs) within the E. coli J96 PAI subgenome that contain homology to ORFs or proteins from other organisms. Such ORFs are protein- encoding fragments within the E. coli J96 PAI subgenome and are useful in producing commercially important proteins such as enzymes used in modifying surface O-antigens of bacteria. A comprehensive list of ORFs encoding commercially important E. coli J96 PAI proteins is provided in Tables 1 through 6. The present invention provides a DNA sequence - gene database of pathogenicity islands (PAIs) for E. coli involved in infectious diseases. This database is useful for identifying and characterizing the basic functions of new virulence genes for E. coli involved in uropathogenic and extraintestinal diseases. The database provides a number of novel open reading frames that can be selected for further study as described herein. Selectable insertion mutations in plasmid subclones encoding PAI genes with potentially significant phenotypes for E. coli uropathogenesis and sepsis can be isolated. The mutations are then crossed back into wild type, uropathogenic E. coli by homologous recombination to create wild-type strains specifically altered in the targeted gene. The significance of the genes to E. coli pathogenesis is assessed by in vitro assays and in vivo murine models of sepsis/peritonitis and ascending urinary tract infection. New virulence genes and PAI sites in uropathogenic E. coli may be identified by the transposon signature-tagged mutagenesis system and negative selection of E. coli mutants avirulent in murine models of ascending urinary tract infection or peritonitis. . Εpidemiological investigations of new virulence genes and PAIs may be used to test for their occurrence in the genomes of other pathogenic and opportunistic members of the Εnterobacteriaceae. One can choose from the ORFs included in SΕQ ID NOs: 1 through 142, using Tables 1 through 6 as a useful guidepost for selecting, as candidates for targeted mutagenesis, a limited number of candidate genes within the PAIs based on their homology to virulence, export or regulation genes in other pathogens. For the large number of apparent genes within the PAIs that do not share sequence similarity to any entries in the database, the transposon signature-tagged mutagenesis method developed by David Holden's laboratory can be employed as an independent means of virulence gene identification. Allelic knock-outs are constructed using different /?z -dependent suicide vectors (Swihart, K.A. and R.A. Welch, Infect. Immun. 55:1853-1869 (1990)). In addition, two different animal model systems can be employed for assessment of pathogenic determinants. The initial identification of E coli hemolysin as a virulence factor came from the construction of isogenic E. coli strains that were tested in a rat model of intra-abdominal sepsis (Welch, R.A. et al, Nature (London) 294:665-667 (1981)). The ascending UTI (Urinary Tract Infection) mouse model was also successfully performed with allelic knock-outs of the hpmA hemolysin of Proteus mirabilis (Swihart, K.A. and R.A. Welch, Infect. Immun. 55:1853-1869 (1990)). The present invention further provides systems, particularly computer- based systems, which contain the sequence information described herein. Such systems are designed to identify commercially important fragments of the E. coli J96 PAI subgenome. As used herein, "a computer-based system" refers to the hardware means, software means, and data storage means used to analyze the nucleotide sequence information of the present invention. The minimum hardware means of the computer-based systems of the present invention comprises a central processing unit (CPU), input means, output means, and data storage means. A skilled artisan can readily appreciate that any one of the currently available computer-based systems are suitable for use in the present invention. As indicated above, the computer-based systems of the present invention comprise a data storage means having stored therein a nucleotide sequence of the present invention and the necessary hardware means and software means for supporting and implementing a search means. As used herein, "data storage means" refers to memory that can store nucleotide sequence information of the present invention, or a memory access means which can access manufactures having recorded thereon the nucleotide sequence information of the present invention. As used herein, "search means" refers to one or more programs which are implemented on the computer-based system to compare a target sequence or target structural motif with the sequence information stored within the data storage means. Search means are used to identify fragments or regions of the E. coli genome that match a particular target sequence or target motif. A variety of known algorithms are disclosed publicly and a variety of commercially available software for conducting search means are available and can be used in the computer-based systems of the present invention. Examples of such software include, but are not limited to, MacPattern (EMBL), BLASTN and BLASTX (NCBIA). A skilled artisan can readily recognize that any one of the available algorithms or implementing software packages for conducting homology searches can be adapted for use in the present computer-based systems. As used herein, a "target sequence" can be any DNA or amino acid sequence of six or more nucleotides or two or more amino acids. A skilled artisan can readily recognize that the longer a target sequence is, the less likely a target sequence will be present as a random occurrence in the database. The most preferred sequence length of a target sequence is from about 10 to 100 amino acids or from about 30 to 300 nucleotide residues. However, it is well recognized that during searches for commercially important fragments of the E. coli J96 PAI subgenome, such as sequence fragments involved in gene expression and protein processing, may be of shorter length. As used herein, "a target structural motif," or "target motif," refers to any rationally selected sequence or combination of sequences in which the sequence(s) are chosen based on a three-dimensional configuration which is formed upon the folding of the target motif. There are a variety of target motifs known in the art. Protein target motifs include, but are not limited to, enzymic active sites and signal sequences. Nucleic acid target motifs include, but are not limited to, promoter sequences, hairpin structures and inducible expression elements (protein binding sequences). Thus, the present invention further provides an input means for receiving a target sequence, a data storage means for storing the target sequence and the homologous E coli J96 PAI sequence identified using a search means as described above, and an output means for outputting the identified homologous E. coli J96 PAI sequence. A variety of structural formats for the input and output means can be used to input and output information in the computer-based systems of the present invention. A preferred format for an output means ranks fragments of the E. coli J96 PAI subgenome possessing varying degrees of homology to the target sequence or target motif. Such presentation provides a skilled artisan with a ranking of sequences which contain various amounts of the target sequence or target motif and identifies the degree of homology contained in the identified fragment. A variety of comparing means can be used to compare a target sequence or target motif with the data storage means to identify sequence fragments of the E. coli J96 PAI subgenomes. For example, implementing software which implement the BLAST and BLAZE algorithms (Altschul et al, J. Mol. Biol. 275:403-410 (1990)) can be used to identify open reading frames within the E. coli J96 PAI subgenome A skilled artisan can readily recognize that any one of the publicly available homology search programs can be used as the search means for the computer-based systems of the present invention. One application of this embodiment is provided in Figure 2. Figure 2 provides a block diagram of a computer system 102 that can be used to implement the present invention. The computer system 102 includes a processor 106 connected to a bus 104. Also connected to the bus 104 are a main memory 108 (preferably implemented as random access memory, RAM) and a variety of secondary storage devices 110, such as a hard drive 112 and a removable medium storage device 114. The removable medium storage device 114 may represent, for example, a floppy disk drive, a CD-ROM drive, a magnetic tape drive, etc. A removable storage medium 1 16 (such as a floppy disk, a compact disk, a magnetic tape, etc.) containing control logic and/or data recorded therein may be inserted into the removable medium storage device 1 14. The computer system 102 includes appropriate software for reading the control logic and/or the data from the removable medium storage device 1 14 once inserted in the removable medium storage device 114. A nucleotide sequence of the present invention may be stored in a well known manner in the main memory 108, any of the secondary storage devices 1 10, and/or a removable storage medium 1 16. Software for accessing and processing the genomic sequence (such as search tools, comparing tools, etc.) reside in main memory 108 during execution. Having generally described the invention, the same will be more readily understood by reference to the following examples, which are provided by way of illustration and are not intended as limiting. Experimental Example 1: High Through-put Sequencing of Cosmid Clones Covering PAI IV and PAI V in E. coli J96 The complete DNA sequence of the pathogenicity islands, PAI IV and PAI V (respectively > 170 kb and -1 10 kb), from uropathogenic E. coli strain, J96 (04:K6) was determined using a strategy, cloning and sequencing method, data collection and assembly software essentially identical to those used by the TIGR group for determining the sequence of the Haemophilus influenzae genome (Fleischmann, R.D., et al, Science 269:496 (1995)). The sequences were then used for DNA and protein sequence similarity searches of the databases as described in Fleischmann, Id. The analysis of the genetic information found within the PAIs of E. coli J96 was facilitated by the use of overlapping cosmid clones possessing these unique segments of DNA. These cosmid clones were previously constructed and mapped (as further described below) as an overlapping set in the laboratory of Dr. Doug Berg (Washington University). A gap exists between the left portion of cosmid 2 and the end of the PAI IV that would represent hepheY junction to the E. coli K-12 genome. Uropathogenic strain E. coli J96 (O4:K6) was used as a source of chromosomal DNA for construction of a cosmid library. E. coli K-12 DH5α and DH12 (Gibco/BRL, Gaithersburg, Md.) were used as hosts for maintaining cosmid and plasmid clones. The cosmid library of E coli J96 DNA was constructed essentially as described by Bukanow & Berg (Mol. Microbiol 77:509- 523 (1994)). DNA was digested with Sau3A\ under conditions that generated fragments with an average size of 40 to 50 kb and electrophoresed through 1 % agarose gels. Fragments of 35 to 50 kb were isolated and cloned into Lorist 6 vector that had been linearized with BamXXX and treated with bacterial alkaline phosphatase to block self-ligation. (Lorist 6 is a 5.2-kb moderate-copy-number cosmid vector with T7 and SP6 promoters close to the cloning site.) Cloned DNA was packaged in lambda phage particles in vitro by using a commercial kit (Amersham, Arlington Heights, IL) and cosmid-containing phage particles were used to transduce E. coli DH5α. Transductant colonies were transferred to 150 μL of Luria-Bertani broth supplemented with kanamycin in 96-well microtiter plates and grown overnight at 37°C with shaking. Two sets of clones, one for each PAI were ultimately assembled, as previously described (Swenson et al., Infection and Immunity 64:3136-3143 (1996)), fully incorporated by reference herein). The two sets of clones contain eleven sub-clones that were employed in the sequencing method described below. One set of four overlapping cosmid clones covers the /^-containing PAI V, ATCC Deposit No. 97727, deposited September 23, 1996. A second set of seven subclones covers much of thepap- containing PAI V, ATCC Deposit No. 97726, deposited September 23, 1996. See Figure 1. A high through-put, random sequencing method (Fleischmann et al, Science 269:496 (1995); Fraser et al, Science 270:391 (1995)) was used to obtain the sequences for 142 (contigs) fragments of E. coli J96 PAIs. All clones were sequenced from both ends to aid in the eventual ordering of contigs during the sequence assembly process. Briefly, random libraries of ~ 2 kb clones covering the two J96 PAIs were constructed, ~ 2,800 clones were subjected to automated sequencing (~ 450 nt/clone) and preliminary assemblies of the sequences accomplished which result in 142 contigs for each of the two PAIs that total 95 and 135 kb respectively. The estimated sizes of the PAI IV and PAI V based on the overlapping cosmid clones are 1.7 X 10 5 and 1.1 X 10 5 bp respectively. The 142 sequences were assembled by means of the TIGR Assembler (Fleischmann et al ; Fraser et al); Sutton et al, Genome Sci. Tech. 7:9 (1995)). Sequence and physical gaps were closed using a combination of strategies (Fleischmann et al. ; Fraser et al). Presently the average depth of sequencing for each base assembled in the contigs is 6-fold. The tentative identity of many genes based on sequence homology is covered in Tables 1, 3, 5 and 6. Open reading frames (ORFs) and predicted protein-coding regions were identified as described (Fleischmann et al; Fraser et al.) with some modification. In particular, the statistical prediction of uropathogenic E. coli J96 pathogenicity island genes was performed with GeneMark (Borodovsky, M. & Mclninch, J. Comput. Chem. 77:123 (1993)). Regular GeneMark uses nonhomogeneous Markov models derived from a training set of coding sequences and ordinary Markov models derived from a training set of noncoding sequences. The ORFs in Tables 1 -6 were identified by GeneMark using a second-order Markov model trained from known E. coli coding regions and known E. coli non-coding regions. Among the important genes that are implicated in the virulence of E. coli J96 PAIs are adhesins, excretion pathway proteins, proteins that participate in alterations of the O-antigen in the PAIs, cytotoxins, and two-component (membrane sensor/DNA binding) proteins. I. Adhesins. It is believed that the principal adhesin determinants involved in uropathogenicity that are present within PAIs of uropathogenic E. coli are the pili encoded by the/?ap-related operons (Hultgren et al, Infect. Immun. 50:310-311 (1993), Stromberg et al, EMBO J 9:2001-2010 (1990), High et al, Infect. Immun. 56:5X3-5X1 (1988)) and the distantly related afimbrial adhesins (Labigne-Roussel et al, Infect. Immun. 46:25X-259 (1988)). The presence of two of these (pap, nd prs) has been confirmed. In addition potential genes for five other adhesins including slα (described above), AIDA-I (diffuse adherence- DΕAC), hrα (heat resistant hemagglutinin-ΕTΕC), fhα (filamentous hemagglutinin- Bordetella pertussis) and the arg-gingipain proteinase of Porphyromonas gingivalis have been found. II. Type II exoprotein secretion pathway. Highly significant statistics support the presence of multiple genes involved in the type II exoprotein pathway. Curiously, perhaps two different determinants appear to be present in PAI IV where one set of genes has the highest sequence similarity to eps-Xi e genes (Vibrio cholerae Ctx export) and the other has greatest similarity to exe genes (Aeromonas hydophilia aerolysin and protease export). At present, the assembly of contigs involving these potential genes is incomplete. Thus, it is uncertain if two separate and complete determinants are present. However, it is clear that these genes are newly discovered and novel to pathogenic E. coli because the derived sequences do not have either the bfp or hop genes as the highest matches. The gene products that are the target of the type II export pathway are not evident at this time. Within PAI IV there are sequences which suggest genes very similar to secD and secF. These two linked genes encode homologous products that are localized to the inner membrane and are hypothesized to play a late role in the translocation of leader-peptide containing proteins across the inner membrane of gram-negative bacteria. In addition, in each PAI, sequences are found that are reminiscent of the heat-shock htrA/degA gene that encodes a piroplasmic protease. They may perform endochaperone-like function as Pugsley et al. have hypothesized for different exoprotein pathways. ///. O-antigen/capsule/carbohydrate modification (Nod genes). J96 has the 04. The O-antigen portion of lipopolysaccharide is encoded by rfb genes that are located at 45 min. on the E. coli chromosome. We have found in both PAIs a cumulative total of five possible r δ-like genes which could participate alterations of the O-antigen in the PAIs. Overall these data suggest that PAIs provide the genetic potential for greater change of the cell surface for uropathogenic E. coli strains than what was previously known. The apparent capsule type for strain J96 is a non-sialic acid K6-type. Sequence similarity "hits" were made in PAI IV region to two region- 1 capsule genes, kpsS and kpsE involved in the stabilization of polysaccharide synthesis and polysaccharide export across the inner membrane. This is not altogether surprising based on the genetic mapping of the kps locus to ser A at 63 minutes on the genome of the Kl capsular type of E. coli. This suggests that these kps-li e genes either are participating in the K6-biosynthesis or perhaps are involved in complex carbohydrate export for other purposes. An intriguing discovery are the hits made on genes involved in bacteria- plant interactions by Rhizobium, Bradyrhizobium and Agrobacterium. Four potential genes identified thus far share significant sequence similarity to genes , encoding products that modify lipo-oligosaccharides that influence nodule morphogenesis on legume roots. These are: ORF 140, carbamyl phosphate synthetase; nodulation protein 1265; phosphate-regulatory protein; and an ORF at a plant-inducible locus in Agrobacterium. To date there are no descriptions in the literature of such gene products being utilized by human or animal bacterial pathogens for the purposes of modification or secretion of extracellular carbohydrate. However, the sequence similarity to the capsular region-2 genes and to lipooligosaccharide biosynthetic genes in Rhizobium spp has been recently noted by Petit (1995). IV. Cytotoxins. Besides the previously known hemolysin and CNF toxins in the PAIs, in each PAI sequences similar to the shlBA operon (cosmid 5 and 12) were found for a cytolytic toxin from Serratia marcescens and Proteus mirabilis. Ironically, the P. mirabilis hemolysin (HpmA) member of this family of toxins was discovered by Uphoff and Welch (1990), but not thought to exist in other members of the Enterobacteriaceae (Swihart (1990)). A shlB-lϊke transporter does also appear to be involved in the export of the filamentous hemagglutinin of Bordetella pertussis which was described above and a cell surface adhesin of Haemophilus influenzae. It has been demonstrated that cosmid #5 of E. coli J96 encodes an extracellular protein that is -180 kDa and cross- reactive to polyclonal antisera to the P. mirabilis HpmA hemolysin. Thus, there is evidence suggesting there is new member of this family of proteins in extraintestinal E. coli isolates. In addition, there is also a hit on the FhaC hemolysin-like gene within the PAI V although its statistical significance for the sequence thus far available is only 0.0043. V. Regulators. A common regulatory motif in bacteria are the two- component (membrane sensor/DNA binding) proteins. In numerous instances in pathogenic bacteria, external signals in the environment cause membrane-bound protein kinases to phosphory ate a cytoplasmic protein which in turn acts as either a negative or positive effector of transcription of large sets of operons. On cosmid 1 1 representing PAI V were found, in two different Pstl clones, sequences for two-component regulators (similar probabilities for OmpR/ AIGB and separately RcsC, probabilities at the 10 "22 level). In addition, the phosphoglycerate transport system (pgtA,pgtC, and pgtP) including the pgtB regulator is present in PAI IV. This transport system which was originally described in S. typhimurium is not appreciated as a component of any pathogenic E. coli genome. The operon had been previously mapped at 49 minutes, near or within one of the S. typhimurium chromosome specific-loops not present in the K-12 genome. It should be noted that the E coli K-12 glpT gene product is similar to pgtP gene product (31% identity), but the E. coli J96 genes are clearly homologs to the pgt genes and their linkage within the middle of PAI IV element (cosmid #4) is suspicious. VI. Mobile genetic elements. There are numerous sequences that share similarity to genes found on insertion elements, plasmids and phages. The temperate bacteriophage P4 inserts within tRNA loci in the E. coli chromosome. The hypothesis was made that PAIs are the result of bacteriophage P4-virulence gene recombination events (Blum et al, Infect. Immun. 6 ~ 2:606-614 (1994). Data supporting this hypothesis was found during our sequencing with the identification of P4-like sequences in each of the PAIs (cosmids 7 and 9). This is a very important preliminary result which supports the hypothesis that PAIs can be identified by common sequence or genetic elements. However, there are indications that multiple mobile genetic elements involved in the evolution of the J96 PAIs. Conjugal plasmid-related sequences may also be present at two different locations (F factor and RI plasmid). Sequences for multiple transposable elements are present that are likely to have originated from different bacterial genera (TnlOOO, IS630, IS91 1, IS100, IS21, IS 1203, IS5376 (B. stearothermophflus) and RHS). Of particular interest is IS 100, which was originally identified in Yersinia pestis (Fetherston et al, Mol. Microbiol. 6:2693- 2704 (1992)). The presence of IS 100 is significant because it has been associated with the termini of a large chromosomal element encoding pigmentation and some aspect of virulence in Y. pestis. This element undergoes spontaneous deletions similar to the PAIs from E. coli 536 (Fetherston et al, Mol. Microbiol. 6:2693-2704 (1992)) and appears to participate in plasmid-chromosome rearrangements. This element was not previously known to be in genera outside of Yersinia. The discovery of the apparent att site for bacteriophage P2 in the PAIs is interesting. P2 acts as a helper phage for the P4 satellite phage. The P2 att site is at 44 min in the K-12 genome. The significance of this hit is unknown at present, but may be explained as either a cloning artifact (some K-12 fragments in the Pst I library of cosmid 5) or evidence of some curious chromosomal-P4/ P2 phage history. It may indicate that the J96 PAIs are composites of multiple smaller PAIs. Example 2: Preparation of PCR Primers and Amplification of DNA Various fragments of the sequenced E. coli J96 PAIs, such as those disclosed in Tables 1 through 6 can be used, in accordance with the present invention, to prepare PCR primers. The PCR primers are preferably at least 15 bases, and more preferably at least 18 bases in length. When selecting a primer sequence, it is preferred that the primer pairs have approximately the same G/C ratio, so that melting temperatures are approximately the same. The PCR primers are useful during PCR cloning of the ORFs described herein. Example 3: Gene expression from DNA Sequences Corresponding to ORFs A fragment of an E. coli J96 PAI (preferably, a protein-encoding sequence provided in Tables 1 through 6) is introduced into an expression vector using conventional technology (techniques to transfer cloned sequences into expression vectors that direct protein translation in mammalian, yeast, insect or bacterial expression systems are well known in the art). Commercially available vectors and expression systems are available from a variety of suppliers including Stratagene (La Jolla, California), Promega (Madison, Wisconsin), and Invitrogen (San Diego, California). If desired, to enhance expression and facilitate proper protein folding, the codon context and codon pairing of the sequence may be optimized for the particular expression organism, as explained by Hatfield et al. , U.S. Pat. No. 5,082,767, which is hereby incorporated by reference. The following is provided as one exemplary method to generate polypeptide(s) from a cloned ORF of an E. coli J96 PAI whose sequence is provided in SΕQ ID NOs: 1 through 142. A poly A sequence can be added to the construct by, for example, splicing out the poly A sequence from pSG5 (Stratagene) using Bgll and Sail restriction endonuclease enzymes and incorporating it into the mammalian expression vector pXTl (Stratagene) for use in eukaryotic expression systems. pXTl contains the LTRs and a portion of the gag gene from Moloney Murine Leukemia Virus. The position of the LTRs in the construct allow efficient stable transfection. The vector includes the Herpes Simplex thymidine kinase promoter and the selectable neomycin gene. The E. coli J96 PAI DNA is obtained by PCR from the bacterial vector using oligonucleotide primers complementary to the E. coli J96 PAI DNA and containing restriction endonuclease sequences for Pstl incorporated into the 5 ' primer and Bglll at the 5' end of the corresponding E coli J96 PAI DNA 3' primer, taking care to ensure that the E. coli J96 PAI DNA is positioned such that its followed with the poly A sequence. The purified fragment obtained from the resulting PCR reaction is digested with Pstl, blunt ended with an exonuclease, digested with Bglll, purified and ligated to pXTl, now containing a poly A sequence and digested Bglll. The ligated product is transfected into mouse NIH 3T3 cells using Lipofectin (Life Technologies, Inc., Grand Island, New York) under conditions outlined in the product specification. Positive transfectants are selected after growing the transfected cells in 600 ug/ml G418 (Sigma, St. Louis, Missouri). The protein is preferably released into the supernatant. However if the protein has membrane binding domains, the protein may additionally be retained within the cell or expression may be restricted to the cell surface. Since it may be necessary to purify and locate the transfected product, synthetic 15-mer peptides synthesized from the predicted E. coli J96 PAI DNA sequence are injected into mice to generate antibody to the polypeptide encoded by the E. coli J96 PAI DNA. If antibody production is not possible, the E. coli J96 PAI DNA sequence is additionally incorporated into eukaryotic expression vectors and expressed as a chimeric with, for example, β-globin. Antibody to β-globin is used to purify the chimeric. Corresponding protease cleavage sites engineered between the β-globin gene and the E. coli J96 PAI DNA are then used to separate the two polypeptide fragments from one another after translation. One useful expression vector for generating β-globin chimerics is pSG5 (Stratagene). This vector encodes rabbit β-globin. Intron II of the rabbit β-globin gene facilitates splicing of the expressed transcript, and the polyadenylation signal incorporated into the construct increases the level of expression. These techniques as described are well known to those skilled in the art of molecular biology. Standard methods are available from the technical assistance representatives from Stratagene, Life Technologies, Inc., or Promega. Polypeptides may additionally be produced from either construct using in vitro translation systems such as In vitro Express™ Translation Kit (Stratagene). Example 4 E. coli Expression of an E. coli J96 PAI ORF and protein purification An E. coli J96 PAI ORF described in Tables 1 through 6 is selected and amplified using PCR oligonucleotide primers designed from the nucleotide sequences flanking the selected ORF and/or from portions of the ORF's NH 2 - or COOH-terminus. Additional nucleotides containing restriction sites to facilitate cloning are added to the 5' and 3' sequences, respectively. The restriction sites are selected to be convenient to restriction sites in the bacterial expression vector pQE60. The bacterial expression vector pQE60 is used for bacterial expression in this example. (QIAGEN, Inc., 9259 Eton Avenue, Chatsworth, CA, 9131 1). pQE60 encodes ampicillin antibiotic resistance ("Ampr") and contains a bacterial origin of replication ("ori"), an IPTG inducible promoter, a ribosome binding site ("RBS"), six codons encoding histidine residues that allow affinity purification using nickel-nitrilo-tri-acetic acid ("Ni- NTA") affinity resin sold by QIAGEN, Inc., supra, and suitable single restriction enzyme cleavage sites. These elements are arranged such that a DNA fragment encoding a polypeptide may be inserted in such as way as to produce that polypeptide with the six His residues (i.e., a "6 X His tag") covalently linked to the carboxyl terminus of that polypeptide. The DNA sequence encoding the desired portion of an E. coli J96 PAI is amplified from the deposited cDNA clone using PCR oligonucleotide primers which anneal to the amino terminal sequences of the desired portion of the E. coli protein and to sequences in the deposited construct 3' to the cDNA coding sequence. Additional nucleotides containing restriction sites to facilitate cloning in the pQE60 vector are added to the 5' and 3' sequences, respectively. The amplified E. coli J96 PAI DNA fragments and the vector pQE60 are digested with one or more appropriate restriction enzymes, such as Sail and Xbal, and the digested DNAs are then ligated together. Insertion of the E. coli J96 PAI DNA into the restricted pQΕ60 vector places the E. coli J96 PAI protein coding region, including its associated stop codon, downstream from the IPTG-inducible promoter and in-frame with an initiating AUG. The associated stop codon prevents translation of the six histidine codons downstream of the insertion point. The ligation mixture is transformed into competent E. coli cells using standard procedures such as those described in Sambrook et al, Molecular Cloning: a Laboratory Manual, 2nd Ed.; Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY (1989). E. coli strain M15/rep4, containing multiple copies of the plasmid pREP4, which expresses the lac repressor and confers kanamycin resistance ("Kanr"), is used in carrying out the illustrative example described herein. This strain, which is only one of many that are suitable for expressing an E. coli J96 PAI protein, is available commercially from QIAGEN, Inc., supra. Transformants are identified by their ability to grow on LB plates in the presence of ampicillin and kanamycin. Plasmid DNA is isolated from resistant colonies and the identity of the cloned DNA confirmed by restriction analysis, PCR and DNA sequencing. Clones containing the desired constructs are grown overnight ("O/N") in liquid culture in LB media supplemented with both ampicillin (100 μg/ml) and kanamycin (25 μg/ml). The O/N culture is used to inoculate a large culture, at a dilution of approximately 1 :25 to 1 :250. The cells are grown to an optical density at 600 nm ("OD600") of between 0.4 and 0.6. isopropyl-β-D- thiogalactopyranoside ("IPTG") is then added to a final concentration of 1 mM to induce transcription from the lac repressor sensitive promoter, by inactivating the laci repressor. Cells subsequently are incubated further for 3 to 4 hours. Cells then are harvested by centrifugation. The cells are then stirred for 3-4 hours at 4°C in 6M guanidine-HCl, pH8. The cell debris is removed by centrifugation, and the supernatant containing the E. coli J96 PAI protein is dialyzed against 50 mM Na-acetate buffer pH6, supplemented with 200 mM NaCl. Alternatively, the protein can be successfully refolded by dialyzing it against 500 mM NaCl, 20% glycerol, 25 mM Tris/HCl pH7.4, containing protease inhibitors. After renaturation the protein can be purified by ion exchange, hydrophobic interaction and size exclusion chromatography. Alternatively, an affinity chromatography step such as an antibody column can be used to obtain pure E. coli J96 PAI protein. The purified protein is stored at 4°C or frozen at -80°C. Example 5 Cloning and Expression of an E. coll J96 PAI protein in a Baculovirus Expression System A E. coli J96 PAI ORF described in Tables 1 through 6 is selected and amplified as above. The plasmid is digested with appropriate restriction enzymes and optionally, can be dephosphorylated using calf intestinal phosphatase, using routine procedures known in the art. The DNA is then isolated from a 1% agarose gel using a commercially available kit ("Geneclean" BIO 101 Inc., La Jolla, Ca.). This vector DNA is designated herein "VI". Fragment FI and the dephosphorylated plasmid VI are ligated together with T4 DNA ligase. E. coli HB101 or other suitable E. coli hosts such as XL-1 Blue (Stratagene Cloning Systems, La Jolla, CA) cells are transformed with the ligation mixture and spread on culture plates. Bacteria are identified that contain the plasmid with the E. coli J96 PAI gene by digesting DNA from individual colonies using appropriate restriction enzymes and then analyzing the digestion product by gel electrophoresis. The sequence of the cloned fragment is confirmed by DNA sequencing. This plasmid is designated herein pBac E. coli J96. Five μg of the plasmid pBac E. coli J96 is co-transfected with 1.0 μg of a commercially available linearized baculovirus DNA ("BaculoGold™ baculovirus DNA", Pharmingen, San Diego, CA.), using the lipofection method described by Feigner et al, Proc. Natl Acad. Sci. USA 54:7413-7417 (1987). 1 μg of BaculoGold™ virus DNA and 5 μg of the plasmid pBac E. coli J96 are mixed in a sterile well of a microliter plate containing 50 μl of serum-free Grace's medium (Life Technologies Inc., Gaithersburg, MD). Afterwards, 10 μl Lipofectin plus 90 μl Grace's medium are added, mixed and incubated for 15 minutes at room temperature. Then the transfection mixture is added drop-wise to Sf9 insect cells (ATCC CRL 1711) seeded in a 35 mm tissue culture plate with 1 ml Grace's medium without serum. The plate is rocked back and forth to mix the newly added solution. The plate is then incubated for 5 hours at 27 °C. After 5 hours the transfection solution is removed from the plate and 1 ml of Grace's insect medium supplemented with 10% fetal calf serum is added. The plate is put back into an incubator and cultivation is continued at 27°C for four days. After four days the supernatant is collected and a plaque assay is. performed, as described by Summers and Smith, supra. An agarose gel with "Blue Gal" (Life Technologies Inc.) is used to allow easy identification and isolation of gal-expressing clones, which produce blue-stained plaques. (A detailed description of a "plaque assay" of this type can also be found in the user's guide for insect cell culture and baculovirology distributed by Life Technologies Inc, page 9-10). After appropriate incubation, blue stained plaques are picked with the tip of a micropipettor (e.g., Eppendorf). The agar containing the recombinant viruses is then resuspended in a microcentrifuge tube containing 200 μl of Grace's medium and the suspension containing the recombinant baculovirus is used to infect Sf9 cells seeded in 35 mm dishes. Four days later the supernatants of these culture dishes are harvested and then they are stored at 4°C. The recombinant virus is called V-E coli J96. To verify the expression of the E. coli gene Sf9 cells are grown in Grace's medium supplemented with 10% heat inactivated FBS. The cells are infected with the recombinant baculovirus V-E. coli J96 at a multiplicity of infection ("MOI") of about 2. Six hours later the medium is removed and is replaced with SF900 II medium minus methionine and cysteine (available from Life Technologies Inc.). If radiolabeled proteins are desired, 42 hours later, 5 μCi of 35 S-methionine and 5 μCi 35 S-cysteine (available from Amersham) are added. The cells are further incubated for 16 hours and then they are harvested by centrifugation. The proteins in the supernatant as well as the intracellular proteins are analyzed by SDS-PAGΕ followed by autoradiography (if radiolabeled). Microsequencing of the amino acid sequence of the amino terminus of purified protein may be used to determine the amino terminal sequence of the mature protein and thus the cleavage point and length of the secretary signal peptide. Example 6 Cloning and Expression in Mammalian Cells Most of the vectors used for the transient expression of an E. coli J96 PAI gene in mammalian cells should carry the SV40 origin of replication. This allows the replication of the vector to high copy numbers in cells (e.g., COS cells) which express the T antigen required for the initiation of viral DNA synthesis. Any other mammalian cell line can also be utilized for this purpose. A typical mammalian expression vector contains the promoter element, which mediates the initiation of transcription of mRNA, the protein coding sequence, and signals required for the termination of transcription and polyadenylation of the transcript. Additional elements include enhancers, Kozak sequences and intervening sequences flanked by donor and acceptor sites for RNA splicing. Highly efficient transcription can be achieved with the early and late promoters from SV40, the long terminal repeats (LTRS) from Retroviruses, e.g., RSV, lHTLVI, HIVI and the early promoter of the cytomegalovirus (CMV). However, cellular elements can also be used (e.g., the human actin promoter). Suitable expression vectors for use in practicing the present invention include, for example, vectors such as PSVL and PMSG (Pharmacia, Uppsala, Sweden), pRSVcat (ATCC 37152), pSV2dhfr (ATCC 37146) and pBC12MI (ATCC 67109). Mammalian host cells that could be used include, human Hela, 293, H9 and Jurkat cells, mouse NIH3T3 and C127 cells, Cos 1, Cos 7 and CV I, quail QC1-3 cells, mouse L cells and Chinese hamster ovary (CHO) cells. Alternatively, the gene can be expressed in stable cell lines that contain the gene integrated into a chromosome. The co-transfection with a selectable marker such as dhfr, gpt, neomycin, hygromycin allows the identification and isolation of the transfected cells. The transfected gene can also be amplified to express large amounts of the encoded protein. The DHFR (dihydrofolate reductase) marker is useful to develop cell lines that carry several hundred or even several thousand copies of the gene of interest. Another useful selection marker is the enzyme glutamine synthase (GS) (Murphy etal, BiochemJ. 227:277-279 (199 l); Bebbington etα/., Bio/Technology .T69-175 (1992)). Using these markers, the mammalian cells are grown in selective medium and the cells with the highest resistance are selected. These cell lines contain the amplified gene(s) integrated into a chromosome. Chinese hamster ovary (CHO) and NSO cells are often used for the production of proteins. The expression vectors pCl and pC4 contain the strong promoter (LTR) of the Rous Sarcoma Virus (Cullen et al, Molecular and Cellular Biology, 438- 447 (March, 1985)) plus a fragment of the CMV-enhancer (Boshart et al, Cell 47:521-530 (1985)). Multiple cloning sites, e.g., with the restriction enzyme cleavage sites BamHl, Xbal and Asp718, facilitate the cloning of the gene of interest. The vectors contain in addition the 3' intron, the polyadenylation and termination signal of the rat preproinsulin gene. Example 6(a): Cloning and Expression in COS Cells The expression plasmid, p E. coli J96HA, is made by cloning a cDNA encoding E. coli J96 PAI protein into the expression vector pcDNAI/Amp or pcDNAIII (which can be obtained from Invitrogen, Inc.). The expression vector pcDNAI/amp contains: (1) an E. coli origin of replication effective for propagation in E. coli and other prokaryotic cells; (2) an ampicillin resistance gene for selection of plasmid-containing prokaryotic cells; (3) an SV40 origin of replication for propagation in eukaryotic cells; (4) a CMV promoter, a polylinker, an SV40 intron; (5) several codons encoding a hemagglutinin fragment (i.e., an "HA" tag to facilitate purification) followed by a termination codon and polyadenylation signal arranged so that a cDNA can be conveniently placed under expression control of the CMV promoter and operably linked to the SV40 intron and the polyadenylation signal by means of restriction sites in the polylinker. The HA tag corresponds to an epitope derived from the influenza hemagglutinin protein described by Wilson et al, Cell 37:161 (1984). The fusion of the HA tag to the target protein allows easy detection and recovery of the recombinant protein with an antibody that recognizes the HA epitope. pcDNAIII contains, in addition, the selectable neomycin marker. A DNA fragment encoding the E. coli J96 PAI protein is cloned into the polylinker region of the vector so that recombinant protein expression is directed by the CMV promoter. The plasmid construction strategy is as follows. The E. coli cDNA of the deposited clone is amplified using primers that contain convenient restriction sites, much as described above for construction of vectors for expression of E. coli J96 PAI protein in E. coli. The PCR amplified DNA fragment and the vector, pcDNAI/Amp, are digested with appropriate restriction enzymes for the chosen primer sequences and then ligated. The ligation mixture is transformed into E. coli strain SURE (available from Stratagene Cloning Systems, La Jolla, CA 92037), and the - transformed culture is plated on ampicillin media plates which then are incubated to allow growth of ampicillin resistant colonies. Plasmid DNA is isolated from resistant colonies and examined by restriction analysis or other means for the presence of the E. coli J96 PAI protein-encoding fragment. For expression of recombinant E. coli J96 PAI protein, COS cells are transfected with an expression vector, as described above, using DEAE- DEXTRAN, as described, for instance, in Sambrook et al, Molecular Cloning: a Laboratory Manual, Cold Spring Laboratory Press, Cold Spring Harbor, New York (1989). Cells are incubated under conditions for expression of E. coli J96 PAI protein by the vector. Expression of the E. coli J96 PAI - HA fusion protein is detected by radiolabeling and immunoprecipitation, using methods described in, for example Harlow et al, Antibodies: A Laboratory Manual, 2nd Ed; Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York (1988). To this end, two days after transfection, the cells are labeled by incubation in media containing 35 S- cysteine for 8 hours. The cells and the media are collected, and the cells are washed and the lysed with detergent-containing RIP A buffer: 150 mM NaCl, 1% NP-40, 0.1% SDS, 1% NP-40, 0.5% DOC, 50 mM TRIS, pH 7.5, as described by Wilson et al. cited above. Proteins are precipitated from the cell lysate and from the culture media using an HA-specific monoclonal antibody. The precipitated proteins then are analyzed by SDS-PAGE and autoradiography. An expression product of the expected size is seen in the cell lysate, which is not seen in negative controls. Example 6(b): Cloning and Expression in CHO Cells The vector pC4 is used for the expression of an E. coli J96 PAI protein. Plasmid pC4 is a derivative of the plasmid pSV2-dhfr (ATCC Ace. No. 37146). The plasmid contains the mouse DHFR gene under control of the SV40 early promoter. Chinese hamster ovary- or other cells lacking dihydrofolate activity that are transfected with these plasmids can be selected by growing the cells in a selective medium (alpha minus MEM, Life Technologies, Inc.) supplemented with the chemotherapeutic agent methotrexate. The amplification of the DHFR genes in cells resistant to methotrexate (MTX) has been well documented (see, e.g., Alt, F. W. et al, 1978, J. Biol Chem. 253:1357-1370, Hamlin, J. L. and Ma, C. 1990, Biochim. et Biophys. Ada, 7097:107-143, Page, M. J. and Sydenham, M.A. 1991, Biotechnology 9:64-68). Cells grown in increasing concentrations of MTX develop resistance to the drug by overproducing the target enzyme, DHFR, as a result of amplification of the DHFR gene. If a second gene is linked to the DHFR gene, it is usually co-amplified and over-expressed. It is known in the art that this approach may be used to develop cell lines carrying more than 1 ,000 copies of the amplified gene(s). Subsequently, when the methotrexate is withdrawn, cell lines are obtained which contain the amplified gene integrated into one or more chromosome(s) of the host cell. Plasmid pC4 contains for expressing the gene of interest the strong promoter of the long terminal repeat (LTR) of the Rouse Sarcoma Virus (Cullen, et al, Molecular and Cellular Biology, March 1985:438-447) plus a fragment isolated from the enhancer of the immediate early gene of human cytomegalovirus (CMV) (Boshart et al, Cell 47:521-530 (1985)). Downstream of the promoter is BamHl restriction enzyme site that allows the integration of the gene. Behind these cloning sites the plasmid contains the 3' intron and polyadenylation site of the rat preproinsulin gene. Other high efficiency promoters can also be used for the expression, e.g., the human β-actin promoter, the SV40 early or late promoters or the long terminal repeats from other retroviruses, e.g., HIV and HTLVI. Clontech's Tet-Off and Tet-On gene expression systems and similar systems can be used to express the E. coli protein in a regulated way in mammalian cells (Gossen, M., & Bujard, H. 1992, Proc. Natl. Acad. Sci. USA 89: 5547-5551). For the polyadenylation of the mRNA other signals, e.g., from the human growth hormone or globin genes can be used as well. Stable cell lines carrying a gene of interest integrated into the chromosomes can also be selected upon co-transfection with a selectable marker such as gpt, G418 or hygromycin. It is advantageous to use more than one selectable marker in the beginning, e.g., G418 plus methotrexate. The plasmid pC4 is digested with appropriate restriction enzymes and then dephosphorylated using calf intestinal phosphates by procedures known in the art. The vector is then isolated from a 1% agarose gel. The DNA sequence encoding the complete E. coli J96 PAI protein including its leader sequence is amplified using PCR oligonucleotide primers corresponding to the 5' and 3' sequences of the gene. The amplified fragment is digested with appropriate endonucleases for the chosen primers and then purified again on a 1% agarose gel. The isolated fragment and the dephosphorylated vector are then ligated with T4 DNA ligase. E. coli HB 101 or XL-1 Blue cells are then transformed and bacteria are identified that contain the fragment inserted into plasmid pC4 using, for instance, restriction enzyme analysis. Chinese hamster ovary cells lacking an active DHFR gene are used for transfection. 5 μg of the expression plasmid pC4 is cotransfected with 0.5 μg of the plasmid pSVneo using lipofectin (Feigner et al, supra). The plasmid pSV2- neo contains a dominant selectable marker, the neo gene from Tn5 encoding an enzyme that confers resistance to a group of antibiotics including G418. The cells are seeded in alpha minus MEM supplemented with 1 mg/ml G418. After 2 days, the cells are trypsinized and seeded in hybridoma cloning plates (Greiner, Germany) in alpha minus MEM supplemented with 10, 25, or 50 ng/ml of methothrexate plus 1 mg/ml G418. After about 10-14 days single clones are trypsinized and then seeded in 6- well petri dishes or 10 ml flasks using different concentrations of methotrexate (50 nM, 100 nM, 200 nM, 400 nm, 800 nM). Clones growing at the highest concentrations of methotrexate are then transferred to new 6-well plates containing even higher concentrations of methotrexate (1 μM, 2 μM, 5 μM, 10 mM, 20 mM). The same procedure is repeated until clones are obtained which grow at a concentration of 100 - 200 μM. Expression of the desired gene product is analyzed, for instance, by SDS-PAGE and Western blot or by reversed phase HPLC analysis. Example 7 Production of an Antibody to an E. coli J96 Pathogenicity Island Protein Substantially pure E. coli J96 PAI protein or polypeptide is isolated from the transfected or transformed cells described above using an art-known method. The protein can also be chemically synthesized. Concentration of protein in the final preparation is adjusted, for example, by concentration on an Amicon filter device, to the level of a few micrograms/ml. Monoclonal or polyclonal antibody to the protein can then be prepared as follows: Monoclonal Antibody Production by Hybridoma Fusion Monoclonal antibody to epitopes of any of the peptides identified and isolated as described can be prepared from murine hybridomas according to the classical method of Kohler and Milstein, Nature 256:495 (1975) or modifications of the methods thereof. Briefly, a mouse is repetitively inoculated with a few micrograms of the selected protein over a period of a few weeks. The mouse is then sacrificed, and the antibody producing cells of the spleen isolated. The spleen cells are fused by means of polyethylene glycol with mouse myeloma cells, and the excess unfused cells destroyed by growth of the system on selective media comprising aminopterin (HAT media). The successfully fused cells are diluted and aliquots of the dilution placed in wells of a microtiter plate where growth of the culture is continued. Antibody-producing clones are identified by detection of antibody in the supernatant fluid of the wells by immunoassay procedures, such as ELISA, as originally described by Engvall, E., Meth. Enzymol 70:419 (1980), and modified methods thereof. Selected positive clones can be expanded and their monoclonal antibody product harvested for use. Detailed procedures for monoclonal antibody production are described in Davis, L. et al. Basic Methods in Molecular Biology Elsevier, New York. Section 21-2 (1989). Polyclonal Antibody Production by Immunization Polyclonal antiserum containing antibodies to heterogenous epitopes of a single protein can be prepared by immunizing suitable animals with the expressed protein described above, which can be unmodified or modified to enhance immunogenicity. Effective polyclonal antibody production is affected by many factors related both to the antigen and the host species. For example, small molecules tend to be less immunogenic than other molecules and may require the use of carriers and adjuvant. Also, host animals vary in response to site of inoculations and dose, with both inadequate or excessive doses of antigen resulting in low titer antisera. Small doses (ng level) of antigen administered at multiple intradermal sites appears to be most reliable. An effective immunization protocol for rabbits can be found in Vaitukaitis, J. et al, J. Clin. Endocrinol. Metab. 33:988-991 (1971). Booster injections can be given at regular intervals, and antiserum harvested when antibody titer thereof, as determined semi-quantitatively, for example, by double immunodiffusion in agar against known concentrations of the antigen, begins to fall (See Ouchterlony, O. et al, Chap. 19 in: Handbook of Experimental Immunology, Wier, D., ed, Blackwell (1973)). Plateau concentration of antibody is usually in the range of 0.1 to 0.2 mg/ml of serum (about 12 μM). Affinity of the antisera for the antigen is determined by preparing competitive binding curves, as described, for example, by Fisher, D., Chap. 42 in: Manual of Clinical Immunology, 2nd ed., Rose and Friedman, (eds.), Amer. Soc. For Microbio., Washington, D.C. (1980). Antibody preparations prepared according to either protocol are useful in quantitative immunoassays which determine concentrations of antigen-bearing substances in biological samples; they are also used semi-quantitatively or qualitatively to identify the presence of antigen in a biological sample. TABLE 1 (PAI IV) Putative coding regions of novel E. coli PAI IV proteins similar to known proteins Contig |ORF 1 Start 1 Stop 1 match 1 match gene name I * slm | % ident | length | ID |lD j (nt) 1 (nt) j acβiaion | 1 1 1 1 (nt) 1 65 | 2 | 1902 | 1042 |gi | 1655838 |0RFB; putative transposes* (Yersinia pestis] ' | 100 | 100 | 861 | 65 | 3 | 2096 | 1821 |gi|467612 |0RF1 [Yersinia pestis) 1 100 | 100 | 276 | 63 |11 | 7856 | 9238 |gi|154262 | ransporter protein pgtP (Salmonella typhimurium) | 98 | 93 | 1383 | 65 | 4 | 2889 | 1915 |βi|1655837 |0RFA; putative transposase (Yersinia pestis] | 97 | 96 | 975 1 138 | 1 | 2 | 172 |gi|l208992 |unknown [Escherichia coll) I 97 | 78 | 171 | 64 1 6 | 4075 I 4338 lgi| 1143207 iDescription: IS630 insertion βlementi ORF5 proteini Method: conceptual 1 92 1 92 | 264 | 1 | j j 1 translation supplied by author (Shigella sonnet ] 1 1 1 1 67 | 1 | 1 | 273 |gi|809648 |ExeF gene product (λeromonas hydrophila] I 92 I 71 | 273 | | 73 | 4 | 3029 | 2511 |gi|799234 |glucose-l-phoβphatβ thymldylyltransferase (Escherichia coll) | 92 I 86 | 515 | | 73 | 5 | 3139 | 2996 |gi|4S4900 |r£bC gene product [Shigella flβxneri] I 92 | 92 | 144 | | 64 | 5 | 3741 | 4088 |gi|47542 |ORP (343 λλ) [Shigella sonnβi] | 91 | 85 | 3-18 | | 73 | 3 | 2613 | 2242 |gi|46985 |glucose-l-phosphat« thymldylyltransferase (Salmonella enterlcal | 91 | 82 | 372 | | 90 | 1 | 1 | 366 lgi|38826 |ExβE gene product [Aβro onas hydrophila] | 91 | 77 | 366 | I 91 | 2 | 604 | 248 |gl|60962S |putatlv« (Vibrio cholera*) I 91 | 67 | S >1 | | 63 | 9 | 6301 | 5234 |gi|858753 |regulatory protein pgtB (Salmonella typhimurium] | 89 | 84 | 106B | | 73 | 2 | 2179 | 1811 |gi|294899 |dTDP-6-dβoxy-L-mannose-<!ehydrogenase [Shigella flexneri] | 89 | 84 | 369 | I 90 | 2 | 201 | 689 |gi|38826 | ExeE gene product [λeromonas hydrophila] | 89 | 60 | 489 | I 95 | 2 | 1519 | 413 |gi|581654 |dTDP-glucose 4, 6-dβhydratase [Salmonella enterica] | 88 | 81 | 1107 | | 96 | 1 | 729 | 457 |plr| S43483 | S434 |Orfl04 homolog - Escherichia coli | 88 | 72 | 273 | | 63 1 6 1 4281 1 3019 lgi| 154255 Iphosphoglycβratβ transport system activator protein (Salmonella 1 87 | 79 | 1263 | 1 1 I 1 1 1 typhimurium] l l l i 1 67 | 2 | 251 | 745 |gi|609628 |putative [Vibrio cholerae] | 87 | 72 | 495 | I 82 112 | 5254 | 4406 |gi|1208992 |unkno n [Escherichia coli] | 87 | 74 | 849 | I 60 1 1 | 693 | 4 | ςji 1609625 |putativβ [Vibrio cholerae] | 86 | 57 | 690 | 1 95 | 1 | 428 | 3 |gi|508238 |dTDP-6-deoxy-L-mannose-dehydrogenase [Escherichia coll) | 85 | 74 | 426 1 1 64 1 7 | 4336 | 4731 |gl|47542 |ORP (343 λλ) [Shigella αonnei] | 84 | 81 | 356 | | 80 | 8 | 2800 | 2582 |gi|38832 |ExeK gene product [λeromonas hydrophila] | 84 [ 53 | 219 | I 82 |10 | 4380 | 3829 |gi|1033137 |ORF_ol52 [Escherichia coll) | 84 | 72 | 552 | TABLE 1 (PAI IV)(CONTINUED) | Contig |ORF | Start | Stop 1 match 1 match gene name j % sim | % ident 1 length | j ID j ID | tnt) I (nt) 1 acesslon (nt) | 1 63 | 8 | 5399 | 4830 |sp|P37433|PGTB_ | PHOSPHOGLYCERATB TRANSPORT SYSTEM SENSOR PROTEIN PGTB (EC 2.7.3.-). 1 83 | 75 | 1 570 | 1 6 | 10 | 7572 | 6259 |gi|l54258 | regulatory protein pgtC [Salmonella typhimurium] 1 83 | 78 | 1314 | 1 65 | 7 | 3351 | 3100 | gi | 1195999 |unknown protein (Transposon Tn3411) 1 82 | 80 | 252 | 1 100 | 1 | 337 1 2 |gi|41004 |URF 2 [Escherichia coll] 1 82 | 64 | 336 | 1 138 | 2 | 109 | 429 |gi|l033128 |ORF_o273 [Escherichia coli) | 80 62 | 321 | 1 74 | 4 | 1331 | 831 |gi|38826 |ExeE gene product (λeromonas hydrophila] 1 " 62 501 | 1 63 | 7 | 4873 | 4256 |sp|P37433|PGTB_ | PHOSPHOO-iYCERλTE TRANSPORT SYSTEM SENSOR PROTEIN PGTB (EC 2.7.3.-). 1 78 72 618 | 1 70 | 13 | 5759 | 5529 |gi|l773143 |Hha protein [Escherichia coll] | 78 58 231 | 1 91 1 3 | 1154 | 534 |gi|609625 |putatlve [Vibrio cholerae] | 77 65 621 | 1 75 | 5 3524 | 3255 |gi|463911 |heot resistant agglutinin 1 (Escherichia coli] 1 76 62 270 | 1 63 | 1 2 | 667 |gi|l574313 |H. influenzae predicted coding region HI1472 [Haemophilus influenzae] 1 75 56 666 | | 104 | 2 485 1 315 |gi|530438 jarabinose transport protein (Mycoplasma capricolum] 1 72 41 171 | 1 63 | 3 2180 | 1629 |gi|622948 |transposase [Escherichia coli) 1 71 60 i 552 | I 63 112 9688 | 10005 |sp|P39213|YI91. . (INSERTION ELEMENT IS911 HYPOTHETICAL 12.7 KD PROTEIN. 1 71 1 57 I 318 | 1 61 | 3 1283 | 876 |gl|581535 |ORF140 gene product (Rhizoblua sp.) | 70 1 54 | 408 | 1 84 | 3 2361 | 3437 |gi|1772623 |Hecλ [Erwinia chrysanthemi] 1 70 1 60 | 1077 | 1 91 | 1 300 1 4 |gi|295430 |epsE [Vibrio cholerae] 1 0 1 49 1 297 | 1 74 | 1 | 541 1 2 |gl|609627 Iputative [Vibrio cholerae) 1 69 1 1 540 | 1 67 | 4 | 1297 | 1581 |gi|l51469 |PilD-dependent protein [Pseudomonas aeruginosa] | 68 1 50 1 28 | 1 84 | 1 | 578 I 1741 |gi|l772622 |KecB (Erwinia chrysanthemi1 | 68 1 5 | 1164 | 1 84 | 2 I 1698 I 2363 |gi|l772622 |HecB [Erwinia chrysanthemi) 1 6 | 48 | 666 | 1 63 | 2 | 1734 | 1393 |gi|l323798 Itransposase [Plasmid pRL1063a] 1 65 | 46 1 342 | 1 71 | 1 I 1134 1 4 |gi|397405 |kpsE gene product [Escherichia coli) 1 65 1 36 1 1131 | ! 64 | 2 | 2838 | 1839 |gil310632 |hydrophobic membrane protein [Streptococcus gordonii] | 64 1 38 | 990 | 1 74 | 2 | 861 1 355 |gi|148436 | secretory component [Erwinia chrysanthemi] | 64 1 54 1 507 | 1 66 | 1 I 556 1 2 |gl|1235662 |RfbC [Myxococcus xanthus) 1 62 1 39 1 55'j | 1 70 | 6 | 3017 | 2814 |gl|1657478 (similar to E. coll ORF_o208 (Escherichia coli] 1 62 1 41 1 204 | TABLE 1 (PAIIV)(CONTINUED) TABLE 2 (PAI IV) Putative coding regions of novel E. co/Ϊ PAI IV proteins not similar to known proteins TABLE 3 (PAI V) Putative coding regions of novel E. coli PAI V proteins similar to known proteins Contig |ORF | Start j Stop 1 match 1 match gene name 1 % sim 1 % ident | length | ID j ID 1 (nt) 1 (nt) 1 acesslon 1 1 1 1 (nt) | 14 | 3 | 2826 | 3686 |gi|16S5838 |ORFB; putative transposase [Yersinia pestis] 1 100 1 100 1 861 | 14 | 2 | 1837 | 2907 |gi|1655837 |0RFλ) putative transposase [Yersinia pestis) 1 99 1 99 1 1071 | 3 1 9 | 7927 | 7595 |gi| 1657499 |putative transposase for insertion sequence IS3 [Escherichia coli) 1 89 1 85 1 333 | 20 | 6 | 3462 | 4304 | gi | 1208992 |unknown [Escherichia coli] 1 87 1 73 1 843 | 6 | 6 | 3541 | 3263 |pir|S43483|S434 |Or£104 homolog - Escherichia coli 1 81 1 62 1 279 | 20 | 3 | 1616 | 2332 |gi| 1033129 |ORF_o233 [Escherichia coli] 1 80 1 61 1 717 | 9 | 1 1 i | 681 |gi|537112 |ORF_o396 [Escherichia coli] 1 77 1 55 1 681 | 15 | 3 | 1899 | 1672 |pir|S43483|S434 |θrfl04 homolog - Escherichia coli 1 75 1 55 | 228 | 20 | 9 | 4302 | 4880 | gi | 1552316 | similar to E. coli ORF_ol52 [Escherichia coli) 1 74 1 60 | 579 14 113 |12972 115359 |gi|1772623 |Hecλ [Erwinia chrysanthemi] 1 70 1 60 | 2388 5 1 3 | 1112 | 1570 |gi|1001717 | regulatory components of sensory transduction system (Synβchocystls sp.] 1 68 1 45 | 459 3 1 1 | 2572 | 1373 |gi |849022 |Lactate oxidase (λerococcus viridans] 1 66 1 46 | 1200 3 1 8 | 6869 | 6498 |gl | 581535 |ORF140 gene product [Rhizobium sp.) 1 66 1 45 | 372 6 | 5 | 3265 | 2951 |gi|642184 |F19C6.1 [Caenorhabditis elegans) 1 66 1 44 1 315 1 14 | 12 |11775 112974 |gi|1772622 |HecB [Erwinia chrysanthemi] 1 66 1 50 | 1200 1 20 | 1 | 545 | 1450 |gi|1033127 |ORF_o289 [Escherichia coli] 1 66 1 45 | 906 1 57 | 1 | 696 | 124 |gi|1772622 |HecB [Erwinia chrysanthemi] 1 66 1 47 | 573 1 3 | 3 | 3320 | 3700 |gi|431950 | similar to a B.subtills gene (GBi BACHEMEHY_5) [Clostridium pasteurianum] 1 65 1 34 | 381 I 5 | 7 | 4565 | 4239 |sp|P39213|YI91_ . | INSERTION ELEMENT IS911 HYPOTHETICAL 12.7 KD PROTEIN 1 65 1 38 | 327 1 22 | 2 | 1651 | 557 |gi|290430 ladhesin [Escherichia coli] 1 64 1 48 | 1095 1 | 4 | 1455 | 1841 |gi| 1575577 |DNA-binding response regulator [Thermotoga maritima) 1 61 1 47 | 387 | 14 |11 |11161 |11937 |gi|l772622 |HecB (Erwinia chrysanthemi) 1 60 1 39 | 777 1 14 | 1 | 930 | 1700 |gi|l657478 Isimilar to E. coli 0RP_o208 [Escherichia coli) 1 58 1 47 1 771 1 5 | 6 | 3834 | 3391 |gi |155032 |ORF B [Plasmid pEa34] 1 56 1 36 | 444 1 3 | 5 1 6500 1 5982 Igi|l633572 iHerpβsvirus sairairi ORF73 homolog [Kaposi's sarcoma-associated herpes-like 54 9 1 virus] 1 25 1 51 1 1 14 1 7 | 8429 | 8809 |gi|H96729 |unknown protein [Bacteriophage P4] 1 54 1 41 | 381 TABLE 3 (PAI V) (CONTINUED) " +5-3> o c o o o c υ> α o • Eb Si K3 o υ cυ > 3 CM TABLE 5 (PAI IV) Putative coding regions of novel K coli PAI IV containing known E. coli sequences 70 1 19 112022 115222 |dbj |D90838|D908 | B.CO11 genomic DNA, Kohara olone 1348 (44.5-44.9 min. ) 89 2667 3201 + + + + + — ______ — ______ TABLE 5 (PAI TV) (CONTINUED) I TABLE 5 (PAI IV) (CONTINUED) TABLE 5 (PAI IV) (CONTINUED) I I TABLE 5 (PAI IV) (CONTINUED) I I TABLE 6 (PAI V) Putative coding regions of novel K coli PAI V containing known E. coli sequences TABLE 6 (PAI V) (CONTINUED) I t I TABLE 6 (PAI V) (CONTINUED) While the present invention has been described in some detail for purposes of clarity and understanding, one skilled in the art will appreciate that various changes in form and detail can be made without departing from the true scope of the invention. All patents, patent applications and publications recited herein are hereby incorporated by reference. SEQUENCE LISTING (1) GENERAL INFORMATION: (i) APPLICANTS: Human Genome Sciences, Inc. 9410 Key West Avenue Rockville, Maryland 20850 United States of America University of Wisconsin 1300 University Avenue Madison, Wisconsin 53706 United States of America APPLICANTS /INVENTORS: Dillon, Patrick J. Choi, Gil H. Welch, Rodney A. (ii) TITLE OF INVENTION: Nucleotide Sequence of Escheri chia col i Pathogenicity Islands (in) NUMBER OF SEQUENCES: 142 (IV) CORRESPONDENCE ADDRESS: (A) ADDRESSEE: Sterne, Kessler, Goldstein & Fox P.L.L.C. (B) STREET: 1100 New York Ave., N.W., Suite 600 (C) CITY: Washington (D) STATE: DC (E) COUNTRY: USA (F) ZIP: 20005-3934 (v) COMPUTER READABLE FORM: (A) MEDIUM TYPE: Diskette, 3.50 inch, 1.4Mb storage (B) COMPUTER: HP Vectra 486/33 (C) OPERATING SYSTEM: MSDOS version 6.2 (D) SOFTWARE: ASCII Text (vi) CURRENT APPLICATION DATA: (A) APPLICATION NUMBER: To be assigned (B) FILING DATE: Herewith (C) CLASSIFICATION: (vii) PRIOR APPLICATION DATA: (A) APPLICATION NUMBER: US 60/031,626 AND US 60/061,953 (B) FILING DATE: 22-NOV-1996 AND 14-OCT-1997 (vin) ATTORNEY/AGENT INFORMATION: (A) NAME: Steffe, Eric K. (B) REGISTRATION NUMBER: 36,688 (C) REFERENCE/DOCKET NUMBER: 1488.074PC02/EKS/CBM (vi) TELECOMMUNICATION INFORMATION: (A) TELEPHONE: (202) 371-2600 (B) TELEFAX: (202) 371-2540 (2) INFORMATION FOR SEQ ID NO: 1: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1178 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 1: CNTANATTAG GCCTGCTNAA TGTATTTATA TCTAAAAAAA TTCGCATCCA AAAGGAATCC 60 AATCTGTACT GTTTTTTCTT GTGCTGACAT CTTCTTTTCC CTGGCTGGTA TGGCAAGTGA 120 CGGAGACAAG AGAAACGTTT TAAGCTCAGT TATCTCCGCC ATCACTTTCC ACGAATGACA 180 AGTAATTTTG CCTATTTTAA AACCATGCAA AAGGCAGGGT AAAAGGAGAA AATTCGATCG 240 AATCGATCGA CAAAATCGAT CATACATGAT GAAGATTTCT TATCGAATCC ATAAAAATAG 300 TGACAGCTAA CCGGCGTTGC AGGAACAGTC AGAAATGGGC GTTTGGGAAA GAGCCATAGC 360 ATACGTCGTC GCTGACATAG AGGAACTGTG CTTTGTTGAT AAGATCCTTT ATACGGCAAC 420 CAATCCACTG GACAAAAGAT GAACTACGTA ATCACCGGGT TCTCACTGAC GAAATACAGA 480 AGTTAATGAC ACAACTGTGC CATGCACCTT GTACAACAGC GGTGGAAAGC TCTCAGAACA 540 ATGGAATTGC AGAAAGGTGT TAAAACGATG AAAGCCTTCA TACCCAAATC GAATGTAAGA 600 ACGGCAGTAA AGACTGAATT GCGTAACCTT GCAGTAGCTC GAGTATTACA CTGCATAGTG 660 TGCAGGGTTA TCTCCCATCG AGAAAATATC GGCGCCAGCG AATAACGTCA CCTTAGATGT 720 AGCAGTTGCC AAATAGTGAC TCAAGGGCGG GCTTACCGCA TACACTGACA CTTAGCGGAT 780 CGACAGAATA TTATTAGCAG ATCATCACTG AACGCTACGT AATTATCGTA ATAAAGGCTT 840 TTTCTGGCTA CCAGGAAGAC CTGACATGGC TCTGCTCTGG AACCAGGCCG CAGGAAGCAT 900 CAATCTGGAG TTTATCAGCT ACTGGAATTC CGGTGTATTG GCAGCCCCTG ATAATCACCT 960 GACCCACGAA GAGCGCTCTG CTTTGCAGAA ACTCTGGGGC GGTTTGGAGA CAGGAGATGT 1020 AACGATTATA GGACGTTCTG ATGAAGTCCA TGATTTTACC TCCGCCTTAA TTAACTGTTT 1080 TCTTTCTGAA GAAGAAATTG TCTGGTGGCA ATCAGGTGGC ATTTTCCCGG ATCCTTGGCC 1140 CGCTAATATA TCCCGGCTGA ACTGACGATT AACGCGAT 1178 (2) INFORMATION FOR SEQ ID NO: 2: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 414 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 2: ATCCTATTCA TTTTGCCATG ACGGGCGAAC TCCAGATAAA GGTTTTGAAA GTAATGAGAA 60 ATTATTAATT CATCCATGTT ACTGGCTTGG TTTGAATCTA AATCGTAATG CACTTGCTCC 120 AGAGGAAGCA GAGGAGATAA ATGACGAATA TGATATTAAT ATTATTTCAG ATAATTCAGC 180 CATTAGAAAT AAAACAATAG GTCAAATAAC TACTCATCTA GATCAGATAC CGATAGGAAA 240 TGAAGGTGCC ACTGAATTTG AACAATGGTG TTTAGACGCA CTAAGAATAG TATTTGCATC 300 CCACCTAACA GACATCAAGT CCCATCCAAA TGGTAACGCA GTTCAGAGAC GAGATATTAT 360 AGGCACCAAT GGTGGCAAAT CTGAWTTTTG GRAACGAGTA TTGGAGGACT ATAA 414 (2) INFORMATION FOR SEQ ID NO: 3: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 8752 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 3: TTGGGATCTG GTACANTCCA CCCAGCGGCA TTATCCNGAA GGCAATATTT TTAAGGATTA 60 TTCGTCCACA AAATCAGTAC TGGAACCAGG CTCAAAAAAG GCTTTAACGT GACCTGCTNC 120 CATCTACAGT AGATGTACAA CCTGTTAAGT TAATTGAAAA TGGTGTTAAT CCGGTTGTTT 180 CTCCAGGGGT AGCAAGGGCC TTATTCGATA CAGTGGGTAA TGTTACTGTA AAATTACCAT 240 CATTCCCTGT GGTCACATTG CAGGTCTGAG CTACAACTTT GCCTGTAAAC GTAATTGTTC 300 CGTCATAGGC CATAGCTGAA CCAACAAACA CAGCAGAAAC AAATGTAGCC AATGCTATAA 360 CTTTTATTTT CATAAAATGA ATTCCTGTTT AATTCCGGTA TTGATCATTT GTTCAGCAAT 420 CATCCCCAAC AAAACAATCA TTTTCAAAAT GTTTTTACCG ATCGATAACC AGCACATGAT 480 AGATTGCACC TATCATGATT GCTAAAACGA TCGGGAAAAG CGATCAAAAA CCATATTTAT 540 TGTGTTGGTA ATGACAAAAG ATATGCTTTA CCCTGAAATG AGCGACCTAT TCATGAAAAT 600 ATGTAGGTCT GTATTTGATT ACTATCATTG CTATATTTCC ACTATCCAAT TTATATTTCA 660 TGATTAAAAT ATACCTTTTT ACACTATTAT TTATTTGTTG CAGCTTGCCT GGCTTTATCT 720 TATTCCGACT ATTTTATGGT AGATACAGAA TACAATTAAT TAAACTTATT TAAAGATTTT 780 ATAAATACCA TATTGGAGTT GACCGATAGA TACCTACTAA CAAGAGCAAT CACCACCACC 840 CCATGAGGTG TTTAGGAATA CAATCAATAA ACAACATCCA TGCCCGGCGA CGTACATACC 900 TGTTTGCTAT GATATCTGTT ACGCTACGCT TGCTAATTTA CTGAAACTCA GCATCTGTCG 960 ACGGAGATTC GTCCGGGCCC TGATACAACA AGGGCAAGAA AACCACCCGA AATACAGATA 1020 TTCTTATAAA AATGGATCAT ATTTCCATGT GCAAGTTCAG CTGGCATCGT CCAGAATGCG 1080 TGTCCAAGAA ATGAAGCAAA CACGGTATAC AGGCACAGAA TAATGCTCAC TGGCCGGGTG 1140 AAAAAGCCRA AAACAATCAT TAATGCTCCA ACGATTTCGA CAAGGACCAC TATTGCTGCA 1200 GTAATCGCCG GAAATATAAG CCCAAGAGAG GCCATTTTAT CGATAGTGCC AGTGAATGAT 1260 AGCAGCTTGG GAACGCCGGA TATCATATAA AGGCATGCCA GCATCAGACG GGCAAGGAGC 1320 AACAATGCCG ACGTGTAATT TCCCATATTA AAATACCTGA TTTTATCCAC TATCAATGCT 1380 CAGTCTCCTT GTTTCTGATA AAGCCCTGAG CCAAATCCTT AAGTGTACGA GCACCACTCA 1440 GTAACATTGC CGTCCTCAGC TCCGTCTTCA GGTGCTCAAT GACACTGGCA ACGCCCCCGA 1500 CACCACCTGC TGCGATGCCA TAAAGAACAG GACGTCCGAC CGCAACAGCC GTTGCCCCAA 1560 GAGAGATAGC CCTTACAACA TCAACCCCCC TGCGAATACC GCTGTCAAAA ATGACCGGAA 1620 CTTTGTGCCC GACTCTTGCA GCAACTTCCT GCAACTGGCT GATGGCAGAA GGAACACCAT 1680 CAATCTGGCG ACCACCATGA TTAGACACCT GGATGGCATC TGCTCCTGCA TCAATGGCGA 1740 CCACTGCATC CTCACCTCTG AGGATGCCCT TGACAATGAC TGGCAGCCCG GTGATTTTTT 1800 TTACAAACTC AATATCAGCC GGGGTCAGCT CAACTTTTTG GTTAAAAAAA TCACCTTTGC 1860 CACCGTAACG GGGGTCATGA TTACCGAACG TCGCTCCTGC AGGGAAAGGC GAGCTCATGC 1920 TGAGAAAAGC ATCACTTGTC CCGGGACCAA GCGCATCCGC TGTGATAATA ATGGCTGAAT 1980 AGCCTGCCGC TTTTGCACGC TCCAGTAAAC TTCGGGTCAC ACCAGCATCC GCGTTAAAAT 2040 ACAGCTGGAA CCATTTAGGT CCTTTACTGG CTTTTGCAAT ATCCTCCAGA GAGCGGTTGG 2100 ATGCCCCTGA TGATTCATAA AGTGCCCCGG CCTTTTCTGC ACCCGCTGCA GCAATCACCT 2160 CCCCTTCCGG ATGGACGAAC ATATGCGCGC CCATAGGTGC TATCAGCAGG GGATGTTCCA 2220 GATGATGGCC CAAAAGGTCA GTCCGGATAT CAATGCTGTG GGCAGCAACT CCACTGAGTC 2280 GGTGAGGTAA CAAAGGATAA TCACTGAANT GCCTGCGGTT CTCATGATAC GTCCACTCAT 2340 CTCCAGCACC ATGAGCAATA TATGCATACG CAGCTTCCGT CATCACATCT TTTGCTGAAG 2400 TCTYCAGTCT GTCCAGACTG ATGATATGAA GAGATTTGCT GGTCGATGTA TCAGCATGTC 2460 CAGACGTTTT ACTGATGATA TGTGCCGTTG AAGATGAGAT ATTTTTGGCA AGGGCCGGCG 2520 CAGTTGACAG CCTGCGGCAG ATATTCCTAA AACGGCATTC TGAATAAAAT TACGTCGGGA 2580 AAGAGGCATA ATAAGCTCCA TATATTATAA ATAAGCCAGG TCTCCCTGGC TTATAATGAT 2640 CATGCCACGC CCTGAAGCGG GTTGGTGTTG AAGGTATAAA GGAAAATTTT CCATTCACCA 2700 TTAATTTTAC TGAGGACAAA AACTTCACGG TTCAGGTCAA TAATGGTTTT CTGCTCTTTA 2760 AAGTTCGTTA CAACAGAACC CACATGGTGG TGAGTGCGGA CAACCGCGGT ATCTCCGTTG 2820 ATCCAGATAG AGTCAAACGC AAAATCGGTC TCAAACTTTT CACGCTTGAA CAGATCATCG 2880 TACTGCCCCT GGCGTTTTTC TGTATTGTCA GCCGTCAACT TATCATTCCA CTGGGAATAA 2940 CTTTCATCAG CAAACAGGCC CAGGATGGTT TTTGTATCCC CGGCATTCAG TGCGTTCTGA 3000 TACTTGATTA TCGTGTCATA CACGTTCTTC TGCTCAGTAG CAATCTTACT GTCTGTGGAG 3060 TATTTGAATG TACCGCCGGA TTGTTCAGGT GAGCTTTCCT TCTGTGCTGT CGACGATGAG 3120 GCAGCCAGAG CATTAGAGCC GAAAAGAAGG GATGATGCCA TGACTGCTGT TGCTATAAAA 3180 TGTTTCATAT ATTCTCCATC AGTTCTTCTG GGGATCTGTG GGCAGCATAT AGCGCTCATA 3240 CTATGCTGCT GTTTCAATAT TAGCGGCAGA CGTCAGCCTT ACCGCACTAC TTATTGGATA 3300 AGAATATCAA AAGTGACCGT GAAGTCAATT TTATCACAAC ACAGAAGGCC ACTATTTATG 3360 CCCAGAAAAT ATGAATCGTC CTCATCATGC ACGAAAGACT CGTAGTTGCA GCCCGGAAAA 3420 AACTGCCAGG ACACGACAGC AGATAGCCCG GGCAGCACTT GAGGAGTTCT CTGCACAAGG 3480 GTTCGCTCGC GCCACATNCA GCAATATCAG CAAGCGCGCA GGAGTAGCTA AAGGCACGGT 3540 ATATAACTAC TTCCCAACAA AGGAATTATT GTTTGAAGCG GTTCTGAAGG AGTTCATTGC 3600 TACCGTCCGT ACTGAACTGG AATCTTCCCC CCGCCGCAAC GGGGNAAACC GTAAAAGCCT 3660 ATCTGTTGAG AGTGATGTTA CCTGCCGTCA GGAAAATTGA CGACGCATCA ACAGGCAGAG 3720 CCAGAATAGC CCACCTGGTT ATGACAGAAG GGAGCCGGTT CCCGGTAATC GCTCAGGCTT 3780 ATTTACGGGA AATACATCAG CCACTACAGC AAGCCATGAC CCAACTGATT CAGGAAGCAG 3840 CATCAGCCGG AGAGTTAAAA GCAGAGCAAC TGCTCTGCKT CCCCTGTTTA TTGCTGGCTC 3900 CAAACTGGTT TGGCATGGTG TATAACGAAT TCTGAACCCG GCAGCACCGG TCAGTACAGG 3960 CGATCTTTTT GAAGCCGGAA TTGGTGCTTT TTTCCGATAG ACACATAACT GTCAGTATTA 4020 TGACCATGCC GTCAGGAGGA GGTATACCAG TGATACCCTG CCATGACCCG GTAACGTCTC 4080 CTGGCTGCCT TAAACCTGAA AGACCTGGCC CCACCACACT GCCGGTTACG CATCAAGATG 4140 CAGCAACCCT TGCATAAGGC TGTTTTGTGC AGAGGGCTAC CGGAAAGATA ATAACGTCAC 4200 AGCCCGTATG CATCAGATAA AACAGTGTAT TTTATCTGTC AGCAGTCACT GGAGCGGATT 4260 GTGGGGCGAG ATTCAGGTGC TGATACTGTA ACGACTCTGC GCCGCTGCTG CGGTAAAAGC 4320 GGCTGCCACC AGGCACGGTT ATCAGAGGAG GATGACCGTG TCCGCCCCTG GTGGTGATGA 4380 ACTCTCCATC ACAATCAATA ATGCCGCCGG GTGGATGAAG CAGACAGGGA TGGCAAGTCC 4440 CACTATCCCG GATAAAATGG GCTCTGGGCG CTCAGAAGAC CTGTGTGTCA GGCAGGGGTG 4500 AGAACGGTGA TGTTTTTTGT TGTCTGAAAG TCCAGCTCCA GCATTGCCTG CCAGCCTCAA 4560 GACTTCCGCT TTCTGCCCTT TCCGGCATTT TCTTCCGTTA CCATCATTCT GTTAATTCAG 4620 AGGCGTAGTA GTAGTAAACG TAATACATAT CCGGGAGGAT GAAGTCATCT AATCCTGCTC 4680 CCCGAATATC ATACAGCCAT TCCTGAGTGT GACTGCACCA TTTCCAATTA TGCAGTCTGT 4740 CCTCATCACA AAAATGTTGC AAGCAGTGCG GAGTCACGTT CCGTATTCAT GCCCTCTGCC 4800 AGATATTGAG CGGGGGAGAA ATGTGTAAGC GTCAACAGAG CGCCGTATTG ACACTTATTT 4860 ATCGGTGAAA ACTACGTTCC ATGGCAGCAG TTCGTCAACA CGGTTGGAGG GCCATTCCGG 4920 CAGTACGCTC AGGATATGGC GCAGATACGC TTCTGGATCG ATACCGTTCA ACCGACAGCT 4980 CCCGATTAGT CCGTACAGCA GAGCTCCGCG CTCGCCTCCA TGATCGTTGC CGAAGAACAT 5040 GTAATTCTTT TTCCCGAGAC AGACGGCACG AAGCGCTCTT TCTGCTGTGT TATTGTCCGC 5100 CTCCGCCAGA CCGTCATCAC TGTAATAACA GAGGGCGTCC CACTGATTCA GGACATAGCT 5160 GAACGCTTSR CCCAGTCTGG ATTTTTTCGA CAACGTGCCA TTCTTCTCCA CCATCCATTC 5220 ATGCAGCGAC GTCAGTAACG CTTTGCTTCG CTGCTGCCTG GCTGCAAGAC GTTCAGACTC 5280 CGGTAAGCCC CGTATTTCAT CMTCAATGGC GTACAGTTCA CTGATGCGCT TCAGAGCTTC 5340 TTCTGCCGTC GTACTTTTGC TGCTGATGTA TACATCGTGG ATTTTTCGCC GGGCATGGGC 5400 CCAGCACGCA ACTTCTGTCA GTGCACCACC TTCACGTTCG GCACTGAACA GCCGATCGTA 5460 ACCGCTGAAT GCATCCGCCT GCAGGATACC CCGGAAGGGA CGAAGGTGTT GTACCGGATG 5520 TTTTCCCTGC CTGTCTGGTG AGTAGGCGAA CCAGACCSCC GGTGGCTCTG ATGAGCCCGC 5580 ATTCCGGTCA TCCCSGACAT ACGTCCAGAT GCGTCCTGTT TTTGCCTTTT TTCTGCCCGG 5640 TGCCAGCACT TTTACTGGTA TGTCGTCAGT GTGAACCTTG CGGGTGTTCA TCACGTAACG 5700 GTACAGGGCA TCATTCAGCG GAGTCATTAA CTGGCAGCAC GCGTCAACCC AGTTGGAGAG 5760 TAATGCACGG CTCAGTTCGG CACCCTGTCG GGCAAAGATT TCACTCTGAC GATACAGTGG 5820 CAGGTGTTCG CAGTATTTTC CCGTTAACAC GCGGGCAAGT AATCCGGAGC CCGCGATGCC 5880 GCGCTCTATC GGGCGGGACG GCGCTGGCGC TTCAACTATA CAGTCACATT TTGTACAGGC 5940 TTTTTTTACC CGAACAGTGC GGATCACTTT CAGGGCGCTA CTCACCAGTT CCAGCTGCTC 6000 AGCACTAACT TCACCCAGAT AATCCAGCTC ACTGCCACAC TCCGGGCAAC AACTTTCTTC 6060 AGGCTCCAGG CGGTGTATTT CACGGGGAAG ATGTGCTGGT AACGGACGAC GATGACGTGA 6120 TTGTCGCAAC TGGCGGGGAA CTGCGGGTCA TCCTCACGCC CACTGTAACG ATCGCTTTCC 6180 TGTTCGCGTT GTTTCAGTTG GGCCTCAGCC TGTTCAACCT CACGCTGCAG TTTTTCAGAA 6240 CGGGTACCGA ACAGCATCCG GCGCAGTTTT TCTATCTGGG CCCTCAGATG TTCTATTTCC 6300 CGCTCCTCCT CTTCGATCTT TTCTTCGGCA CGTGCCARTG CAGAGCGCAG GAAGGCCTCC 6360 GTCTCTTCAA CCAGACTCAG TTGCTGATCT TTCTGACGGA GGGCTTCAGC CTGCTCAGAG 6420 AGTAGCCTTT CCAGCTCAGT GATACGAATG AGGTATTTCC GACTCATGAC CGTTTTTATA 6480 ATCCGGCCAT GACATTTTTA CAACATTGTC AGTGCATTAA GGCGGGATGT TTTGGGTTGA 6540 CGCCAGTCCA GTTTATCGAG GAGCATTGCC AGCTGCGAGC GGGTAATGGA TACCTTACCG 6600 TCACGCACCG CAGNCCAGAT AAACTGGCCT TCCTCCAGAC GTTTGGTGAA CAGGCACAGA 6660 CCATCAGCAT CAGCCCACAG GATTTTAATC GTGTCACCCC GTCGGCCGCG AAAGATAAAC 6720 AGGTGACCGG AGAAGGGGTT CTCATCCAGC ACATGTTGTA CCTGTTCACC CAGACCGTTG 6780 AAGGATTTAC GCATATCAGT AACGCCGGCA ACCAGCCAGA TTCGAGTGTC TGATGGGAGC 6840 GAGATCATCG TCCTCTCCCG GTCAGTTCAC GGATCAACAC CGTGAGCAGC TCTGGTGAAG 6900 GATTTTCCAG CGTCATGTTA CCGTGGCGGA ACTCAACTTT ACAGGAACTG GCACTGACTG 6960 TGCTTTGTGA AGGAGTGGAT AAAAGCGGAG TAAGAGCCGC CATAGGCTCT TTCTGCTCAT 7020 CAGGCGTTAT CTCAACAGGT AATAATTCAA CGCCAGCGCC AGAAGAGGTT GTTACCGGAA 7080 GACGCCGCGA TATACGCCCT TCGTTCTGCC AGAGCCTGAG CCATTTGAAC AGGAGGTTAT 7140 CATTGATATC GTGTTCCCTG GCAATACGGG CAACAGAGGC TCCTGGTTGT GAAGCCAGTT 7200 TAACCATTTG AAGTTTAAAC TCATTTGAAA ATGTTCTGCA GGGTTCTGCG GATAATATTT 7260 TCTGTTCCAT AACAGGTGTC CACTAGTTGA AAAAGTGGGC ACCTACGTTA CCAATACTGG 7320 CTTAATGGCT ACATACGGCG GTCAGTTTAC GCTTACAGAA ATGTAATGAA CACGTCCTAC 7380 CATTAACTGA AGAGCATGGT GACGGATGAA GGAAAAAGCA GGAGTGTGTG GTGCCTCACA 7440 GATTTCCGAC ATCATAGCTG TCAACGACGG ATGAAAAGCG GCTCTTCCGC AACTTGGGTG 7500 GAAGAAAATG GATGAAACTT TCTGGTGTGA GAACCTTAAG GAAACAACAT GTTGGGTGGA 7560 GCGGACAATC CAAATGGTGA ATTACCGTCT TATATCACTG GCGCTGACAT TCCGGGCGTC 7620 TTCTCCGCCA CAACGCCATT TGCAGTGCAT CACAGGCCAG TTGTGCTGTC ATTCGCGGTG 7680 ACATCGACCA GCCAATAACG GCGCGTGACC ACAGGTCGAT GACTACTGCG AGATACAACC 7740 AGCCCTCATC GGTACGCAAG TAMGTGATGT CACCCGCCCA MTTCTGGTTC GGAGCCTGGC 7800 GCTGAAGTTC CTGCTCCAGC AGATTCTCCA ATACGGGCAG GCCATGTGCA CGGTAGCTGA 7860 CCGGGCTGAA CTTCCGGCTG CTTTCGCCCG CAGCCCCTGA CGACGCAGGC TGGCGGCAAT 7920 GGTTTTAATA TTGAACTCCG GCATTTCGTC AGCAAGGCGG GGAGCACCGT ATCGCTGCTT 7980 TGCCTCAATG AATGCCTTAT GGACAGCGGC ATCGCAGGTG AGCCGAAACT GTTGGCGCAG 8040 GCTCATCTGG TGACGACGCC TGAGCCAGAC ATACCAGCCG CTGCGGGCAA CCCGAAGTAC 8100 ACGACACATC GCTTTGATGC TGAACTCTGC CCGATGATTT TCGATGAAGA CATACTTCAT 8160 TTCAGGCGCT TCGCGAAGTA TGTCGCGGCC TTTTGGAGGA TGGCCAGTTC CTCAGCCTGC 8220 TCCGCCAGTT GTCGTTTAAG GCGGACATTT TCAGCGGCCA GTTCGCTTTC GCGCTCTGAC 8280 GAACTCATTT GTTGCTGCTG TTTACTGCGC CAGGCATAAA GCTGAGATTC ATACAGGCTG 8340 AGTTCACGGG CTGCGGCGGC CACACCGATG CGTTCAGCGA GTTTCAGGGC TTCGTTACGA 8400 AATTCAGGCG TATGTTGTTT ACGGGGCTTC TTGCTGATTG ATACTGGTTT TGTCATGAGT 8460 CACCTCTGGT TGAGAGTTTA CTCACTTAGT CCTGTGTCCA CTATTGGTGG GTAAGATCAC 8520 TCAGCAACGT ATCAAAAGTC TGTAAAATCA TGGGCGTTTC GCGTGATACA TTTTATCGTT 8580 ACCGCGAACT GGTCGATGAA GGCGGTGTGG ATGCGCTGAT TAATCGTAGT GCCGCGCTCC 8640 TAACCTTAAG AACGTACCGA TGAGGCAACT GAACAGGCTG TTGTTGATTA CGCCGTCGCT 8700 TTCCCGGCAC ACGGTCAGCA CCGGACCAGC AAACAAGCTG CGTAAACAGG GC 8752 (2) INFORMATION FOR SEQ ID NO: 4: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 2417 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 4: TGGTCAAAGA TGCAACTGCA TTTCGTCGCG GCTTTGCGGC AAATACTTAC ATCGCAGAAA 60 TACTGTGCGG AAATCTGCAT CCATTTCCAC TTGCTGTATG GCATAACTTT TCAGGCGGTC 120 CGGATACTGC CGAAGATTAT TATGCCACAT ACCACCCGTT ATGGGGGCAA TATCCGGAAG 180 CATTGCTGTT TGTAAACTGG CTCTATAATC ATTCCTCTGT GCTGCATGAA CGGGCAGAAA 240 TCATTAAATG CGCCGAAATG CTGATGCAGG AAGATGATTT CGAAATATGC GAAAGTATTT 300 TAAGACAGCA GGAGAAGTTG CGTGAAAGAA TTGATGAGAC GCTTTCTGAG AAAATTGTAC 360 AGAAATGCAG AAATATGAAT GGTGAATATG TCTGGCCCTG GATATTGCCG TTTTCAGCGG 420 CAGGCATGAA ACATACTGGC ATACAGTATC AGTAGATATT GCATTAGTGT ATCCTGCACA 480 CAAGTAATAA TTTATCCACC AATAATAACA CTGTTAATGT CCCCTTCCCC TGGTTGTCAG 540 CCAGGGGTTA TCTTCTGAAT ATTTCTTTTG AAAAGGATAA CACAATAAAT TATTTTTATG 600 AATTATCCCA TGGACTCATT AACACCCTTT CATAATGTTT TATTGTCAAA CACGTTATGG 660 CTGACATCAA AAAAAACCGG ATTTCCTCTG CCAGCGGGTA ATCACCTCCC CGGTGTTTTC 720 GGTTGGTCTG GTTACTCCTG TCTGGTTATT AGCAAGATAA TTGCTATAAA CAGTGGAAAA 780 CTCATCGTAC ATAATCTGGT GATGAACATT ACGCTTATTT TCCCTTGACC GGAAGAATCA 840 GAGGCTGCGG TTTCAGACTG TCTGCCGGTA CATTCCTCTC TCCGTTAAAA ACCATAATGG 900 GTTCATTATC TTCGTCTGTC AGTAGATTGA ATGGCGGTAT ATTTTCAGTA CGAATGCCGG 960 TCAGCCACTG AAAAATACCT GCGAAATGAC GGGCACTGAT TTTTCTGCTG ACGGACTGAT 1020 GAGACGTGAT GTCACTGGCG GTAATAATCA GGGGAACGCT GTAGCCTCCC TGCACATGAC 1080 CATCATGATG AACAGGATTA GCACTGTCGC TGACCGACAG CCCATGGTCA GAAAAGTAAA 1140 GCATGACGAA ATGACGGGAA TGCCGGCGAN GGATACCATC AAGCTGACCG AGAAAGTTAT 1200 CCAGTTTACT GATGCTGGCG AGGTAACAGG CAACCTTTCG GGGATACTGC TCCAGGTAAT 1260 GATTCGGCCA GGAGTGAAGC CGGTCACACG GGTTCGGATG AGACCCCATC ATGTGCAGGA 1320 ATATCACCTT CGGAGAGGAT TTATCCGCCA GCGCACGTTC TGTTTCCTGT AACAACAACA 1380 TGTCATCCGT TTTACGGGAA GCGAATGCSC TTTCTTGAGG AAAACGGTAT GCTCCGCATC 1440 AGAAGCAATA ACAGAGATGC GTGTGTCATG CTCTCCCAGT TTTCCCTGAT TGGATATCCA 1500 CCATGTGCTG TATCCTGCTT TTGCTGCCAG CGCCACCACG TTGTTGCCGG AATCAGGGTT 1560 CTGCTCATAG TCATAAATCA GTGTCCSGCT CAGGGAAGGT ACGGTACTGG CTGCTGCCGA 1620 TGTATAGCCG TCAATAAATA AACCGGGAGC TGTCATTCCA GCCACGGCGT GGTTGGCCAC 1680 GGGATAACCA TATACCGACA TATAATCCCT GCGCACACTC TCACCAGTGA CAATCACAAT 1740 CGTGTCATAT AACGGTGTTC CCCGGCCAGG ATTTTCCCAG TTGTCAGCCC CGTGCTGACT 1800 CAGTTGTTTA TAATGCTGCA TTTCACGCAA TGTGTCAGTT GTCCCCACAA CAGTTCCTTT 1860 AACCATCCGC AACGGCCAGC TGTTTACTGA GCATAATACG AACAGCAGCA GTGCCAGCCA 1920 GTTACGGTGA CCACGGCGGT GTGTTCGCCA GAAAATCACC ATGAATACCT GAATCGCGGC 1980 ACTGACCAGA AAATGATAAA CAGGAATCAT CCCGGTAAAC TCCGCTGCCT CATCAGTTGT 2040 GGTCTGCAGC AACGCGACAA TAAAACTGTT GTTGATTTTA CCGTACGTCA TACCGGCAGG 2100 CGCATACAGT GCACAACAGA ACAGAAATAA CAGCGCTGTA ATGGATGTGA GGGTATTTCT 2160 GTGTGCAAGG AGCAGAAGGA GAAACAGAAG CAGCACATTT CCTGTTGCAT TCCTCTCAGT 2220 GTATCCGCAT GCAATTGTGG TTATTGCAGA CACAACAAAA AAGAATAAAA ACAATAAAAT 2280 CCGGGGGGGG TTGCCCGGAC AAAACAGTTT TCTGATATTC ATCGGAGTAT ATCGACAACA 2340 TTATTATGAA GAGAACAGGA TAATAAAAAT CAGAAATTAT TGTAAAACAG ATAAAAGCAN 2400 CNATGCAGTA ATAGACT 2417 (2) INFORMATION FOR SEQ ID NO: 5: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 6294 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 5: AGACAAAAAC CAGTTACGGT TATCACGTAC CAGCCCCCGT ATTTCCAATT TATAATCCTG 60 GCCATCAATT ACTGGGATCT CTTCTTCTCC ATAGAAGGCA TTAAAAGGGA ATGGAGTGGT 120 AATGTCCTCT GGAAGATATT CTGGTGCCAC ACTGTTTTTG CTGAACAGAA AACTTTGAAT 180 CCGGTCATTA AATCTGGATA TACGGAACAA TGCTTTTTCA ATATCATCAT TATTGCTTAT 240 ATCACAGCCA GTCAGCATCA TAATTCCCCC AAGCGTCAGT CCCTGTTGGA GTAAACGACG 300 TCTGTCCGGC GCAAGGATTT TTTCTGCATC TTTCACCACG TAATGGGCAT CACTGTCAGA 360 CAAAAAACGT TTTTTCTTCA TTAGTGACCC CGTATCATAG ATAACAATGC ACGCGGAACC 420 AATAACACCA TAACCAGGTG AATAATAATG AACAGTACCA TAATGTTCAT GCACAGAAAG 480 TGGATATAAC GCGCTGTATC ATAACCACCG RATAGTATAG TCAGAAGGGA AAACTGAACG 540 GGTTTCCATA AAACCAGACC AGACAATAGA AGAGCAGCGC CATCTAAAAT AATCAGAATA 600 TAGGCGACTT TTTGCACCAT ATTGTATTCC TGCATATTCG TATGATGCAG CTTTCCATAC 660 AGTGCCTGCG TAAGGGATTT TTTCAGTGAG GTCCATGACA GCGGGAAAAA CTTGCTCCGG 720 AAACGTCCGC TACAAATTCC CAGAGTAAGA TAGATCGTGG CATTAATCAG CAGAATCCAC 780 ATCAGGGCGA AGTGCCACAG TAACGCACCG CCAAGCCAGC CACCGAGAGT TAATGCTGCC 840 GGATAGTTAA AAGAAAACAA AGGAGAAGCA TTATAAATGC GCCATCCACT ACATATCATG 900 CCTGCGACAG TAACAGCATT AATCCAGTGG CAACAGCGTA ACCACAGAGG RTGTATTTGT 960 TTTAACGGTA ATGGCTGCAT TATGTGATCT CTGTCTGTAA ACTAAGTATA TTATGGAAAG 1020 GAATGTTCAT CACATCCTCA CAAGAGTTTA AAAAAAATGT GACAANTCAT CGTCAAATGC 1080 TGGGGTAAAA TTCAGATAAA GAATATGTGG ATAACTTTTG ATGAATAACG TAAAAAAAAT 1140 ACTGCTGATG GAAGATGATT ATGATATTGC AGCTCTGTTG CGGCTTAATC TGCAGGATGA 1200 AGGGTATCAG ATAGTTCATG AAGCGGATGG CGCCAGAGCT CGTTTATTAC TAGACAAGCA 1260 GACCTGGGAT GCCGTAATAC TTGATCTTAT GCTGCCTAAT GTTAATGGGC TGGAGATTTG 1320 CCGTTATATC CGTCAGATGA CCCGTTATCT GCCTGTGATT ATCATCAGTG CCCGTACCAG 1380 CGAAACCCAC CGCGTCCTGG GACTGGAAAT GGGGGCTGAT GACTATCTAC CGAAACCCTT 1440 TTCCATTCCT GAGCTGATTG NCCCGCATCA AAGCGTTGTT TCGTCGTCAG GAAGCCATGG 1500 GGCAAAATAT TCTCCTGGCA GGTGGACTGA TTTGCTGTCA CGGTCTGTGC ATCAATCCAT 1560 TTTCACGTGA AGTTCATTTG CATAATAAAC AGGTTGATCT TACCCCACGC GAGTTTGATC 1620 TGCTGCTCTG GTTTGCACGT CATCCTGGCG AAGTTTTTTC CCGTCTTTCA CTGCTGGATA 1680 ATGTCTGGGG GTATCAGCAT GAAGGATATG AGCATACAGT CAACACGCAT ATCAACCGTC 1740 TTCGTGCCAA AATTGAACAG GATGCAGCAG AGCCAAAGAT GATCCAGACC GTCTGGGGAA 1800 AAGGGTATAG GTTTTCAGTT GACAATGCAG GAATGCGATA AATGAATTGT AGCCTGACAT 1860 TAAGCCAGAG GTTAAGCCTA GTATTTACAG TCGTTTTGCT GTTTTGCGCC GTGGACATGT 1920 GGCGTTCATA TTTACAGCAG TAATCTGTAT GGCAATGCAA TGGTACAGCG TTTATCTGCA 1980 GGCTGGCGCA ACAGATTGTC ATCACGGAGT CTCTGCTGGA TAATCGTGGG CAGGTGAATC 2040 ACCGGACATT AAAGAGTCTG TTTGAGCGTC TGATGACGCT TAATCCCAGT GTGGAGCTGT 2100 ATATTGTCTC GCCGGAAGGT CGGCTGCTTG TGGAGGCCGC CCCTCCAGGT CATATCAAAC 2160 GTCGGTATAT CAATATAGCG CCCTTGAAAA AATTTCTCTC CGGTGCTGTC TGGCCCGTAT 2220 ATGGTGATGA TCCCCGAAGT GTAAATAAGA AAAAAGTTTT CAGTACCGCA CCGCTTTACC 2280 TGAGGGATGA TCTGAAAGGA TATCTGTATA TTATTTTACA GGGAGAGGAA CTTAATGCTC 2340 TTACTGATGC AGCCTGGACA AAGGCACTAT GGAATGCACT GTACTGGTCG CTGTTTCTGG 2400 TAGTGATATG TGGTCTGCTG TCGGGTATGC TGGTCTGGTA CTGGGTAACC CGTCCCATAC 2460 AGCAACTAAC TGAAAATGTC AGCGGGATAG AGCAGGACAG TATTAGTGCC ATTAAACAAC 2520 TGGCAATTCA GCGCCCTGCC ACCCCCCCTA GCAACGAGGT CGAGATATTA CACAATGCCT 2580 TCATTGAACT GGCCCGTAAA ATATCCTGTC AGTGGGATCA ACTTTCAGAA AGTGATCAAC 2640 AGCGCCGTGA ATTTATTGCC AATATCTCCC ATGATTTACG GACGCCATTA ACATCACTTC 2700 TGGGATATCT GGAAACCCTG TCAATGAAGT CGGATTCGCT ATCATCAGAG GACTGTCATA 2760 AATATCTGAC AACAGCTCTC CGGCAGGGAC ACAAGGTGAG GCATCTGTCC TGTCAGCTTT 2820 TTGAGCTGGC ACGTCTTGAG CATGGTGCTA TAAAACCTCA ACTGGAGCAA TTTTCTGTCT 2880 GTGAACTTAT TCAGGATGTA GCTCAAAAAT TTGAGCTCAG CATAGAAACC CGTCGATTGC 2940 AACTAAGAAT TATGATGTCA CATTCCCTGC CTCTTATCAG GGCAGATATT TCAATGATAG 3000 AGCGTGTGAT AACAAATTTA CTGGATAATG CTGTACGCCA CACACCTCCG GAAGGCTCGA 3060 TCAGGCTGAA AGTCTGGCAG GAAGATAATC GGTTGCACGT CGAAGTGGCT GACAGCGGCC 3120 CTGGACTAAC TGAAGATATG CGAACTCATC TTTTCCGGCG GGCATCAGTG TTATGTCATG 3180 AACCGTCAGA AGAGCCCCGG GGAGGACTGG GATTGCTGAT TGTACGCAGG ATGCTGGTAC 3240 TACACGGTGG TGATATCAGG TTGACTGATT CAACGACTGG AGCCTGCTTT CGTTTTTTTC 3300 TTCCATTATA ACATCAGGCG GCATATTTTG GGGTGGTTAT GTGTATCTGC CTTTGTAAAA 3360 GGGATACAAG TTCTGTAGTG GAGCACAAAA TCAGGACACC GGAATAACCT GTTTCCACTT 3420 TTCTTCATGT AAGCAAGGCG GTAAACCATC GTTGTTCGTG TGAGGTCGAT AAACGTTGTA 3480 ATAACCATTA ATCCACTGGT TTATATCACG TACCGCATGG ATAAAATCAC CATAACCACC 3540 TTTCGGAAGC CATTCATTTT TAAGGCTGCG AAAGACTCTT TCCATCGGCG AATTATCCAG 3600 GCCATTCCCT CTGCAACTCA TACTTTGCAT TACCCCATAA CGCCAGAGTA ACTTTCTGTA 3660 TTTATTGCTT TTATACTGAA CACCTTGATC TGAATGAAAC AGCAGGCGGC CATCACGCGG 3720 TCGAGTTTCC AGTCCGTTAC GCAAAGCCCT ACACACCAAC TCAGCATCAG CGGTTAATGA 3780 GAGGGCTGAA CCGATAATCC GCCGTGAATA TAAATCAACA ACGAGCGCGA GCTAACACCA 3840 TTTGTCCTGC AGGCGAATAA AACTGATGTC GCGCACCAGA CGCAGTTTGG TGCGGCGGGG 3900 TGAAATTGCC GGTTCAGTAA ATTTGGCAAT GGCGGACTTT TGTCTTCGTT TACCCGGTTG 3960 TGATGTTTAA CCGGCTGTCG ACTTGTCAGC CCTCATTCCC GCATCAGTCG TCATGCCAGC 4020 CACCGGCCTG CATCAACGCC ACTCTGGCGC AACATCTGAC TGATTGCCCG GCTACCCGGC 4080 TGCGCCACGA CTGAGAGCAT GGAAAGCCCT CACCCGGCTT CGTAATTCAA TTCTTTGCAC 4140 ATTAACAGGA CGCTTCACCT GCGCGTAATA AACGCTACGG TTAATACCGA ATAAATGACA 4200 AATAACCCAC ACTGGCCACT TTGCTTTCAG CTGTGTGATT AGCGCGACAG CTTCCCGGGG 4260 ATTTCGCTCA TCAGCACGGC AGCCTGCTTT AGTATTTCTT TTTCCATCTC AACGCGCTTT 4320 ATCTGCGCTT TAAGCTGCTG AATTTCGCGT TGTTCAGGGG TAATAGCATT ACCAGCTGGC 4380 TCAATACCCT GAAGTTCCTG CTTATACAAC CGTATCCATT TACGCAAATG GTCAGGGTTG 4440 AGCTCGAGTG CCTGCGCGAC TTCTCTGACA TCACGCTGGT ATTTAACCAC CACCTGCTCG 4500 AAAGCTTCAA GCTTGAACTC CGGGGAAAAG GTACGTTTAG TCCGACGAGT TTTGATCATG 4560 CATCACCTCA TTTTCACTGT TTTAACATTA ACAGGATTTC GAGGTGTCCT GAATTACCGA 4620 TCCACTACAA AGTACGACAG GTACTGTGGA GGTACTCCCG TAAAGACGGC CATCAAGCTC 4680 CCGCTCCGAC ATACCTGCGG GCAGAGGCCA TGAAAAGCCA GCTTTGCGAA AGCGCACGAA 4740 CATACCACAA GCTGTTGATT TTGGTACGCC CAGGCGACGC CCGACCACAA CCTGGGGTAA 4800 ATGTTCTTCA AAGTGAAGAC GTAAAGCTTC AGTGATCCAA GTCCGGTGTT TCATACGATA 4860 GTGTCCATTA AAAATGATGG ACATTATTTT TGTAAAACCG GAGGAAACAG ACCAGACGGT 4920 TTAAATGAGC CGGTTACATG TAATCCATAC TCATCCAAGG TTTAATTCTG ACACAATAAG 4980 AAAATATGGA AAGTCTCGCT CTAGAGATGG GGAGAGGGAT ATTGAAGTGT ATGATATTCC 5040 AAGAACTGCC GGAGATATCC TCGTAAATGG ATTTTCCAGT GCAAACTGAT AACAAATTCG 5100 AAGTCATTAT CTGCAACAAG ATTGATTGAT GTAGGGGATA TGTTAGAGCA TTATAATGCT 5160 CAAGGATTTG GCGTGATGAC ATCTGCGCCA ATTGATGCGA CACTATATGA TAAACTGGAT 5220 GCTATTTGCA GTAAGTGTAA AATAGAACAA ATAAATTTTT CAGTATTAGA GTCAGAACGC 5280 GCACTATATT ATGACGATAT ATTAAGATGC CGTTACTTTG GTAAATAMCA TAAAATTAAT 5340 CAATATGGTA ATATATCAGT TGTAATTGAT CGAAACAAAG CACATAAATG CCATCTTATA 5400 AAGATGGTGT TTKTTAAGCA TATAAAATAT ATTTTCTATA AGATATAGGG CAAACTAAAT 5460 TTCTTGACTT CTATGATGGA CTAACTAGAT ATACATGCCG CCAGTTTTTA TAAAACGACG 5520 GCATATATAA TCATTTATAT ATCTTTTGAT TTTATTCGTA ACCACTCATG TTGATCTAAA 5580 CCTATTCTTG ACAGATTAGC AACAATATCA GTTGTTATTT TTTGCGCGTA CGTTGTTTTT 5640 ATTTCCCCGA TCCATTTCAA TACTTTTGGA GTAGATATTT TTTCAACGAG TAAAGGAACG 5700 AATGAGATAT AGTCAGTATT AACTAGATTG TTCTTTTTCC CTATGATGAC ACCGTTTCCA 5760 TTTTCGACTC CAAATGAAAA TGAAATAATA TTAGAAGCTT TTGCCGGCAT TTTAATTTTA 5820 TAAAAACCGC CATATTCATC TTCGATTAAC AAATTGTAAT TATTATCGTC CAGTGTTCCC 5880 CTGAGGAATA AAAAATCGGC TTTTTCATGC AATCTGACGC TATCACATAA TGGTTGTATG 5940 CATAGATAGA CAAAATTATA TGCATCTAAA AGTAAAGTTC CTTGTTTTAA GGACACATTA 6000 TCTATATGAG AATGATATCT TAAACTCCTG CGCGTGATTT CCAGAGAGCA TAATTGCATT 6060 AACTTTTTAT CTTCTTCACC ATCTTGGCTT AAGTATTCCT TTTTACCTAA AGATGCGTGT 6120 TCAATAGCGT GTTGAATTTC TTCTAAAGAA TCAGCAGAGA GTATATTCCT TAGATGTTCT 6180 ACTGATAAGT CTTTTTGTTT TTTTCCAGTT AATAGAAAAT TCTTACAACC ATTTTTTGCA 6240 TAGTGAAAAA TAGGCCAATG GGATAAGGAG TTTTTGCTTA GAGATTTCTG GGGA 6294 (2) INFORMATION FOR SEQ ID NO: 6: ( ) SEQUENCE CHARACTERISTICS: (A) LENGTH: 4519 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 6: TATTCCTTTC TCTCCCATGA TAGGGCGAAA GGCTTTATTA CTATCCACTG CTGGTTTATT 60 AATTGCATCA TCGTCGATTA ATTTGCTGGA GGTTCCAATA GTCAACCACC TCTCTTCAAA 120 TTCATCGGTT GTCATACCTA ATCCATCATC TCTCAAGATA AGAAGATTTT CTTTCCTAAA 180 AAAATCAACT TCGACATTAT CAGCATAGGC ATCATGAGCA TTTTTAAATA ACTCACTCAA 240 GGCAGTAGGT ATACCTGCAA TTTGTTGTCT GCCAAGCATG TCCAAAGCTC GAGCCTTTGT 300 TCTTATTTTA GCCATATATC TATGAATCCT TATTAGTACA ATTTTCTATG AGATGTAGCC 360 CAAATAGTCT AGCGAGTTCG CAAGGTACAG CATTGCCGAT TTGCTTTGCC ATTGAATTCA 420 GCGAACCTTT AAAAACATAG CTTAAAGGAA ATGTTTGTAA TCTTGATGCT TCTCTTATGC 480 TAATTGCTCT ATGTTGAGTG GGGTCAGGAT GCCCAAAACG ACCATTGGAG TAACTATTAC 540 ATTTCGTCGT AAGTGTAGGC GCAGGCTTAT CCCAACTCAT TCTTCCATAA GTATCTGTGT 600 GGCCATCATA ATTTTTATGG CATTTATTAA CTAACTCTTC TGGCCAATTT CTTCTATCCC 660 CTCCTTCTGG AGTGTGCATA AKTCTTTTTA GGTTAAGAGG GCTCAGTGTT CCAGCCCTAT 720 GTAAAGGATC TTTGGGGTCG GTTTCTCCTG AACATAACTT TGTGAAGTCC TGGATATAAT 780 CTCGTACAGT TTTGAATGGG ATTTTATTTT TACCATGGGT TATCTCTGGT AGGGTAACTT 840 TACCTACTCG ACTAGCTAAG AGCACGAGTC TTTTTCTTCT TTGGGGAATC CCATAGTTCT 900 CAGCATTGGC TATAAAAGAT ATATAGTTAT ACTCTAACTC TTTAAGTAGC TTAATAAACT 960 CCTGAAATGG GCCTTCTTTT TCTTCATCAA TTTTTTGCAT TCCAGGAACA TTTTCAAGCA 1020 TAATATATTC AGGAAGAAGT TCTCTAATAA AACGATGAGT TTCATTTAGT AGATTTCTCC 1080 TTGAGTCGTC ACTAGTTTTA TTTTTATTCT GTTGCGAAAA TGGTTGACAT GGTGCACATG 1140 CACTCAGTAA CAAAGGCCGT TTAGCTTTAA TATCAATGAT GTCGGAGATA TCTTGAGGTT 1200 CGATTTTCCT AATATCATCT TGGATGAATT TTGCATCAGG GAAATTAGCT TTAAATGTTT 1260 CTGATGCTTG TTGGTCAATA TCTAATCCAA GCTCGATATC AAAGCCAGCC TGACGTAGCC 1320 CTTCACTGGC TCCACCACAG CCACAAAAAA AATCTATAAC TATCAATTTG ATACCTTCTT 1380 TGAACTAAAT AAAACAACTC GAATAAGTTG ATATTTTAAA TAAAAATAAT TGGTATGGAT 1440 ATGAACTTTG GTCACGCTAC CGCCCTGAGK TCATGGCCAT CCCCAGACCT TTTAAAGGGA 1500 TTATGAACAA CACCCAGCCG ACGTTCAACG GTGTTACCCA TACATATCAC AAAGTTAGTT 1560 AATTGGTTGG TCGTAAATTG ACCTAAAATG GATTGAGGGC AATGCAAAAA TCATTGGGAA 1620 ATCCAGGCGA CACAGATGTT CGGAAGAGAC TGAATGTTAA AAATATAGAA TGTATATTCT 1680 CAAAAAAGAG ATATTTCATT ACATTTTATA TGTGTATAGG AAAGTGAGAT TGGCGAATCA 1740 CCTCCCAATC ATCCCGCCAG CGCTCCATTC AGCGCCACGC CAACCCTCAC TCCAGCCCAC 1800 GTCATCGCCC CCAGCCAGAA TGTCGGCAAC ACCAGAAACA TCAACCTCAT CACCAGATTG 1860 ATAATCACGT CATCCTGCGT ATTCTGGATC CCGGCTAAAT TCCAGCTACT GTGGGTATCG 1920 CTGTTGTAGA GCACATCCAG CAGCCAGCTA TCAAGCCACC GTGCCAGTTC CCACCAAAAG 1980 GTGAGGAAAA ATAGTGCAAA CTGCACAAAC GTCAGCGTCA TCACTACTTT CACATCCCAC 2040 GCCGAACAGA GCGTTATCAG CGGAATACAG ATCACCAGCG CTATTTGCAG TGCGCCTGTA 2100 CCATCGGTAG TGCCTAACGC ACGCTGTCGA ATGCCGTACA TGCCGCTATG CTGCCGAGGA 2160 TATTTCTAGC GCCGGATGCC AACCGGGTGG CGGCATTGGC GACGGTGCCA TCAACGTTAC 2220 CGCCATAGCT TGGATAAACG CGCCCATTCT GCGATACCTG CATATTTCGT TCACTGACCC 2280 GCGAGCGCAG CACGGCCTCT TCATACACTA CCTGCGACTG GTCGATTTTT TTAAACGCCG 2340 TCCAGATATC TAGGGCAGGA AGTTGCAGTA GACGGGCTTT CAGCCCAAGC GGTGTCGTCG 2400 GCCCACCGCT GTTTACAAGT GGGATAGCCG CCCGCGCCCG TATCGGCCAG CCCGGCATCG 2460 CGCGATGCAC TGTACGGCCA AGCACTGTGT GGTGAAAGCG CATGGTCGGA AAAGGCCTGT 2520 TCAGCTAACC AAGCACATCC CACCATCACA AGAATCGCCA GAAAACCAAA CTCAGTCAGA 2580 ATAACTCTTC CTGATTCAGG CTTTGCTCCT GCATTATGGC TACCACTATT GTTTGCCTGC 2640 ACGTATCATC TGATAACGGT TAATTAACTG ATTTAGCGCC ATTTCAGCCT GTTTTTGCTG 2700 CTGTTCACTG CCATTCTGGT TACGGACTTC ACCGTAGCGA CGTAACTGCT CTTCCGCCGG 2760 GATATGCCGG TTAAAAGCCT GCATGATGCC AAACACCTCC GTTTTCAGTT CACTGACCGT 2820 CATGTATTTT CCCCGCTGTT CATCCTGACG GTTCAGGCGC TCAGCCAACT GCTGTAAGCG 2880 GATCATGCCT TCGTTCCAGC CCGTCATCGC CTCTTCCGGG AGCGCACGAC TCCTTACACT 2940 CTTCTGCCAG TTATCCACCA TTTCCTGAAC ACGGGGATTG CCGGGGACAA GAACCCTCAG 3000 TTGCTGCAGC AGCTGCGCAC TGCACCGCAG GTTGTATGCT GGAGGTAATT CTGCCAGTCG 3060 CGTTATCTGC TGACCGGAAA GGGTTATCCA GTGCACTCAG GGCAGATACC GGATTCAGGT 3120 TAATTTTTTC AAACAGGGAA GCATATACGC TGTCGCCGGT ATGCGTTTCA GATACCACAC 3180 TCTCTGCGAC GTTCTTTTCT TTCTGTACAG ACATCAGCAT TTTCTGTAAG CGTACAGCGA 3240 GGGCCGTATT GACGGGGATG TGTTATTCAG CTGGCAGTGC TATGCGCCAC GGAAGCAGTT 3300 CGCTGACCCG GTTGACCGGC CAGTCTGCTA TGACGGCAAG CACATGGCGA AGGTAGCTTT 3360 CTGGATCCAC GTCATTCAGT TTGCACGTCC CGATCAGGCT GTACAGTAGC GCTCCCCGCT 3420 CACCACCATG GTCAGAGCCG AAGAACAGGA AGTTTTTACG ACCCAGACTG ACCGCCCGCA 3480 GGNCATNTTT CAGCGATGTT GTTGTCGATT TCCACCCAGC CATCGTTCGC ATAGTACGTC 3540 ATGCCGGCCA CTGGTTAAGT GCGTACGCGA ACGCCTTCGC CACCATCAGG CTGGACAGGG 3600 GACTTTCACC CCCAAGCTGC TGAACATGCC CGGCACACAA AGAAGATCTC GGCTCAGTGG 3660 CCGGGATTAG TTATACAATT ATCTGATTGA TTTTTAATAT ATCTTTTCTT AAATCATCGT 3720 TAATATCTGA CGGTTCTAGC TGGTTTATAA GTTGCCTTAT TTGGGTAAAG GTACTTTTCT 3780 GATCTTTTAG ATCTTCTCCT TTTATCGTTG ATAAAGCTGC AATTAGTTCA CCATCGTAAT 3840 ATTCACCCGC TAACGGCTCT TTAGTTAGAA CTTCCAACAC TCTTGGCATC AACTGATCAA 3900 TACATAAATT TTGTCGGATA GCGCGGCAAA GATCTTCCAC TGTTAACTTT TCAAGAGGCA 3960 CATCTATGAT ACGTTCGAAC CAGAGTTCAA GCGGTGATTG TTGCTCAGGC TCTTTTGTCA 4020 TATTGATGTT TCCAATCAAT TTACGTAAGG TAATCATATT CCATATCCTT TCAAGGCTGA 4080 TTCTATTTTA TTAATAGCAT CTGTTGCTCT GCCATACGCA GCCTGAGCTT CAGGATTGTT 4140 GACGTTTTTC AACGTATCCG CATGATTTCT TAATCCTCTG AGCGTATTTT GCATTTCCTG 4200 CATATGATCC CAATATCCTC CATTCTCTTT AGGAACTGGC TTACCATCCA TATCCTTGAG 4260 AGTTCCAATT AATATCATGA ATCTTTTCAG ANCATTTTTT TAATAGTGGT TAATCGANTC 4320 TTCTTTAANT CGGCAACTTT TCTTGGCCTT CCTGGAATTA AAGGCTTTAA TCCTAACAAG 4380 TTTTTTTCTC AATTTTTGGC TGGCTTTAGG GAATCAATTT TTCCCGGATT GGGTGGGTGG 4440 GTGGTAACCC GGGTTTCCCT TGAAGCCCGG GAAACCCGGC CCCAAGTTCT TACTTTTTTT 4500 CCCGCAATCG GGTCAAGAT 4519 (2) INFORMATION FOR SEQ ID NO: 7: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1213 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 7: ATTACAGAAT GTGGAAATTA AGTATGATTC GAAAAAAGAT TCTGATGGCT GCCATCCCCC 60 TGTTTGTTAT ATCCGGGGCA GACGCTGCTG TTTCGCTGGA CAGAACCCGC GCGGTGTTTG 120 ACGGGAGTGA GAAGTCAATG ACGCTTGATA TCTCCAATGA TAACAAACAA CTGCCCTATC 180 TTGCTCAGGC ATGGATAGAA AATGAAAATC AGGAAAAAAT TATTACAGGG CCGGTTATTG 240 CCACCCCTCC GGTTCAGCGC CTTGAGCCGG GTGCGAAAAG CATGGTCAGG CTGAGTACCA 300 CACCGGATAT CAGTAAACTT CCTCAGGACA GGGAATCACT GTTTTATTTT AATCTCAGGG 360 AAATACCGCC GAGGAGTGAA AAGGCCAATG TACTGCAGAT AGCCTTACAG ACCAAAATAA 420 AGCTTTTTTA TCGCCCGGCA GCAATTAAAA CCAGACCAAA TGAAGTATGG CAGGACCAGT 480 TAATTCTGAA CAAAGTCAGC GGTGGGTATC GTATTGAAAA CCCAACGCCC TATTATGTCA 540 CTGTTATTGG TCTGGGAGGA AGTGAAAAGC AGGCAGAGGA AGGTGAGTTT GAAACCGTGA 600 TGCTGTCTCC CCGTTCAGAG CAGACAGTAA AATCGGCAAA TTATAATACC CCTTATCTGT 660 CTTATATTAA TGACTATGGT GGTCGCCCGG TACTGTCGTT TATCTGTAAT GGTAGCCGTT 720 GCTCTGTGAA AAAAGAGAAA TAATGTACCG CAATAACGGT TAAATGCGGG TGGGATATTA 780 TGGTTGTGAA TAAAACAACA GCAGTACTGT ATCTTATTGC ACTGTCGCTG AGTGGTTTCA 840 TCCATACTTT CCTGCGGGCT GAAGAGCGGG GTATATACGA TGACGTCTTT ACTGCAGATG 900 AGTTGCGTCA TTACCGGATA AATGAACGGG GGGGACGCAC CGGAAGCCTG ACCGTCAGTG 960 GTGCACTGCT GTCCTCACCC TGCACGCTGG TGAGTAATGA GGTGCCGTTA ARCCTCCGGC 1020 CGGAAAATCA CTCTGCGGCA GCCGGAGCAC CTCTGATGCT GAGGCTGGCA GGATGTGGGG 1080 ACGGTGGTGC ACTTCAGCCC GGAAAACGGG GCGTTGCGAT GACAGTCTCC GGCTCACTGG 1140 TAACCGGTCC CGGAAGCGGA AGTGCTTTAC TTCCTGACCG TAASCTATCC GGCTGTGACA 1200 TCTTGTTATA CAC 1213 (2) INFORMATION FOR SEQ ID NO: 8: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 451 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 8: ACGCTCTAGT ATTCTCTGTC GTTCTGCCTG GGCCACTGCA GATAGAATAG TGACAACCAT 60 TTTACCCATC TCCCCATCGG TACTGATTCC GTCATCAATA AACCGAATGG ATACACCTTG 120 GGCGTCAAAC TCTTTTATTA ACTGGATCAT GTCAGCAGTA TCGCGCCCAA GGGGTTCAAG 180 TTTCTTCACC AAGATGACGT CACCTTCCTC CACCTTCATC CTCAGCAAGT CCAGCCCTTT 240 CCGATCGCTT GAACTGCCCG ATGCCTTGTC AGTAAAGATG CGATTTGCTT TCACGCCTGC 300 GTCTTTGAGT GCCCGAACCT GAATATCGAG AGATTGCTGG CTGGTTGATA CCCGTGCGTA 360 ACCAAAAAGT CGCATAAAAA TGTATCCYAA ATCAAATATC GGACAAGCAG TGTCTGTTAT 420 AACAAAAAAT CGATTTNAAT TAGACACCNT T 451 (2) INFORMATION FOR SEQ ID NO: 9: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 720 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 9: GACAAGGCTT ATAAACTCAC TGACGGGGCT GGCATGTTCC TGCTGGTACA TCCTAATGGT 60 TCCCGTTACT GGCGTCTCCG TTATCGTATT CTGGGTAAGG AGAAGACTCT GGCACTTGGT 120 GTGTATCCAG AAGTTTCTCT CTCCGAAGCT CGTACAAAAC GGGATGAGGC CCGAAAACTG 180 ATTTCGGAGG GGATTGACCC TTGCGAACAG AAAAGAGCTA AAAAAGTAGT CCCTGATTTA 240 CAGCTCTCTT TTGAACATAT TGCACGACGC TGGCATGCCA GTAATAAACA ATGGGCACAA 300 TCACACAGCG ATAAAGTACT CAAAAGCCTC GAAACACACG TTTTCCCCTT TATCGGCAAC 360 CGGGATATCA CAACACTCAA TACCCCGGAT CTGCTTATCC CTGTTCGTGC TGCAGAAGCT 420 AAACAAATTT ATGAAATCGC CAGTCGTCTG CAGCAAAGAA TATCTGCCGT AATGCGTTAT 480 GCCGTACAGT CTGGCATCAT CAGATATAAT CCTGCTCTGG ATATGGCTGG CGCATTGACT 540 ACGGTAAAAC GCCAGCATCG CCCCGCTCTT GATCTTTCAC GTCTGCCTGA ACTTCTGTCG 600 CGTATTAACA GTTATAAAGG NCAGCCTGTC ACCCGGCTTG CGTTGATGCT GAATTTACTG 660 GGTTTTTATT CGTTCCAGTG AACTCAGATA CGCCCGCTGG TTCTGAAAAT TGATATTGGA 720 (2) INFORMATION FOR SEQ ID NO: 10: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 2920 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 10: NCNTTAATTT TATATCTCGT AAAATAAAAT GTTTTCTGTA CCGCTCTCCG GAGGGGGGAA 60 TGATTCGTTT ATCATTATTT ATATCGTTGC TTCTGACATC GGTCGCTGTA CTGGCTGATG 120 TGCAGATTAA CATCAGGGGA AATGTTTATA TCCCCCCATG CACCATTAAT AACGGGCAGA 180 ATATTGTTGT TGATTTTGGG AATATTAATC CTGAGCATGT GGACAACTCA CGTGGTGAAG 240 TCACAAAAAC CATAAGCATA TCCTGTCCGT ATAAGAGTGG CTCTCTCTGG ATAAAAGTTA 300 CGGGAAATAC TATGGGAGGA GGTCAGAATA ATGTACTGGC AACAAATATA ACTCATTTTG 360 GTATAGCGCT GTATCAGGGA AAAGGAATGT CAACACCTCT TACATTAGGT AATGGTTCAG 420 GAAATGGTTA CAGAGTTACA GCAGGTCTGG ACACAGCACG TTCAACGTTC ACCTTTACTT 480 CAGTGCCCTT TCGTAATGGC AGCGGGATAC TGAATGGCGG GGATTTCCGG ACCACGGCCA 540 GTATGAGCAT GATTTATAAC TGAGTCATAC CCAAATGAAT AACTGTAATT ACGGAAGTGA 600 TTTCTGATGA AAAAATGGCK CCCTGCTTTT TTATTTTTAT CCCTGTCAGG CTGTAATGAT 660 GCTCTGGCTG CAAACCAGAG TACAATGTTT TACTCGTTTA ATGATAACAT TTATCGTCST 720 CAACTTAGTG TTAAAGTAAC CGATATTGTT CAATTCATAG TGGATATAAA CTCCGCATCA 780 AGTACGGCAA CTTTAAGCTA TGTGGCCTGC AATGGATTTA CCTGGACTCA TGRTCTTTAC 840 TGGTCTGAGT ATTTTGCATG GCTGGTTGTT CCTAAACATG TTTCCTATAA TGGATATAAT 900 ATATATCTTG AACTTCAGTC CAGAGGAAGT TTTTCACTTG ATGCAGAAGA TAATGATAAT 960 TACTATCTTA CCAAGGGATT TGCATGGGAT GAAGCAAACA CATCTGGACA GACATGTTTC 1020 AATATCGGAG AAAAAAGAAG TCTGGCATGG TCATTTGGTG GTGTTACCCT GAACGCCAGA 1080 TTGCCTGTTG ACCTTCCTAA GGGGGATTAT ACGTTTCCAG TTAAGTTCTT ACGTGGCATT 1140 CAGCGTAATA ATTATGATTA TATTGGTGGA CGCTACAAAA TCCCTTCTTC GTTAATGAAA 1200 ACATTTCCTT TTAATGGTAC ATTGAATTTC TCAATTAAAA ATACCGGAGN ATGCCGTCCT 1260 TCTGCACAGT CTCTGGAAAT AAATCATGGT GATCTGTCGA TTAATAGCGC TAATAATCAT 1320 TATGCGGCTC AGACTCTTTC TGTGTCTTGC GATGTGCCTA CAAATATTCG TTTTTTCCTG 1380 TTAAGCAATA CAAATCCGGC ATACAGCCAT GGTCAGCAAT TTTCGGTTGG TCTGGGTCAT 1440 GGCTGGGACT CCATTATTTC GATTAATGGC GTGGACACAG GAGAGACAAC GATGAGATGG 1500 TACAGAGCAG GTACACAAAA CCTGACCATC GCAGTCGCCT CTATGGTGAA TCTTCAAAGA 1560 TACAACCAGG AGTACTATCT GGTTCAGCAA CGCTGCTCAT GATATTGCCA TAAATGGTTT 1620 ATCCGGAGCC GGATAGTGTG TTGTGGATAT CTGGCATGCC CCGGGAAGTC ACCTTTCAGA 1680 CGGGCGGAGG GCTGGTGAAT TATCCGCGAT TACTGAGCAG TATGGATAAT CCTTTTTCAC 1740 AGACTTGTCA GCAGCCAGCA TTTATGTTCT TTTATCTGAG GGAATTTATC TGTACGCTGT 1800 GCCGGGATAT CTCAGTTATA CAGAAATCAG GCAGGAATAA ATTGTAGTGG AAAGTCGATG 1860 TTTACCGGAT GACTGATGCG CGCTTGTACA CAGACAGTGT GTTTCAGTAA TATGGAGAAT 1920 AATGAAATGA ATAACACAGA CACATTAGAA AAAATAATCA GACACCAAAA AAACAAAGAC 1980 CCCGCATATC CTTTCGGGAA CATTTGTTGA TGCAGCTCTG TATTCGCACA AATAAAAGAA 2040 TGCAGGATAA TATATCTGAA TTTCTGGGGG CGTATGGAAT AAATCACTCA GCATATATGG 2100 TCCTCACCAC ATTATTCGCA GCGGAGAACC ATTGTCTGTC ACCTTCAGAG ATAAGCCAGA 2160 AACTTCAGTT TACCAGAACT AATATTACCC GCATTACAGA TTTTTTAGAA AAAGCCGGAT 2220 ATGTAAAAAG GACGGATAGC AGGGAGGATC GCCGTGCTAA AAAAATCAGT CTGACATCTG 2280 AAGGTATGTT TTTTATTCAG AGGCTCACTC TTGCACAAAG CATGTATCTG AAAGAAATCT 2340 GGGATTATCT GACCCATGAT GAACAGGAAC TGTTTGAAGT CATTAATAAA AAATTACTGG 2400 CACATTTTTC TGATGCCAGC TCATAAAGTG CGAAATATCT GAGGATGCCG GATAGCTTCA 2460 GGCAAAATAA TAATGATTCT TGCAGATGTG TTTTTCCGGA TACAAAAACA AATGATAAAA 2520 ATTGCAGCGC CAGGCACCTT TCAAAGCAGG GAGACCTGTA CCGCGTCGAA AATTTCAGCC 2580 AGTTAATATC ATTGTCTGAA CCAGGCACTT TGCCCGGGCA GGAGAAGGAG TTGTGGCGGT 2640 CTCAGCCCGG AACAATTTGA AAACCATAAT CTCGCTTAGG GCCGTGTCCA CATTACGTGG 2700 GTAGGATCAC TCCTGGATTT TCTCTTTTTG GACATTGACG TCTCCATTGG TTTAAACACG 2760 GCAATGGAGA CTGCGGTGAA AAGAGTTAAT TCCCGGAGTG ACTGGCTGGA TGCCAATCAA 2820 TGATCGGAAG CATGCCAAAC TGTGAACGGA GATGGATGCC GCCAAATCAT GATCGATTCA 2880 GATGCCATAT TTGCAATATC GCGTTAATCG TCAGTTCAGC 2920 (2) INFORMATION FOR SEQ ID NO: 11: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1678 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (x ) SEQUENCE DESCRIPTION: SEQ ID NO: 11: GGTAAGGAAG TTATATATAT GAGCAACTAT ACATCTTAGA TGTATGATAA AGAAAAAGAT 60 AACAGTTCTT TAGAATATGT ATATTGAAGA GAATGCAATA GCATGGTTTA TATAAATTAC 120 GCATAAAAAT AAGCATATGT AAGCATTTTG GTTTGCTTTT TTTAACCTGC CACCGCAATG 180 AATGCTTTTT TTATGTTAAT GTGCGTTATG AAACTAAATG CAAGAAACAT ATTTAAAGGA 240 TTAATATCGT TCTCTCACAG ACTCCGTTTA CTTATTCAAG AATATAATTT AATTTATAGT 300 GAGCTTATTA TGAATATGAA CAATCCATTA GAGGKTCTTG GGCATGTATC CTGGCTCKGG 360 GGCCAGTTCC CCATTACACA GAAACYGGCC AGTTTCTTTG TTTGCAATAA ATGTATTACC 420 TGCAATACGG GGCTAACCAA TATGCTTTAT TAACCCGGGG ATAATTACCC TGTTGCATAT 480 TGTAGTTGGG GCTAATTTAA GTTTAGAAAA TGAAATTAAA TATCCTAATG ATGTTACCTC 540 ATTAGTCGCA GAAGACTGGA CTTCAGGTGA TCGTAAAKGG TYCATTGACT GGATTGCTCC 600 TTTCGGGGAT AACGGTGCCC TGTACAAATA TATGGGAAAA AAATTCCCTG ATGAACTATT 660 CCGAGCCATC AGGGTGGATY CCAAAACTCA TGTTGGTAAA GTATCAGAAT TTCACGGAGG 720 TAAAATTGAT AAACAGTTAG CGAATAAAAT TTTTAAACAA TATCACCACG AGTTAATAAC 780 TGAAGTAAAA AACAAGACAG ATTTCAATTT TTCATTAACA GGTTAAGAGG TAATTAAATG 840 CCAACAATAA CCACTGCACA AATTAAAAGC ACACTACAGT CTGCAAAGCA ATCCGCTGCA 900 AATAAATTGC ACTCAGCAGG ACAAAGCACG AAAGATGCAT TAAAAAAAGC AGCAGAGCAA 960 ACCCGCAATG GGGGAAAACA GACTCATTTT TACTTATCCC TAAAGATTAT AAAGGACAGG 1020 GTTCAAGCCT TAATGACCTT GTCAGGACGG CAGATGAACT GGGAATTGAA GTCCAGTATG 1080 ATGAAAAGAA TGGCACGGCG ATTACTAAAC AGGTATTCGG CACAGCAGAG AAACTCATTG 1140 GCCTCACCGA ACGGGGAGTG ACTATCTTTG CACCACAATT AGACAAATTA CTGCAAAAGT 1200 ATCAAAAAGC GGGTAATAAA TTAGGCGGCA GTGCTGAAAA TATAGGTGAT AACTTAGGAA 1260 AGGCAGGCAG TGTACTGTCA ACGTTTCAAA ATTTTCTGGG TACTGCACTT TCCTCAATGA 1320 AAATAGACGA ACTGATAAAG AAACAAAAAT CTGGTAGCAA TGTCAGTTCT TCTGAACTGG 1380 CAAAAGCGAG TATTGAGCTA ATCAACCAAC TCGTGGACAC AGCTGCCAGC ATTAATAATA 1440 ATGTTAACTC ATTTTCTCAA CAACTCAATA AGCTGGGAAG TGTATTATCC AATACAAAGC 1500 ACCTGAACGG TGTTGGTAAT AAGTTACAGA ATTTACCTAA CCTTGGATAA TATCGGTGCA 1560 GGGTTAGATA CTGTATCGGG KATTTTATCT GCGRTTTCAG CAAGCTTCAT TCTGAGSCAT 1620 GCAGATGCAG ATACCGGRAC TAAAGCTGCC AGCAGGTGTT GGATTNACCA ACGGAANT 1678 (2) INFORMATION FOR SEQ ID NO: 12: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 2676 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 12: AAGGATTACT TTGGAATCTG ACAACAAAGT TACTATGAAA AAGAACTAAC AAAGTTATAT 60 AATGACGCTA AAAATGCTTT GAAAGATGTG CAATCTAAAG CAAATAGGTT AATTTCTGAT 120 AATAAGANAA AACATAAGAG TGAACTAAAA AACATTTCTT ATGAATTCCA ATCAACTAAT 180 CTCAATGGCA AAGATACTGC GTATATATTG GATGTARAAA GAAATCTAGA AAGTAAAATT 240 GAGAATACTT CAAACGAATG AGTGTAATGA AATAAGAAAA CTAACCGACC AGATTGCAAT 300 AATTAGTGAT AGTACCACTT CTGAAAATTT ATCATCGGCT CAAGTAACTG AAGCAATCGA 360 AACTGAACTT GAACATTTAC GAGACCAACA AGCAAATAAC GCAGAGTTAA TACTACTTGG 420 CATGGCTCTT TCTGTAGTAC ATCATGNATT TAATGGTAAT ATTAGGGCAA TTAGAAGTGC 480 GCTAAGGGAA TTAAAAGCAT GGGCTGACAG AAATCCTAAG CTTGATATTA TATACCAAAA 540 AATCAGAACT AGTTTTGATC ACTTAGATGG TTATTTAAAA ACCTTTACAC CATTGACAAG 600 ACGTTTAAGT CGCTCTMAAA CCAATATAAC TGGAACTGCC ATTTTAGAAT TTATCAGAGA 660 TGTATTCGAT GATCGTCTTG AGAAAGAAGG AATTGAATTA TTCACTACCT CAAAGTTTGT 720 TAATCAAGAA ATTGTAACTT ACACATCAAC CATTTACCCT GTCTTTATAA ATCTAATTGA 780 TAACGCAATA TACTGGCTTG GGAAAACAAC TGGAGAAAAA AGACTTATAC TTGATGCKAC 840 TGAAACAGGA TTTGTTATTG GTGATACTGG TCCCGGTGTT TCAACTAGAG ATCGAGATAT 900 AATATTTGAT ATGGGATTTA CACGAAAAAC AGGAGGGCGT GGAATGGGAT TATTCATTTC 960 CAAAGAGTGT TTATCTCGAG ATGGATTTAC TATAAGATTG GATGATTACA CTCCTGAACA 1020 GGGTGCTTTC TTTATTATTG AGCCATCAGA AGAAACAAGT GAATAGCGGA TATAAATAAA 1080 TGACAAGCTC TACTGATTTN CATAAACTTT CTGAAGACTG CGTTCGCCGT TTTTTACATT 1140 CTGTAGTTGC TGTAGATGAC AATATGTCTT TTGGAGCTGG TAGTGATACT TTCCCTACAG 1200 ACGAAGATAT TAATGCTTTA GTTGATCCCG ACGATGATCC TACACCAATA ATAACAGCAT 1260 CAGCATCCCC AAGGATAGAA TCAACTAAAT CAAAAGCAAA GGTAAAAAAC CATCCTTTTG 1320 ATTACCAAGC TCTAGCAGAA GCTTTCGCCA AAGATGGTAT TGCTTGTTGC GGATTATTAG 1380 CTAAGGAAGG TGCGAATAAG CGGGGAAATT CTTCTCGGCT GACTCAGTCA TTTCATTTCT 1440 TCATGTTTGA GCCGATTTTT TCTCCCGTAA AT ' GCCTTGAA TCAGCCTATT TAGACCGTTT 1500 CTTCGCCATT TAAGGCGTTA TCCCCAGTTT TTAGTGAGAT CTCTCCCACT GACGTATCAT 1560 TTGGTCCGCC CGAAACAGGT TGGCCAGCGT GAATAACATC GCCAGTTGGT TATCGTTTTT 1620 CAGCAACCCC TTGTATCTGG CTTTCACGAA GCCGAACTGT CGCTTGATGA TGCGAAATGG 1680 GTGCTCCACC CTGGCCCGGA TGCTGGCTTT CATGTATTCG ATGTTGATGG CCGTTTTGTT 1740 CTTGCGTGGA TGCTGTTTCA AGGTTCTTAC CTTGCCGGGG CGCTCGGCGA TCAGCCAGTC 1800 CACATCCACC TCGGCCAGCT CCTCGCGCTG TGGCGCCCCT TGGTAGCCGG CATCGGCTGA 1860 GACAAATTGC TCCTCTCCAT GCAGCAGATT ACCCAGCTGA TTGAGGTCAT GCTCGTTGGC 1920 CGCGGTGGTG ACCAGGCTGT GGGTCAGGCC ACTCTTGGCA TCGACACCAA TGTGGGCCTT 1980 CATGCCAAAG TGCCACTGAT TGCCTTTCTT GGTCTGATGC ATCTCCGGAT CGCGTTGCTG 2040 CTCTTTGTTC TTGGTCGAGC TGGGTGCCTC AATGATGGTG GCATCGACCA AGGTGCCTTG 2100 AGTCATCATG ACGCCTGCTT CGGCCAGCCA GCGATTGATG GTCTTGAACA ATTGGCGGGC 2160 CAGTTGATGC TGCTCCAGCA GGTGGCGGAA ATTCATGATG GTGGTGCGGT CCGGCAAGGC 2220 GCTATCCAGG GATAACCGGG CAAACAGACG CATGGAGGCG ATTTCGTACA GAGCATCTTC 2280 CATCGCGCCA TCGCTCAGGT TGTACCAATG CTGCATGCAG TGAATGCGTA GCATGGTTTC 2340 CAGCGGATAA GGTCGCCGGC CATTACCAGC CTTGGGGTAA AACGGCTCGA TGACTTCCAC 2400 CATGTTTTGC CATGGCAGAA TCTGCTCCAT GCGGGACAAG AAAATCTCTT TTCTGGTCTG 2460 ACGGCGCTTA CTGCTGAATT CACTGTCGGC GAAGGTAAGT TGATGACTCA TGATGAACCC 2520 TGTTCTATGG CTCCAGATGA CAAACATGAT CTCATATCAG GGACTTGTTC GCACCTTCCC 2580 TAAGAGTTTT AATGTTTGAA GAAAGAGATA TAATTACAGC ATCATCCCAC AAAGCAGATA 2640 TTACAATACC TTGACTGGGN TATTGCCAAG CGGATA 2676 (2) INFORMATION FOR SEQ ID NO: 13: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1485 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 13: AAATTTGTCC TCCGGNTCTT TTCCCGTGGA TACGGGCATT GAGACCCGAA AGGSCCTGTA 60 TTTGCGACCG GAGAGGCATC CTGGGGGCTC AGTAAACCAG TGGTCGCTGT ATGGCGGGGC 120 TGTGCTTGCC GGTGATTATA ATGNCACTGG SAGCCGGTGC CGGCTGGGAC CTGGGTGTGC 180 CGGGGACCCT TTCCGCTGAT ATCACGCAGT CAGTAGCCCG TATTGAGGGA GAGAGAACGT 240 TTCAGGGAAA ATCCTGGCGT CTGAGCTACT CCAAACGGTT TGATAATGCG GATGCCGACA 300 TTACGTTCGC CGGGTATCGT TTCTCAGAGC GAAACTATAT GACCATGGAG CAGTACCTGA 360 ACGCCCGCTA CCGTAATGAT TACAGCAGTC GGGAAAAAGA GATGTATACC GTTACGCTGA 420 ATAAAAACGT GGCGGACTGG AACACCTCTT TTAACCTGCA GTACAGCCGT CAGACATACT 480 GGGACATACG GAAAACGGAC TATTATACGG TGAGCGTCAA CCGCTACTTT AATGTTTTCG 540 GACTGCAGGG TGTGGCGGTT GGATTGTCAG CCTCAAGGTC TAAATATCTG GGGCGTGATA 600 ACRRTTCTGC TTACCTGCGT ATATCCGTGC CGCTGGGGAC GGGGACAGCG AGCTACAGTG 660 GCAGTATGAG TAATGACCGT TATGTGAATA TGGCCGGCTA CACTGACACG TTCAATGACG 720 GTCTGGACAG CTACAGCCTG AACGCCGGCC TTAACAGTGG CGGTGGACTG ACATCGCAAC 780 GTCAGATTAA TGCCTATTAC AGTCATCGTA GTCCGCTGGC AAATTTGTCC GCGAATATTG 840 CATCCCTGCA GAAAGGATAT ACGTCTTTCG GCGTCAGTGC TTCCGGTGGG GCAACAATTA 900 CCGGAAAAGG TGCGGCGTTA CATGCAGGGG GAATGTCCGG TGGAACACGT CTTCTTGTTG 960 ACACGGATGG TGTGGGAGGT GTACCGGTTG ATGGCGGGCA GGTGGTGACA AATCGCTGGG 1020 GAACGGGCGT GGTGACTGAC ATCAGCAGTT ATTACCGGAA TACAACCTCT GTTGACCTGA 1080 AGCGCTTACC GGATGATGTG GAAGCAACCC GTTCTGTTGT GGAATCGGCG CTGACAGAAG 1140 GTGCCATTGG TTACCGGAAA TTCAGCGTGC TTAAAGGGAA ACGTCTGTTT GCAATACTGC 1200 GTCTTGCTGA TGGCTCTCAG CCCCCGTTTG GTGCCAGTGT AACCAGTGAA AAAGGCCGGG 1260 AACTGGGCAT GGTGGCCGAC GAAGGCCTTG CCTGGCTGAG TGGCGTGACG CCGGGGGAAA 1320 CCCTGTCGGT AAACTGGGAT GGAAAAATAC AGTGTCAGGT AAATGTACCG GAGACAGCAA 1380 TATCTGACCA GCAGTTATTG CTTCCCTGTA CGCCTCAGAA ATAAATGAAA GTCCGGAATA 1440 TTAACGGCTG ATTGAATTGC GGTTTATGCC ATTTTCCCGG ACCAA 1485 (2) INFORMATION FOR SEQ ID NO: 14: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 22671 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 14: TTACCAATTT CATCGTCCGG TACATCCTCC AGAACATCTC GCAATAAACT CTCGTCTGCC 60 TCATTCCATG CCACACCAGC ATTTGGGAAA CGAGGATCGA TCTCTCTTTC CTTCTTCTCC 120 TTCTTACTTT GCTCTTTTCG GGATGATACA GATACGACAG AACGTTCTTT TACCGCTGTA 180 ATTGCCATAA CTGCATTGAG CAGAGATCTG CGCTCCACAT CGTTCAGCAT TTTTCCTTCA 240 CAGATCAAAT CATTCAGGAT GTCAATGACT AGATTCAGAC TTTCTTCTGT TAGCTTCATA 300 TTTCAGACCT TGAAGTATGT AGATAATCAG CACAATTACT AATGTGATAA ATATCAGAAG 360 ATAATTTACA GGTAAACCGG AAAATACATC TGAAGAATAA AGGCCTCAGC TTAACGTTTC 420 AGCCAGTTTG TGAGCTGATT GAGGTACGGC GATGACATTA ACGGGAATTA CTCCCCTATA 480 GCTCTGAGCT TATTTTTCAC CCTGGCAACA TATGGTGGCT ACTGCGCATG GTTTTGGAGT 540 AGATATCTTA CTACTCGTAG AATTGTGCTT ACTGGTCAGG CCAGCGCACA GGCATTCCGT 600 GCAATCAATA GAACACTGGT TTTTTAGTCT TCCGTTACCC ATCAGGATGT TAGTGCAGAT 660 TCCGGTGTAT TCGATCAGTT GTTCGGCGAA TCAGCGATCG ATCACGATGC GATTTCGTAT 720 GTTAGGGATG CTGGTATGAT TACTCGCTGA AAAATAATGT GAAAAGGCAG TTTTTCTTTA 780 GACATTTAGC TCATTCATGC TGTTGTTTTA CGTTTTGCTG TCGTGTGCAG GATTATCTTT 840 TCGTTACGGG ACGATTCATT CCGTTTTAAT CAGGAGCTAT TGGCGTTGCT CATTGGTGGG 900 ATGCCGTAAA GTTTTACCGC GGCGATTAAT GATGTGAAGT CAATCCAAAT CAACGGAGAT 960 CTCTCATCAT GAATCAACCA ATACACAATG ATTACTGGTT ATCCCGTTTT GAAAGTATTC 1020 TCAACAGTGC CCTGGTGCAA CACCGTGCCG TCTCGTTAAT CTGGGTGGAT TTACGTTTCC 1080 CTGAGCATAT GCCTGTCACC ATCATGGATC CCGATCCGGA TTCAGCGGTG ATTTCTCGTT 1140 TTTTCGAATC CCTGAAAGCC AAAATTCAGG CTTACCAGCG GAAAAAACGA CGTACCAACA 1200 AGCGTGTGCG TGCAACCACC CTGCATTATT TCTGGTGTCG GGAGTTTGGC AAGGAAAAAG 1260 GCAGGAAACA TTATCACGTG ATATTACTGC TCAACAAAGA TACCTGGTGC TCGCCAGGGG 1320 ATTTCACCGT TCCTTCTTCG CTGGCGACGC TGATCCAACT GGCATGGTGT AGCGCTCTGC 1380 ATCTTGAGCC CTGGCAGGGT AATGGACTGG TTCATTTTTC CAGGCGGACG CYTTTCCGTA 1440 AACCGGTATC ATCTGATGCT CGCCCTTCTT CCGATGATAC GCCTTTGTCG GGTGGATGTT 1500 CTGAAACCAG GAAGGCTTCA GACAAAAAGC CGGGTGAAGC CGCTGTTCTC TGGATCAAGC 1560 GTGGTGATGT GGAAGCGATG CAGAAAGCCA TGGAGAGAGC CCGTTATCTC GTGAAGTATG 1620 AGACGAAGCA GCATGACGGT TCTGGTCAAC GTAATTATGG TTGCAGCCGT GGAGCGGGGC 1680 GTCTACTGGA TGGCAGGTGA ACCCTGTAAA ACGGCATCCG GTGCCAGAGT ATATGTCACA 1740 GTAAGGGCGT GGTTGATGCC CTTAGCTCGT TTTCTGAAAA AGTCGTCCTG AAGTCATGTG 1800 TCACGAACGG TGCAATAGTG ATCCACACCC AACGCCTGAA ATCAGATCCA GGGGGTAATC 1860 TGCTCTCCTG ATTCAGGAGA GYTTATGGTC ACTTTTGAGA CAGTTATGGA AATTAAAATC 1920 CTGCACAAGC AGGGAATGAG TAGCCGGGCG ATTGCCAGAG AACTGGGGAT CTCCCGCAAT 1980 ACGGTTAAAC GTTATTTGCA GGCAAAATCT GAGCCGCCAA AATATACGCC GCGACCTGCT 2040 GTTGCTTCAC TCCTGGATGA ATACCGGGAT TATATTCGTC AACGCATCGC CGATGCTCAT 2100 CCTTACAAAA TCCCGGCAAC GGTAATCGCT CGAGAGATCA GAGACCAGGG ATATCGTGGC 2160 GGAATGACCA TTCTCAGGGC ATTCATTCGT TCTCTCTCGG TTCCTCAGGA GCAGGAGCCT 2220 GCCGTTCGGT TCGAAACTGA ACCCGGACGA CAGATGCAGG TTGACTGGGG CACTATGCGT 2280 AATGGTCGCT CACCGCTTCA CGTGTTCGTT GCTGTTCTCG GATACAGCCG AATGCTGTAC 2340 ATCGAATTCA CTGACAATAT GCGTTATGAC ACGCTGGAGA CCTGCCATCG TAATGCGTTC 2400 CGCTTCTTTG GTGGTGTGCC GCGCGAAGTG TTGTATGACA ATATGAAAAC TGTGGTTCTG 2460 CAACGTGACG CATATCAGAC CGGTCAGCAC CGGTTCCATC CTTCGTTGTG GCAGTTCGGC 2520 AAGGAGATGG GCTTCTCTCC CCGACTGTGT CGCCCCTTCA GGGCACAGAC TAAAGGTAAG 2580 GTGGAACGGA TGGTGCAGTA CACCCGTAAC AGTTTTTACA TCCCACTAAT GACTCGCCTG 2640 CGACCGATGG GGATCACTGT CGATGTTGAA ACAGCCAGCC GCCACGGTCT GCGCTGGCTG 2700 CACGATGTCG CTAACCAACG AAAGCATGAA ACAATCCAGG CCCGTCCCTG CGATCGCTGG 2760 CTCGAAGAGC AGCAGTCCAT GCTGGCACTG CCTCCGGAGA AAAAAGAGTA TGACGTGCAT 2820 CCTGGTGAAA ATCTGGTGAA CTTCGACAAA CACCCCCTGC ATCATCCACT CTCCATTTAC 2880 GACTCATTCT GCAGAGGAGT GGCGTGATGA TGGAACTGCA ACATCAACGA CTGATGGCGC 2940 TCGCCGGGCA GTTGCAACTG GAAAGCCTTA TAAGCGCAGC GCCTGCGCTG TCACAACAGG 3000 CAGTAGACCA GGAATGGAGT TATATGGACT TCCTGGAGCA TCTGCTTCAT GAAGAAAAAC 3060 TGGCACGTCA TCAACGTAAA CAGGCGATGT ATACCCGAAT GGCAGCCTTC CCGGCGGTGA 3120 AAACGTTCGA AGAGTATGAC TTCACATTCG CCACCGGAGC ACCGCAGAAG CAACTCCAGT 3180 CGTTACGCTC ACTCAGCTTC ATAGAACGTA ATGAAAATAT CGTATTACTG GGACCATCAG 3240 GTGTGGGGAA AACCCATCTG GCAATAGCGA TGGGCTATGA AGCAGTCCGT GCAGGTATCA 3300 AAGTTCGCTT CACAACAGCA GCAGATCTGT TACTTCAGTT ATCTACGGCA CAACGTCAGG 3360 GCCGTTATAA AACGACGCTT CAGCGTGGAG TAATGGCCCC CCGCCTGCTC ATCATTGATG 3420 AAATAGGCTA TCTGCCGTTC AGTCAGGAAG AAGCAAAACT GTTCTTCCAG GTCATTGCTA 3480 AACGTTACGA AAAGAGCGCA ATGATCCTGA CATCCAATCT GCCGTTCGGG CAGTGGGATC 3540 AAACGTTCGC CGGTGATGCA GCCCTGACCT CAGCGATGCT GGACCGTATC TTACACCACT 3600 CACATGTCGT TCAAATCAAA GGAGAAAGCT ATCGACTCAG ACAGAAACGA AAGGCCGGGG 3660 TTATAGCAGA AGCTAATCCT GAGTAAAACG GTGGATCAAT ATTGGGCCGT TGGTGGAGAT 3720 ATAAGTGGAT CACTTTTCAT CCGTCGTTGA CATCATGCAA TGTTTCCTGG TTTTCATGCA 3780 TCCATCATTT GTCGCTGCGA TGCCAGACTT CTGGATGCAC ACATGTTGTT TTACTTTTGT 3840 CAGCATCATA AATGCGCCGG GACTGGTGAA TGGAGATAAG CCATTTTATT ATCGACGTCA 3900 GCGAACATAC TCACCATGCC GGTATGTTCC TGAACTGAAC AATAAGTTTT GCGCTGATTA 3960 CAGTATGTGA AGGAGGTCCG TTACAATGAA TTCCGCTTAT ATGCAATCCT TGCAGACATC 4020 CCACCACTTC CCAGCTGATT TAACCTACAG ATTATTTCCT AGTGAGCTTG CATATCTCAT 4080 TGACGACTTA TATGAAAGTA CCCAACTTCC GCTGGAGCTC ATTTTTAATA CTGTACTGGC 4140 AACGCTCTCA CTCTCCTGTC AGTCACTGGT TGACGTTGTT CATCCTCACA CCAACATGCC 4200 GGAACCCTGC TCACTTTATC TGTTGGCAAT CGCAGAGCCA GGCGCGGGAA AAACAACGAT 4260 AAACAGACTG GTGATGAACC CCTGTTACGA ATTTGCCGAT CGACTCATTC AACAATACGA 4320 AGAGAGAAAC AAAGATTATA AGACTGAACT ACAGATCTGG AATACCCGGC AGAAAGCGCT 4380 TGCTGCCAAT TTAAGAAAGG CTGTTAACCG GGGGTATCCG GGGGAACAGG AAGAAGAGGC 4440 GCTGCGTAAT CACGAAAGAA ATAAACCGAC ACGTCCGGTT CGACCGAATT TTATCTATGA 4500 AGATGTTTCG CTTAAAGCGC TTGTGGAAGG GCTCAATGAA CATCCTGAGG CAGGGGTTAT 4560 TTCTGACGAG GCGGTCACTT TTTTCAGAAG CTATCTGAAA AATTATCCGG GCCTGTTGAA 4620 TAAAGCATGG AGTGGACAAC CGTTTGATTT TGGACGGGCT GACGAGAAAT ACCATATCAC 4680 GCCACGTCTG ACATTTTCGT TAATGTCCCA GCCGGATGTC TTTACGAATT ATATAAATAA 4740 AAATGACGTA CTGGCGTGGG GAAGCGGATT TCTTTCCCGG TTTCTGTTCA GTCAGACCGG 4800 AAGTCCTTCC CGGGTACGGG ATTATACGAG AGGCGAGTTC AGAACAAAAC CAACCCTGGA 4860 GAAGTTTCAT AAAAAGATTA ACGGATTTCT GTTAAGCCAT AACATTAATT CCCCCGGTAT 4920 GAGCACCGAA AGGAAAACAT TAAAACTTGC AAAGAAAGCG TTGGGGGAGT GGCAGGAAAA 4980 CCAGATTAAG ATTGAAAGAA AAGCGCTTGC AGGAGGGGAG TGGGAACACA TCAGAGATAT 5040 TGTTCTGAAA GCAGGTTCTA ATATACTGAG GATAGCTGGA ATATTCACCT GCTATTGCTA 5100 TAAAGATGCT GAGGAAATTG AATCAATTGC GCTTTTTAAA GCTATGCATC TCATGGGCTG 5160 GTATCTGGAG GAGGCGAGCA CAATATTTTA TCCCATGTCT GCACGATGCC AGTTTGAACA 5220 GGATGCCTGT GAACTGTATG CATGGATTAT GACCCGAATA AGGCAGAATA ATTGGCGTGC 5280 TATCAGGAAA ACAGACATTG AAAGATATGG TCCCAATCGT CTGAGAAGAG CAGAAAAACT 5340 TACACCTGTA CTCAATCAGT TAATCGYTCA GAATTATTTC CGTATCATCM AAGATGCGAT 5400 CGCATCAGGC ACTTTATGTT TCTGCTCTTG ATAATAATGG TTACATCCTT CCTTTCGGCG 5460 CAATGTCTTA CGAACCGTTT GATATTGTTC CACCCCAGTA TAACCATAAT GCGAAAACAT 5520 ATTCCGTTGT TATTCCACCG GCATTAATTC AGTCATTTAC ACCTGATTCC TCAGCTTACA 5580 CCTTATTTTA AAACAATTTT GTGAGTAGAA AACGAAAATC ATAATCCTTC GAATGAAGGT 5640 TAATGATAAG GTGTGTTGCA TATCCTGCAC CTGTGCAAAT ATTCACCAAT CATTGGGTGT 5700 GAATGAAAAT TTCTCTGAAA AAATCGCTAT GGTAGCAACA GTAGCAGCAC ATACACTACA 5760 TCTGTGATTT GGTTTTGTTT TCATAATGAC CTGCTGTCAG AGCTGATTGA ATGCTGGGAT 5820 GTGCGCACTG GTGGAAGAGT GGTTTTCGTT TCAGATATAA CGAAAGGTAA TCGAAAGATT 5880 GTTTTAAACA TGGATTAAAG CTAATAATTA ACCATATTGT GTGAGTTTTT ATATATAAGT 5940 TTGTTTGATT CTTGCCGTGA TGAGTGCTGG GGTATATGAC GATGTCGCTC TCTTTCTGAA 6000 TAACAAATTA TTATTCGTCT GTTACTGATA AGGGATGCGA TTCATGTTTT AATAGAGGGT 6060 TGAAGAAAAT TAATTTGATA TTTTTTTGTA AGGGAATGGA ACTGTCCGGA ATATGTTCAG 6120 AACGGCGGAT TTCTCATTTC CATTCATTAA ACATGGATAA TTTTAATTTA GGTTTATTAC 6180 TATTATTATA CTCACTCCCT TTTTCATACA ATCTCTATTG TTATTTACTT CCTGTCTTTA 6240 CTCACTCTCT ATCTTTACGA TTATATTCAC TCTATCGTTA CACATTCCAT TAGTATTACT 6300 CTTGTTATCG TATTCATTCC ATCCCTCAAT CATATTTACT GTAACTCATA TGATGTTCAG 6360 GTAAGTTATT CTCTACCATT CTACTGATGA TATCCATCTG TTCTCATTTT CAGTGAAACA 6420 GCAATTGATT TTAATCTTAT CCATCATGAA CTGTATTTGC TTAACAATGA TTGTTTATCT 6480 GAAGTGTTTT AACTATTCTG GTTGGAAACA ATTTCTCTGT CATCACAGAT TAACTGAATG 6540 TTTACTCTTT GATAAGGTAT CCATGATTCC GTCATGTTTA ACAGCGCAGG ATAAACAACA 6600 GAATTAACAG AGTGAATTTC TGATTATATT TGTTGCCGGT TGTATTGTTT AAGGTACTGG 6660 GTGAAAATTA TTCATCCATG GTATGTTGTC TTATGCTATC GTGTGTCGTT AACGTTCATA 6720 TCCTGGAGAA CAGATTGAAT GAGCGCATAT AAGTTTATTG CATTGGCCTT GTACACGGTT 6780 TTTACAACCA CTGAGAGCAA GTTTGTAGTT TATGATGTGA TTGGTCGCAA TATGTTTCTT 6840 AACCTTCTGG TCGTGGTGTT TTATCGCGTA TTTTGCAGTA TTTCGTGATG TTTTATTGAG 6900 TCTGTATTTT CTTTACTCCT CGTTTATCTC ATCTCTTTAG CTAATACCAT CAGATAATCC 6960 ATTTCTTTCT GCATAATGCT GCGTATCGTT AATAACCCGT CGTATCCATT CTGCTACAGC 7020 ATGCCTGATA AATACCATCT GTAAGTTATT ACCGTTTTAG ATCTGATTAT GAGCGAAAGC 7080 ATTAATTCGT TCACAGAGCT TAAAACATCA TTAACTTTCA GGAGTCATCA ACATGCCTAA 7140 ATCTTACACA CCAAACTGGT TTTTTACCGC TTTACTTGAC AATCACATCA ATCAAATGAT 7200 GGCACGCTAT TCCTGCCTGC GGGCCTTACG CATGGATTTC TTCTACAGGA AAGATACGCC 7260 CGATTTCTTA CAACCTGATC ATCGCTGGCT TGAATTGCAG TTGCGTATGA TGCTGGAGCA 7320 GGTGGAACAA TTTGAAAATA TCGTTGGCTT CTTCTGGGTG ATTGAATGGA CGGCTGATCA 7380 TGGTTTTCAT GCGCATGCGG TTTTCTGGAT CGATCGTCAG AGGGTTAAAA AAATATATCC 7440 CTTTGCGGAG CGGATTACGG AATGCTGGCG GTCTATTACG CATAACAGCG GTTCGGCACA 7500 CCGCTGCACA TATCAGCCGC ATTATACATA CAACATCAAC ATTCCTGTGC GCCACAACGA 7560 TCCTGAAAGC ATCGATAATA TTCGCGGTGC CCTGCATTAT CTGGCGAAAG AAGAGCAAAA 7620 AGACGGGCTG TGTGCTTACG GCTGCAATGA AGTTCCTGAA CGTCCTGCTG CAGGGCGTCC 7680 TCGTAAGCCT CACTTCTGAA GCTTAAGGCC TGAGCCTTCG CTCCTGGAAA CACTCCGTCG 7740 GTAAAAACTT ACCGCCTTGA TTAATGATGT GAACTGAAGT CAACGGAGAT CATTCATCCT 7800 GAACCTGCAT CCGGTGTTTT GTTCCTTGTC TTCCCGTTCT GCTTCGGTTC TTCACTTATT 7860 CCATCAATCT CATTCCGCAA GCCATAACAC GTCAGCTCAT TCACGGGCAG GACGCATTGT 7920 GGGCTGCGCA TAACGGAACA TATCTTATGA ATGCTATTCC TTATTTCGAC TATAGCCTGG 7980 CACCCTTCTG GCCATCTTAT CAGAACAAAG TCATCGGCGT CCTTGAGCGT GCGCTGCGTG 8040 AGCAGTCCGG CTCACGGATA CGGCGGATCC TGCTTCGTCT GCCGTGGGAA CATGACAACG 8100 CCTTCAGCAG CAGAAAGATC TGGTTCGGTA TGGACTTTAT CGAAACCGTC AGTGCGCTGA 8160 TGAATGCGAA ACCCGGACGC GACCTTTGCT GGCTCCTGAC CCGTCATCCG GAAAAGCCGG 8220 AATACCACGT GGTGCTGTGC GTCAGACAGG AGTATTTCGA CGGCCCCGAA CTGGATCGGT 8280 TGATACTGGA TGCCTGGAGT AATGTGCTGG GTTTCGCGTC ACCAGGTGAA GCAAAGCCGT 8340 ACCAGAAGCA GATCACCCGG GATGTGGTAC TGGATCGCCG GTCACCGGAC TGCGAAGCCC 8400 TGTTTAAGGA CCTTATCTGG GCGTTCAGTG ATTTCGCCCG CGATCGCCGT GGAGTGTGCG 8460 ATCCGGAAGC CCGTTGCCTT GCCGGCAATC CCGGTTGGCA GTGCTGAAAG CAGCACGCCA 8520 TCCCATCCCC CGTATTACCC CATTCTTCAT AAATCTCACT GAGGACATTC TGACCATGTT 8580 GACCACAACA AGCCACGACA GCGTATTGCT GCGTGCCGAC GATCCCCTGA TCGACATGAA 8640 CTACATCACC AGTTTCACCG GCATGACCGA TAAATGGTTT TACAGGCTGA TCAGTGAAGG 8700 GCATTTTCCT AAACCCATCA AACTGGGGCG CAGCAGCCGC TGGTACAAAA GTGAAGTGGA 8760 GCAGTGGATG CAACAACGAA TTGAGGAATC ACGAGGAGCA GCAGCATGAA ACGTGTTGTG 8820 ATGCCAGTAC GTTGGCAATG TGCAAAATGC CAGCGCTGGT ATTGTGGAAA TCAGCCCTGT 8880 CCCTGGTGCT GGCGACATTC CCGCTTATCT TTCCGCTGAC ACCCTCCGGT CAGCCAACTG 8940 TTAGTCATCA TTTCCTGACT GATTCGTCAT TCCATTCTTA TTGATTATAA CTGGCATTAC 9000 ACCGGTGCTG GCGTGCTTTC CTGCGTGTCT GCACCGGTTT GACAAAATTC AACAGGGTTT 9060 GAAAAGGAAC ATTTCGTGCA AATAACCGAA GCCTTAATTT CAGAGCCGGG AGACATCCGG 9120 CGTTTTATTC AACATGCTGT TGACCACTGG CCGCGTCTGC TGGCAGTCCA CTTCATACTC 9180 CATTCGACAG AAGGAAACAT CTACGGGCAA CAGATTCATG CATTCTGCAC TTCCTTTTAT 9240 CGACAACTGC ATGAACGTAT TACTGAGAGC AATCACACTG CCAGTCCATC ATCGTCGGTG 9300 GTATTACGCT GGTTGCGGGA ACAACATGGA GGAGCAACAA TTCGATGCCT GTTGCTGCTC 9360 AGCCAGACGA GTATTTGTCA CCCGCGAGCC AGTGTCACAG TTGATGAACA ATGTTCGCAA 9420 GTGGTGGATT TACTGCAACA TAGCTGGCAG GTGATAAGTG CTGGCGGACA ATGCCGGGTG 9480 GAAAGGTGTT TTCGGGTTGC CCGGGGTGAT ACATCCGGTC AGTATGTTGC GTTAAAAACA 9540 GTCGCATTGT CTCTGGGGTT ACCGGTTGTG ACCGCCATTA CCCATCGTCC GGTACAGCGC 9600 TGTACATTGA TTACAGCTCA GTGAATCAGC GCTTTCTGGC TTTTCGTCGG TCATTCTGTC 9660 AACGCCACGA TGTTTGACCG TTATGGGGAT GCGGACGATT CCCTGCACAG CGTTGTTTCA 9720 CGGTGGTGGA TGACGCAACA CCGCTGTTAA AAACAGTCGT TCAGTCCTTT GTGTTACCGG 9780 TTGTGACAAC AATCAGTTGG TAATGGACGT GTGAACCATC TGCGCTTCCG TTGATTTTTA 9840 TGGACTGATA AAGTTTTGCC AGCTGAATCT TTATACGGAA TGCTCTTCAG TATGCGTACA 9900 CGAATTGACT ATCTGGCGGA TAAATACTCT TTTACCGAAC GGAATGAATC TCCACGCCTT 9960 CGCCGGCAGT GGCAGGATGT TCTGGAGGAG TGTCGGCTGA CAGAGGCCGG ACCAGAAGAA 10020 CGGCTGCGTA TTGCCCTGCT GAATGTGGAT TACGTCACCA GTTTTGAACT GCCTTTTCGC 10080 TTGTTGCTTA CTCGTACACC ACAACTGATT GCCGCGCTTC GGGAAGAATG GGGCCTCAGC 10140 CAGAAAAATG TGGTGTTCAA CGATAAACGG TTTGGCTGCG TGTACAGCCT GAAGGCCAGT 10200 CTTTCTGGTG TACCGGATAC ATTCCGGTAT CATCTGTCTC ATCGTATTCG CCGGATGGTT 10260 GGGAATGAAA ATACATCATC GCCATATCAG CAGATTGCCC GGGAAGTGAA AGTGCCCCGT 10320 GAACGGCTGA AGTATGCGCT GGAAGCCGGT TTACTGGTGA CTGCACTGGA CGGGCTGTTC 10380 TGGTCTGGTA GTCAGCGCAT TGCGGCTGAT ATCCTGAGAC TGAGAAAGAG CGGAATGCCG 10440 GTGGTGACAA CGTCCGTGGA AGCGAGCGAT AACCTGACGG GAACAACCCG CAAAATACCG 10500 GCATACCATC TCTGACATTG CGATGAAGGG CAGATTTCAC CTTGACAGGG GCAGAGTGCC 10560 GCTTTTTATA CTTTATTCCC GTGTCTGAAA AAAATGTGCA AAGGAAACGG GAATGGCAAG 10620 GTCCGATTAC GATTTTATCA ATCTGTCTCT GGGACATGAA CTGAATGAGT GGCTGGCAGA 10680 GAGAGGTTAT GCCGGACAGG CGGATAACCG GAACCGACTG GCAGAGGTGG TTACCCGCAA 10740 ATTGCGGGAC AGTTTTTATG CGGACGTCTC CTGGGATGCG CTGAATGTGG CATACAGTGA 10800 ACACCCTGAG TGGTTTTCAG AGCTTGCCTC CGGGGATGAG GATTAACAGG CAAATTATGC 10860 TGCTATCGGG CAGAGTGATT ACCTGCAGGG ATTTCCATTT ATAAGAATAC GCCGCTTCGG 10920 GAAAGCTCCG GTTCTCCGGA GAGTTACGAT TATTTTTACT CAAATTCACA ACACCTGAAC 10980 TGGAACTTGC GTTGTGTCCC GGATTGTTAC TCCGCAGAAG CATCCTTTTT ACCATACGGA 11040 TGTTTGTTTT CCATTTCCCC TCCGAAAAAT ACAACTCCGA TCACATTTCT GATATTTTCC 11100 CCGGATTTTA CATAACAGGA TTGTTTCTGT ATGTTTTTTA TCTGGTGTAA ATTTCAGCAC 11160 TGACATTCCG CTTACGTTAA TTTACACTGG ATACCCCACG AGGAGAATAT GCAGCACCGG 11220 CAGGATAACT TACTGGCGAA CAGAAATTTG TTGCCTGGTA TGGTTTCCGG TCAGTACGCA 11280 TTCAGGATCC GTACCTTATC TCAGGTGGTA CGCTATTTTT CCCTCCTCCC CTGCCTTTGC 11340 ATTCTTTCAT TTTCGTCTCC GGCAGCCATG CTGTCTCCGG GTGACCGCAG TGCAATTCAG 11400 CAGCAACAGC AGCAGTTGTT GGATGAAAAC CAGCGCCAGC GTGATGCGCT GGAGCGCAGT 11460 GCGCCGCTGA CCATCACGCC GTCTCCGGAA ACGTCTGCCG GTACTGAAGG TCCCTGCTTT 11520 ACGGTGTCAC GCATTGTTGT CAGTGGGGCC ACCCGACTGA CGTCTGCAGA AACCGACAGA 11580 CTGGTGGCAC CGTGGGTGAA TCAGTGTCTG AATATCACGG GACTGACCGC GGTCACGGAT 11640 GCCGTGACGG ACGGCTATAT ACGCCGGGGA TATATCACCA GCCGGGCCTT TCTGACAGAG 11700 CAGGACCTTT CAGGGGGCGT ACTGCACATA ACGGTCATGG AAGGCAGGCT GCAGCAAATC 11760 CGGGCGGAAG GCGCTGACCT TCCTGCCCGC ACCCTGAAGA TGGTTTTCCC GGGAATGGAG 11820 GGGAAGGTTC TGAACTGCGG GATATTGAGC AGGGGATGGA GCAGATTAAT CGTCTGCGTA 11880 CGGAGCCGGT ACAGATTGAA ATATCGCCCG GTGACCGTGA GGGATGGTCG GTGGTGACAC 11940 TGACGGCATT GCCGGAATGG CCTGTCACAG GGAGCGTGGG CATCGACAAC AGCGGGCAGA 12000 AGAATACCGG TACGGGGCAG TTAAATGGTG TCCTTTCCTT TAATAATCCT CTGGGGCTGG 12060 CTGACAACTG GTTTGTCAGC GGGGGACGGA GCAGTGACTT TTCGGTGTCA CATGATGCGA 12120 GGAATTTTGC CGCCGGTGTC AGTCTGCCGT ATGGCTATAC CCTGGTGGAT TACACGTATT 12180 CATGGAGTGA CTACCTCAGC ACCATTGATA ACCGGGGCTG GCGGTGGCGT TCCACGGGAG 12240 ACCTGCAGAC TCACCGGCTG GGACTGTCGC ATGTCCTGTT CCGTAACGGG GACATGAAGA 12300 CAGCACTGAC CGGAGGTCTG CAGCACCGCA TTATTCACAA TTATCTGGAT GATGTTCTGC 12360 TTCAGGGCAG CAGCCGTAAA CTCACTTCAT TTTCTGTCGG GCTGAATCAC ACACACAAGT 12420 TTCTGGGTGG TGTCGGAACA CTGAATCCGG TATTCACACG GGGGATGCCC TGGTTCGGCG 12480 CAGAAAGCGA CCACGGGAAA AGGGGAGACC TGCCCGTAAA TCAGTTCCGG AAATGGTCGG 12540 TGAGTGCCAG TTTTCAGCGC CCCGTCACGG ACAGGGTGTG GTGGCTGACC AGCGCTTATG 12600 CCCAGTGGTC ACCGGACCGT CTTCATGGTG TGGAACAACT GAGCCTCGGG GGTGAGAGTT 12660 CAGTGCGTGG CTTTAAGGAG CAGTATATCT CCGGTAATAA CGGCGGTTAT CTGCGAAATG 12720 AGCTGTCCTG GTCTCTGTTC TCCCTGCCAT ATGTGGGGAC AGTCCGTGCA GTGACTGCAC 12780 TGGACGGCGG CTGGCTGCAC TCTGACAGAG ATGACCCGTA CTCGTCCGGC ACGCTGTGGG 12840 GTGCTGCTGC CGGGCTCAGC ACCACCAGTG GTCATGTTTC CGGTTCGTTC ACTGCCGGAC 12900 TGCCTCTGGT TTACCCGGAC TGGCTTGCCC CTGACCATCT CACGGTTTAC TGGCGCGTTG 12960 CCGTCGCGTT TTAAGGGATT ATTACCATGC ATCAGCCTCC CGTTCGCTTC ACTTACCGCC 13020 TGCTGAGTTA CCTTATCAGT ACGATTATCG CCGGGCAGCC GTTGTTACCG GCTGTGGGGG 13080 CCGTCATCAC CCCACAAAAC GGGGCTGGAA TGGATAAAGC GGCAAATGGT GTGCCGGTCG 13140 TGAACATTGC CACGCCGAAC GGGGCCGGGA TTTCGCATAA CCGGTTTACG GATTACAACG 13200 TCGGGAAGGA AGGGCTGATT CTCAATAATG CCACCGGTAA GCTTAATCCG ACGCAGCTTG 13260 GTGGACTGAT ACAGAATAAC CCGAACCTGA AAGCGGGCGG GGAAGCGAAG GGTATCATCA 13320 ACGAAGTGAC CGGCGGTAAC CGTTCACTGT TGCAGGGCTA TACGGAAGTG GCCGGCAAAG 13380 CGGCGAATGT GATGGTTGCC AACCCGTATG GTATCACCTG TGACGGCTGT GGTTTTATCA 13440 ACACGCCGCA CGCGACGCTC ACCACAGGCA AACCTGTGAT GAATGCCGAC GGCAGCCTGC 13500 AGGCGCTGGA GGTGACTGAA GGCAGTATCA CCATCAATGG CGCGGGCCTG GACGGCACCC 13560 GGAGCGATGC CGTATCCATT ATTGCCCGTG CAACGGAAGT GAATGCCGCG CTTCATGCGA 13620 AGGATTTAAC TGTCACTGCA GGCGCTAACC GGATAACTGC AGATGGTCGC GTCAGTGCCC 13680 TGAAGGGCGA AGGTGATGTG CCGAAAGTTG CCGTTGATAC CGGCGCGCTC GGTGGAATGT 13740 ACGCCAGGCG TATTCATCTG ACCTCCACTG AAAGTGGTGT CGGGGTTAAT CTGGGTAACC 13800 TTTATGCCCG CGAGGGCGAT ATCATACTGA GCAGTGCCGG AAAACTGGTC CTGAAGAACA 13860 GCCTTGCCGG CGGCAATACC ACCGTAACCG GAACGGATGT CTCACTTTCA GGGGATAACA 13920 AAGCCGGAGG AAATCTCAGC GTTACCGGGA CAACGGGACT GACACTGAAT CAGCCCCGTC 13980 TGGTGACGGA TAAAAATCTG GTGCTGTCTT CATCCGGGCA GATTGTACAG AACGGTGGTG 14040 AACTGACTGC CGGACAGAAC GCCATGCTCA GTGCACAGCA CCTGAACCAG ACTTCCGGGA 14100 CCGTGAATGC AGCTGAAAAT GTCACCCTTA CCACCACCAA TGATACCACA CTGAAAGGCC 14160 GCAGCGTTGC CGGGAAAACA CTCACTGTCA GTTCCGGCAG CCTGAACAAC GGTGGGACAC 14220 TGGTTGCCGG GCGCGATGCC ACGGTGAAAA CCGGGACATT CAGTAATACC GGTACCGTCC 14280 AGGGGAATGG CCTGAAAGTT ACCGCCACTG ACCTGACCAG CACCGGCAGT ATTAAAAGTG 14340 GCAGCACACT CGATATCAGC GCCCGCAATG CCACACTGTC CGGTGATGCC GGTGCAAAAG 14400 ACAGTGCCCG CGTTACCGTC AGCGGTACAC TCGAAAACCG CGGCAGACTT GTCAGCGATG 14460 ACGTGCTGAC GCTCAGTGCC ACGCAGATAA ACAACAGCGG TACCCTCTCC GGGGCAAAGG 14520 AACTTGTGGC TTCTGCAGAC ACACTGACCA CCACAGAAAA ATCGGTCACA AACAGTGACG 14580 GTAACCTCAT GCTGGACAGC GCGTCTTCCA CACTGGCGGG TGAAACCAGT GCGGGTGGCA 14640 CGGTGTCTGT AAAAGGCAAC AGTCTGAAGA CCACGACCAC TGCGCAGACG CAGGGCAACA 14700 GTGTCAGCGT GGATGTGCAG AACGCACAGC TTGACGGAAC ACAGGCTGCC AGAGACATCC 14760 TTACCCTGAA CGCCAGTGAA AAGCTCACCC ACAGCGGGAA AAGCAGTGCC CCGTCGCTCA 14820 GCCTCAGTGC GCCGGAACTG ACCAGCAGCG GCGTACTTGT TGGTTCCGCC CTGAATACAC 14880 AGTCACAGAC CCTGACCAAC AGCGGTCTGT TGCAGGGGGA GGCCTCACTC ACCGTTAACA 14940 CACAGAGGCT TGATAATCAG CAGAACGGCA CGCTGTACAG TGCTGCAGAC CTGACGCTGG 15000 ATATACCGGA CATCCGCAAC AGCGGGCTTA TCACCGGTGA TAATGGTTTA ATGTTAAATG 15060 CTGTCTCCCT CAGCAATCCG GGAAAAATCA TCGCTGACAC GCTGAGCGTC AGGGCGACCA 15120 CGCTGGATGG TGACGGCCTG TTGCAGGGCG CCGGTGCACT GGCGCTTGCT GGCGACACCC 15180 TCTCACAGGG TAGTCACGGA CGCTGGCTGA CGGCGGACGA CCTCTCCCTC CGGGGCAAAA 15240 CACTGAATAC CGCAGGACCA CGCAGGGACA GAATATCACC GTGCAGGCGG ACAGATGGGC 15300 GAACAGTGGT TCCGTGCTGG CAACCGGTAA CCTTACTGCT TCGGCAACCG GTCAGTTGAC 15360 CAGTACCGGC GATATCATGA GCCAGGGTGA CACCACGCTG AAAGCAGCCA CCACGGACAA 15420 CCGGGGCAGT CTGCTTTCGG CCGGCACGCT CTCCCTTGAT GGAAACTCAC TGGATAACAG 15480 CGGCACTGTC CAGGGTGACC ATGTCACGAT TCGCCAGAAC AGTGTCACCA ACAGTGGCAC 15540 GCTCACCGGG ATCGCCGCGC TGACGCTTGC CGCCCGTATG GTATCCCCTC AACCTGCGCT 15600 GATGAATAAC GGAGGTTCAT TGCTGACCAG CGGCGATCTG ACAATCACCG CAGGCAGTCT 15660 GGTAAACAGC GGGGCGATCC AGGCGGCTGA CAGCCTGACT GCACGTCTGA CGGGTGAGCT 15720 CGTCAGCACA GCGGGCAGCA AAGTCACCTC GAACGGTGAA ATGGCGCTCA GTGCACTGAA 15780 TTTAAGCAAC AGCGGACAAT GGATTGCAAA AAATCTGACC CTGAAGGCGA ACTCACTGAC 15840 CAGTGCGGGT GACATCACCG GTGTGGATAC TCTCACGCTC ACGGTGAATC AGACGCTGAA 15900 CAATCAGGCG AACGGAAAAC TGCTCAGTGC AGGTGTGCTG ACGCTGAAGG CAGACAGTGT 15960 CACAAACGAC GGGCAATTAC AGGGAAATGC CACCACCATC ACGGCAGGAC AACTCACAAA 16020 CGGCGGGCAT CTGCAGGGCG AAACGCTGAC GCTGGCCGCC TCCGGTGGCG TGAACAACCG 16080 TTCCGGTGGT GTTCTGATGA GCCGGAATGC ACTGAATGTC AGTACTGCGA CCCTGAGTAA 16140 CCAGGGCACG ATACAGGGTG GTGGCGGGGT TTCCCTGAAC GCCACTGACC GTCTGCAGAA 16200 CGACGGCAAA ATCCTCTCCG GCAGTAACCT CACGCTGACG GCGCAGGTGC TGGCGAACAC 16260 CGGCAGCGGA CTGGTACAGG CTGCCACCCT GCTGCTGGAT GTGGTGAATA CTGTCAACGG 16320 CGGACGCGTA CTTGCCACCG GCAGTGCCGA CGTTAAAGGA ACCACGCTGA ATAATACCGG 16380 TACGCTTCAG GGTGCGGACC TGCTGGTGAA TTACCACACA TTCAGCAACA GCGGTACCCT 16440 GCTGGGAACC TCCGGGCTTG GCGTCAAGGG CAGTTCACTG CTGCAAAATG GTACAGGGCG 16500 GCTGTACAGT GCAGGCAACC TGCTGCTTGA CGCTCAGGAC TTCAGTGGTC AGGGGCAGGT 16560 GGTGGCCACC GGTGATGTCA CACTGAAACT GATTGCTGCC CTCACGAATT ACGGTACCCT 16620 GGCCGCAGGG AAAACCCTTT CCGTCACGTC GCAAAATGCC ATCACCAACG GCGGTGTCAT 16680 GCAGGGTGAT GCCATGGTGC TCGGTGCCGG AGAGGCATTC ACCAACAATG GAACGCTGAC 16740 TGCCGGTAAA GGCAACAGTG TTTTCAGCGC ACAGCGTCTT TTCCTTAACG CACCGGGTTC 16800 ACTTCAGGCC GGTGGCGATG TGAGTCTGAA CAGCCGGAGT GATATCACCA TCAGTGGTTT 16860 TACCGGCACG GCAGGCAGTC TGACAATGAA TGTGGCCGGT ACCCTGCTGA ACAGTGCGCT 16920 GATTTATGCG GGGAATAACC TGAAGCTGTT TACAGACCGT CTGCATAACC AGCATGGTGA 16980 TATCCTGGCC GGCAACAGTC TGTGGGTACA GAAGGATGCT TCCGGCGGTG CAAACACAGA 17040 GATTATCAAT ACTTCCGGGA ATATTGAGAC GCATCAGGGC GATATTGTTG TAAGAACCGG 17100 GCATCTTCTG AACCAGCGGG AGGGATTTTC TGCCACAACA ACAACCCGGA CTAACCCCTC 17160 ATCCATTCAG GGAATGGGAA ATGCTCTGGT TGATATTCCC CTTTCCCTTC TTCCTGACGG 17220 CAGCTATGGC TATTTCACCC GTGAAGTTGA AAATCAGCAC GGTACGCCCT GCAACGGGCA 17280 CGGGGCATGC AATATCACAA TGGATACGCT TTATTATTAC GCTCCGTTTG CTGACAGTGC 17340 CACACAGCGC TTTCTCAGCA GCCAGAACAT CACAACAGTA ACCGGTGCTG ATAATCCGGC 17400 AGGCCGCATT GCGTCAGGGC GTAATCTTTC TGCTGAGGCT GAACGACTGG AAAACCGGGC 17460 GTCATTTATC CTGGCGAATG GGGATATCGC ACTCTCGGGC AGAGAGTTAA GCAATCAGAG 17520 CTGGCAGACG GGGACAGAGA ATGAATATCT GGTATACCGC TACGACCCGA AAACGTTTTA 17580 CGGTAGCTAT GCAACAGGCT CTCTGGATAA ACTGCCCCTG CTGTCACCGG AATTTGAAAA 17640 CAATACCATC AGATTTTCAC TGGATGGCCG GGAAAAAGAT TACACGCCCG GTAAGACGTA 17700 TTATTCCGTT ATTCAGGCGG GCGGGGATGT TAAGACCCGT TTTACCAGCA GTATCAATAA 17760 CGGAACAACC ACTGCACATG CAGGTAGTGT CAGTCCGGTG GTCTCTGCAC CTGTACTGAA 17820 TACGTTAAGT CAGCAGACCG GCGGAGACAG TCTGACACAG ACAGCGCTGC AGCAGTATGA 17880 GCCGGTGGTG GTTGGCTCTC CGCAATGGCA CGATGAACTG GCAGGTGCCC TGAAAAATAT 17940 TGCCGGAGGT TCGCCACTGA CCGGTCAGAC CGGTATCAGT GATGACTGGC CACTGCCTTC 18000 CGGCAACAAT GGATACCTGG TTCCGTCCAC GGACCCGGAC AGTCCGTATC TGATTACGGT 18060 GAACCCGAAA CTGGATGGTC TCGGACAGGT GGACAGCCAT TTGTTTGCCG GACTGTATGA 18120 GCTTCTTGGA GCGAAACCGG GTCAGGCGCC ACGTGAAACG GCTCCGTCGT ATACCGATGA 18180 AAAACAGTTT CTGGGCTCAT CGTATTTTCT TGACCGCCTC GGGCTGAAAC CGGAAAAAGA 18240 TTATCGTTTC CTGGGGGATG CGGTCTTTGA TACCCGGTAT GTCAGTAACG CGGTGCTGAG 18300 CCGGACGGGT TCACGTTATC TCAACGGACT GGGTTCAGAC ACGGAACAGA TGCGGTATCT 18360 GATGGATAAC GCGGCCAGAC AACAGAAAGG ACTGGGATTA GAGTTTGGTG TGGCGCTGAC 18420 AGCTGAACAG ATTGCTCAGC TTGACGGCAG CATGCTGTGG TGGGAGTCAG TCACCATCAA 18480 CGGACAGACA GTCATGGTCC CGAAACTGTA TCTGTCGCCG GAAGATATCA CCCTGCATAA 18540 CGGCAGCGTT ATCAGCGGGA ACAACGTGCA GCTTGCGGAC GGCAATATCA CCAACAGCGG 18600 CGGCAGCATC AACGCACAGA ACGACCTTTC GCTCGACAGT ACCGGCTATA TCGACAACCT 18660 GAATGCAGGG CTGATAAGCG CGGGCGGTAG CCTGGACCTG AGCGCCATCG GGGATATCAG 18720 CAATATCAGC TCAGTCATCA GCGGTAAAAC CGTACAACTG GAAAGCGTGA GTGGCAACAT 18780 CAGCAATATC ACCCGGCGTC AGCAATGGAA TGCGGGCAGT GACAGCCGAT ATGGTGGTGT 18840 GCATCTCAGC GGTACGGACA CCGGTCCGGT TGCGACCATT AAAGGCACTG ATTCACTTTC 18900 ACTGGATGCA GGGAAAAACA TTGATATTAC CGGGGCAACG GTCTCGTCCG GTGGAGACCT 18960 TGGAATGTCT GCGGGTAATG ACATCAACAT TGCCGTAAAC CTGATAAGCG GGAGCAAAAG 19020 TCAGTCCGGT TTCTGGCACA CTGATGACAA CAGTTCATCA TCCACCACCT CACAGGGCAG 19080 CAGCATCAGC GCCGGCGGTA ACCTGGCGAT GGCTGCAGGC CATAATCTGG ATGTCACAGC 19140 ATCCTCTGTT TCTGCCGGGC ACAGCGCCCT GCTTTCTGCA GGTAACGACC TGAGTCTGAA 19200 TGCAGTCAGG GAAAGCAAAA ACAGTCGCAA CGGCAGGTCA GAAAGTCATG AAAGCCACGC 19260 AGCTGTGTCC ACGGTGACGG CGGGCGATAA CCTCCTCCTT GTTGCCGGTC GTGATATTGC 19320 CAGTCAGGCT GCCGGTATGG CTGCGGAAAA TAACGTGGTC ATCCGGGGCG GACGTGATGT 19380 GAACCTGGTG GCAGAGTCTG CCGGCGCAGG CGACAGCTAT ACGTCGAAGA AAAAGAAAGA 19440 GATTAACGAG ACAGTCCGTC AGCAGGGAAC GGAAATCGCC AGCGGTGGTG ACACCACCGT 19500 CACCGCAGGA CGGGATATCA CCGCTGTTGC GTCATCCGTT ACCGCAACCG GCAATATCAG 19560 CGTGAATGCC GGTCGTGATG TTGCCCTGAC CACGGCGACA GAAAGTGACT ATCACTATCT 19620 GGAAACGAAG AAAAAAAGCG GAGGTTTTCT CAGTAAGAAA ACCACCCACA CCATCAGTGA 19680 GGACAGTGCC TCCCGTGAAG CAGGTTCCCT GCTGTCGGGG AACCGCGTGA CCGTTAACGC 19740 CGGTGATAAN CTGACGGTAG AGGGTTCGGA TGTGGTGGCT GACCGGGATG TGTCACTGGC 19800 GGCGGGTAAC CATGTTGATG TTCTTGCTGC CACCAGTACA GATACGTCCT GGCGCTTTAA 19860 GGAAACGAAG AAATCCGGTC TGATGGGTAC CGGCGGTATT GGTTTCACCA TTGGCAGCAG 19920 TAAGACAACG CACGACCGCC GCGAGGCSGG GACAACGCAG AGTCAGAGTG CCAGTACCAT 19980 CGGCTCCACT GCCGGTAATG TCAGTATTAC CGCGGGCAAA CAGGCTCATA TCAGCGGTTC 20040 GGATGTGATT GCGAACCGGG ATATCAGCAT TACCGGTGAC AGTGTGGTGG TTGACCCGGG 20100 GCATGATCGT CGTACTGTGG ACGAAAAATT TGAGCAGAAG AAAAGCGGGC TGACGGTTGC 20160 CCTTTCCGGC ACGNTGGGCA GTGCCATCAA TAATGCGGTC ACCAGTGCAC AGGAGACGAA 20220 GGAGAGCAGT GACAGCCGTC TGAAAGCCCT GCAGGCCACA AAGACAGCGC TGTCTGGTGT 20280 GCAGGCCGGA CAGGCTGCGG CAATGGCCAC CGCAACCGGT GACCCGAATG CGACGGGAGT 20340 CAGCCTGTCG CTTACCACCC AGAAATCGAA ATCACAACAA CATTCTGAAA GTGACACAGT 20400 ATCCGGCAGT ACGCTGAATG CCGGGAATAA TCTGTCTGTT GTCGCAACCG GCAAAAACAG 20460 GGGAGATAAC CGCGGAGATA TTGTGATTGC AGGAAGCCAG CTTAAGGCCG GTGGTAACAC 20520 AAGCCTGGAT GCCGCGAATG ATGTTCTGTT GAGTGGCGCT GCAAACACAC AAAAAACAAC 20580 GGGCAGGAAC AGCAGCAGTG GCGGTGGCGT GGGTGTCAGT ATCGGTGCCG GTGGTAACGG 20640 TGCCGGTATC AGCGTCTTTG CCAGCGTTAA TGCGGCAAAA GGCAGCGAGA AAGGTAACGG 20700 TACTGAGTGG ACTGAAACCA CAACAGACAG CGGTAAAACC GTCACCATCA ACAGTGGTCG 20760 GGATACGGTA CTGAACGGTG CTCAGGTCAA CGGCAACAGG ATTATCGCCG ATGTGGGCCA 20820 CGACCTGCTG ATAAGCAGCC AGCAGGACAC CAGTAAGTAC GACAGTAAAC AGACCAGCGT 20880 GGCTGCCGGC GGCAGTTTTA CCTTTGGCTC CATGACCGGC TCAGGTTACA TCGCTGCCTC 20940 CCGGGATAAG ATGAAGAGCC GCTTTGACTC CGTTGCTGAA CAAACCGGGA TGTTTTCCGG 21000 AGATGGCGGC TTCGATATCA CGGTCGGCAA CCACACCCAG CTCGATGGTG CGGTTATCGC 21060 TTCCACGGCG ACGGCAGATA AAAACAGCCT CGATACCGGG ACGCTCGGCT TCAGCGATAT 21120 TCACAACGAA GCGGATTATA AAGTCAGTCA CAGTGGAATC AGTCTGAGCG GTGGTGGCAG 21180 CTTCGGGGAT AAATTTCAGG GTAACATGCC GGGTGGCATG ATATCCGCCG GAGGTCACAG 21240 CGGACATGCG GAAGGAACGA CTCAGGCCGC AGTGGCAGAT GGCACAATCA CCATCCGGGA 21300 CAGGGACAAT CAGAAGCAGA ATCTGGCGAA CCTGAGCCGT GACCCTGCGC ACGCTAATGA 21360 CAGTATCAGC CCGATATTTG ACAAGGAGAA AGAGCAGAGG CGTCTGCAGA CAGTGGGGCT 21420 TATCAGTGAC ATTGGCAGTC AGGTGGCGGA TATCGCGCGG ACGCAGGGGG AACTGAATGC 21480 GTTGAAGCTG CGCAGGATAA ATATGGGCCT GTTCCGGCGG ATGCGACGGA AGAACAGCGG 21540 CAGGCATATC TGGCAAAACT GCGTGATACG CCGGAATACA AAAAGGAACA GGAAAAGTAT 21600 GGTACCGGCA GCGATATGCA GCGCGGTATC CAGGCTGCAA CGGCTGCACT TCAGGGCCTG 21660 GTGGGCGGCA ATATGGCAGG CGCGCTGGCA GGTGCTTCAG CGCCGGAGCT GGCGAACATC 21720 ATCGGTCATC ACGCGGGTAT TGATGACAAT ACAGCGGCAA AAGCCATTGC CCATGCCATT 21780 CTCGGTGGTG TGACAGCAGC CCTTCAGGGC AACAGTGCGG CAGCAGGCGC AATTGGTGCG 21840 GGTACTGGTG AAGTGATCGC GTCAGCCATT GCGAAAAGCC TCTACCCGGG CGTAGATCCG 21900 TCGAAACTGA CAGAAGATCA GAAGCAAACT GTAAGCACGC TGGCAACGCT GTCAGCGGGT 21960 ATGGCCGGCG GCATTGCCAG TGGCGATGTG GCTGGCGCGG CTGCTGGAGC TGGTGCCGGG 22020 AAGAACGTTG TTGAGAATAA TGCGCTGAGT CTGGTTGCCA GAGGCTGTGC GGTCGCAGCA 22080 CCTTGCAGGA CTAAAGTTGC AGAGCAGTTG CTAGAAATCG GGGCGAAAGC GGGCATGGCC 22140 GGGCTTGCCG GGGCGGCAGT CAAGGATATG GCCGACAGGA TGACCTCCGA TGAACTGGAG 22200 CATCTGATTA CCCTGCAAAT GATGGGTAAT GATGAGATCA CTACTAAGTA TCTCAGTTCG 22260 TTGCATGATA AGTACGGTTC CGGGGCTGCC TCGAATCCGA ATATCGGTAA AGATCTGACC 22320 GATGCGGAAA AAGTAGAACT GGGCGGTTCC GGCTCAGGAA CCGGTACACC ACCACCATCG 22380 GAAAATGATC CTAAGCAGCA AAATGAAAAA ACTGTAGATA AGCTTAATCA GAAGCAAGAA 22440 AGTGCGATTA AGAAGATCGA TAACACTATA AAAAATGCTC TGAAAGATCA TGATATTATT 22500 GGAACTCTCA AGGATATGGA TGGTAAGCCA GTTCCTAAAG AGAATGGAGG ATATTGGGAT 22560 CATATGCAGG AAATGCAAAA TACGCTCAGA GGATTAAGAA ATCATGCGGA TACGTTGAAA 22620 AACGTCAACA ATCCTGAAGC TCAGGCTGCG TATGGCAGAG CAACAGATGC T 22671 (2) INFORMATION FOR SEQ ID NO: 15: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 2385 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 15: GGGCGACACG GAAATGTTGA ATACTCATAC TCTTCCTTTT TCAATATTAT TGAAGCATTT 60 ATCAGGGTTA TTGTCTCATG AGCGGATACA TATTTGAATG TATTTAGGCA ACTGAAACCC 120 GCTGACGGAT NANGTGTACA GTGGCATCAG TGGACGGMTT ACAGCATAAG TGCTTAAGGC 180 GCGTGACCAT ACAGMTACGG TCGCTGCAGA GAACAGGGAG AATATCATCC GGAACACGGT 240 GGCCATAAAC CGTAACACCA GGGGGCTGCT TTCCCCGGGA GAGGTGCTGG AGATGCATGC 300 GGACGTCTGA ACAGTCAGCA GGGCTGATTA ATGAGAATCA CGAGGAAATG AAGCGGGAGC 360 CGTACAGTGA GGATAAATTT AACGCCATAG CGGCTGTGGG CGGGTATAGT GCCAAGCAGA 420 CTGCTTAAAG GCAGGTACTA CTTTCAGTGG CGGCTATGTT TCCTGGAATG TGGGTGTCAA 480 CTGGTAGTTC TGAACCCGGG CCTGAGTCAC CGGGGAGGCA GTTTTCGGTA TGAAGTAATG 540 ATTCGCTGCC TGTTTTTCTC CCCGATGGCA TAACTGACTG TTCCCGGGTA TTCCTGAAGA 600 TCTGAGAGGA AGAGTGTATA TGCTGAACTA TCGCATAAGG TCAGTGCAGC TATTTATTGT 660 AAACGGTCGG GCTGACAGGG CGCAGGTGCG TCTGGAATGC GACGATGAAG CCGTTTTTGA 720 ATGTTATCTT CTTGCTGAAG GGGAAGGGGA ACTGAAAGAA CTGAGCCTGT CAGAGCTGGA 780 AGAGCGGGCG CTGATGTATG CGGCAGACAG TTTCCGTTAT GAATGATAAG TCAGTTATAC 840 CGGTAATGGT AAACGGAGCC GGTATCCGGG ATACAAGGGG CAGAGAGTAT GCTGATTATT 900 ATTATGACCC GGGACAGATA TCTGGAATAT GGCCTGATGC GTATACTGAG CGGATATCAG 960 GTCACGACAG GCAGAGAGCT GTTTAATGCC GGAAAGCAAC GTCAGTCACT TCCCGAAGAC 1020 AGTTATGTGA TTCTCTGTGA CCGTAATCTG GAAAGGCTTA CATACTCTAT GTTCTGTGGG 1080 CGTCGGTTTC TTGTCATTCC TGTTTCCTCT GTGAGATGCC TGACAGATAT CAGGCAAACC 1140 ATCCGCCGTG GAGCGTGGCT GTTCGGACAT ACGGCAAGGC CACTGACCCG GACAGAGATG 1200 GTGGTGGTCT TCGGGGTTGT TTTCCATGAC TACGGGTTTA CCTTTCTGGC AGACCGGCTG 1260 GGGATAACCA TGAAGACGGT ATGTGCGCAT CTTTACAATG CGATGGAGAA AAATGGTATG 1320 CGCGGCGTCA GTATTAAATA TCTCTGCAAC ACCATAGACC GGTAAAAAGA TGGTTTTCTG 1380 ATAAAGGCTG TTGCGACGGG GATTTCTGTG CATGCTGTGT CACGGGCATC CCAGCTCTCC 1440 GGATAATTAA TGTTATGTAG TCAGGCGTGA TAAATTTCAT ATGGAACAGG TATGCGTTTT 1500 ATTTGTGATA ACAGTTAATG AGGTGTTTCC ATACACACTG AAGTTACCTG TAATATTAGC 1560 GGGGGATTTG AATGATGTTG CGTGTCTGCG ACCACTCGTT TATTCATGCA AATAAGTGGA 1620 CTGCTGGATC CACGGTAAGA GTACAGCGAG GGCCGTATTG ACGGGGATGT GTTATTCAGC 1680 GGGCAGTGCT ATGCGCCACG GAAGCAGTTC GCTGACACGG TTGACCGGCC AGTCAGCTAT 1740 GACGCCAAAC ACATGGCGAA GGTAGTTTTC TGGATCCTCG TCGTTCAGTT TGCACGTCCC 1800 GATCAGGCTG TACAGTAGCA CTCCCCGCTC ACCACCATGC TCAGAGCTGC GTATTACCGT 1860 GAAGGAGATC GGTGAGTAAC CCTCTGTGTC GGCACATTAT AGCCGTCACA TCGGATAACT 1920 GTTATCCTTC TGTTCTGATG TATTCTGGGA GGTGATGTTT CACTCCTGAT AAGAGCATTA 1980 CTAATTACAG CTGCTTTTCG GATAACATTC GGGCAGTTTT CTTTAATTCT GAAGTCTGAA 2040 AGAGATATCA GTAATTGTAT TGCTTTTAAA CATTGTCAGT ATTTATTTGT CCAAATCGTT 2100 CACGTTTCTC ATAATCTTCC CGACAGTCAC CATCACAAAA CAATCCAGTC TTAACAGGTT 2160 CTCCGCAGTT ATAGCAGAAT CCTGTTTCAG GGAGTCTATT CCGGATACGA TTTTTTAGTC 2220 TGATGCTCAT GCTGAATTGT TCATTTTCAT AAGCAATATC TGCACTATCT GCCATAAACG 2280 ATCCTCTGAG GAGACCACAT CTTTATAACC CACCACCGAA ATATTACAAA GTAATACTCA 2340 TTGTATAATC TTTAACCRGG GGCAGGATAA TTGTATCCTG CCCCT 2385 (2) INFORMATION FOR SEQ ID NO: 16: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 746 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 16: CTTTCAGACC AGCGTTTCCT GTCAGGAGAT GAGGAAGAAA CATCAAAGTA TAAAGGCGGC 60 GATGACCATG ATACGGTATT CAGTGGCGGT ATTGCGGCCG GTTATGATTT TTATCCGCAG 120 TTCAGTATTC CGGTTCGTAC AGAACTGGAG TTTTACGCTC GTGGAAAAGC TGATTCGAAG 180 TATAACGTAG AT AAGACAG CTGGTCAGGT GGTTACTGGC GTGATGACCT GAAGAATGAG 240 GTGTCAGTCA ACACACTAAT GCTGAATGCG TACTATGACT TCCGGAATGA CAGCGCATTC 300 ACACCATGGG TATCCGCAGG ATTGGCTACG CAGAATTCAC CAGAAAACAA CCGGTATCAG 360 TACCTGGGAT TATGAGTACG GAAGCAGTGG TCGCGAATCG TTGTCACGTT CAGGCTCTGC 420 TGACAACTTC GCATGGAGCC TTGGCGCGGG TGTCCGCTAT GACGTAACCC CGGATATCGC 480 TCTGGACCTC AGCTATCGCT ATCTTGATGC AGGTGACAGC AGTGTGAGTT ACAAGGACGA 540 GTGGGGCGAT AAATATAAGT CAGAAGTTGA TGTTAAAAGT CATGACATCA TGCTTGGTAT 600 GACTTATAAC TTCTGACGAC ACTGCTCCTG AACGATAATT GCGTATATTC TGTAATTAAG 660 ATAATTGCAT ATCKTCTGCA ATTAARCAGA AATACCCTGC AGTCTATTAC TGCAGGGNTG 720 TCTTTTATCT GTTTTACAGA NAATTT 746 (2) INFORMATION FOR SEQ ID NO: 17: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 411 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 17: TCTGTTTGTC GTTTTTTCCC CGTTGTAGCG GYTCTGCTCC TGGCTTCCCT GATAGTCAGC 60 CCGCAGGCGC CAGGGCCCCA GATTCCCCCC CACAGTCCCG TTATAACTGA ACTGATGAGA 120 GTCTCCTCCC TGATAATTAC GGGAAACCGT CCCGTTGAGG TTATAATCCA GCATCAGTCC 180 GGGAATGCCG TCGTCCCAGC GTGAGGGAGG CAGCCAGGTG GCATCAGAAT ACTCAAGCCC 240 AGCTGCGGCA TATTGATGCG TAATACGCCC GCTCCGGTAT CAGGACGAAT ATCCACTCCC 300 GGCAACCCAT GAAAATCCGC ACACTGACCA TCATGCCAGT AAACAACTTT ATCCAGAGAT 360 TCTGCTGTTA ACCCCATCAG TCTGACCATA TCTGATGTCA GACAGGCCTG C 411 (2) INFORMATION FOR SEQ ID NO: 18: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 977 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 18: TATTATCGCG CGCGCGCTGC ACAGGGGTTA TCTACATCTG CTGCTGCTGC CGGTTTAATT 60 GCTTCTGTAG TGACATTAGC AATTAGTCCC CTCTCATTCC TGTCCATTGC CGATAAGTTT 120 AAACGTGCAA ATAAAATAGA GGAGTATTCA CAACGATTCA AAAAACTTGG ATACGATGGT 180 GACAGTTTAC TTGCTGCTTT CCACAAAGAA ACAGGAGCTA TTGATGCATC ATTAACAACG 240 ATAAGCACTG TACTGGCTTC AGTATCTTCA GGTATTAGTG CTGCKGCAAC GACATCTCTT 300 GTTGGTGCAC CGGTAAGCGC ACTGGTAGGT GCTGTTACGG GGATAATTTC AGGTATCCTT 360 GAGGCTTCAA AGCAGGCAAT GTTTGAACAT GTTGCCAGTA AAATGGCTGA TGTTATTGCT 420 GAATGGGAGA AAAAACACGG TAAAAATTAC TTTGAAAATG GATATGATGC CCGCCATGCT 480 GCATTTTTAG AAGATAACTT TAAAATATTA TCTCAGTATA ATAAAGAGTA TTCTGTTGAA 540 AGATCAGTCC TCATTACTCA ACAACATTGG GATATGCTGA TAGGTGAGTT AGCTAGTGTC 600 ACCAGAAATG GAGACAAGAC ACTCAGTGGT AAAAGTTATA TTGACTATTA TGAAGAGGGA 660 AAGCGGCTGG AAAGAAGGCC AAAAGAGTTC CAGCAACAAA TCTTTGATCC ATTAAAAGGA 720 AATATTGACC TTTCTGACAG CAAATCTTCT ACGTTATTGA AATTTGTTAC GCCATTGTTA 780 ACTCCCGGTG AGGAAATTCG TGAAAGGAGG CAGTCCGGAA AATATGAATA TATTACCGAG 840 TTATTAGTCA AGGGTGTTGA TAAATGGACG GTGAAGGGGG TTCAGGACAA GGGGTCTGTA 900 TATGATTACT CTAACCTGAT TCAGCATGCA TCAGTCGGTA ATAACCAGTA TCGGGNAATT 960 CGTATTGAGT CACACCT 977 (2) INFORMATION FOR SEQ ID NO: 19: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 400 base pairs (B) TYPE: nucleic ac d (C) STRANDEDNESS: double (D) TOPOLOGY: linear (x ) SEQUENCE DESCRIPTION: SEQ ID NO: 19: TTTCTTAAGT CCGGCATTGC CACGCGTAAC CCCCACTTCA ACCGCATGAT TGAGCAGATC 60 GAAAAAGTGG CGATCAAATC CCGCGCGCCG ATTCTGCTTA ACGGTCCAAC CGGCGCGGGC 120 AAGTCATTTC TGGCGCGACG CATCTTAGAG TTAAAACAGG CGCGGCATCA GTTTAGCGGC 180 GCKTTTGTGG AAGTGAACTG CGCCACCCTG CGCGGCGATA CCGCCATGTC GACGCTGTTT 240 GGTCATGTAA AAGGCGCGTT TACCGGGGCG CGGGAATCTC GTGAAGGTTT ATTACGCAGC 300 GCCAACGGGG AAATGTTGTT TCTTGATGAG ATTGGCGAAC TGGGCGCGAC GAACAGGCAA 360 TGCTGCTGAA ACCCATTGAA GRGGAAAACC TTTTACCCGT 400 (2) INFORMATION FOR SEQ ID NO: 20: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 12368 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 20: GTATGCGTTT TCATTAAGAT ATTCTCTGCT GTAGAGAAAC TTATAGCAAT ATAATCTGAT 60 AATATCTTTT ATGTAAAATT TAAATAGTTC ACCTGTGACA GATATATGTT TTCTGCTCAG 120 TAACTCCTGT GTATTAAGCC ATTCCCGTGA CCGAAGCACA CCCTTGTGAA AACTTTTTCT 180 TACTTGCTTT GAGGCACGGC ATTGATGTAA TATTTTTGCG TCCTCAATAA TTCTCTTTCC 240 CGTTTTATTT TTTGCAGCAT CTCTTACTCC ATAAAATATC TCCCGGTCCA GACTTTTGTC 300 ATATTTACTG ATTATACGAC AAATATTCCT GACCCGACGA TTCTCTTTAT TTCGCTTCCA 360 TAGCTTATAA TGATCATCGC ATAACCTTAA GGCATTTGCC TCATCAAATT CTGAAACAGG 420 ATTACTGCAT TTTTTATTCC GACAAATACC TTTGTTTTTA GCCATACTCT TCTTCCCGTC 480 AATGGAAAAA TTTTCACACC CATATTACCT GAATGATAAA CCGGATTAGT GTGATCCGGT 540 TCAGTGAAAT CAACAGGATA CCGGTATGCC ATTCAGCAAT TCTTCCCTCT CCGCGCAAGT 600 GAAATCATAT CTGACGTTTC TTCCTGAAGA AATACGCCAG AAAATCCTTG AACATCTCCA 660 CGGTGTTATT CATTACGAGC CCGTGATTGG CATTATGGGT AAATCCGGCA CCGGCAAGAG 720 CAGCCTGTGT AATGCCATTT TTCAGTCCCG TATCTGCGCC ACGCATCCCC TGAACGGCTG 780 CACCCGCCAG GCTCATCGTC TTACCCTGCA GCTCGGTGAA CGCAGAATGA CGCTGGTCGA 840 TCTGCCCGGC ATTGGTGAAA CACCGCAGCA TGATCAGGAA TACCGAGCGC TTTATCGTCA 900 GTTACTGCCG GAACTGGATC TGATTATCTG GATCCTGCGG AGTGATGAAC GTGCGTATGC 960 TGCCGATATT GCCATGCATC AGTTTTTACT GAATGAGGGC GCAGATCCCT CGCGCTTTCT 1020 GTTTGTTCTC AGCCATGCCG ATCGCATGTT TCCTGCTGAA GAATGGAATG CCACAGAAAA 1080 ATGCCCGTCC CGTCACCAGG AACTCTCACT GGCGACAGTA ATAGCCCGGG TGGCCACCCT 1140 GTTCCCTTCA TCATTTCCGG TACTCCCTGT AGCCGCACCT GCAGGCTGGA ACCTTCCAGC 1200 GCTGGTGTCA CTGATGATCC ACGCGCTGCC ACCACAGGCA ACCAGCGCAG TTTATTCACA 1260 TATCAGGGGG GAAAACCGCT CTGAACAGGC CCGGAAACAC GCACAACAGA CTTTTGGTGA 1320 TGCCATCGGG AAAAGTTTTG ACGACGCCGT TGCCCGGTTC AGTTTTCCGG CCTGGATGTT 1380 ACAGCTTCTG CGTAAAGCCC GGGACCGCAT TATCCACCTG CTGATCACAC TGTGGGAGCG 1440 TCTGTTCTGA CACACTCACG CCGACAGATG TGTCGCTGGA TTAACGAGCA TTCTTCTTTT 1500 TATGAAATCA TGCTTAAAAA TCAGATAATT ARAAGAATAT TTTTTCTGCT GCATTTTATT 1560 CCTGATTATC CGGATGCGAC ACATCCTTTC AACATCATGA TGCATAATAA CATCATGAAA 1620 TAAAAGATGT TTTCTTACGG AGTGCACATC TATGTCTGAT AATCGTTCCC GGCATGATCG 1680 CCTGGCGGTT CGCTTATCAC TCATTATCAG CCGACTGATG GCCGGAGAAT CTCTGTCACT 1740 AAAAACACTG TCAGATGAAT TTGGCGTTAC AGAACGTACT TTACAGCGCG ATTTTCATCA 1800 GCGTCTGGTT CACCTAGATT TAGAGTACAG AAATGGCAGG TACAGCCTCA GACGACAGAG 1860 CAGCCCAGGT GCGATCCCTG AAATGCTTTC TTTTATACAG AATACCGGGA TCGCACGGAT 1920 ACTTCCGCTC CGGAACGGAC GACTGATAAC CTGTCTTACC GACAACCAGG AGCCCTCTCC 1980 CTGCCTTATC TGGCTACCGG CGCCGGATAT CACTGCAACG TTCCCCGAGT GTTTCTCGCA 2040 ACTCATCCTG GCAATAAGAC AGTGTATCCA CATCTCTCTG ATGACTGAGC GATGGTATCC 2100 GTCACTGGAG CCCTGCCGGC TCATTTATTA CAGCGGTAGC TGGTATCTGA TCGCGTTACA 2160 GAAGGGAAAA CTGCAGGTCT TTCCTCTGGC AGATATCAAA TCAGTCAGCC TGACATCAGA 2220 ACGGTTTGAA CGGAGAGGCC ACATCCACAG TCTGGTCGCT GAAGAGCGTT TTATCTCCGC 2280 CCTGCCACAT TTCTCTTTCA TCCATAAACT TATCAACACC TTTAACCTGT GATCGCCGGC 2340 CTGCCAAAGC CGTCCCGACA GGTATGGAGA CAATATGTTG AACAGAAAAC TAAATATACG 2400 GCTACGTCAT TCCCTGAACA GTCACTGCAT ACCTTCCATC ATTATCAATA ACACCGTACG 2460 TTCATTTCAG AGGTCAGTCA TGAATACCAG AGCTCTTTTT CCCCTGCTGT TCACTGTGGC 2520 ATCATTCTCC GCCTCCGCCG GCAACTGGGC TGTCAAAAAC GGCTGGTGTC AGACCATGAC 2580 GGAAGATGGT CAGGCGCTGG TAATGCTGAA AAATGGCACG ATTGGTATTA CCGGCCTGAT 2640 GCAGGGATGC CCGAATGGTG TACAGACGCT CCTGGGCAGC CGTATCAGTA TTAACGGTAA 2700 CCTGATCCCC ACATCACAAA TGTGTAATCA GCAGACGGGA TTCAGGGCTG TTGAGGTGGA 2760 AATCGGACAG GCGCCGGAAA TGGTCAAAAA AGCCGTTCAC TCCATAGCAG AGCGTGATGT 2820 GTCCGTTTTA CAGGCATTTG GTGTACGAAT GGAATTCACC CGCGGTGATA TGCTGAAGGT 2880 CTGTCCGAAA TTTGTCACAT CACTTGCCGG TTTTTCCCCG AAACAGACGA CCACTATTAA 2940 TAAAGATTCC GTCCTGCAGG CTGCCCGGCA GGCATACGCC CGGGAATATG ACGAGGAAAC 3000 AACAGAAACC GCTGATTTTG GCTCTTACGA AGTAAAAGGC AATAAGGTTG AGTTTGAAGT 3060 ATTCAATCCT GAAGACCGTG CGTACGACAA AGTGACCGTC ACGGTTGGTG CTGACGGTAA 3120 TGCCACCGGC GCCAGCGTTG AATTTATCGG AAAATAGCCG GTATGTCGGA CTGCCACCCT 3180 GTTTTATTGC CCGAAGGCCC TTTCTCACGC GAACAGGCGA TGGCTGTCAC AACAGCTTAC 3240 CGCAATGTGC TTATTGAAGA TGACCAGGGA ACGCATTTCC GGCTGGTTAT CCGCAATGCC 3300 GAAGGGCAGC TACGCTGGCG GTGCTGGAAT TTTGAACCTG ATGCCGGAAA ACAGCTAAAT 3360 TCGTATCTCG CCAGTGAGGG AATTCTCAGG CAATAAACGT CTTCATTTCA TCCATCAGGC 3420 CGCGTCTTCT CCGGGAGACG CGGCCTTTTC GTTTATACCG CTAATTCATT CATAAGGAGC 3480 AAAGTATGCA ATTAGCCAGT CGTTTTGGTC ATGTAAATCA GATCCGTCGG GAGCGCCCAC 3540 TGACACGCGA AGAACTGATG TACCACGTCC CGAGTATTTT TGGAGAAGAC CGGCACACCT 3600 CCCGCAGTGA ACGGTATGCG TACATTCCCA CCATCACCGT CCTGGAAAAT CTGCAGCGGG 3660 AAGGCTTTCA GCCGTKCTTC GCCTGCCAGA CCCGTGTGCG CGACCAGAGC CGCCGGGAAT 3720 ATACCAAACA TATGCTGCGT CTGCGGCGGG CCGGACAGAT AACCGGTCAG CATGTGCCTG 3780 AAATTATTCT GCTCAACTCC CATGACGGTT CATCCAGCTA CCAGATGTTA CCCGGATATT 3840 TTCGTGCCAT TTGTACCAAT GGCCTGGTCT GCGGTCAGTC GCTGGGAGAA GTCCGGGTGC 3900 CACACCGGGG AAACGTGGTG GACAGGGTCA TAGAAGGTGC TTACGAAGTG GTGGGCGTGT 3960 TTGACCTGAT TGAGGAAAAG CGTGATGCCA TGCAGTCGCT GGTCCTGCCG CCACCGGCAC 4020 GCCAGGCGCT GGCACAGGCG GCGCTGACTT ACCGTTATGG TGATGAACAT CAGCCCGTCA 4080 CCACTACCGA CATTCTGACG CCACGACGCC GGGAGGATTA CGGTAAGGAC CTGTGGAGTG 4140 CTTATCAGAC CATCCAGGAG AATATGCTGA AAGGCGGGAT TTCCGGTCGC AGTGCCAGAG 4200 GAAAACGTAT CCATACCCGG GCCATTCACA GCATCGATAC CGACATTAAG CTCAACCGGG 4260 CGTTGTGGGT GATGGCAGAA ACGCTGCTGG AGAGCCTGCG CTGATACCGT TTCCCTGAAA 4320 GCGCAGTCCT GTTCACGGCT GTCCCTTCCC CCAGACATTC CACCATTCAT TTACTTTTTA 4380 TAAGGAATAA TCTCATGACA ACCTCTTCGC ATAATTCCAC CACACCTTCT GTTTCCGTGG 4440 CCGCTGCATC AGGGAATAAC CAGTCTCAGT TGGTTGCCAC TCCCGTCCCT GATGAACAGC 4500 GCATCAGCTT CTGGCCGCAG CATTTTGGCC TCATTCCACA GTGGGTCACC CTGGAGCCCC 4560 GTGTCTTCGG CTGGATGGAC CGTCTGTGCG AAAACTACTG CGGGGGTATC TGGAATCTGT 4620 ACACCCTGAA CAACGGTGGC GCATTTATAG CACCTGAACC GGATGAAGAT GATGGAGAAA 4680 CCTGGATACT GTTCAATGCC ATGAACGGTA ACCGCGCTGA AATGAGCCCG GAAGCTGCCG 4740 GCATTGCCGC CTGTCTGATG ACGTACAGCC ATCATGCCTG TCGTACGGAG AATTATGCCA 4800 TGACGGTCCA TTATTACCGG TTGCGGGATT ACGCCCTGCA GCATCCGGAA TGCAGCGCCA 4860 TTATGCGCAT CATTGACTGA AAGGGGCCGG AATAATGCAA CAGATTTCCT TTCTGCCCGG 4920 AGAAATGACG CCCGGCGAGC GCAGTCACAT TCTGCGGGCC CTGAAAACCC TGGACCGCCA 4980 TCTTCATGAA CCCGGTGTGG CCTTCACCTC CACCCGTGCG GCACGGGAAT GGCTGATTCT 5040 GAACATGGCG GGACTGGAGC GTGAAGAGTT CCGGGTGCTG TATCTGAATA ACCAGAATCA 5100 GCTGATTGCC GGTGAAACCC TCTTCACCGG CACCATCAAC CGCACGGAAG TCCATCCCCG 5160 GGAAGTGATT AAACGCGCCC TGTACCACAA TGCCGCTGCC GTGGTGCTGG CGCACAATCA 5220 CCCGTCCGGT GAAGTCACAC CCAGTAAGGC AGACCGGCTT ATCACCGAAC GTCTGGTACA 5280 GGCACTGGGC CTGGTGGATA TCCGGGTGCC GGACCATCTG ATAGTCGGTG GCAGCCAGGT 5340 TTTCTCCTTT GCGGAACACG GTCTGCTTTA ACCCGTCACC GTCACAATCA CCTTCATATC 5400 ACTTCAGTTT CTCTTTCTCA GCTGTTTCTT ACTTTCACAT TCAGGAGGAC TATTCTCATG 5460 AAAATCATCA CCCGTGGTGA AGCCATGCGT ATTCACCGTC AGCATCCTGC ATCCCGTCTT 5520 TTTCCGTTCT GTACCGGTAA ATACCGCTGG CACGGTAGCA CGGATACATA TACCGGCCGT 5580 GAAGTACAGG ATATTCCCGG TGTGCTGGCT GTGTTTGCTG AACGCCGTAA GGACAGTTTT 5640 GGCCCGTATG TCCGGCTGAT GAGCGTCACC CTGAACTGAA TCAGGACGGG CATTCAGAAG 5700 AGCAGAATTA TCGCCACCAC CGGACCATTC TTAACCAATT TTCTGTGAGG ATTTTATCGT 5760 GTCAGACACT CTCCCCGGGA CAACGCATCC CGACGATAAC AACGACCGCC CCTGGTGGGG 5820 GCTACCCTGC ACCGTGACGC CCTGTTTTGG GGCACGTCTG GTGCAGGAGG GTAACCGGTT 5880 GCATTACCTT GCAGACCGCG CCGGTATCAG AGGCCGGTTC AGCGACGCGG ATGCGTACCA 5940 TCTGGACCAG GCCTTTCCGC TGCTGATGAA ACAACTGGAA CTCATGCTCA CCAGCGGTRA 6000 ACTGAATCCC CGCCATCAGC ATACCGTCAC GCTGTATGCA AAAAGGCTGA CCTGCGAANC 6060 GACACCCTCG GCAGTTGTGG CTACGTTTAT ATGGCTGTTT ATCCGACGCC CGAAACGAAA 6120 AAGTAACTCT CCAGAATAAC CTTCTGCCCC GGCCTGGTGC TTTCACCACG CCACTTTTCC 6180 ATTTTTCATC TCTGCATATC AGGAAAATCT TCAGTATGAA CACATTACCC GATACACACA 6240 TACGGGAGGC ATCGCATTGC CAGTCTCCCG TCACCATCTG GCAGACACTG CTCACCCGAC 6300 TGCTGGACCA GCATTACGGC CTCACACTGA ATGACACACC GTTCGCTGAT GAACGTGTGA 6360 TTGAGCAGCA TATTGAGGCA GGCATTTCAC TGTGTGATGC GGTGAACTTT CTCGTTGAAA 6420 AATACGCACT GGTGCGTACC GACCAGCCGG GATTCAGCGC CTGTACTCGT TCTCAGTTAA 6480 TAAACAGTAT TGATATCCTC CGGGCCCGCC GGGCAACCGG CCTGATGGCC CGCGACAATT 6540 ACAGAACGGT AAATAACATT ACCCTGGGTA AGCATCCGGA GAAACGATGA AACTTTCCCT 6600 GATGCTGGAA GCCGACAGAA TTAATGTGCA GGCACTGAAC ATGGGGCGAA TTGTCGTTGA 6660 CGTCGATGGT GTTAATCTCA CTGAACTGAT TAACAAGGTC GCTGAAAACG GTTATTCACT 6720 CCGCGTGGTG GAGGAATCCG ACCAACAGTC AACCTGCACA CTACCACCGT TTGCAACCCT 6780 TGCCGGCATA CGCTGCAGTA CCGCACATAT CACGGAAAAG GATAACGCCT GGCTGTACTC 6840 GCTGTCACAC CAGACCAGTG ACTTCGGTGA ATCAGAATGG ATTCATTTCA CAGGTAGCGG 6900 ATATCTGTTA CGTACCGATG CGTGGTCATA TCCGGTTCTG CGGCTTAAAC GCCTGGGGCT 6960 GTCAAAAACG TTCCGTCGTC TGGTTATCAC ACTTACCCGA CGTTATGGCG TCAGTCTCAT 7020 TCATCTGGAT GCCAGCGCTG AATGCCTGCC GGGTTTACCC ACTTTCAACT GGTAACCAGG 7080 AACAACATGA AATCATTAAC CACGGAAACC GCACTGGATA TTCTGATTGC GTGGCTGCAG 7140 GACAATATCG ACTGCGAATC GGGAATTATC TTTGACAACA ATGAGGATAA AACGGATTCA 7200 GCAGCACTGT TGCCCTGTAT CGAACAGGCC AGAGAGGATA TCCGTACCCT GCGCCAACTG 7260 CAGCTTCAGC ACCAGAACCG GTGAGTCTCA CTCATCATCT CACTCACCAG ACTTCATTCC 7320 ACTSACGCCA GCCTGAACAC GGCTGGCGTT TTCATTTATC TGCAAAAAGG AATATCGATT 7380 ATGTCTGAAA TCACAGTCTC CCGTCCGGAA GTGGTCAACG AGAATACGGA CGTTATCTGC 7440 TCCACCTCAG TCAGGTACAG GTCACTGGAA TATGATAATT TTCCGGAAAT CAGCGAAGCG 7500 AACATTCTGA GCACATTTGA ACAACTGCAC CAGAACAAAG ATGAAGTGTT TGAACGGGGA 7560 GTGATCAACG TCTTCAAAGG GCTGAGCTGG GATTACAAAA CCAACTCACC CTGTAAATTT 7620 GGCAGTAAAA TTATCGTCAA CAATCTGGTG AGATGGGACC AGTGGGGATT TCATCTTATC 7680 AGTGGAATGC AGGCAGATCG CCTGGCTGAC CTGGAAAGAA TGTTGCATCT GCTCAGCGGT 7740 AAACCGATCC CCGACAACCG AGGGAATATC ACCATTAATC TGGATGACCA CATACAGTCC 7800 GTTCAGGGTA AAGGACGCTA TGAAGATGAG ATGTTCATCA TTAAATACTT TAAGAAGGGA 7860 TCTGCACACA TCACTTTCAA AAGGCTGGAG CTGATTGACA GAATTAACGA TATAATAGCC 7920 AGGCACTTTC CTTCTGTGCT CTCAGCCTGA CCCCGAGTTT GATTCCCTTT CGATATCAAA 7980 AGGGACTGCG GGTACAAAAG AGGGTACATC TTTCACCAAA CCAAACAAAA TAAACTAATA 8040 TCAACATGAT AGAAGCATTC TTCGATTCCG AGTCCGGCAC CAAATTCATA TAAACGGACC 8100 TCCACGGAGG TCCGTTTTTC GTTTCAGGAC GCCACGATTT AAGCGTCCTG CCGCCAAATC 8160 AATTCTACCG AACTCAACCA GATTCTCCCC ACATCACCAG CAATTTGCGG GCATATCCCA 8220 ATTCGGGAAA ATTTGTTTCT GAGCTATAGC GCTGACTGAC GTGAAATGTC GTGCGGCCCC 8280 GTGATGCTGT TGAAMGTCAA ATGACGTCAT CAGGAGCGTA ACGCACCCAT AAAGCACAAC 8340 ATCGGGCAGA ACGCCAACTG ATGAGATTTT CTGAATGAGA ACAAAGAGAA ATGTATCAGT 8400 CCGTTTGCTC ATGCAAAGAC TAACAATCCA TTAAAATAGT AAGCGCTCCG GACAATTTTC 8460 CATGGATTAT TTTCTGAACA TTTTTCTTTG GCAAAGATGA TGAATTTTGA TGGTAAGGAA 8520 AATTACTTCT GGTTCTCAGT AAAATCCTTT CGTAATACTA TGTAATCAAG AAGTTTATGG 8580 CTAGTAAAAA TAACGTCTTG CATTCACCAA TAATATGTAA ATAAACCCAT CTATAGATGG 8640 AAAAAATAGG TTATGGAATT ATCATTGCAT CATTCCCTTT TCGAATGAGT TTCTATTATG 8700 CAACAACCTG TAGTTCGCGT TGGCGAATGG CTTGTTACTC CGTCCATAAA CCAAATTAGC 8760 CGCAATGGGC GTCAACTTAC CCTTGAGCCG AGATTAATCG ATCTTCTGGT TTTCTTTGCT 8820 CAACACAGTG GCGAAGTACT TAGCAGGGAT GAACTTATCG ATAATGTCTG GAAGAGAAGT 8880 ATTGTCACCA ATCACGTTGT GACGCAGAGT ATCTCAGAAC TACGTAAGTC ATTAAAAGAT 8940 AATGATGAAG ATAGTCCTGT CTATATCGCT ACTGTACCAA AGCGCGGCTA TAAATTAATG 9000 GTGCCGGTTA TCTGGTACAG CGAAGAAGAG GGAGAGGAAA TAATGCTATC TTCGCCTCCC 9060 CCTATACCAG AGGCGGTTCC TGCCACAGAT TCTCCCTCCC ACAGTCTTAA CATTCAAAAC 9120 ACCACAACGC CACCTGAACA ATCCCCAGTT AAAAGCAAAC GATTCACTAC CTTTTGGGTA 9180 TGGTTTTTTT TCCTGTTGTC GTTAGGTATC TGTGTAGCAC TGGTAGCGTT TTCAAGTCTT 9240 GAAACACGTC TTCCTATGAG TAAATCGCGC ATTTTGCTCA ATCCACGCGA TATTGACATT 9300 AATATGGTTA ATAAGAGTTG TAACAGCTGG AGTTCTCCGT ATCAGCTCTC TTACGCGATA 9360 GGCGTGGGTG ATTTGGTGGC GACATCACTT AACACCTTCT CCACCTTTAT GGTGCATGAC 9420 AAAATCAACT ACAACATTGA TGAACCGAGC AGTTCCGGTA AAACATTATC TATTGCGTTT 9480 GTTAATCAGC GCCAATACCG TGCTCAACAA TGCTTTATGT CGGTAAAATT GGTAGACAAT 9540 GCAGATGGTT CAACCATGCT GGATAAACGT TATGTCATCA CTAACGGTAA TCAGCTGGCG 9600 ATTCAAAATG ATTTGCTCCA GAGTTTATCA AAAGCGTTAA ACCAACCGTG GCCACAACGA 9660 ATGCAGGAGA TGCTCCAGCA AATTTTGCCG CATCGTGGTG CGTTATTAAC TAATTTTTAT 9720 CAGGCACATG ATTATTTACT GCATGGTGAT GATAAATCAT TGGATCGTGC CAGTGAATTA 9780 TTAGGTGAGA TTGTTCAATC ATCCCCAGAA TTTACCTACG CGAGAGCAGA AAARGCATTR 9840 GTTGRTATCG TGCGCCATTC TCAACATCCT TTAGACGRAA AACAATTAGC CAGCACTGAA 9900 CACAGAAATA GATAACATTG TTACACTGCC GGAATTGAAC AACCTGTCCA TTATATATCA 9960 AATAAAAGCG GTCAGTGCCC TGGTAAAAGG TAAAACAGAT GAGTCTTATC AGGCGATAAA 10020 TACCGGCATT GATCTTGAAA TGTCCTGGCT AAATTATGTG TTGCTTGGCA AGGTTTATGA 10080 AATGAAGGGG ATGAACCGGG AAGCAGCTGA TGCATATCTC ACCGCCTTTA ATTTACGCCC 10140 AGGGGCAAAC ACCCTTTACT GGATTGAAAA TGGTATATTC CAGACTTCTG TTCCTTATGT 10200 TGTACCTTAT CTCGACAAAT TTCKCGCTTC AGAATAAGTA ACTCCCGGGT TGATTCATGC 10260 TCGGGAATAT TTGTTGTTGA GTTTTTGTAT GTTCCCGTTG GTATAATATG GTTCGGCAAT 10320 TTATTTGCCG CATAATTTTT ATTACATAAA TTTAACCAGA GAATGTCACG CAATGCATTG 10380 TAAACATTGA ATGTTTATCT TTTCATGATA TCAACTTGCG ATCCTGATGT GTTAATAAAA 10440 AACCTCAAGT TCTCACTTAC AGAAACTTTT GTGTTATTTC ACCTAATCTT TAGGATTAAT 10500 CCTTTTTTCG TGAGTAATCT TAGCGCCAGT TTGGTCTGGT CAGGAAATAG TTATACATCA 10560 TGACCCGGAC TCCAAATTCA AAAATGAAAT TAGGAGAAGA GCATGAGTTC TGCCAAGAAG 10620 ATCGGGCTAT TTGNCCTGTA CCGGTGTTGT TGCCGGTAAT ATGATGGGGA GCGGTATTGC 10680 ATTATTACCT GCGAACCTAG CAAGTATCGG TGGTATTGCT ATCTGGGGTT GGATTATCTC 10740 TATTATTGGT GCAATGTCGC TGGCATATGT ATATGCCCGA CTGGCAACAA AAAACCCGCA 10800 ACAAGGTGGC CCAATTGCGT ATGCCGGAGA AATTTCCCCT GCATTTGGTT TTCAGACAGG 10860 TGTTCTTTAT TACCATGCTA ACTGGATTGG TAACCTGGCA ATTGGTATTA CCGCTGTATC 10920 TTATCTTTCC ACCTTCTTCC CAGTATTAAA TGATCCTGTT CCGGCGGGTA TCGCTGTTAT 10980 TGCTATCGTC TGGGTATTTA CCTTTGTGAA TATGCTCGGC GGTACCTGGG TAAGCCGTTT 11040 AACCACGATT GGTCTGGTGC TGGTTCTTRK TCCTGTGGTG ATGACTGCTA TTGTTGGCTG 11100 GCATTGGTTT GATGCAGCAA CTTATGCAGC TAACTGGAAT ACTGCGGATA CCACTGATGG 11160 TCATGCGATC ATTAAAAGTA TTCTGCTCTG CCTGTGGGCC TTCGTGGGTG TTGAATCCGC 11220 AGCAGTAAGT ACTGGTATGG TTAAAAACCC GAAACGTACC GTTCCGCTGG CAACCATGCT 11280 GGGTACTGGT TTAGCAGGTA TTGTTTACAT CGCTGCGACT CAGGTGCTTT CCGGTATGTA 11340 TCCGTCTTCT GTAATGGCGG CTTCCGGTGC TCCGTTTGCA ATCAGTGCTT CAACTATCCT 11400 CGGTAACTGG GCTGCACCAC TGGTTTCTGC ATTCACCGCC TTTGCGTGTC TGACTTCTCT 11460 GGGCTCCTGG ATGATGTTGG TAGGCCAGGC AGGTGTACGT GCCGCTAACG ACGGTAACTT 11520 CCCGAAAGTT TATGGTGAAG TCGACAGCAA CGGTATTCCG AAAAAAGGTC TGCTGCTGGC 11580 TGCAGTGAAA ATGACTGCCC TGATGATCCT CATCACTCTG ATGAACTCTG CCGGTGGTAA 11640 AGCCTCTGAC CTGTTCGGTG AACTGACCGG TATCGCAGTA CTGCTGACTA TGCTGCCGTA 11700 CTTCTACTCT TGCGTTGACC TGATTCGTTT TGAAGGCGTT AACATCCGCA ACTTTGTCAG 11760 CCTGATCTGT TCTGTACTGG GTTGCGTGTT CTGCTTCATC GCGCTGATGG GCGCAAGCTC 11820 CTTCGAGCTG GCAGGTACCT TCATCGTCAG CCTGATTATC CTGATGTTCT ATGCTCGCAA 11880 AATGCACGAG CGCCAGAGCC ACTCAATGGA TAACCACACA GCGTCTAACG CACATTAATT 11940 AAAAGTATTT TCCGAGGCTC CTCCTTTCAT TTTGTCCCAT GTGTTGGGAG GGGCCTTTTT 12000 TACCTGGAGA TATGACTATG AACGTTATTG CAATATTGAA TCACATGGGG GTTTATTTTA 12060 AAGAAGAACC CATCCGTGAA CTTCATCGCG CGCTTGAACG TCTGAACTTC CAGATTGTTT 12120 ACCCGAACGA CCGTGACGAC TTATTAAAAC TGATCGAAAA CAATGCGCGT CTGTGCGGCG 12180 TTATTTTTGA CTGGGATAAA TATAATCTCG AGCTGTGCGA AGAAATTAGC AAAATGAACG 12240 AGAACCTGCC GTTGTACGCG TTCGCTAATA CGTATTCCAC TCTCGATGTA AGCCTGAATG 12300 ACTGCGTTTA CAGATTAGCT TCTTTGAATA TGCGCTGGGT GCTGCTGATG ATATTGCTAA 12360 CAAGATCC 12368 (2) INFORMATION FOR SEQ ID NO: 21: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 833 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 21: GCACGGCACT CTGATGTANC TTTTATCTGT TCCCAGTGGA AGCATGCCCC ACAACTGAGT 60 CATTAAGTGT GGAAGAACAG TTTTGTCCCC GCCTGCAATC TCTCCCTTTC NAAAAACCAG 120 TATGTCGCCA TGCCTCGCCT TAATGGAGAG CGCTGAACCA TACCTTCTTT TTCCCAGTAA 180 TAACAGGTAA TAGCGTGCCT GGTAATCCGT TACCGCCAGC GCCTCCGCAA TTTCTGCGGT 240 TTTCCCTCCA TTATGCCTGT TCAGAAATYC CAGTATTTCA TTCTTCATAT ATTCACTCAT 300 CTCACTGTAA CAAAGTTYCT YCGAATAATA AAAATCATGC TTTCTGTTAT CAACGGAAAG 360 GTATTTTTAT TCTCTGTGTT TGCTTTATTT GTGAAATTTA GTGAATTTGC TTTTTGTTGG 420 CTTTATTTGN ATGTGTGTCA CATTTTGTGT GTTATTTTTC TGTGAAAAGA AAGTCCGTAA 480 AAATGCATTT AGACGATCTT TTATGCTGTA AATTCAATTC ACCATGATGT TTTTATCTGA 540 GTGCATTCTT TTTGTTGGTG TTTTATTCTA GTTTGATTTT GTTTTGTGGG TTAAAAGATC 600 GTTTAAATCA ATATTTACAA CATAAAAAAC TAAATTTAAC TTATTGCGTG AAGAGTATTT 660 CCGGGCCGGA AGCATATATC CAGGGGCCCG ACAGAAGGGG GAAACATGGC GCATCATGAA 720 GTCATCAGTC GGTCAGGAAA TGCGTTTTTG CTGAATATAC GCGAGAGCGT AYTGTTGCCC 780 GGCTMTATGT CTGAAATGCA TTTTTTTTTA CTGATAGGTA TTTCTTCTCA TTC 833 (2) INFORMATION FOR SEQ ID NO: 22: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 2916 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 22: TGCACCATCA CTGATACCAC CGGGACCCCG GATTTTATCC GGTCCCCGCG GACTGACAGG 60 GTTTGTGACA CCTGAGTCAT ATCCGATGTA AACTTCATTT TCACGGGTTG TACAGGAAAA 120 CTCCCCTGTG CCATTGAGTT CTGATGTGTG CCCTTCGCCA CAACTCCCAC CGTCACGGCA 180 CCAGTTGCAT CTGACGCCGA CCAACTGCTG AGAGCCATGC CGTTTCCGGC TTTGTCGACA 240 ACGCATGCTG CAGTTCCCAG CGATGCGAAC TGGTCTGGCA TGCATTCACG AACCAACAGC 300 AGTGGTGCTA CGTCCGGATG CAATTCGCAT GAGCTCCAAC CGCGGTTGTA AGTTCAGCAG 360 CCCGGGCCTC TGCCCCCGGC ACAGTCGCAT AAGTATTCGA TACCGTGCGA CACCATTACC 420 TTCAGGATAC GCCACGGACC CGTCACCCTA CGAAAACGCC GGAGCACCGG CAATCAGCAA 480 AGGCAGCAGT GATAAAAGAC TGATATATTT CCTGTCATTA TTTTTCATAT TAATTTAACT 540 CCTGATTAAC CGGTTTTTAT TGATATGAGA AAGTAATAGT TGCAATAGCC TTCACACTTC 600 CAGGTGTAGT TGCATCAGCA ATTTTTATAT AATTGGCTCT TAAATTGATA TGTGGATTTA 660 CCTCTCCCCT GTAATCGGAG AAGTGCCATT GACTGCCATT TCCTTTCACA GGGGAGTCTT 720 CACCATAGCT GATGGCAGTT ACATCACTGT CTTTATATAG CCTGATGCCA AATCCTTTTG 780 CAGTGGATTC ACTGCTTAAG GTCAATATAT CTGTTCTGTT CACTGGCTGT GATGCATCTG 840 TCAATGTAGC ATAAACATCA ATTCCATCCG GGCATTGTAG GTGTATGTCA ATTTTACCTC 900 CCTGTATTTC TTTATACAAA GATGTGAACT GTGATTGATA TACGGTATTT AATGGCACCA 960 CATAGTTTTT TTGCCCCATG GTACATGTCT GACTCTGTAC CTGAATGCGC CCACCATTTA 1020 ACATAACAGG TGCTGTCAGT CCTTTATTAT TTAAACTTGT ACGTTTTGCT TCCAACAAAA 1080 TAGTACCAAG CTGCCTGGTG GGTATTGTTA TATATCCATT GGGTAATCTT CCCGTTGCGA 1140 CAAAAGCAAC AAACAAACGA GCTCCGAAGC TTGCTGTCGC ACCGTTATAA GTATTGGGGT 1200 TTGTATTGGC ACCTACAGGG TCAATATATA TACCTGAGCT ATTTATGGGG ACCAGAGGCG 1260 TTGCGGGCCA ATAGCCCGCC ATGCCAATAA TAATACCCAG TCCGGATACA CCAATATCAT 1320 AGATATCAAA ATCAGATGAA TCACGGCTGT TTCCTTGATG GAAAGTATAC GTAATACTTC 1380 CAATTTTAGG CAGTGCGGGT GTAAACTTTC CACGCATCAG AGCGATGGCA CCGCCATTAA 1440 AAACATACTG GTTACTTGTT CCCGCCAGCT CTCCTATCAC CCGGGGATAG GTATGGGCAT 1500 CAGCAGGACC AATCACAACA CCTGGCAATG TGGATGTATT AACCGCTATC TGCGAAGGCA 1560 CATAATCATC CGGACCCGCT ACCGCCAGCT TAGGGAGTAA AATTAAAAAC AATGGTATGA 1620 AAAAGATTCT TTTCATGTTT TTTCCTGATT AGGGTGCTGT ATACACAGAA CAGGAACGAG 1680 CTGAGATTGC ATATCATCTT TATTGTGTGC AACATGATAT ACAAATGAAC ATCTGTCTTT 1740 ATTATCTGGT CCCCATACAA CGCTGAGATG ACCTTTTTCA GGGAGTCCCC TGGTAAATAC 1800 CTTCCCGGCC TGAGCGACAT ATCCGGCCAA CTGTCCATGT TCATCCAGAA CTTCAGAAGC 1860 CATTGGAGGG GGATTGCCAG TAGACATACG AATATCAAAT AACAGACTTC TTCCTGTTTT 1920 AGTGTCAAAT TTYACTAACG TGGCGCTATT AGCACGAGGA ATGATTTCCT GCTCCGTCGC 1980 CGATAATTCA ACATTCAAAT CTAAATTGGA GGGATCGATG CTAATTTGAT TTTTCTCATA 2040 GGGTGTAACA TAAGGAACAA TACCATTTCC CCAAAAATCC AGACGACTAC CAGAGGCATT 2100 ATTGATGGCA GCCCCCTGAG CTCCTTCAGC ATGGATAATG GCAAAAGTAT CACTCAGGTC 2160 ATTACTCAAT GTCACTCCAT AGGGGTGTGC GACCACCGCT CCCGACGCAC CAAATGACCT 2220 TTGATTATTA TTCTGAGTAT CATGCCCGAC TGTTGTGGTT ATATTTACAT AAGGTGAACG 2280 ATAACCCCCA TTCATTGCAT AACCGGAAGG CCCGTTTTCC TGGCTGTTTC CTGAAAGACC 2340 ATAAGAGAAC TGATTATCCT CCCCGCCAGT ACCACTAATT GATGTCTGAA TACTATTTTT 2400 CTCTTCTTTG CTATAATTTA AAACAGTGGA AAACACCGGG CTTTGAACAC TTNCCTCCCA 2460 GAGGGAGAGT AAAATTAATA TAAAATCTGT CATCACGGCG TTGTTGCTCA TTATCTCTTG 2520 ACTGAGACAA TCCAATTTGA TAGCCGAGTT GTTTCCAGAA GTTGCTGTAC CCCATCTGGT 2580 ATTCATTACG ACTTCCTTTA TGTCCCCAGT AATTATAGGT TGTTCCTGTT AAATACATCC 2640 CACCCCATTT TTCACCTAAT TCCTGGTTGA TTGAAATCTG GAATTGATTC CTGGGACGAT 2700 AAAACGCTGT ACTTTTTACA GAAACATCAT CAATAAACGC GTTGTGATTA GCTGATAGCG 2760 CATCCTTCAG ATGATAAAAA TCTTTTGATG AATAACGATA AGCCGCCAGA GTTATATTTG 2820 TGTTTTGAGG GCTGGGAATA TTGGATGGCT AATAACTTGG AGTNGCAGGA CTAATAAACC 2880 TTTTACGGCG GTTACACCGG GAATACCNGG AAATGC 2916 (2) INFORMATION FOR SEQ ID NO: 23: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 2677 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 23: ACCGCATCGC CAATCTCAGC GGCAGTGGTT TACATGTCTT CCGTGATGGA AGGTCATGGC 60 ATCAGCTACC TCCATCTGCT CTCCGTGGTC ATCCCGTCCA CCCTGCTGGC GGTTCTGGTG 120 ATGTCCTTCC TGGTCACTAT GCTGTTCAAC TCCAAACTCT CTGACGATCC GATTTATCGC 180 AAGCGTCTGG AAGAGGGCCT GGTTGAACTG CGCGGTGAAA AGCAGATTGA AATCAAATCC 240 GGTGCAAAAA CGTCCGTCTG GCTGTTCCTG CTGGGCGTAG TTGGCGTGGT TATCTATGCA 300 ATCATCAACA GCCCAAGCAT GGGTCTGGTT GAAAAACCAC TGATGAACAC CACCAACGCA 360 ATCCTGRTCA TCATGCTCAG CGTTGCAACT CTGACCACCG TTATCTGTRA ARTCGATACC 420 GACAACATTC TCAAYTCCAG CACCTTCAAA GCAGGTATGA GCGCCTGTAT TTGTATCCTG 480 GGTGTTGCGT GGCTGGGCGA TACTTTCGTT TCCAACAACA TCGACTGGAT CAAAGATACC 540 GCTGGTGAAG TGATTCAGGG TCATCCGTGG CTGCTGGCCG TCATCTTCTT CTTTGCTTCT 600 GCTCTGCTGT ACTCTCAGGC TGCAACCGCA AAAGCAYTGA TGCCGATGGC TCTGGCACTG 660 AACGTTTCTC CGCTGACCGC TGTTGCTTCT TTTGCTGCGG TGTCTGGTCT GTTCATTCTG 720 CCGACCTACC CGACACTGGT TGCTGCGGTA CAGATGGATG ACACGGGTAC TACCCGTATC 780 GGTAAATTCG TCTTCAACCA TCCGTTCTTC ATCCCGGGTA CTCTGGGTGT TGCCCTGGCC 840 GTTTGCTTCG GCTTCGTGCT GGGTAGCTTC ATGCTGTAAT GACCCATYGC GGGGCGTTCA 900 CGCCCCGCTT TCTTTCCCGC CGACTAACAT CCTTTCCCCG TCCGTTGTAT AGTGACCTCT 960 CTCTTGCGGT TCCATCTGTT CTTGCGAGGT GTTTATGCTT GATGAAAAAA GTTCGAATAC 1020 CACGTCTGTC GTGGTGCTAT GTACGGCACC GGATGAAGCG ACAGCCCAGG ATTTAGCCGC 1080 CAAAGTGCTG GCGGAAAAAC TGGCGGCCTG CGCGACCTTG ATCCCCGGCG CTACCTCTCT 1140 CTATTACTGG GAAGGTAAGC TGGAGCAAGA ATACGAATGC AGATGATTTT AAAAACTACC 1200 GTATCTCACC AGCAGGCACT GMTGAATGCC TGAAGTCTCA TCATCCATAT CAAACCCCGG 1260 AACTTCTGGT TTTACCTGTT ACACACGGAG ACACAGATTA CCTCTCATGG CTCAACGCAT 1320 CTTTACGCTG ATCCTGCTAC TTTGCAGCAC TTCCGTTTTT GCCGGATTAT TCGACGCGCC 1380 GGGACGTTCA CAATTTGTCC CCGCGGATCA AGCCTTTGCT TTTGATTTTC AGCAAAACCA 1440 ACATGACCTG AATCTGACCT GGCAGATCAA AGACGGTTAC TACCTCTACC GTAAACAGAT 1500 CCGCATTACG CCGGAACACG CGAAAATTGC CGACGTGCAG CTGCCGCAAG GCGTCTGGCA 1560 TGAAGATGAG TTTTACGGCA AAAGCGAGAT TTACCGCGAT CGGCTGACGC TTCCCGTAAC 1620 CATCAACCAG GCGAGTGCGG GAGCAACGTT AACTGTCACC TACCAGGGCT GTGCTGATGC 1680 CGGTTTCTGT TATCCGCCAG AAACCAAAAC CGTTCCGTTA AGCGAAGTGG TCGCCAACAA 1740 CGAAGCGTCA CAGCCTGTGT CTGTTCCGCA GCAAGAGCAG CCCACCGCGC AATTGCCCTT 1800 TTCCGCGCTC TGGGCGTTGT TGATCGGTAT TGGTATCGCC TTTACGCCAT GCGTGCTGCC 1860 AATGTACCCA CTGATTTCTG GCATCGTGCT GGGCGGTAAA CAGCGGCTTT CCACTGCCAG 1920 AGCATTGTTG CTGACCTTTA TTTATGTGCA GGGGATGGCG CTGACTTACA CGGCGCTGGG 1980 TCTGGTGGTT GCCGCCGCAG GKTTACAGTT CCAGGCGGCG CTACAGMACC CATACGTGCT 2040 CATTGGCCTC GCCATCGTCT TTACYTTGCT GGCGATGTCA ATGTTTGGCT TKTTTACTCT 2100 GCAACTCCCC TCTTCGCTGC AAACACGTCT CACGCTGATG AGCAATCGCC AACAGGGCGG 2160 CTCACCTGGC GGTGTGTTTA TTATGGGGGC GATTGCCGGA CTGATCTGTT CACCYTGCAC 2220 CACCGCACCG CTTAGCGCGA TTCTGCTGTA TATCGCCCAA AGCGGGAACA TGTGGCTGGG 2280 CAGCGGCACG CTTTATCTTT ATGCGCTGGG CATGGGCCTG CCGCTGATGC TAATTACCGT 2340 CTTTGGTAAC CGCTTGCTGC CGAAAAGCGG CCCGTGGATG GAACAAGTCA AAACCGCGTT 2400 TGGTTTTGTG ATCCTCGCAC TGCCGGTCTT CCTGCTGGAG CGAGTGATTG GTGATATATG 2460 GGGATTACGC TTGTGGTCGG CGCTTGGTGT CGCATTCTTT GGCTGGGCCT TTATCACCAG 2520 CNTACAGGCC AAACGCGGCT GGATGCGCGT GGTGCAAATA ATCCTGCTGG CAGCGGCATT 2580 GGTTAGCGTG CGCCCACTTC AGGATTGGGC ATTTGGTGCA ACACATACCG CGCAAACTCA 2640 GACGCATCTC AACTTTACAC AAATCAAAAC AGTAGAT 2677 (2) INFORMATION FOR SEQ ID NO: 24: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 537 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 24: ATCCTGATGA CGCCGTAAAT GTGCATTTGC CAGGATTGCC GCATAGAGGG CACGAAGAAA 60 AGGTCGGTTG TCAGGATGTA TCCAGATGAT TCTGCCACTG AAACCTTCAG GGATAAGACG 120 ATTGCCAACT GCCAGTCCTT TAAGGGCAGC ATTCAGCGCC TTACGCGGGG CATTCTGCTC 180 CAGAAATACG TATGCCAAGT GAGCGTGTAC ATCAATAAAG TCATTCTCCT GTCGGGCAAG 240 GCGCCTGAGT TTGTTGATGT AACTTGTTTC GCTGATTTCA TCCGCATCGT ATGCATCAAT 300 CAGTTCTTCA AACTCATCCA GCAACGAGCC AAACCAGGTT TCCGGAAATA TGAAACAGCC 360 CTGGTTATCG TTCACTTCAA AGCGTAATTT GCCAGTCATA TTCTGAACCT GTAAAAAAGG 420 ATAGACCATA ATCTGCAGGC TATAAAAATT GTGGATGCCT GGCATCGGGT GTCCTTTTAT 480 TGTCCGGGAT TAACGTTGCC CATGATAATA CAGTGAATCC NGTTCTGTGG TAAGACG 537 (2) INFORMATION FOR SEQ ID NO: 25: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1128 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 25: CGCTCGAGCA CCAGATTCAC TGACATGCGC AAACTCATGT GTAAATCCTG TCTGGGCATC 60 TATCTCAAGT AACAGTTCCG TTAAATCTAC CGGTGGGAGT AGCTGTTTGA TCCGATTATT 120 TAGACGAAGC AATGATGGTG GCTCTTCCTG TTTCTCCAGA CAACTGATAG TCAGGGATGG 180 ATATTTACCT TCATTACAGA TATGAACTTC CGCATTCTTT TCAAATCGTG ATGCCAGGCT 240 TTCCAGGTCT CATCCAGCTG AATAGCCAGT TGTTGCACAC CTTTACGTCC ATCGACAGGA 300 TGTCCCAGTG CCCGACAGAC AGGAATACGC TGAGTCTGCC ACTCTTCACC TTGCAACAAC 360 TTCTCGCGAG GATCTCCCCA GCGATCACTG TTTTCAAGCC CAGATGTCCC CGGCGGCGCA 420 RTGCATCCTG AAGGCGTTCC AGCAAACATA GTGAATAACC TGCACGCTGT ATCCCGTCCC 480 TCCGCATCGT ATACGAGGCG TTTCCAGGGA CCGGTGATAA TATGTTCAGC GCATCATCAA 540 GGATGCGCTT TTTCGAACCA TTCAGTTCTG CCAGATAATG AATCGCAGCC AGTACATGTC 600 ACCTGCCGGT GCCGCACGGA AATGCAGGTC CCGCAACACC GCCGGAAGAA AACGTTTAAC 660 CCGACCGTAC TGCTCAACCA TTTCGTCATG GAAATTATTG TTCTGTGGAC GAGCAAGTTC 720 ATTAACCTTG CTTACAGATT CTGCCAGTCT GTTTTTGGGT ACGCACTTGA AGATAACCTG 780 CCTGAGATCT GGGACATCTG TATTATCATC CAGCAACAAT GCACATGCCC GCGCCAGTAA 840 CAATGCGGCC TGATCAAGAT CTTTCAGTGT CCTGAGTCTT TTTTTTTGCC CGGTTTTCTT 900 TGCTTCGCGG ATAATGTCCA GAATTAGCAT ATCAAGCACA TCAACGGCAT CGTCTAATGC 960 CGTTATTTCC TGTGCTTTAA CGAATGCAGT AAGTACAGCA AGCTTTCTCT GCTGTGGCAT 1020 TCGAGCGATA TATTTTACCG ACGCCATGCC AGCATGAACG AGCCAGATTA CGCNTTGGNA 1080 ATGGTCAGGC AGACCGGGAA AAGTTCCAGT CGGGNAAAAC TCCAAGAA 1128 (2) INFORMATION FOR SEQ ID NO: 26: ( ) SEQUENCE CHARACTERISTICS: (A) LENGTH: 2311 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 26: GGNTGATAAA AATCYTTTGA TGAATAACGA TAAGCCGCCC AGAGTTATAT TTGTGTTTGA 60 GGCTGGAATA TTGATGCTAT AACTTGAGTG CAGACTATAA CCTTTACGCG TTACACCGGA 120 ATACCTGAAT GCTGTTCTGG ACAATGTAAT GTCAGATGCT ATAGCACCCA GATGGGTATT 180 AAAGGCCAGG CCAGCTAACC CCGCTGTATA TCCTGAAGCT GTGGTAAGAC CACTGTTTAA 240 AGTAATATCA TTCGTCAGGC CGTATTGATA GGTGCCTTGT GCTATTAAAT CATTATATGT 300 TTTATTCGCA TAACGATACT TTCCCACTGA CATTTGCCAG CGACTAAATC CGGGACGAAT 360 GAGTTGAGCA ACGGCCGCAA AAGGAACCGT GAACATTCGT GTCTGGCCAT TAGACTCTGT 420 TATCTTAACG AGAAGGTCAC CAGCATATCC ACTGGGATAT AAATCATTGA TGACAAATGG 480 TCCGGCTGGC ACCGTCGTTT CATAGAGGAT ATGAGCATTT TGATAAATGG TTACTTTAGC 540 ATTACTGTTA GCTATTCCCC GGACAGCAGG RGCATAGCCA CGTAAAGAAC CGGGTAACAT 600 TCGTTCATCC GATGCTAACC TGACTCCCCG CAAACTGAGG CTATCCATTA GCTCACCATT 660 CGTATAAAAA TCCCCTAATG TGAATTGTGC TCTCAATGGG GCAAGGTCAT GCATTATACT 720 TGTTTCTATA TTCTGATATC CGGCAGGATA GCTATTATTC CAGCTCTCAC TGCCACGGTG 780 GCGCAAAGCC ATCCCCACAA ATTGAATCCA GCTTTTAATC CCAGATAAGT CTGTTCGTTA 840 CTCGTCCCGG AAGAGCTATA CTGGTAATAG TTAGCATCAT AGTTTATAAA TGCTGCAGGA 900 ACACCACTTT GCCACTGAGA AGGGGAAATA TATCCTCTTG GACGTGTATT CAGCAGTGCT 960 GCGGGATTTC GATATTCAAC CTTAAAGTCG ATAAGTCAAA ATTAATTCTG GCTGAAGAAA 1020 GCCCTGTTGA CGCCGGAAAG CAGGAGGTGT TTCCCGACAT AGTATCTTTG ACTAAATCAA 1080 TCAATGAAAG CAGCTCAGGC GTCAGGCATA ACGTCGGAGC ACCGGTATTG GCAGTACGTA 1140 AATACTGCAA ATCAGCCTTC CCCTTCCATA CATTATTAAC ATAAATATCA GAATAATACC 1200 TGCCCTCAGG CACAGGGTTA CCATGACTAA AGCGGCGGAT ATCAATAGCA TTTATCCCTT 1260 TATCCAAATG CAAAAACTCA GAATCAAACT CAGCCTCTTC AGCAGCAAAT GAATGGTTTG 1320 TTACTGTTAA CCCTAATGCA GCAAAAAGCA GAAGAGAACA ACGACAGTAA ATCAGGCATG 1380 ACAGATTATT AGCGTTCATT ATTACCTTAC TCCAGAACAG ATTCTCCTTG CTGATATCCT 1440 CCGTAATCAT TAACAATAAC CCAGGAAACT TTGCTGGTGG CGCAGTTCTG CCTTTAAGTG 1500 CAAATACTGT TGAAGAGAAA GGGGGAATCA TTCCACCATG TTCAACAGGC GTTAAGTGCT 1560 TATTCTGGTC AACTGCAATT TTGTTGTAGG TTATGTAATA AGGTGTTGGA TTAACTGCTT 1620 TAATTCGGCC TTCCTCCTGG TGCCAGGTAA CTTTCAGATA AGCATCATTT GGTGTTAACT 1680 TCAGGTGAGC AGGACGAAAG AAAAATTTTA TGCGACTACG AACAGCTAGT TGCAAATAAT 1740 TATTATTCCG CTGCTCTGAG TTATCGGAGT CTTTTTTTGC CCTGGGCTTT GCTGGAATAT 1800 CCAGAACATT TAGATAGAAA AGAGATTCTC GGTCTTTCGG TAGTGACTCG CCTGTATATA 1860 CAATTCTGAC TGTTTGTCCT GATTTAGAGT CCATACGAAA TATTGGCGGA GTAATGATAA 1920 AAGGACGTGG ACTGACTCAG GGGGAGCTGC TGCATCTCCA TCGYCAACCA GGACTGGACT 1980 AATGCCGAGA TTTCATTGTC ATTATTTNAA CGTATGCTAA TACTCTTTTG AGTCGCCGGA 2040 TAAACAACAC GGGTTCCCAT GATAACTACA CTACCCTGAA CAACTGCAGA TACAGATAGA 2100 GTAAAAAAAA ACAGCACAAA CCTTAGCATG GTATCTCCAG AAGAAAGCAG GGCAGTATTT 2160 CCTGCCCCAA AATACAAAAC CGTTTGTTAT TCGTAGGCGA TGGTATAATT GACTGTTGTT 2220 TTTACATTGC CTGGAGTTGA TGTCCCGGTC GCATAATATT GAGCCATATA ACGTAATGTG 2280 GCATTACCAT CCCCACCAAT AGTTTCAGAA T 2311 (2) INFORMATION FOR SEQ ID NO: 27: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1118 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 27: TATTACCTGT GATTTTTCCG GGCGTAAATG GAGTCCCTAA AGTTATCGCA GTCCCAATAT 60 TTCCTGCATT ACTGTTATAA AGATAAACGA GTAACCCATC AGAAGATGTG TTTGATGTAT 120 TCTGAACTAA AATAGCATTG TNATAAGTGT TTGTTGCCGT TATCGTAACC TTCATTGTTC 180 CCAGATTATA GGGACACCGC ATATTCACAG TAAACTCTTT TTCGTGANTT CCATTTTGAC 240 TCAGGGTCTG AATCTCTACA NCCTGCCAGT CAACAGTTGT GTTGCTTACA GTACAGGCAG 300 GAATAATCAG TTTTCCTCTG AAGGTCAGAT TATCAACTGC ATGTACATGC TGAGACATTA 360 ACACTGCCCC CAGCATTACC GGAAGACACA AACCTCTTAT CTTTTTCATC TGAAATATCC 420 TGTACAAAAA TTTTGCTAAC GATATGTCAA TTCAAACGTG GCTGTTGCTT CATAATCACC 480 GGGTACCACA CTCTTCGTCC GCAGGGCTTC CGGCGTTGCC ACAACATACG CGCCGAAAGG 540 AAGCTCAAGA CTGTTTCCGG TAACCTTTTC CCCCTGGCCT TTGTTATGGG AGGTGCCGGG 600 TTTCAGCAGA CTGCTGCCAT CGGTGTCCAG CAGTGCAATG CCTAACCGGC CAGCATTCAC 660 TCCGGTTACC TTCAGATGGC CCGGGAGRCG CYNTCTTCCG TCCCCTTAAA GGTCAGGGTC 720 ACAATTTTGC CAACTGCTGT TGCATGGCAG TTTTCCAGCC TGATGACAAA CGACTCTGTC 780 GGCGAACGTC CGGGCGGATA CCAGAAATCC CTGGACGCCC GGGTTTTGAA GACGACATGT 840 TTATTCAGAC TGTCACCGGA CACATGGCAG GGTCTGTCAA GCAGATTACC CCTGAATGCC 900 ACATCTGAGG CTATTGCCTG TCCGGCAGAC AGTGCGGCAA ACAGTAAAAG AGCGCCTGTG 960 CTTTTTATCA TCACATTCCC TTACTCATAT TTTATGCTCA GACGCAGCAT GGCCGGATTG 1020 CTCCTGGCAT CAGAATACTC AACCTCCTGT GGCGGCCTTT TCCTCCAGGC GGGCAAGCAT 1080 CTCCTCCTGG CGGCGGGTAA GGCGGGGACA GTAAAAAA 1118 (2) INFORMATION FOR SEQ ID NO: 28: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 562 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 28: TTCGTGGGTG AAATCGTAGG CCGCGCTTTT TTGCTGATCG GCCAGTTGAT GAATAGGGTG 60 GCCAKGATCG GGATAAAACG TACAGGCAGC GATAAACAGA CAGCCCGGAT AGCGGTTGTT 120 TTTAACGCAC TCCGATAACG CCTGATAACG TGCCAGCAAC TTTTGTTCGG CGGTTTGCGT 180 TTCGTCCAGC ATCAGCTGAC GACGCCAGAC ATCTATCTGT TGGCTAAGAT AACGCAGCGC 240 ATCGTAGAGG ATTGCCTCTT TGTCTGGCCA GAAGCGGCGT ACTCGTCCAG TGGATAATCC 300 ACACGTTCAG CAACCATCTC CAGCGTGGTG TTGGCAATCC CTTGTAATTC TAATAATTTC 360 AGGGCTTCTC CCAGTACATC TTCACGTTGC ACGCTATTTT CCTCCGKCTT TCCCACTGCA 420 ATGTTCGKTC ACGGTTGGCG ATCGCGCAAA TGTGCGCTGG AAGGTTTCAG CATCCATAAA 480 GCCCGTGACG CGTGCTTGTG GATGCTCCTG GCCTTGGTCC GGTCAAAAAA GAGAATTTGT 540 CCGGTAGGGC CAAGGATATT AA 562 (2) INFORMATION FOR SEQ ID NO: 29: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 745 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 29: CCATCGCTTT ACCCCAGAAA AGTTAAGCCA TATAATGTGA GGGATATAAG TCGTCGTATC 60 CGGTAAGTAC AGATAACCAC AACATAAGCT CATTCAGTAA ATTTTATCTC TGAACAAACG 120 ACTATGGCAT GCTCATTTAT ACTATTCATA AGAAAGTGTG ATTATCTGTA AGCATTAACC 180 ATCAAATCAT ATAACCATAC TAAACTGGCG GATCATCAGC ACCATTAGCA GGTAACTTAT 240 TGAAATTTTA TTATGTGTTT TTTGTTGATA ATTAATATGC AATATGAATT TGCTATTTTA 300 GAATCATGAA CACCATTTAA AATTACCATC ATTAACATCA TATAAAAATA TATTTTTACT 360 AAAACATGAA TTGTATATAT TTATTAGCTC AGGAAAATTA TCAGGGTTCA CCTTCAAATT 420 AACCTGAATG TTATGCTTAA TTTCACCCAG TAGTTCTTCA TGTGTAGATT TTATTATCCC 480 ATTATTATAA TCGATAAATG CACACATGTT TTTTATGAAT TCAAAACCTT TTCCTGTATA 540 CAGTTTAATG AATGCCACCA GAGCAAACAT TTCAAGATGT AGCCATAATG CTACGTTAGT 600 TTTTTGCAAA GTATAAAAAA TTGAATTCGC CACTTTTTTA CTTATTGCTC TTTTATACTG 660 TGATCGAGCA AGATTCAGTA GCGGAAGTCC TCGTTCAATA AATGAATGTG AAAAGACTGG 720 ATAAATTGAT GTCGGAAACC TTTCA 745 (2) INFORMATION FOR SEQ ID NO: 30: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 400 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 30: GCGTTNATGC ATTTCGASAT TTTCCACTTC GTTCTGACGT TGCACTGCTT TGGCGTCATC 60 ATTACGTAAC GTATCGAGGA AATCGAGGTA GCCCTGATCA ACATCTTTGG TGACGTAGAC 120 GCCGTTGAAC ACCGAGCATT CAAACTGCTG GATATCCGGA TTTTCAGCGC GAACGGCGTC 180 GATCAGATCG TTCAGATCCT GGAAAATCAA CCCGTCAGCA CCGATGATCT GGCGAATTTC 240 ATCAACTTCG CGACCGTGAG CGATCAGTTC CGTGGCGCTC GGCATATCAA TACCATAAAA 300 CGTTCGGGAA AGCGAATTTC CGGTGCCGCA GAAGCGAGGT ACACTTTCTT CGCTCCGGCT 360 TCGCGTGCCA TCTCGATAAT CTGTCAGAAG TGGTGCCACG 400 (2) INFORMATION FOR SEQ ID NO: 31: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 824 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 31: TGTCGACGAT GAGGCAGCCA GAGCATTAGA GCCGAAAAGA AGGGATGATG CCATGACTGC 60 TGTTGCTATA AAATGTTTCA TATATTCTCC ATCAGTTCTT CTGGGGATCT GTGGGCAGCA 120 TATAGCGCTC ATACTAGGGG TTTGAGGGCC AATGGAACGA AAACGTACGT TAAGGAGATA 180 ATTCGTTGTT TATATTTAAA TTTAGAGCTC TCAGTTCCCC TTTTAAAATA TCCTCTGGCA 240 ACGTGAATGT ATAATGGCCC AACATATTGA TATGCCCGTG CATCAGGGGA GATAGCCGAG 300 CGATATCTTC ATCTATAATT TCTTCGCCAT TACGGCGCAT CCAGCTCAAC GCTTCCTCCA 360 TATAGAGCGT GTTCCACAGA ACCACTGCAT TAGTAACCAG GCCCAGCGCC CCCAGTTGAT 420 CTTCCTGCCC TTCACGATAA CGCTTTCTGA TCTCTCCGCG TTGTCCGTAA CAAATCGCAC 480 GAGCCACAGC GTGCGKTCCT TCTCCTCGAT TAAGCTGCGT CAGGATCCGC CGACGATAAT 540 CTTCATCATC AATATAATTG AGGAGATATA GCGTTTTGTT TACACGCCCT ACTTCCATAA 600 TTGCCTGTGC CAGTCCTGAT GGGCGCGAGC TTTTCAGTAA AGAGCGAATG AGTTCTGACG 660 CATGAATTGT ACCCAACTTC AGGAACCAGC GGTTCGCATC ATCTCATCCC ACTGACTCTC 720 CGCTTTTGAC AGATCTGCAT ATCCTCGGGC CAACTTATCC AGTACTCCGT AGTTTGCCGA 780 TTTATTCACC CGCCAGAACA CCGCCTCACC TGCATCGGCA AGCC 824 (2) INFORMATION FOR SEQ ID NO: 32: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 911 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 32: ACAAATCAGA CCAGTTAACC AGTCAGTCGG TTTTATGATT TCACTCACTA TACTTTGTTT 60 CATAAGGATT TCAGGATCTG CCAGACTGCG CAGAAATGAT GCTTACGAAT ACACAGTAAA 120 GGCAATGTCA TTTCCGATAC AGAGCCTGAC ATTGCCATAA TGAGCTATTT ATCTGAAAAA 180 CGACAGAATA TGATGTTTTA TCGTAACGTA ATTTTAAGTT CTCAACTTAT TGAGACATAT 240 TGTCTTTTTT ACCCATGTGG TCATTTTTCA TCCCATCCGT TTTGCTCATG TGTTCTTTCT 300 CCATTTTCTC TTTATCCATT GCATTTTTGC ACATACCATC CTTGCACATT TTATCATGCG 360 CGCTGGACAT GCTGCCTTTT ACTTCATGTG TTTTATCCAT TGTGTCTGCT GCCTGAGCAT 420 TGAACATGAA CAGCGCGGAT AGTACAGTTG CAGAAATAAT ATTTTTCATG GTTCTTCCTC 480 ATTTTTAACA ATTGTATCAA CAACCACCAA ACCAGTTATA ACCCTGGTCT TCCCAGTACC 540 CCCCCGGAAA ATGATTAGTG ACCTCTATAA CCTGAACATG CTTGGGGTTT TTATATCCCA 600 GCTTAGTAGG GATACGTATC TTTATGGGAT AGCCATATTC TTTTGGCAAT ACCCTGTTAT 660 TCCATGTCAA TGTCAGCAAT GTTTGTGAAT GTAGTGCTGT CGCCATATCA ATACTGGTGT 720 AGTAACCATC GACGCAACGA AAACTGACGT ATTTTGCCCG CATATCGGCA CCAATCAGCG 780 TCAGGAAATG CCGGAATGGT ATCCCTCCCC ATTTTCCTAT TGCACTCCAT CCTTCAACAC 840 NGATATGACG GGTTATCTGA CTCACATGCT GCATGTTATA CAATTCAGAC CAAAAACCAG 900 TTACGGGTTA T 911 (2) INFORMATION FOR SEQ ID NO: 33: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 463 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 33: NGGGGCAGGA TAATTGTATC CTGCCCNGTA TATAATTCTC AGCACAGGTG TTGACTAAAG 60 AGCGTGAAAC TTTGCTATTA TGTCTTCGTA AGATTCACGG ACGGTTATAC TTGAGCCTGA 120 TTCTGTGAAG TAAACAACAG CAGAAGCATC GTTGCCTTTT TCAATGTATG AAACATTCCA 180 GTCATGGATA GCCACTGCGG GCTGACCATT ATCCCGACGG TGCGTCTTAA TGAATCGCGG 240 AAGTAATTCT GCAATATCGT TAAAAACACC ATTTACGGTA TGAGTGATAC CACCAACGCA 300 ATGTAGATGA GTTGACTCCG GGGTATCATT GTCTGCTTCT GCAAAGAGTA TAGCTGTCTT 360 GCTAATTGTA ACAGGCGCCT GTGARCGGGA TAATTCGAGA GAAATAAACC CGGATTCTGC 420 CATAAAAACT CCAGTTTGTG ATGTTATATC ATTTCATATG TTT 463 (2) INFORMATION FOR SEQ ID NO: 34: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 565 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 34: TTCTAACCTC TGACCAAAAA CAGAATTACG GTTGTTATGC TGCAGAACCT AATGACGTGC 60 AACTGGCGCG CTATTTTCAT CTTGATGAAC GGGATCTGGC CTTCATTAAC CAACGACGGG 120 GCAAACATAA TAGGCTGGGC ATTGCGCTTC AGCTCACCAC AGCCCGTTTT CTGGGAACAT 180 TTCTGACGGA TTTAACTCAG GTTCTGCCTG GTGTTCAACA TTTTGTCGCG GTACAGCTTA 240 ATATCCACCG TCCAGAAGTT CTCTCCCGCT ATGCTGAACG GGACACTACC CTTAGAGAAC 300 ATACTGCATT AATTAAGGAA TATTACGGCT ATCATGAATT TGGTGATTTT CCATGGTCTT 360 TCCGCCTGAA GCGTCTGCTA TATACCCGGG CGTGGCTCAG TAATGACGAC CGGGTCTGAT 420 GTTTGATTTT GCCACTGCAT GGTTGCTTCA AAATAAGGTA TTACTGCCCG GAGCAACCAC 480 ACTAGTACGT CTCATCAGTG AAATTCGTGA AAGGGCAAAT CAGCGGCTGT GGAAAAAGCT 540 GGCCGCACTG CCGAACAAAT GGCAG 565 (2) INFORMATION FOR SEQ ID NO: 35: ( ) SEQUENCE CHARACTERISTICS: (A) LENGTH: 512 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 35: CGATGGCGTC CGGGGTGAAC GCCGGATAAG TTTAATTTAT CCGGTCAGGC AAAAGGCATT 60 AATCTGCAGA TAGCTGATGT CAGGGGAAAT ATTGCCCGGG CAGGAAAAGT AATGCCTGCA 120 ATACCATTGA CGGGTAATGA AGAAGCGCTG GATTACACCC TCAGAATTGT GAGAAACGGA 180 AAAAAACTTG AAGCCGGAAA TTATTTTGCT GTGCTGGGAT TCCGGGTCGA TTATGAGTGA 240 GTCACTCCGG TGAGATGTCC GGTTATTTAT CTTTTTTGTG AATCTGGTGA TGCGTGGAAT 300 GAAAGACAGA ATACCTTTTG CAGTCAACAA TATTACCTGT GTGATATTGT TGTCTCTGTT 360 TTGTAACGCA GCCAGTGCCG TTGAGTTTAA TACAGATGTA CTTGACGCAG CGGACAAGAA 420 AAATATTGAC TTCACCCGTT TTTCAGAAGC CGGCTATGTT CTGCCGGGGG CAATATCTTC 480 TGGGATGTGG AATTGTTAAC GGGGCCAAAG TA 512 (2) INFORMATION FOR SEQ ID NO: 36: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 827 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 36: TTGCCGGTGC GGTTANTAGT GGCAGTGGTG TCTTTTGGTG TAAATGCTGC TCCAACTATT 60 CCACAGGGGC AGGGTAAAGT AACTTTTAAC GGAACTGTTG TTGATGCTCC ATGCAGCATT 120 TCTCAGAAAT CAGCTGATCA GTCTATTGAT TTTGGACAGC TTTCAAAAAG CTTCCTTGAG 180 GCAGGAGGTG TATCCAAACC AATGGACTTA GATATTGAAT TGGTTAATTG TGATATTACT 240 GCCTTTAAAG GTGGTAATGG CGCCAAAAAA GGGACTGTTA AGCTGGCTTT TACTGGCCCG 300 ATAGTTAATG GACATTCTGA TGAGCTAGAT ACAAATGGTG GTACGGGCAC AGCTATCGTA 360 NTTCAGGGGG CAGGTAAAAA CGTTGTCTTC GATGGCTCCG AAGTGATGCT AATACCCTGA 420 AAGATGGTGA AAACGTGCTG CATTATACTG CTGTTGTTAA GAAGTCGTCA GCCGTTGGTG 480 CCGCTGTTAC TGAAGGTGCC TTCTCAGCAG TTGCGAATTT CAACCTGACT TATCAGTAAT 540 ACTGATAATC CGGTCGGTAA ACAGCGGAAA TATTCCGCTG TTTATTTCTC AGGGTATTTA 600 TCATGAGACT GCGATTCTCT GTTCCACTTT TCTTTTTTGG CTGTGTGTTT GTTCATGGTG 660 TTTTTGCCGG TCCGTTTCCT CCGCCCGGCA TGTCCCTTCC TGAATACTGG GGAGAAGAGC 720 ACGTATGGTG GGACGGCAGG GCTGCTTTTC ATGGTGAGGT TGTCAGACCT GCCTGTACTC 780 TGGCGATGGA AGACGCCTGG CAGATTATTG ATATGGGGGA ATACCCC 827 (2) INFORMATION FOR SEQ ID NO: 37: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 400 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 37: CCAGGGGCCC AAAATCCGTG TATCCACCTT TAAAGAAGGC AAAGTTTTCC TCAATATTGG 60 GGATAAATTC CTGCTCGACG CCAACCTGGG TAAAGGTGAA GGCGACAAAG AAAAAGTCGG 120 TATCGACTAC AAAGGCCTGC CTGCTGACGT CGTGCCTGGT GACATCCTGC TGCTGGACGA 180 TGGTCGCGTC CAGTTAAAAG TACTGGAAGT TCAGGGCATG AAAGTGTTCA CCGAAGTNAC 240 CGTCGGTGGT CCCCTCTCCA ACAATAAAGG TATCAACAAA CTTGGCGGCG GTTTGTCGGC 300 TGAAGCGCTG ACCGAAAAAG ACAAAGCAGA CATTAAGACT GCGGCGTTGA TTGGCGTAGA 360 TTANCTGGCT GTCTCCTTCC CACNCTGTGG CGAAGATNTG 400 (2) INFORMATION FOR SEQ ID NO: 38: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 578 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 38: CCGATTTTTT GCGAAACGTT CCGCCTGGCA TCAGGATAGT TTGTTCGTTA TCCAGTTCGG 60 ATAGCGCATT GACGATATGC AGGCTGTTGG TCATCACCGT GATGTNATTA AAGCGCGAGA 120 GCAGGGGAAC CATCTGCAAA ACGGTACTGC CAGCATCAAG AATGATCGAA TCGCCATCAT 180 GGATAAAACT AACGGCAGCT TCTGCAATCA GCTCTTTCTT GTGGGTGTTG ATGAGTGTTT 240 TATGATCGAT AGGCGGATCG GATTCCTCTT TATTCAACAC CACTCCGCCA TAAGTACGAA 300 TGACGGTTCC GGCATGTTCC AGAATGACCA GATCTTTGCG AATGGKTGTG CCTGTGGTGT 360 CAAATATTGC GCCATTCTTC AACCGAGCAT TTACCCTGCT TTGCAGATAC TCCAGAATGG 420 CGGCCTGACG CTGACGAGTT TCATGGGCGT GATACCTGAT TTAGGTTCAA ATGATAACTC 480 GCAAGCAGTA ACATCACACG NAATATCCAC GTTCAGTTAA GCGCCATGAT AGAGCATCCG 540 TGATAGGGNC AGGGGNAGTC ACACGGCGTA ATCACCGC 578 (2) INFORMATION FOR SEQ ID NO: 39: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 399 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 39: TGTTAGGTCA GGGCCCACAG TCAAGCTTAG GTTTTACTGA ATATACCTCA AATGTTAACA 60 GTGCASATGC AGCAAGCAGA CGACACTTTC TGGTAGTTAT AAAAGTGCRC GTAAAATATA 120 TCACCAATAA TAATGTTTCA TATGTTAATC ATTGGGCAAT TCCTGATGAA GCCCCGGTTG 180 AAGTACTGGC TGTGGTTGAC AGGMGATTTA ATTTTCCTGA GCCATCAACG CCTCCTGATA 240 TATCAACCAT ACGTAAATTG TTATCTCTAC GATATTTTAA AGAAAGTATC GAAAGCACCT 300 CCAAATCTAA CTTTCAGAAA TTAAGTCGCG GTAAATATTG GATGTGCTTA AAGGACGGGG 360 AAGATTTCAT CGACACGTCN GCGTGCAATC TATCCGTAT 399 (2) INFORMATION FOR SEQ ID NO: 40: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 327 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 40: CAGCCTCCGT TACCGGACAG CAAGGAGGCT GAATGGAGTT TACAGGATTT GCTTTTTTAT 60 AATGTCTGGC CATGCAGTMA AACCGGACAG GTTTTATTAT CATGTGAGGT ATTCTGACAT 120 AAAATGCTGG ATTTTTATTT TGTGACGAAT GCTGCAAAAT TGCATCTGCA CTCTGATGTA 180 GCTTTTATCT GTTTCAGTGA AGCATGCCCA CAAACTGAGT TATTAAGTTG TGGAAGAACA 240 GTTTTGTCCC GCCTGCATAT CTCCTTTCAA AAACCAGTAT GTCGCCATGC CTCGCCTTAA 300 TGGAGAGCGC TGAACCATAC CTTCTTT 327 (2) INFORMATION FOR SEQ ID NO: 41: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 314 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 41: GGAGATGGGC ATGGAACTCA CTTCATAATA ATGCCTACCG AAGAAATATT AATAGATGAC 60 ATTTCCACGA GNGATAGCAA TAAAACATCA GAGCAGTCTT CTCGCTTAGA AAAAGCTTTA 120 TTAGGTTTTA CAAACACAAT GTACAGTGAT TCAAACCCTC CTATTATAGC TCGTTTTAGA 180 GACTATCTGG AAGATGGTGA GTGCATTGAC AGAATTAGCG AATCAATTTT TTTTACACCG 240 CAAGAATTCA ATCTTGCAGA TCACCACATT GAAGGATGGT TCAATGAATT TGGTCAATTC 300 AGTGGAACTG TTTC 314 (2) INFORMATION FOR SEQ ID NO: 42: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 590 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 42: TCCCAAGATC TTTTTGGCCG CAAATCCACA AAACCCGTCG TTANTGTCGC GCAGCCANTT 60 GCAGGCCGAA TTTGCACCGT TTTAGAAAGC GGCGTTTTGT AGAGCAGCAC GCAGTGAGAA 120 GCCACCGCGC CACGACCTAC GNGCNCGCGC AGCTGGTGTA ATTGCGCCAG ACCCAGACGC 180 TCCGGGTTTT CGATAATCAT CAGACTGGCG TTAGGCACAT CAACGCCGAC TTCAATAACG 240 GTTGTGGCAA CCAGCAGGTG TAGCTCACCT TGTTTAAACG ACGCCATCAC CGCCTGTTTC 300 TCGGCAGGTT TCATCCGCCC GTGTACCAGG CCAACGTTCA ACTCTGGTAG CGCCAGTTTC 360 AACTCTTCCC AGGTAGTTCC GMCGCCTGCG CTTCCAGCAA TTCCGACTCT TCAATCAACG 420 TACAAACCCA GTATGCCTGA CGACCTTCAG TTATGCAGGC GTGGTGCACC GGGTGCAATG 480 GATGTCGGTA NNGCGGGTAT CAGGAATAGC GACCGTAGTC ACTGGGCGTG CGGCCTGGGC 540 GGCACTCCAT CTATCACCGA GGGTATCGAG ATCGGGCATA CGCNTGCATT 590 (2) INFORMATION FOR SEQ ID NO: 43: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 400 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 43: GACGAAAGGG CCTCGTGATA CGCCTATTTT TATAGGTTAA TGTCATGATA ATAATGGTTT 60 CTTAGACGTC AGGTGGCACT TTTCGGGGAA ATGTGCGCGG AACCCCTATT TGTTTATTTT 120 TCTAAATACA TTCAAATATG TATCCGCTCA TGAGACAATA ACCCTGGATA AATGCTTCAA 180 TAATATTGAA AAAGGAAGAG TATGAGTATT CAACATTTCC GTGTCGCCCT TATTCCCTTT 240 TTTGCGGCAT TTTGCCTTGC CTGTTTTTGC TCACCCAGAA ACGCTGGTGA AAGTAAAAGA 300 TGCTGAAGAT CAGTTGGGTG CACGAGTGGG TTACATCGAA CTGGGATCTG CAACAGCGGT 360 AAGATCCTTG AGAGTTTTTC GCCCCGAAGG AACGTTTTTC 400 (2) INFORMATION FOR SEQ ID NO: 44: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 400 Dase pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 44: ATTCGGAAAG ATGCTTCTAN TTTTTTTAAG CACGTATAAA CTGTTAATTC AGGTTCAATG 60 CTACGAAATG CACTAGTTAT AACCTGTATT GAAGGAAAGA TCTTCTGATA CTCTTTCCAG 120 AGATCTTCAA GTCTGGCCAT GGAAATTGAC TTGGCTGCAT ATTCTAGGTC AGTGTTTATG 180 ATAGTTTCTC TATTCTCTCT GAATGCGGAA AAAAAAGCTT CATTCAACAA TGATAGTAAA 240 TCCCTGGGCC GGTAAAGGGT AAATTGCAAA CATCGCTTAA AACCATTCCT CCCTTTAAGA 300 TCATCCGCTG TGCATCTATC CCAAACTCGT TGATCTTTCT CAATATCTAG CTTAAATGCT 360 ACTTTCATTC TTTTAGCTGA CAGCATTAGG AGTTGTGCCC 400 (2) INFORMATION FOR SEQ ID NO: 45: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 585 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 45: TAATGTTGAA GACAGAGATA TAATNTACAG CATCATCCCA CAAGGCAGAT ATAACAATAC 60 TTGACTGGGA TATGCAAAGC GATAGTGGGC AATTTGCTAT TGAAATAATA AAATCGATAA 120 TCGTTTCAGA TATAAATTCT GGAGGACGTT TACGTCTTCT TTCTATTTAT ACTGGTGNAC 180 ATGTTACTGC TGTTATAACT AAGTTGAACA ATGAGTTAAA GAAAACATAC CGTAGCGTAA 240 TAAAAAATGA TGATAGTATT TTTATTGAAG ATAACTATGC ACTCGAACAA TGGTGTATAG 300 TTGTTATTAG TAAAGACGTT TATGAAAAAG ATCTTCCAAA TGTGTTAATA AAAAAATTCA 360 CTAACCTTAC AGCTGGGTTG CTATCCAACG CCGCACTCTC TTGCATTTCT GAAATAAGAG 420 AWAAAACCCA TGGGATATTA ACAAAATATA ATAATAAATT AGACACTGCA TATGTTTCCC 480 ACATCTTAAA TTTAATAAAA TCCAAGGRGT CAAGGGCATA TGCTTATGAA AATGCTCATG 540 ATTATGCAGT AGATTTAATT TCTGAAGAAA TAAGATCAAT ATTGC 585 (2) INFORMATION FOR SEQ ID NO: 46: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 390 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (x ) SEQUENCE DESCRIPTION: SEQ ID NO: 46: ANTCATCCAA CTGGCCGATC AGCAAAAAAG CGCGGCCTAC GATTTCACCC ACGAACTGTT 60 AACCACGCTG GAAGTTGACG ATCCGGCGAT GGTAGCAAAG CAGATGGAAC TGGTGCTGGA 120 AGGCTGTTTA AGCCGAATGC TGGTGAATCG TAGCCAGGCG GATGTCGACA CCGCACATCG 180 GCTGGCGGAA GATANTCNTT GCGTTCGCCC GCTGCCGTCA GGGTGGTGCA CTGACCTGAC 240 AGAAACACAG AAAAGAAGCG ATTTGCCGCA ATCTTAAGCA GTTGAATCGC TTTTACTGAA 300 ATTAGGTTGA CGAGATGTGC AGATTACGGT TTAATGCGCC CCGTTGCCCG GATAGCTCAG 360 TCGTAGAGCA GGGGATTGAA AATCCGTTGT 390 (2) INFORMATION FOR SEQ ID NO: 47: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 473 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 47: GGATGCCAGT GTCAGCGACT GGTTAAAGTG GTCGATATCG ATGAGCAAAT TTACGCGCGC 60 CTGCGCAATA ACAGTCGGGA AAAATTAGTC GGTGTAAGAA AGACGCCGCG TATTCCTGCC 120 GTTCCGCTCA CGGAACTTAA CCGCGAGCAG AAGTGGCAGA TGATGTTGTC AAAGAGTATG 180 CGTCGTTAAT TTTATCTCGT TGATACCGGG CGTCCTGCTT GCCAGATGCG ATGTTGTAGC 240 ATCTTATCCA GCAACCAGGT CGCATCCGGC AAGATCACCG TTTAGGCGTC ACATCCGTCG 300 TCCCCTGGCA AACGGGGGCG ATTTTCCTCC ATTTGCCTCA GTGGCTGGCG TTTCATGTAA 360 CGATACATGA CAGCGCCCGA CAAGATCCTG ATACTCTTTG GGTATTCAAC CGTTTCCAGT 420 GTAATTCGTC GTTCACNAAC ATTGGCGTTA CAGGCGGGGC TGGCNGTNAC CCA 473 (2) INFORMATION FOR SEQ ID NO: 48: ( ) SEQUENCE CHARACTERISTICS: (A) LENGTH: 482 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 48: GAAGTGACGG ATGGCTGTGG TTTCTCCATC GGTCACCAGC AGCAGTTNGC ATCATGGATT 60 GCCTATAAAG TCGCGCCGTT CCTCGGNAAA AAAGAGGAGA GCGTTGAAGA CCTCAAATTG 120 CCGGGCTGGC TGAACATTTT CCACGACAAC ATCGTCTCCA CGCGATTGTG ATGACCATCT 180 TCTTTGGTGC CATTCTGCTC TCTTCGGTAT CGACACCGTG CAGCGATGGC AGGCAAAGTG 240 CACTGGACGG TGTACATCCT GCAAACTGGT TCTCCTTTGC GGTGGCGATC TTCATCATCA 300 CGCAGGGTGT GCGCATGTTT GTGGCGGAAC TCTCTGAAGC ATTTAACGGC ATTTCCCAGC 360 GCCTGATCCC AGGTGCGGTT CTGGCGATTG ACTGTGCAGC TATCTATAGT TCGCGCCGAA 420 CGCCGTGGTC TGGGGCTTTA TGTGGGGCAC CATCGGTCAG CTGATTGCGG TTGGCATCCT 480 AG 482 (2) INFORMATION FOR SEQ ID NO: 49: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 185 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 49: GACGACCTGC AGGCATGCAA GCTTGGCACT GGCCGTCGTT TTACAACGTC GTGACTGGGA 60 AAACCCTGGC GTTACCCAAC TTAATCGSCT TGCAGCACAT CCCCCTTTCG CCAGCTGGCG 120 TAATAGCGAA GAGGCCCGCA CCGATCGCCC TTCCCAACAG TTGCGCANCT GAATGGCGAA 180 TGGCG 185 (2) INFORMATION FOR SEQ ID NO: 50: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 491 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi ) SEQUENCE DESCRIPTION: SEQ ID NO: 50: TAACGCTTCA ATACGCGCGA CCAGCTGGCG GCGCTCATAC GGCGTAATTT TGGCGTCGGC 60 GAGCAAAATC CCTTGTTTAA AGGTATTTTG CCAGCTGCCG TCGTCATATT GGCGAGCTTG 120 CTGACGCGAC TGCGCAGGCA TTAAACGATC AGCACAATCC ATCGCCCGCA GCCAGTAAAG 180 CGGATTGGTT TCGGTTGATT TACCTTGCAG CGCCCAGATG TCGCTACATT CAGTAGAAAG 240 ATAGTCAGCC AGTTGATAAA CCGGAATTTT TTCTTCTGCT GGCGTATCAA TGGCTGGCTT 300 ATTGTGATTC TGCACGCAAC CCAGCAATGC CAGACATGGA GACCCTGCCA GCCACAGCCG 360 TCGGGGCAAT AATCGTTGAA AAATGTGTCG CATATTCACC AGACTTAAAG CCTATCCCAG 420 TGGGCGTAAT TGTTGCAGAC AGTCTGGACA TGGACAGCGC GGAGAAACCG GNAGCGTACA 480 TATCGTACGT G 491 (2) INFORMATION FOR SEQ ID NO: 51: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 106 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 51: ACTTGAACGG CAATTATTAT TTATCCATGC AACTTCAAGT TGCAGTATCG GAACATTAAC 60 TTTTCTGGGG TGAATATCAC TCTGATATCG TTTTTTGTAT GCGTNT 106 (2) INFORMATION FOR SEQ ID NO: 52: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 481 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 52: TTTATGTGCG GTATTGATGG CTGAAGCCTG TAATATCGGA CTGGAACCGC TGATAAAGCA 60 CAATATACCA GCACTGACCC GCCATCGGCT CAGTTGGGTG AAACAGAATT ACCTTCGTGC 120 AGAAACGCTG GTCAGCGCCA ATGCCCGCCT GGTTGATTTT CAGTCCACAC TGGAGCTTGC 180 TGGTCGTTGG GGAGGTGGAG AAGTGGCATC AGCTGACGGC ATGCGCTTTG TCACACCAGT 240 GAAGACCATC AACTCAGGAT CTAACAGAAA ATATTTTGGT TCTGGGACGA GGCATCACCT 300 GGTATAACTT CGTATCTGGA TCAGTACTCT GGGTTCCATG GCATTGTGGT ACCCGGTACA 360 TTACGGGRCT CGATTTTGTA CTGGAAGGAC TTCTTGAGCA GCAGACAGGG CTGAATCCAG 420 TTGAAATCAT GACAGACANT GCGGGTAGCA GCGATATTAT TTTCGGTCTG TTCTGGCTAC 480 T 481 (2) INFORMATION FOR SEQ ID NO: 53: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 558 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 53: TGGNCCGTAA TTCCCAACCA TTTGCCGAGG TCCAGNTTTT TCACCATGTT ACTCGGGATA 60 GCCAAAACNG ATACCGATGT TGCCGCCGTC CCGGTGCGAG GATCGCGGTG TTGATACCGA 120 TCAGTTCGCC GTTCAGGTTA ACCAGCGCAC CACCGGAGTT ACCACGGTTG ATCGCTGCAT 180 CGGTCTGGAT GAAGTTTTCG TAGTTTTCGG CATTCAGGCC GTACGCCCCA GCGCAGAGAC 240 AATCCCGGAA GTTACCGTCT CGCCCAGACC AAACGGGTTA CCAATCGCTA CGGTGTAATC 300 ACCCACGCGC AGTGCATCAG AATCCGCCAT CTTAATTGCG GTCAGGTTTT TCGGGTTCTG 360 GATTTGGATC AGCGCGATAT CAGAGCGCGG ATCTTTGCCA ACCATCTTCG CGTCGAACTT 420 ACGGCCATCG CTCAGTTGAA CTTTAATGAC CGTCGNGTTA TNAACAACGT GGTTGTTGGT 480 GACGACATAG CCTTTATCGG CATCAATGAT GACGCCGGAA CCCAGCGCCA TGAATTCTGT 540 TGCTGGCCGC CACCATTA 558 (2) INFORMATION FOR SEQ ID NO: 54: (1) SEQUENCE CHARACTERISTICS: (A) LENGTH: 263 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 54: CACCTGCGTG ACGTGACCGA CCTTTTCTCC TCGCTGNTTG TTTCCCCTAT CGTCGGCCTG 60 GTCATTGCGG GAGGCCTGAT ATTCCTGCTG CGACGCTACT GGCGCGGGAC GAAAAAAGCG 120 TGACCGTATT CGCCGCATTC CGGAAGATCG CAAAAAGAAA AAACGGCAAA CGTCAACCGN 180 CATTCTGGAC GCGTATTGCG CTGATTGTTT CCGCTGCGGG CGTGGCGTTT TCGCACGGCG 240 CGAACGACGG ACCAAAAGGG ATC 263 (2) INFORMATION FOR SEQ ID NO: 55: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 683 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 55: GTAACGCGTC TGGAAGATGG CCTGCCAGTG GGCGTCGTCG ATGTGGTCGA GGGGCTGGAC 60 GGTTGCCATT CCGCCAATAT CTCACCGGAC AACCGTACGC TGTGGGTTCC GGCATTAAAG 120 CAGGATCGCA TTTGCCTGTT TACGGTCAGC GATGATGGTC ATCTCGTGGC GCAGGACCCT 180 GCGGAAGTGA CCACCGTTGA AGGGGCCGGC CCGCGTCATA TGGTATTCCA TCCAAACGAA 240 CAATATGCGT ATTGCGTCAA TGAGTTAAAC AGCTCAGTGG ATGTCTGGGA ACTGAAAGAT 300 CCGCACGGTA ATAATCGAAT GTGTCCAGAC GCTGGATATG ATGCCGGAAA ATTCTCCGAC 360 ACCCGTTGGG CGGCKGATAT TCATATCACC CCGGATGGTC GCCATTTATA CGCCTGCGAC 420 CGTACCGCCA GCCTGATTAC CGTTTTCAGC GTTTCGGAAG ATGGCAGCGT GTTGAGTAAA 480 GAAGGCTTCC AGCCAACGGA AACCCAGCCG CGCGGCNTCA ATGTTGATCA CAGCGGCAAG 540 TATCTGATTG CCGCCGGGCA AAAATCTCAC CACATCTCGG TATACGAAAT TGTTGGCGAN 600 CAGGGGCTAC TGCATGAAAA AGGCCGCTAT GCGGTCGGGC AGGGACCAAT GTGGGTGGTG 660 GTTAACGCAC ACTAACCGCT GAT 683 (2) INFORMATION FOR SEQ ID NO: 56: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 282 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 56: TGGATGCAGG GAAAAACATT GATATTACCG GGGCAACGTG CTCGTCCGGT GGAGACCTTG 60 GAATGTCTGC GGGTAATRAC ATCAACATTG CCGTAAACCT GATAAGCGGG ACAAAAGTCA 120 GTCCGGTTTC TGGCACACTG ATGACAACAG TTCATCATCC ACCACCTCAC AGGGCAGCAG 180 CATCAGCGCC GGCGATAACC TGGGCGATGG CTGCAGGCAG AGATKCTGGG NTGTCACAGC 240 ATCCTCTGTT TCTGCCGGGC ACAGCGCCCT GCTTTCTGCA GT 282 (2) INFORMATION FOR SEQ ID NO: 57: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 697 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi ) SEQUENCE DESCRIPTION: SEQ ID NO: 57: ATGAACGGCC CCCCCCACAG CCCGTTAACA AACGGNTGCC CCGGCGATAA TCGTACTGAT 60 AAGTTAACTC CAGCAGGCGG TTAATTGAAA GCGAACGGGA GGCTGATGCA TGGTAATAAT 120 CCCTTAAAAC GCGACGGCAA CGCGCCAGTA AACCGTGAGA TGGTCAGGGG CAAGCCAGTC 180 CGGGTAAACC AGAGGCAGTC CGGCAGTGAA CGAACCGGAA ACATGACCAC TGGTGGTGCT 240 GAGCCCGGCA GCAGCACCCC ACAGCGTGCC GGACGAGTAC GGGTCATCTC TGTCAGAGTG 300 CAGCCAGCCG CCGTCCAGTG CAGTCACTGC ACGGACTGTC CCCACATATG GCAGGGAGAA 360 CAGAGACCAG GACAGCTCAT TTCGCAGATA ACCGCCGTTA TTACCGGAGA TATACTGCTC 420 CTTAAAGCCA CGCACTGAAC TCTCACCCCC GAGGCTCAGT TGTTCCACAC CATGAAGACG 480 GTCCGGTGAC CACTGGGCAT AAGCGCTGGT CAGCCACCAC ACCCTGTCCG TGACGGGGCG 540 CTGAAAACTG GCACTCACCG ACCATTTCCG GAACTGATTT ACGGGCAGGT CTCCCCTTTT 600 CCCGTGGTCG CTTTCTGCGC CGAACCAGGG CATCCCCCGT GTGAATACCG GATTCAGTGT 660 TCCGACACCA CCCAGAAACT TGTGTGTGTG ATTCANC 697 (2) INFORMATION FOR SEQ ID NO: 58: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 4835 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 58: TTCGACTGAG CACCACAAAT ACTGGGTATC TCCCCAGATA GTTCATTGCG GTACAAGCAA 60 TATAGGTGCA GAAAGTCAAC CTGCTGCACC CTATTGGATA ATTATATATG GCCTTCAATA 120 AAGTTTGCGG TTGTCGACGT TGGCTATATC AGCCATTTCC AATGCATAGT TCTTTGGTTT 180 AGCACCATCA AGTTATAGAT TTGGGAATAG TTTCAACTGG TATTGATTGA ATTGGGTTTC 240 ATCGTCGATG ATTAATACTA TTTGTAAAGA CTTTATTGTT GATTTCTTAT TATACCACAA 300 ACCCAAACTG GTCTAGGTCA TCATTTGGTG TTGATAACGG GCTCTGATAA TTTCTGCTCT 360 TCTGCTATAC TGGGGATTAT GAAGAATATT AAGGCTGAGT GTATTGAGGT AGTGTTCTTT 420 GAACCGACCA TTCATGACAA TATATTCTTC AATTCGTGAG TGATCCAGCA ACTGGTTGAA 480 TTTAAAACAC TGAGTGATGT TATCCTCTGT AATCGTATGG TTGCTGAACT AGTTGATGTA 540 GCCGATAAGG TTTATACCAG ATATCTTTTG GGGGGATTAG ATAACGTAGC CGCGGATAGC 600 AAACGAGATA GTTGAATTTT ATTACCGTAA TTTCTTCCAT TGAGAAAAGC TTATTTTTCT 660 TGGTGGTATT CGCAGTTATG TATCTTCCAT AAAGACTTGG GAATATCTTG CTTGAAARGC 720 TATCTGGAGA TAGCCTTAGT TATTTGATAA ATATTTCAAA TAGGAGGAGC CGTATGGCTG 780 TCATTTATAC CCTCACTAAA TCGTCACTTG TCAAGTCTGG TGGTCAATTA CATTGGAATA 840 TTGATTCGCC ATCAGAACAA CAGCCACAAA AGATCGTCAA TGGTCGGGTT GCGCTTCGGG 900 GATGGTTACT GGCAGATGTG GAAAAAGATC TCCGTGTTGC GGTTAAAATT GAACATTTGA 960 CATACAGTTT TCCCTTCAAT ATAAAGCGCC CTGATGTTAT TTCAGCTATA CTGAAACAGC 1020 CACCTGAAAA ACATCAAAGA CTTCATTGTG GATTTGATAT CAATGTCCCA TTTTCTACTA 1080 AAATAATTAT TGGCCTTGAG TCTGATGGGT TGATTACCTG GTTGGAAGAG TTATTATTTC 1140 TCCTGCCTGA TAATTGAATT AAGTATCTAT ACCGATAGTA TCGCGATAGA TATATTTTTT 1200 TACAGGATGA TAATTTGAGA ATCTATATAG CCGCTATTAT CAAGGATGAG TATTCAAGTT 1260 TACTTGAATG GATTGCCTAC CATCGAGTAT TAGGTGTTGA TGGGTTTAKT ATTGCAGATA 1320 ATGGCAGTCG TGAWGGTAGC CGAGAATTAC TATTTTCCCT CGCTCGCCTA GGTATTGTGA 1380 CGATGTTCGA ACAACCGACT TTGGTGAATC AAAAGCCACA ATTACCTGCA TATGAACATA 1440 TTTTACGTAG CTGTCCCAGA GACATAGACC TGCTTGCATT TATAGATGCT GATGAATTTT 1500 TATTGCCACT TGAATCGGAT ACCAATTTGT CAGATTTTTT TTCTGAAAAG TTTCAGGATG 1560 AGAGTGTCAG CGCTATTGCA TTGAATTGGG CAAATTTTGG TTCTAGTGGT GAATGGTTTG 1620 CTGAAGAGGG GTTGGTTATT GAACGTTTTA CCTATCGTGC CCCGCAATCC TTTAACGTTC 1680 ATCATAACTT CAAAAGCGTG GTCAAACCCG AACGAGTTAA CCGCTTTCAT AATCCGCATT 1740 ATGCTGATTT GCGTTATGGT CGATATATCG ATGCATTGGG TCGTGATTTG ATTCTGCACC 1800 CGAGGCATGG TAATGGGGTT AGTGCTGAAG TGACTTGGAG CGGTGTCAGG GTAAATCACT 1860 ATGCAGTTAA ATCACTTGAG GAATTCTTGT TGGGCAAGCA TCTGCGTGGT AGTGCTGCCA 1920 CTGCTAATCG AGTAAAGCAT AAAGATTATT TCAAGGCACA TGATCGTAAT GATGAAGAGT 1980 GCCTTCTCGC TGCCGCATTC TCAGAACAAG TAAAAGCTGA AATGGAACGA TTAAGTGTGA 2040 AGTTGACTGA GTTACCAGCA GTTGAACCTA TTCCTACTGG TTCTTGGTTC AAAAAAAAAA 2100 TGAAGAAATG GATGGTTTGA ATATATTGAG CAAGCACTTT GGTATTTATT TCTGCTCTTA 2160 TCTACAGGTC TGCTAATAAG GATCTGTATC CCCCAGGTGT TACCTTGGAC TGTAAGTTAT 2220 ATTATGTGTA GCTATTGCGA TTGGCAGCCT CTGACATTGC CAGACTCGTT TTCTCTTCAT 2280 TCTGGTTGGC TTCTGATTCG GGGGCGCGTG TTGACGACTC AAACTCGAGG TGAAACTCGT 2340 CTGCGCTGGC AATGCGGACA AGGAATATGG CATGAACAGA AGTTGCCGGT CACTCGTCGA 2400 GGCACGTTGC TGGAGCTGGT TTATCTACCY TCGGGAGCTA GTCATTKGTC TTTGCTGGCA 2460 AGTAATAAGG GCGCTGAGTG TAATGTTGAA ATTACTCAGC TTTGTTGTGT ATCCCGTGCC 2520 GAGAGTCTCT GGCGTCGATT GCGCCGGGTT GTACCTTTTT ACCGACGCTT AACGAAGTCC 2580 AGACGCAAAA GGTTAGGCCT TTCATGGCAT TTGTGGCTCA CGGACTTGCA GCAAGCTTAC 2640 CAACTTGTCA GCAGAGTTCG CGATGATAAA CCACTCAATA GCTATGATGA GTGGCTAGCA 2700 GACTTCGACA CCCTTGAACC CGCCGAATAC AAGCTGATTA AGCGCCAGCT GGCTCGCTGG 2760 GGCACATTAC CACGTTTCTG TTTGCATCTT GTTGGCGTTG GGGATGAACA GAGCCGCCAC 2820 AAGACCCTGG AGAGTATTCA GGCACTCTGT TATCCGGCAA GCAATATAAA CCTGCAGGAG 2880 CATGGTGCAT ATCCAGAAAT CTCCAGTCAG TCAAGCGGCG AATGGCAGTG GGTGTTGCCT 2940 GTAGGGGCAG TGGTTTCGCC AAGCGCCTTA TTTTGGGTTG CCCACCAGTT ACGCCAGAAT 3000 CCTGATTGTT TATGGATATA CGGTGATCAC GATCTGCTTG ACGAGAGAGG TGAACGTCAC 3060 TCTCCCAACT TCAAACCTGA TTGGAATGAA ACGCTGCTAC AGAGCCAAAA CTATATTAGT 3120 TGGTGTGGTT TGTGGCGTGA ACAAGGTGCT GGCCGTGTTC CCTTTGATGC GGCGACATGC 3180 CATCAGTGGT GGCTACAGTT GGCAAAGATG TGTGAACCGA AACAGATAGT CCATATTCCA 3240 TCATTGATGA TGCATTTGCC TGCAAGAGCG TTGATTTCGG ATGATTTTGA GTCGCTGAAA 3300 GATAAAGAAG ATTTACTGCC ATCAGGAGTG AGCATTGAGG CAGCACCTCA TGGTGTATGT 3360 CGTTGGCGCT GGCCGTTGCC AGCGCAATTG CCATTGGTTT CAGTGATTAT CCCTACTAGA 3420 AATGGTATTG CTCATTTACG CCCTTGTATC GAAAGCCTGA TACAAAAGAC GCAATATGCC 3480 AATATGGAAG TCATAGTGAT GGATAATCAG AGCGATGAGG AGGAGACGCT TGCTTATCTT 3540 GCTCATATCG AACAGGTTTA TGGCGTTAGG GTGATTTCTT ATGATCAACC GTTTAACTAT 3600 TCAGCCATCA ACAATCTGGC AGTGAGAAAC GCACATGGAG ATATGATATG TTTGCTGAAT 3660 AATGATACTC AGGTAATCAG TATTGACTGG CTGGATGAAA TGGTTTCTCA TTTATTACGC 3720 CCCGGCGTGG GTGTGGTAGG AGCAAAGCTG TATTACGGAA ATGGCTTGAT TCAGCATGCA 3780 GGCGATGCTG TCGGCCCTGG CGGTTGTGCA GATCATTTTC ATAATGGTTT GTCAGCTAAC 3840 GATCCTGGAT ATCAGCGTAG GGCTGTTAGT GCCCAAGAGC TGTCAGCTGT GACTGCAGCT 3900 TGTTTATTGA CTCATAAAGA GTTATATCTG GCGCTCGGAG GACTTGATGA AACGAATTTG 3960 CCGATAGCTT TTAATGACGT RGATTATTGT CTCAGAGTTC GAGATGCTGG CTGGAGAGTA 4020 ATCTGGACTC CCTTCGCTGA ATTGTATCAT CATGAGTCTA TTTCCCGTGG TAAAGATGTA 4080 TCAAAACAAC AGCAGATACG AGCGAAATCT GAGTTGCGCT ATATGAAAAA ACGATGGGCA 4140 TGTGCACTTA AACACGATCC AGCCTACAAC CAAAATTTGA GTTATGAACG TCCTGATTTC 4200 TCTTTAAGTA GAGCTCCTAA TATAGTATTG CCATGGATGA ATTAATTCGC AGGAAACTAT 4260 TTAAGCCTTA TCGTAAATTA AATAAACAGA GTTATAGAAG TCCGCAAAGC TCTGAGATTA 4320 ACTTTGAACG ATTGTTTATA TTACATGAGG GAAAATCACC TACATTAGCC TATTTTGAAT 4380 CGGCTATTAT AAGTCGGTTT CCTGATGCAG AATGTCATTT TATCGACACA TTAGCATCCA 4440 CTGATATATT TATTCCTAGA GGATCTGCCC TTGTCGTCAT TAGATTCATC TCCCCAAAAT 4500 GGCAACAGCA CATAGAAAGA TATAACGACA GGTTTTCTCG AATTGTTTAT TTTATGGATG 4560 ACGACCTGTT TGACCCGACT GCACTATCTA CGTTACCAAA AGAGTATCGT ACCAAGATAA 4620 TAAGGAGGTC GGCGGCTCAG CATCGATGGA TTACGCAATA TTGTGATAAC ATTTGGGTTT 4680 CAACTGCCTA TTTGGCTAAT AAATATGCAC ATCTTAACCC GGAGATTGTT TCTGCTAAAC 4740 CGTCACTGGC ACTCATTGAA ACACATCGAT CAGTAAAAAT CGCTTATCAT GGCTCAAGTT 4800 CTCATCGGGA AGAAAAATAT TGGTTGAGAC AAATC 4835 (2) INFORMATION FOR SEQ ID NO: 59: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1746 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 59: GAAAAATGNC ATAACCGCAT TCCATCAAGC CCGTNAATAT CCCGGACTTT CATTTATTTC 60 TGAGGCGTAC AGGGAAGCAA TAACTGCTGG TCAGATATTG CTGTCTCCGG TACATTTACC 120 TGACACTGTA TTTTTCCATC CCAGTTTACC GACAGGGTTT CCCCCGGCGT CACGCCACTC 180 AGCCAGGCAA GGCCTTCGTC GGCCACCATG CCCAGTTCCC GGCCTTTTTC ACTGGTTACA 240 CTGGCACCAA ACGGGGGCTG AGAGCCATCA GCAAGACGCA GTATTGCAAA CAGACGTTTC 300 CCTTTAAGCA CGCTGAATTT CCGGTAACCA ATGGCACCTT CTGTCAGCGC CGATTCCACA 360 ACAGAACGGG TTGCTTCCAC ATCATCCGGT AAGCGCTTCA GGTCAACAGA GGTTGTATTC 420 CGGTAATAAC TGCTGATGTC AGTCACCACG CCCGTTCCCC AGCGATTTGT CACCACCTGC 480 CCGCCATCAA CCGGTACACC TCCCACACCA TCCGTGTCAA CAAGAAGACG TGTTCCACCG 540 GACATTCCCC CTGCATGTAA CGCCGCACCT TTTCCGGTAA TTGTTGCCCC ACCGGAAGCA 600 CTGACGCCGA AAGACGTATA TCCTTTCTGC AGGGATGCAA TATTCGCGGA CAAATTTGCC 660 AGCGGACTAC GATGACTGTA ATAGGCATTA ATCTGACGTT GCGATGTCAG TCCACCGCCA 720 CTGTTAAGGC CGGCGTTCAG GCTGTAGCTG TCCAGACCGT CATTGAACGT GWCAGTGTAG 780 CCGGCCATAT TCACATAACG GTCATTACTC ATACTGCCAC TGTAGCTCGC TGTCCCCGTC 840 CCCCAGCGGC ACGGATATAC GCAGGTAAGC AGAATCNTTA TCACGCCCCA GATATTTAGA 900 CCTTGAGGCT GACAATCCAA CCGCCACACC CTGCAGTCCG AAAACATTAA AGTAGCGGTT 960 GACGCTCACC GTATAATAGT CCGTTTTCCG TATGTCCCAG TATGTCTGAC GGCTGTACTG 1020 CAGGTTAAAA GAGGTGTTCC AGTCCGCCAC GTTTTTATTC AGCGTAACGG TATACATCTC 1080 TTTTTCCCGA CTGCTGTAAT CATTACGGTA GCGGGCGTTC AGGTACTGCT CCATGGTCAT 1140 ATAGTTTCGC TCTGAGAAAC GATACCCGGC GAACGTAATG TCGGCATCCG CATTATCAAA 1200 CCGTTTGGAG TAGCTCAGAC GCCAGGATTT TCCCTGAAAC GTTCTCTCTC CCTCAATACG 1260 GGCTACTGAC TGCGTGATAT CAGCGGAAAG GGTCCCCGGC ACACCCAGGT CCCAGCCGGC 1320 ACCGGCTGCC AGTGCATTAT AATCACCGGC AAGCACAGCC CCGCCATACA GCGACCACTG 1380 GTTACTGAGC CCCCAGGATG CCTCTCCGGT CGCAAATACA GGCCCTTCGG TCTCATGCCC 1440 GTATCCACGG GAACGACCGG AGACAAGTTT GTACCGGACC TGTCCCGGAC GCGTCAGATA 1500 AGGAACCGAG GCCGTATCGA CCTGAAAGTT TTCTTCCGTC CGTTCTGTTC AATAACCTCA 1560 ACATCAAGAC GTCCGCGAAC TGAACTGTCC AGGTCCTGAA TACTGAATGG CCCTGCGGGG 1620 ACCATCGAGT CGTACAGCAC CCGTCCCTGC TGCGACACCA CAACACGGGC ATTAGTCTCC 1680 GCAATCCCGG TAATCTGCGG TGCATAAGCC TTCGCATTCT TGGGGCGGCA CATTCCGGGT 1740 CAGCGN 1746 (2) INFORMATION FOR SEQ ID NO: 60: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 723 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 60: TGTACTGAGC ACGGCGAATA TCCAGTGTTC AAATTCCACT TTGCAGCGAC TGCATGATGT 60 CTGCGGCGCG GTAACAATCA GGGCATTACT GTGTTTGCTG GCGGCGATGG AGACAACCTC 120 ACGCCCGCTA CCGACCGTGC CTTCCGCCTC TTCTTTAGCC GCCGTGAGCG TGCCGCTGAC 180 CTGCTTCAGC ACATCGACCA GATCTTCGGC TTTGCTGTAT TTGAGATAGA AAACCTGGCT 240 GTTGCCGCTG CGTTCCATTT CTGAGTCCAG CCGACGGATC AGGCGGCGCA TTTTGTCCCG 300 CGTGGCCGGG TCACCACTGA CAATCACACT GTTGGTGCGT TCGTCGGCGA CAATTTGAGA 360 TTTCAGCGTC GCAGGCTGGT TCTCGCCGCT GTTTTTAGTC AGGCTTTCCA GCACGCGGGC 420 GATTTCCGAA GCAGAGGCGT TATCCAGCGG GATCACCTCT TCAGTGCGAT TANCCGCGTG 480 ATCCACACGC TGGATCACTT CCGTCAGCCG CTCCACGACG GAGGCGCGCC CGGTGAGCAT 540 AATCACGTTG GAGGGATCGT AATTAACAAC GTTGCCTGAG CCTGCGCTGT CGATCATCTG 600 GCGCAGAATC GGTGCCAGTT CGCGTACCGA AACATNACGT ACCGGCACGA CTTTGGTGAC 660 CATTTCATCG CCCGCGTATT GTCGCTGCCT TCACCAACCA GCGGCAGGGC TCGACTTTCG 720 CGG 723 (2) INFORMATION FOR SEQ ID NO: 61: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 2556 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi ) SEQUENCE DESCRIPTION: SEQ ID NO: 61: TAGAGGATCC CCGGCGTTGC GATCGTCACG AACATAGACC CACAKCCGTC CGGTAGGTAT 60 TTACCCTGAC CCGGYTCCAG TACATTTACC GGCGTGTCAT CGGCATGCAC TTTACCCGGC 120 ATCAGCACAT AGTGCTTCAG TTCATCATAC AGCGGGCGAA GCTGCTCTCC CATGATGTCA 180 ACCCAGCGCC CCATCGTATT GCAGTGCAGC TCCACGCCCT GGCGGGCATA GATTTCCGAC 240 TGACGGTACA GCGGCAGATG CTCGGCGAAC TTAGCCATGA TTATGCGGGC CAGCAGAGCC 300 GGACTGGCGT AACTGCGCTC GATGGGTTTT GGTGGCTGCG GAGCCTGAAC TATACAGTCG 360 CACCGGCTGC AGGCCAGTTT TGGGCGAACC GTTTCGATTA CCCTGAACGC GGTGTTGATG 420 ATATCCAGTT GTTCAGAGAT GCTTTCTCCC AGCGGTTTCA GTTTGCCGCT GCAGACGGGG 480 CATTCGGTTT CTGCCGGGGA GATAACCTGC CTGTCACGGG GAAGTGTTGC CGGAAGTGCT 540 TTGCGGACGG GAGAGTCTGA TGTTTTCGGC GCTGTCTCTC CGGCCATTGA GGTGAGTTGC 600 AACTGCGCCT CACCAAGCCT GTTCTGGAGC TCGGTTATAC GCGTTTCTGC CCGTGCGATC 660 TTCTTTTCTA TCTTCTCGCG GCTTTTCTCG CTGCTGCGAC CGAACAACAT TCTCTGTAGT 720 TTAGCGACCA GCGCTCTGAG TGAGCTGATC TCGCGGCATA GCCGGTTATT TCACCAGACA 780 GACGGACGAT AACAGCCTGC TGTGCGATCA GCAGGGCCTT CAGTTGCTCG ATGTCGTCGG 840 GGAGTGTGTT GTTCATTCCC CTGTTTTATC ACGGGTTATA TCCGGATGCC AGGCCGTTCT 900 GTCCGTTTGG GATGTTGCCA CGCGATCCCC TCCAGTAGCA TGGATAACTG AGCTGGCGTC 960 AGGTGCACTT TCCCTTCCCG GGTTACCGGC CAGACGAAGC GGCCCCGTTC CAGGCGTTTG 1020 GCGAACAGGC ATAACCCGTC ACGATCGGCC CACAGTATTT TCACCATTTT GCCACTGCGG 1080 CCCCGGAAGA CGAAGATATG CCCGGAGAAC GGGTCATCTT TCAGCGTGTT CTGCACCTTC 1140 GAAGCCAGGC CGTTGAAGCC ACAACGCATA TCTGTGATGC CAGCGATGAT CCAGATTCTG 1200 GTACCGGTTG GCAGCGTTAT CATCGGGTAC CTCCTTTTAT TTCGCGGATT AGCGCCCGTA 1260 ACATTTCCGG AGTGAGAGGG TCAAACAGTT TTACCACACC TGATTTAAGA TGCAGCTCGC 1320 ACCGTGGGAC GTTTCCGGGA TCACACTCAG GGCACTCATC AGGCTTGTTA CGCCAGAAGG 1380 GATTTGTAAC TGGTCTGGTC GGCTCTGGCG TATCAGTCAG AGCCACCGGG ACAGGCATGC 1440 ATTCCTGTAT GTCATCATCG CTCAGTAAGC CGTCCTCGTA CTGGCTTTTC CATTTAAACA 1500 GCAGGTTATC ATTGATACCG TGCTCTCTGG CGATCCGGGC AACAACAGCA CCGGGCTGTA 1560 ATGCCTGCTT AGCCAGACGG ACCTTAAATT CACGGCTGTA GCTGGCTCGC CGTTCTTTTC 1620 GCCATGTGCC TTCGCTGATT TGAGGCTCTG TTAATTCCTT CTTTCTGTTG GCATAAAGGA 1680 TGGCGTCAAG CTGAGCTAAT GAAACTGAAT CGGGCAATGG CCATGCGATA CCGGATGCAA 1740 TAAATCGCTG AAAAAGCGTA TGTATTGTGG AATGACTGAG ACCTAGACGC TGAGCGATGG 1800 CCCGGATGGT CAGTTTATCT TCAAATCTTA AACGCAGAGC ATCAGGCAAA TAAGAACGGA 1860 AGCAGGGAAT ATCTTTTTTT GTCTGGGAAT TCATCGTTCG TGTCCATCTA TATAGATGGG 1920 CGCGATTGTT GCCAGACAGG ACAATTTTCA CAAGACGTCG CAGATGGGGC GCTTACCAGA 1980 AATGCGCGGG TACGACAGTG ACTCGTCAAA TCTCAGTTGT AGCACACGCG GGATCAATTC 2040 CGGATTGTCT GCCAGTACCG CCTTTCGTGC ATTCATCTTA AATGTCCCTT TACTGCAAAA 2100 ATGGACATTA GTATCGGAAA CAGGAAAGGG AGGCGAAAGA CGGTTTAAAT GAGACGGTTA 2160 CCATTGTGTC GGGCTGTGTA CGTTCTCCCC GGACAGACAG CCTCAGTTCG TAGAATCTAT 2220 AAATTACTGC TACTGATGCT GCCGGGGAAA GGCGTAACGA AAAAACAGCC TCCGTTACCG 2280 GACAGCAAGG AGGCTGAATG GAGTTTACAG GATTTGCTTT TTTATAATGT CTGGCCATGC 2340 AGTAAAACCG GACAGGTTTT ATTATCATGT GAGGTATTCT GACATAAAAT GCTGGATTTT 2400 TATTTTGTGA CGAATGCTGC AAAATTGCAT CTGCACTCTG ATGTAGCTTT TATCTGTTTC 2460 AGTGAAGCAT GCCCACAAAC TGAGTTATTA AGTTGTGGAA GAACAGTTTT GTCCCGCCTG 2520 CATCTCTCCT TTCAAAAACC AGTATGTCGC CATGCC 2556 (2) INFORMATION FOR SEQ ID NO: 62: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 790 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 62: CAGTTAGTGT TAAAAAATNT CCTCTGCTNC AGAAATTACA CCCACCAATA TACAATNATT 60 AATAAATTTT CGGTTGGGTT AGGTAATGGC TGGGATTCGA TAATATCTCT TGATGGGGTT 120 GAACAGAGTG AGGAAATATT ACGCTGGTAC ACAGCCGGCT CAAAAACAGT AAAGATTGAG 180 AGCAGGTTGT ATGGTGAAGA GGGAAAGAGA AAACCCGGGG AGCTATCTGG TTCTATGACT 240 ATGGTTCTGA GTTTCCCCTG AATAAGATGA TGGATTATCT GACTGGCTGT TCATCAGTCG 300 GATAATGATG AAAACTGATG AGCAACAGGT TGTGCGGGCA ATGTGCAGGA TCCGTCACCA 360 AAGGGTGGAA GTTGCGGGCG ACTCAGATAA ACGGGTTACA TGAGCTATTT CTGGAGTTTG 420 ACGAAGCCGT CTGGAAGGGA GAAGAGGCGA TTCCATTGAT GTCTCTGGAA AACATCTGTC 480 AGTCGTGCTG CTGGAAATAT TGATAGAGCA ATGGGAATGG TTATCCAACA TTGATGAACA 540 TATTGTATAT TTACAGAAAT TTTTAAAAAC AGGACTCAGC AGGTTAAATC GTGTAAAAAT 600 TACTCATGAA TACCATTATG GGCTTACAAA GCGATGTGGT TAAGCAGATC TTATTCAGGC 660 CTGTGCAGCG TAGGATTACA ATAGGATCGA ATAACGCCAT ACAGGGGAAT GGGAGATAGG 720 CTGATTCATC CTGTGGCTAT AACCAGGAGC ATATCGGGAA TCMANTATGT TACCCCAGAT 780 GGAACACCAT 790 (2) INFORMATION FOR SEQ ID NO: 63: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 10906 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (x ) SEQUENCE DESCRIPTION: SEQ ID NO: 63: GCGGCCGCAG TACTGGATCT CTTTGCGGCA TGACGATGAG GGGGAGAGAA ATAAACTTAA 60 CCCAGTCATG GCAGATGAAG AACAGGCTTA CGTAAAAGGG TTATATGAAG GGATTATGCT 120 GATTGGTAAT ATAATCAATA AGCCTGAAGA AGCTAAAGCG TTAATCAAGG CAACTGAAAA 180 TGGCTGCAGA ATGGTGAGTA ACCGGCTGCA ACTTCTACCC GAAGAGCAGC GTGTTCGTGC 240 CTATATGGCG AATCCTGAAT TGACCACTTA TGGTTCCGGA AAATATACAG GATTAATGAT 300 GAAACATGcT GGCGCAGTAA ACGTCGCCGC TTCCACCATT AAAGGTTTCA AACAGGTCTC 360 GATAGAGCAA GTCATTGAAT GGAATCCTCA GGTAATTTTT GTGCAGAATC GTTATCCTGC 420 TGTAGTGAAT GAAATACAGT CAAGCCCACA GTGGCAGGTA ATAGATGCTG TCAAAAATCA 480 TCGTGTTTAT TTGATGCCAG AGTATGCCAA AGCATGGGGC TATCCGATGC CCGAGGCTAT 540 GGGGaTTGGG GAATTGTGGA TGGCGAAAAA GCTGTATCCA GAAAAATTCA ATGATGTTGA 600 TATGCATAAA ATAGTCAATG ACTGGTATAG AACGTTTTAC CGTACTGATT ATCAGGGTGA 660 AGACTAATGC GAGTGCTTGC TGCGGGCAGT TTACGCCGGG TATGGAAATC ACTTGTGTCA 720 GAGTATCAGG CCGATAATAT ACAGTGTGAT TTTGGACCAG CGGGTATATT AAGGGAGCGT 780 ATTGAGGTGG GTGAGGCATG CGATTTTTTT GCATCAGCCA ATATGACTCA CCCACAGATA 840 TTAATGtCCG CAGGanGAGC ATTGTGTATT AAACCTTTTG CCAGAAATCG TTTGTGTTTG 900 TATGTTCGGG CGAATAAATT CAATGAGAAT GACGACTGGT ATTCTTTATT AAATCGGGAA 960 ACATTGCGAA TCGGAACATC AACGGCGGGA TGTGATCCAT CTGGTGATTA CACTCAGGAA 1020 CTGTTTGAAA ATATGGGGAG TGTCGGTGAA AAAATAAGGC AACGGGCTGT AGCATTAGTT 1080 GGGcgGGAGG CATTCGTTTC CTCTTCCAGG AAATGCGATA gcAGCGCAGT GGTTAATTGA 1140 AAATGATTAT ACTGATCTGT TCATCGGTTA TGCCAATTAC GCTCCTGGCT TGCAATCAAT 1200 TGATTCAGTA AAAGTTATAG AAATACCGGA ACCTTATAAT CCGATTGCTA TCTATGGATT 1260 TGCCTGTCTG ACCGATAATG CCCTGCCACT TGCCGACTTT TTAGTTTCAC CTGTTGCCAG 1320 AGGTATACTT GAACAGCATG GGTTTATGCC TCCAGGTACG TTATAGCCCC CTGTCTTACA 1380 GCTGtCTCTT gATCAGATCT CCTGATCAAG AGACTTCATC ACCAGGTAAC CCTCAACCAT 1440 ATCCTGCATA TCCTGAAGTC TGAACCAGCC ATCCCACATA ACTACCCAAC CGGGGCGGCC 1500 TGTGCGTTTG CTGTCATGCC ATCGCCCCAG TTTCGCCAGT TTCAGACAGG CCCATTTCAG 1560 TGTCGGCGTC TGTGACGGAA GCGGTTTTCC TTCCAGCTTA ACCCACAGCA GTTTCCACTC 1620 TGTCGGCGTC AGTATTTTCT TACAGCTGTC ATTTTGTGTT TCTTCACTGA TACCTCCCTG 1680 CCGCAGGCCa GCACCCGTAC CGCGATAAAC GCCTTGATAA CCACCATGCG CTCAAGGTTA 1740 TCCCGGGTCT GCATTCGCAG CGATTCCACA CATGTACCAC CACTTTTCCA CGCCTTGTGG 1800 TATTCCTCTA TCAGCCaGCG TCGCTCGTAA TGGCTGACGA TACGTCGCGC ATCGGCGGCA 1860 CTCGCCACTT TTTCTGACGT CAGCAGATGC CAGCAGGCAC CGTCCTCTGC CTGCTCCCGG 1920 CAACAGACAT ACGTGAGCGG GAGCGCCTGG CCGCTGTTGT CGGGATTTTT TATGCTGAcT 1980 TCGTTGTAAC TGATGAACAT CCGGGCCtgg CGGGCTGCCC GCCCGCCTTT TTGCATCACA 2040 TTCAGCGTGT GGCTTCCCGC GGTTGCCAGG ACTTCCGGCA GTTCGAAGAG CTTGCCGGGT 2100 GCTTCTTCCA GCCGGCGATT CTGTGCAGCA CGCACCACGA AGCGCTGTCC GTGGCTGACT 2160 TTATAATGCA GGTAATGCTA GATATCCGCT TCCCGGTCAC AGACAGTGAT TACCCGTTTC 2220 TGTATCTCCC CCAGCCGTTC GGCCATACGC TCCGAAGCCT GCTGCCAGCG GTAACTTTCT 2280 TTTTCTTCAT AGGGACGTTC TTTTCGCTGG TGCTTAACAC CATAGGTgtC CGTGACCCGA 2340 CTCCAGCGCT GCTGTTCGAT AAGACCGACT GGCAGGGCGC TGTCGGGGGC GTACATCAGG 2400 ACAGAGTGAG CCAGCAGCCC GCGCGTCTTC GGGTTAGTGG TGGTATTCCC CAGGTCATCA 2460 GATGCCGTAC TGTGGCTGAA GTTAATGGTG GTGGTGTCTT CCAGTGCGAG GAGCAGCGGA 2520 TGAGCCTCAC ATGCCCTTAC AGTGGCGGTA AATCCGGCTT CGGCAATGGC TTGCGGGGAC 2580 ACAGACGGGT TACGTATCAG GCGGTACGCA CCTTCAACCT GAGCAGTGGA CTGGGATGAT 2640 TTCACAATAG AAAGACCTGC ATGCTGAGCG AGAGAAGAGG TCAGTGACAC AAGGCGTCGT 2700 GTACGACGCG GATCACCGAG ACGGGCATGT CCAAACTGCT CGTTAGCCCA TGAATAACAA 2760 TCAGAAAGTA CCATAACAGA GTCGAATAAA ATGAAATATA AGAGAAGATC AACGGGTGAA 2820 GAAAAAGTTC AAAAAATGGC TACCGGGGAG GAAGGAAAGT ACCGGATGGA AAGAGCCCCC 2880 CTAAAGCAGA CTGACAGACA TCACAAATCC CCGGGGGGGA CTTGTGTATA AGAGACAGGT 2940 CTTACAGGGG GAGCGTCCGT CTTTTTATCA ACATCAGGCA ATGACATAAC ATTATGAACA 3000 AGCTCACAAG TCTGATGGTT AAATTTTATA ATGCTCCTTA CTAAGACCGT ATTTTTTCAT 3060 TCTGAGATAG AGTTTTTTCC GCGGGATTTG TAAATATTCA GCAACCTCAT TGATACGCCC 3120 CTGATGGATA TTAAGTGCCT CTGTGATTAT CTGTCGCTCA GCGTCCTCCA CTCGTCTGTC 3180 AAGCGGTGTC GGGGTTCCGA CGTGCATCAA CGGATTTGCT GTTTCTGCCA GCGGTAATAC 3240 TCCTACAGTA AATAGTTCTG CTGCATTGGC CAGCTCTCGC ACATTATTTG GCCACATGCG 3300 GCGCATCATC TCTTTGAGCA TCTCTTTTCC CACTTCCGGA ACAGGATGGT TAAGCCGTTG 3360 ACATGCTTTA CAAAGGTAAT GGCGAAACAG TGGTTCAATA TCATCGGGGC GTTGAGTTAA 3420 TGGCAGGCAA GCGATTTGTG TCATTGCAAA GCAGTAATAG AGCTCCGCGA TGATATGGTT 3480 GCTGGCGGCC AGCTCGACCA GCGAAGTGTC TCCAATACCA ATCAGGCGAA AAGGTCGGTG 3540 TTCCTGGCTT TGTAACTGAA CCAGATGGTA CTGCTGTTCA CGCGTCAGGT GTTCAGGATG 3600 GCTGAGCACT AATGTTCCCC CCTGAGCCAG CGCAATGAAA TCATTAAGCT GTGGTGCATT 3660 GTCTGGTGTC AGCTCGCGGT AGATAAATTC GCCTTGTGCA TTACGTCCAA ATTGGTGCAG 3720 ATAACGTGCA CCGGTCATCC GTCCTGTGCC TGGGGCACcG TAGAGCCAGA CGGCAATATC 3780 TGTTTCAGAC AACTGCTGTA AACGTCGCCG ATACTGATTT ATCCATTCAC TTCTCCCTAT 3840 CAACTCCACC TGCAACGTCT GTTGGCAATA CTGACGACGC GCAATGATTG ATTGACGCTG 3900 GCGTAgcGCC TCTTCAACCA GAGAAAGCAA TTTGCCGGGA TCAACCGGTT TTTGCAAAAA 3960 ATCCCACGCG CCTTTTTTTA CCGCATCAAC TGCCATTGGC ACGTCGCCGT GCCCGGTaAT 4020 AAGCAGAATG GGGATCTGTT GATCATCCTG GTGAAATAAC ATCATCAAAT CGATACCAGA 4080 GCAGCCAGGC ATACACACAT CACTTAGCAC AATACCTGGC CAGTCTGGTT GTATCCACGT 4140 CTGCGCCTCA AAAGGATTGT TACAGGCAAA AACCCGATAG CCTGACTGTT CAAGTAACTG 4200 TGTGTAGGCG TCCAGCACGT CAGCATCATC ATCAATCAGC AGAATCGAAT ATTCACTACT 4260 TAGCATCTTC CACATCCGTT AGTCTGAATT GCAGTACCAC ACAGGCATTC CTGGTCATCG 4320 TTGATGCCAG CCGTAATTCA CCTTTCATTT GCTCCATCAA CGACACACAA ATTGAAAGAC 4380 CAATACCCAG TCCTACTTCT TTACTGGTGG TAAACGGCTT CAATAACGAA GGCAACAATG 4440 CCTCAGGCCA GCCCGGGCCA TTATCGCCAA TGAATACGTT CAGCGTTTTA CCCTGCATTT 4500 GCCAGTTAAC GGTAATGACA GCGCCTTGCC CACAAACATC AAGCGCATTC GCCAGTACGT 4560 TAACCAGTAC CTGCTGGGTT CTGACCTCAT CGCCTGAAAC TGTGGCTGTA CCTTGCGGCA 4620 GAACAAGCGT AGCTTGCAAA GGGCGATGAC GCATGGCCAG AAGTTCCCAG GCCGCACTGA 4680 ACATCTGTGC TAAATCAACG GAATGGAGTG ATATTTCCAG TTCGGCGCGC CGGGTAAACT 4740 GCCGTAGTGA ACGGATAATG GCGTCAATGC GACCAATCAC CCcTTCGGCT TTACCAAGCA 4800 TCATGCTGGC CTGTTCTGTC TGGGTCTGTT cAaTGcCTGC GGGCTGTAAA CAGATACATC 4860 GACAGCGCAT TTAGCGGCTG ATTGATCTCG TGGGCCAGCG TGGTCATCGT TTGCCCGACT 4920 AnCCGCaGct TCGCTGTCTG AATCAGTTCG TCCTGGGTGG CTCGCAGATC GGCTTCTATC 4980 ACCTTTCGAT CGGTAATTTC TTGTTCAAGT TGCTGTTTTT GCACATTGAG CTGCCCGAGA 5040 GTATGGCGTA ATAATCCTGC AATTCTCCCC AGTTCATCAT TCCCATAAAC AGGAATAGCC 5100 GTTTCCGTGC CTCCCAGACC AATTTGCACA ACGGCCTGAT TCAGTAGGGT AAAGCGTTTC 5160 ACCAACCGTG AGCGGATAAA ATAATGGTTG AATACCCATG CCAGCAGTAA CGCCAGTGcT 5220 GTCGCCACCA GGATCAGCCC ACCgctAACG CGAACAATTT GTTCCATTCG TTGATTAAAC 5280 ATCTGCATTT GTTGATGAGT ACTGCcAAGT GCGCTTCCAG TAACGTTCTG AAGCGACCCA 5340 GTGTCGCTTc CCTGGTGCGA CTGGCATCCT CTAAGGCTTT TTGGGCGGTG ACATATTCAC 5400 GCATCGTAGC CGGCATTTTG TTTTTTACGA TTCCCATATC CAGCAATTCA TCGATAGTCT 5460 GCCTCAGGGT AATGGTGCCA GGCCAGTCAT CCAGCATACG TATATTTTCA TCTGCCGTTT 5520 TTTTCAGATT TTCAAAATAA CGGAGATGAG TTTCCACCTG TGTGTCGTCA TCACGTCCTG 5580 ATTTGAGTTC ATTGAGTCTG TCACGCAGAT CGTCAACAAT CTGATTTTCA ATGCGTGCCA 5640 GGGTATAAAC CTGCTGCTGT TCATTTTGCA CTTCACGAGA TCGCTTCAGG TATTGCGCCG 5700 TATCGCCyTG TCGGGAGGCG ATTTGATCCA GCAGCGTTCC CTGCTGCCAG GTGAAATCCT 5760 GCACTAAAGA ATTAAGCTCG GTAGTAAAAT CATCGTGTAA CCAGTCAATC CTCGCTGATA 5820 GCTCACTCAC CTTTTCCCGT AGTAAAAACA TGTTGTAAAG CGCACGATCC AACTCGGATA 5880 ACAGTGATCG ACTGTCCTGC AAAAtGACCG TCAGTTGTTG GCGTTCCCGG GATGACAGCC 5940 CCCGACTAAG CCGTTCTATG GTGTCGAGAT GCTGAATAAT CTGGGTACGA AGTTGCAATC 6000 GCACCGTGGT GTTGGGAGCC TGCAAAAATT CATTTAGCTG GTCTACCACC AGATTCAGGT 6060 TCCCTTCAAT AAGGAAAGCA GAGTGAATAC GGGGAAAATA CTCATCCAGC GAGTAACGAA 6120 TTTGTGAGCT TTGTTCATGC CATGAATACA GACTGACACT ACTGACAATC AGGGTCAGAA 6180 GTGCCCCCAT CAGAAATGCG CAACGTAAGC TGGTACTGAT ACTGACCTGT CTTAAACGCT 6240 GCCACAGCGT TATGTTTTTC ATTTCAGCTC TTCCAGTTTT TTTATCGCCA GGCGCTGGTT 6300 ATTCAGAAAC CAGAGTTGCC ATTCCATCAT TTGCTGCTCG GCAAAGCTTT TGTTATCGAA 6360 CTGTGCCAGC CAGACGGGAT CTTCACTGCT GGCCGCTGCA ACGGGCACTT GTGTTAACAG 6420 TGCACGTATT TCTGGTAATG GTTTCTTCAG ACGTGCCTCG GTACTGTGCA GCGCTCGCCA 6480 GGCATCTTTT AGCTGTGCTA ACCGAAAGCT AATTGCCGTA TCAAACAAGC GCTGCACCAG 6540 ACGCTGACGT TTCAGGATAA GGTGATAATT CAGCGGGGGT TGATTCATCA GGAGCTGTTG 6600 TTGCGTTGCC CGCGGATTGT CTGCGGCAAG TGGTGTCACC GGATATTTTC CTGTATTGGC 6660 ATCGGCCAGA ATACGCTGTC CTTTCGGACT TAACAGGTAG TGAATAAAGC GACGGGCTGC 6720 ATCGACGTGT GGGCTTTTCC TGAGAATTGC AACGTAGGTG GGGGATACCG CAGACCGGGG 6780 GAAATAGGTA AAAGAGAGAT GGGGGTCATT TAACAGTAAA TTAGCATAGT TATCGATAAC 6840 GGGGCCGGCA ACGCCGAGTC CGCTTTTTAT TTTAnTCGcT ACGCCAAAAC TGCGGGAGGA 6900 GATTGTCACC AGGTTTCCTG CACTTGTCAG CAACGTTTCC CATCCTTTCA CCCAGCCTTT 6960 TTGCTGTAGT AATGACTCAA CCATTAAATG GTTAGTATCT GAACGCGACG GACTACTCAT 7020 CAATAAAGCG TCCTGATAGA TCGGCAAAGC AAGATCGTCC CAGTCAGCAG GGGCAGGAAG 7080 GTGTTTTACA GAAAGCGCCG GACGATTAAT GAGCAGACCA AAACCTGATA TTGCTACTGC 7140 AACGGAGGTT GCACGGATCG ACTCCGGCAC CAGGTTTTGG CTTTCTGCGG GTGCATCATC 7200 AAACGGGGCC AGTTTCTGGT GCTCCTGAAG GTGCTGGAGC AGCATTGGTG ATGAAGTCAG 7260 GATAAGATCG ACGTTTTCTA CGTTGGCCGT ATCAAGCAAc TGTTCCAGTG AGGCACTGGT 7320 GCGGTTAAGC GTACGGATCA TTACCGACTC AGGCTCTGTT TGCCAGCGCT GTATTATCCA 7380 CGCGGTAGCT CCGGGTGAGA ATGTGGTGGC CATCACCAGT TCATTTCGTT GAGCCcTGAC 7440 GGCCCCGGCG TCCATCAGCA ACAGTAAAAG AATCATGGTT TTGATGCCGA TTTCGCACCA 7500 GCTAAAAAAT CGGTTTGTGA TCCAGGTCAT AAATATTAAT ACACCGCAAA AATCGCATTG 7560 AGACAAAAAT TACCCGTTTC AGACATTCGT CTGATAACAC GTCTGCTCAA AGAGACCGTT 7620 AATATATTAA TCAGAGATTA CCCGATAATC AGCATGAGAT TTGTTAATAT CCGCACATGC 7680 TAACAACAAA CCAGATAAAG CATAAATCTA CCTTGTCTAT GCATCAATAA AATGGGTCAA 7740 AAACAGGCTT TGATTTTATT ATTTTGTGTC AATTGTGACA CATTTTTTCA GTTTGATGTT 7800 TCATYTCAAT TATATGACTC TCATTGTCAG AATACTCCTG ATGTTCATAT CAATATAAAA 7860 TACAGGTGAA GACATGTTAT CAATATTTAA AACGGGGCAA TCGGCGGATA GTGTTCCGGT 7920 GGAGAAAATT CAGGTGACAT ATCGTCGCTA TCGTATGCAG GCGTTACTTA GCGTATTTCT 7980 GGGGTATCTT GCATACTATA TCGTGCGTAA TAATTTCACT TTATCGACGC CTTATCTTAA 8040 AGAGCAATTA GATCTCAGCG CCACACAAAT TGGCGTACTG AGTAGCTGTA TGCNTATCGC 8100 CTATGGTATC AGCAAAGGAG TGATGAGTAG CCTTGCCGAT AAAGCCAGTC CGAAAGTCTT 8160 TATGGCGTGT GGGCTGGTGT TATGTGCCAT CGTTAACGTT GGCCTGGGAT TCAGCACTGC 8220 ATTCTGGATT TTTGCGGCAT TGGTTGTTCT GAATGGTCTT TTCCAGGGAA TGGGCGTTGG 8280 TCCTTCTTTC ATCACTATTG CTAACTGGTT CCCTCGCCGG GAGCGTGGTC GGGTTGGTGC 8340 TTTCTGGAAT ATCTCTCATA ACGTCGGTGG TGGTATTGTT GCCCCTATTG TTGGTGCCGC 8400 TTTTGCCCTA CTCGGCAGCG AGCACTGGCA AGGTGCGAGC TATATCGTTC CGGCCTGCGT 8460 GGCTATCGTT TTTGCGGTAA TTGTGCTGAT TCTCGGTAAA GGTTCCCCAC GTCAGGAAGG 8520 TCTACCCTCT CTGGAAGAGA TGATGCCGGA AGAAAAAGTC GTCCTGAATA CCCGACAGAC 8580 GGTAAAAGCA CCAGAAAACA TGAGCGCCTT TCAGATTTTC TGCACTTATG TATTACGCAA 8640 CAAAAATGCC TGGTATGTCT CACTGGTTGA CGTATTTGTA TACATGGTGC GCTTCGGGAT 8700 GATTAGCTGG TTGCCTATTT ACCTGCTGAC GGTGAAACAT TTTTCTAAAG AACAAATGAG 8760 CGTCGCGTTT TTATTTTTTG AATGGGCCGC AATCCCTTCC ACGCTACTTG CCGGTTGGTT 8820 GTCAGACAAA CTGTTTAAAG GGCGTCGTAT GCCATTGGCG ATGATTTGTA TGGCGCTGAT 8880 TTTCATTTGC CTGATTGGCT ACTGGAAAAG TGAATCGCTG TTTATGGTGA CAATTTTTGC 8940 TGCCATTGTT GGTTGCCTGA TTTACGTTCC ACAATTTCTG GCTTCCGTTC AGACTATGGA 9000 GATCGTTCCC AGCTTTGCTG TTGGTTCTGC AGTAGGCTTA CGCGGTTTTA TGAGCTATAT 9060 CTTCGGTGCG TCTCTGGGCA CCAGCCTGTT TGGTATTATG GTCGATCATA TTGGCTGGCA 9120 TGGCGGATTT TATCTTCTTG GCTGCGGTAT TATTTGTTGC ATCATTTTCT GCTGGTTATC 9180 ACATCGTGGT GCAATTGAAC TTGAACGTCA CAGAGCCGCA TATATAAAAG AACACTGATT 9240 ACCTTCCCCA GGGCCGTCTC CCTGGGGAGT GGAGTATATT ATGATTTATA AGATATCTGG 9300 AAATCAGAGA TTAATATGGA AATTTTATAA GACTGATTAC AATAAATGGA GATGGTATTG 9360 TCATGAGAAA AATGGATATC TTTTGTCTCA ATCAGATAAC GCATATAATT CGCAATTGTT 9420 ATGCATTGAA AATGCTAAAA AACAGGGATA CTCAGACGAA TCGGTCTTGC CACTTTTTCT 9480 ACATATTTCC TATATTCAGG AAAAAGGCTG GAAATGGTAT CAATGTTATG ATTGTGGATA 9540 TATTGTAAAA GAAACCTCTG TTTTTTTTTC GACATACCAG GAATGTGTCA ATGATGTTAA 9600 AAGGAATATA CTAGCATCTA TGTGTAGTGG TTGTAGTGGC ACAGTAAATT TGGCCACCTG 9660 ATTAAAGGTG ATATTCTCAC CACAACATAA AACAACAAGA AAACAAAGCG TACCTTCTCT 9720 CCTGAGTTTA AACTGGAATG CGCCCAACTT ATCGTTGATA ACGGTTACTC ATACCGGGAA 9780 GCTACTGAAG CTATGAATGT TGGTTTCTCT ACTCTGGAGG CATGGGTACG TCAGCTCAGA 9840 CGGGAACGTC AGGAGATCAC GCCTTCTGCT GCAGCACCAC TCACATCAGA GCAGCAACGT 9900 ATTCGTGAGC TGGAAAAGCA GGTGCGTCGT CTGGAGGAAC AAAATACGAT ATTAAAAAAG 9960 GCTACCGCGC TCTTGATATC AGACTTCCTG AATAGTTACC GATAATCGGG AAACTCAGAG 10020 CGCATTATCC GGTGGTCACA CTCTGCCATG TGTTCAGGGT TCATCGCAGT AGCTACAGAT 10080 ACTGGAAAAA CCGTCCTGAA AAACCAGATG GGCTGTATTA CACAGTCAGG TACTTGAGCT 10140 ACATGGCATC AGCCACGGTT CGGCCGGAGC AAGAAGCATC GCCACAATGG CAACCCGGAG 10200 AGGCTACCAG ATGGGACGCT GGCTTGCTGG CAGGCTCATG AAAGAGCTGG GGTTGGTCAG 10260 CTGTCAGCAG CCGACTCACC GGTATAAACG TGGTGGTCAT GAACATGTTG CTATCCCTAA 10320 AAGCAACAGC AAACAGCGAC CACTGGGGAG CCCTGCATTG CGGGATTGTA TTGTTCAGCG 10380 GGCCATGCTG ATGGCGATGG GGCCGAGGAG AGTGATTTTC ATACGCTCTC ATATGGTTTT 10440 CGACTTGTGC GAAATGTCCA CTACGCGATC CGCACGGTGA AACTGCAACT CACCGACTTC 10500 AGGGGAAACT CGGGGCCGCT GGGTAATCTC ACATAAAAGT TCTTCGGTGT CATAAACAAC 10560 GAGAGTATTT GATTCCTTTA TGGTGGCCTG GTGCAGAGCT GCCCTTTCCC AGGACCTCCA 10620 TATAATTTTT GTAGCGGCAG TCAGTGGCAC ACTCAGTTAA CTACTTTCAC TTCAGTGACT 10680 TTGAATGAGT CAGGGCTGCC GTTAAAGGTG TTAATGAAGG CTTGTATTTT CCACTTCTGG 10740 CCTGGTTCAA GATTGGATGC TGTGTCGATT GTTTGACCGA TAACGACTCC ATCTTTTAAN 10800 AGATTAAATT TTACATAAGC ATTTTTGACA ACAGAGTTTG ATTTATTTNC AGCATAACCC 10860 ACAATTGCCT TCGTCCCACT TGGGGTGTTT TCCACATGAA GGTTAG 10906 (2) INFORMATION FOR SEQ ID NO: 64: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 7430 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 64: ATGGTTATTT TTATTTCCTG CACCTTGCTT CATTTGAAAT AAAAACATAT GCATACGACG 60 CTGCCATTGA GCAGAAAAAT ACAGGAATTA ATGTTATGAG TTAACCATAA TACCTGTGTT 120 ATGAATATCT GACATAAACA AGAACAATTC ATATCTTCTG TATTCAGCAG AATAATAAAA 180 GTTCGTCTGC CATTCTCAAA CTTATTCTTC GGAATACGTT GTTTCATGAA AGAAGGGGCC 240 GGAATAAAAG CTGGTCACCG TAATGCTAAT ATTAATGCAG ACTACCGCCT TCTGGAATTA 300 ACAGTCATCA ACCAGCACAA ACCATTAGCA ATCAAACAAA TTTTAATTAA CAAAATTTTA 360 GCTAATACAA TTACTGCATT AACCACTCTG CAGTTTGCCT TCTCAATAAG TTACAGATGC 420 CAAACAATAC TCTTTTATAT GTTATAACAT AACACAAACA ATAAATAAAG AACAGACGGC 480 ACTCCATTTC TCCACGTAAG TGAGCCATCA GAATCGCTTA TGAATGTGTA CGGCAGACGT 540 ATACTCGTGT TTTACTGCAG CAACCGGAGC AAAAGTTGCA CTTCCACAGC CTGGGTTAAG 600 TTTTTCATGC TTGTGGGCTC GTCCTCCCTC CATTTCCACC GCGGGCAAAC AAGGCCATCT 660 TTTGTCTGGC CACACAGCAG ATGGAGAGTC GAATTATGCT GTCTGACGAC ACCGGGAACA 720 AATATGCCAT GCCTTCGCAC AATGAACCCG GGCATCATCG TTTTATCTTT ATAATCGAGA 780 CAGGTATGAG GGAAAGTCGG ATGATAAGCA GATAGTGAGT GAGGCGCTGG AACATGGCGC 840 TCTGGCAAGA GAAGTGTCAC AGGTTACCTG ATGATATGGG GCAACCTGAT ATCTACTTAC 900 TTTTTTGCCT ACTCTCTTAC TTCATGCCAG CAGCGAGGGT ATCGACATTG TGTTTGAACG 960 CTGCCGTGTA GGTAGCAGCG AGGCCGCTAC TGTCGGTAAG TGCTTCCGGA TAAAGCTCTC 1020 CTCCCGCTTG TGCACCACTG GCATTGGCGA TTTGTTTCAC CAAACGGGGA TCTGTCTGGT 1080 TTTCGATAAA GTACAATTTT ACGTGCTCTC TCTTAATTTG ATTAATCAGT TTCGCCACAT 1140 TTTTACTGCT AGCTTCCGAC TCAGTGGAGT ACCCCACTGG CGACAGAAAG CGAACCCCGT 1200 AGGCGGCAGC GAAATACCCA AACGCATCAT GACTGGTCAG TACTTTACGT TTTTCTCTTG 1260 GAATAGCAGC AAACGTCTGC GTGGCGTAAT TATCCAGTTG CTTCAACTGC TGGATATAGC 1320 TGTCACCCTG TTTTCGATAA TCGCTGGCGT GCTCCGGGTC TGCTTTGCTC AGGCCATTGA 1380 CAATGTTGTG AGCATAGACA ATACCGTTTT TCATGCTGTT CCAGGCGTGC GGATCAGTGA 1440 TGGTGATCCC ATCCTCTTTC ATTTTCAGTG TATCTATTCC GTTAGACGCG GTAATTACCT 1500 CACCTCTGTA GCCAGAGGCT TTCACCAGAC GGTCCAGCCA TCCCTCCAGT CCCAATCCAT 1560 TGACAAAGAC AACATCCGCC TGTGCCAGCG TTTTGCTGTC TTTCGKCGAC GGTTCAAATT 1620 CATGTGGATC ACCATCCGGT TGCACCAGAT CAGTGACATG AACGTATGGG CCGCCAATCT 1680 GGCTGACCAT ATCGCCCAGT ACCGAGAAAC TTGCCACCAC ATTCAACTCT TTTGCAATCA 1740 CCAGTGGGCT CACTAGTAGG CTGGACAGTG CCACAACCAA AATGGACCGT TTCATCTTTC 1800 CTCCTTCATC TCGTTGCTAT GTGTAAAAAC ACTTCTTGTC AGCGACATCT GCATAACATG 1860 CCGCCATTAG AGCCAAACAG AACTGAAAAG CAGAAAAACA GAGTGCTCGT GAGGATGACT 1920 GCAGGACCTG CAGGCAAATC AGCGTAATAA GACCAGATCA GTCCAACCAG ACTGGCGCAG 1980 GTACCAATAC CCACTGCAGC TAACAACATG ATGGACAGAC GTTGACTCCA GAAACGCGCG 2040 CTGGCAGCCG GTAACATCAT AATACCGACT GTCATCAGGG TGCCAAGTAG CTGGAAACCT 2100 GCCACCAGAT TGAGTACCAC CATTGACAAA AACAGGCAGT GGATCAGCGC CCGCGACCGA 2160 CGTGACAGAA CTTTCAGGAA AGTGACATCA AACGACTCAA TCACCAGCAC CCGGTAGATC 2220 AACGCCAGTA CCAGAACCGA ACCGGAACTA ATTATGCCGA TAGTGATCAG AGCATTGGCG 2280 TCAATAGCCA GAATGGAACC GAACAGCACA TGCAGCAGGT CGACACTGGA GCCACGCAAA 2340 GAGACCAGGG TGACGCCAAG TGCCAGCGAG CCGAGGTAAA ACCCGGCGAA ACTGGCGTCT 2400 TCTCTCAATC CAGTGCGGCG GCTGACCACA CCAGACAACA TCGCCACAGA CAGCCCGGCA 2460 ATGAAGCCAC CGACTCCCAT CGCAACCAGC GACATGCCCG ATACCAGGTA GCCAATTGCT 2520 ACTCCCGGCA ACACCGCATG GGACAGTGCA TCACCGATCA GGCTCATACG GCGCAGTAGC 2580 AAAAAACAGC CAAGTGGCGC GGCGCTCAGG GTCAACGCCA GACATCCGAC CAGCGCCCGA 2640 CGCATAAAAC CGAAATCGCC AAATGGCTCG CACAACAGGT GCAGTAACAT CATGGCAGCA 2700 GCCCCTGCTG CGGTGGCGTG GCTGCAGCCG TGAGGGAATG GAGTATATCG GCACTTCTCC 2760 CCCATCGGTG GCCTTCCGCA CTGAGCATCA GTACATGAGG AAAGTATTTT TCTACCTGTT 2820 CCATGTCATG CAACACCGCA AGAATTGTAC GTCCTTCCAG ATGTAGCTGC CGAATAACAA 2880 CCAGCAGAGT ACGGATAGTC TGAATATCAA TGCCAGTAAA TGGTTCATCC AGCAGAATAA 2940 CCGACGGCTG CATCACCAGC AGTCGTGCGA ACAGTACGCG CTGTAACTGA CCACCGGAAA 3000 GTGTGCCGAT GTGCATCGGC GAAAATTCTG TCATACCGAC GGTATCCAGC GCTTCGATAG 3060 CTTTTTTTCG CCATAGACCG GAAATACGAC CGAACATCCC GCTGTGTGGA ATACATCCCA 3120 TCAGCACCAG ATCGTTAACA CTCAGTGGAA ACTGGCGATC AAATTCAGTC AATTGGGGCA 3180 AATAACCTAA CTGGCGTTGC CCCTGCGGTG CCATGCAGAA GCAACCACCC AGAGGTGGCA 3240 GCAGACCGGC CAACGTTTTA AGCAAGGTGG ATTTACCTGT GCCATTCGCT CCGATAATGG 3300 CAGTCAGTGA ACCGGTGTCA AAACATCCAT TCAGCGTACC CAGCGGGTGC TGTCCCGAAT 3360 AGCCAAATGC CAGTGAATGT AATGCGATCA TGTCAGTACC ACCGCCCAGG AAATAAGAGT 3420 CCATAACAGT ACCAGCAGCA CACCGACGAT ACCCAGTCGG GCTATTGCGG AAAAAGCATA 3480 AAGACTGACC ACAGTATCCC CCATCAAAAT TGTTATAGTA TAACATTATT GCTTTATGGG 3540 TGCCGATGAT AGGTAAGAAA ATGTGTCATG GCTTCTGCAG CGTAAGCATA CAGCGAGAGC 3600 AGTATTGACA GGGATGCGTT AGTCATTTAG CAGTGTAATG CGCTAAATAG NTGCGCGGAA 3660 TAGTAGATCA CTTTGAGGGT ACTCAGCCCG GATTGTGCGC TCTGATCAAT CGCCAAATCA 3720 AAACAAATCA CCAACCGAAC TGAGCAATGC CGATCATAGC ACCAATTTCC CGTGACGAAC 3780 GACACCGGAT GCAGAAAGCC ATCCATAAAA CACACGATAA AAATTATGCC CGCAGACTGA 3840 CTGCCATGCT GATGCTGCAC CGGGGCAACC GTATCAACGA CGTTGCCAGA ACGCTCTGCT 3900 GCACCCGTTC ATCTGTTGGA TGCTGGATTA ACTGGTTACT AAAATCATTC CCTGCCGGGC 3960 GTGCCCATCG CTGGCCATTT GAGCATATCT GCACACTGTT ACGTGAGCTG GTAAAACATT 4020 CTCCCGACGA CTTTGGCTAC AAGCGTTCAC GCTGGAATAC AGAACTGCTG GCAATAAAAA 4080 ATCAATGAGA TAACCGGTTG CCTGTTAAAT GCCGGAACCG TTCGCCGTTG GTTGCCGTCT 4140 GCGGGGATAG TGTGGCTAAG GGTTGTGCCA GCTCTGCGTA TCCGTGACCC GCATAAAGAT 4200 GAAAAGATGG CAGCAATCCA TAAGGCACTG GACGAATGCA GCACAGAGCA TCCGGTCTTT 4260 TATGAAGATG AAGTGGATAT CCATCTTAAT CCCAAAATCG GCGCTGACTG GCAGTTACGC 4320 GGACAGCAAA ACGGGTGATC ACGCCGGGAC AGAATGAAAA ATATTATCTG GCCGGAGCGC 4380 TGCACTGCAG GACAGGTTAA AGTCAGCCAT GTGGGCGGCA ACCGCAAAAA TTCGGTGCTG 4440 TTCATCAGTC TGCTGAAGCG GCTTAAAGCG ACATACTGTC GAGCGAAAAC CAGCACGCTG 4500 ATCGTGGGCA ACAACATTAT CCACAAAAGC CGGGAAACAC AGCGCTGGCT GAAGGAGAAC 4560 CCGAAGTTCA GGGGCATTTA TCAGCCGGTT TACTCGCCAT GSGTGAACCA TGTTGAACGG 4620 CTATGGCAGA CACTTCTCGA CACAATAATG TGTAATCATC AGTACCGCTC AATGTGGCAA 4680 CTGGTGAAAA AAGTTCGCCA TTTTATGGAA ACCGTCAGCC CATTCCCGTA GGGGAACATG 4740 GGCTGGCAAA AGTGTAGCGG TATTAGGAGC AGCTATTTAG GAGAACAGCT CGCTGACCCG 4800 GTTGACTATG ACTCAAGCCC ATGACGAAGA TAGCTTTCTG GATCAACATC GTTCAGTCTG 4860 CACGTCCCAA TCCAGCCACC AGCCACCAGC CACCAGCCAC CAGCCACCAG CCACCAGCCA 4920 CCAGCCAGGC TACAGTGCCA TCCCGACCTC CCCACGTAAA CCCAGGGACA GGCTAAAGGC 4980 AGAAAATGGG GAAGGCAGTA TGACTCTCCG TGACACAGAT GCGGGTACCT GATGGGAGTG 5040 AGATCATCTT CCCCTCCCGG TCAGTTCCCG GATCAACACC GTGAGCAGCT CTGGCGAAGG 5100 TTTTTCCAGC GTCATTTTAC CGTAACGAAA TTCAACCTTA CAGGAACTGG CACAGACTGT 5160 GCACTAAGTG GCAGTGGATA AAAGCGGAGT AAGAGCCGCC ACAGGCTCTT TCTGCTCATC 5220 AGGCATTATC TCAACAGGTA ATAATTCAAC GCCAGCGCCA GAAGAGGTTG TTACCGGAAG 5280 ACGCCGCGCC CCCCTTCGTT CAGCCAGAGC CTGAGCCATT TGACCAGGAG GTTATCATTG 5340 ATATCGTGTT CCTGGTCAAT ACGGGCAACA GAGGTGCCTA CGACGTTTTT TCAGTTCGGT 5400 TATCTATTGA CTTAACTCTT TGGCCAGTAA TGCTGCAGCC CCCGTGCCAT GAATAAACGA 5460 GTGGTCGCAG ACCACGCAAC ATGCAACATC ATTCAGATCC CCCGCTAATA TTACAGGTAA 5520 TTCAGAATCA GCAATACTTT TCCCGACCAT TAAAAGTTCT GAGTCACGAT CAGTTGACTC 5580 ATCACTTTCA GTCGGGCTCG GTGGAACAGG ATGAAGACAA TGTAATCTTA TTCTCAAACC 5640 TTCTGGCATA TGAACTATCA TATTCATGGA GGGAATTTCC TTGTCCACTA AATACTGTAT 5700 TTCTGCATCA CTTAAAATCA TCCAGGAATA TACATGCATG CCATATAAAT TTTCTTTCGG 5760 GCATTTCAGG GAGTATGGAA ACACTTCATC CAGAGGTGAT AGTTTCTGTT CCCACCATAA 5820 GTTTGTTTCA AGAAGAACAA GTATATCAGG TTTTTCTTTA TTTATAAGTT CAAGAATGGG 5880 TATATATTTT TTATTGGTCA TAAGAACATT GAATACCAGT ATACTTAAAC CCAGAAATCC 5940 ATCAGAGTCC TTTATTTCCT TTACCTGCTT CTTGCCAATT ACTGTATAAG GAATTATCCA 6000 TACCAACTGG TAAGCGACAC AAATTAAACT TATTATCCCA ACAAACAACT CTGTAAATAA 6060 GTCAAGAAAA ACAACAGACA GAAAAACATT CAAAGTACAC AGCAAAAGTA TCTGTAGTCG 6120 GGGAAAATCC CATCCCCCGA CAACCCATGA TGTATTACCG GAAACAGGGA TAAAAGTTAT 6180 GACTGCCAGA AGGATAGCAG TAAAAATAAA AACACAAGTT ATCACAAATC GCTCCTTGTT 6240 CTGAACCGGA ACACAAAACT GTCATATACG TTTCAAAAGT AAAAATACAC TGCTGCCACA 6300 AGATTTACAG CGTAACCGGA CAGCATATCC TGATTACGGA CAATCCATGA AACCGCCTCA 6360 CCAGAAGCGT CCATCACATC CGTTTTTTCC CTGTTTTATA TTCCCCGAAA CATTTTATTT 6420 TCAGGAATCT CCGGGCCTTT ATCCCGCATC ATTGCAAAAT GGCATCTGAA TCGATCATGA 6480 TTTGGCATCC ATCTCCGATC ACAGTTTGGC ATCACAATCG ATCACGATTT GGCATGCTTC 6540 CGATCATTGA TTAGCATCCT GCCAGTCACT CCGGGAATTA ACTCTTTTCG CCACAGTCTT 6600 CATTGCCGTG TTTAAACCAA TGGAGACGGC AATGTCCAAA AAGAGAATAT CCAGGAGCAC 6660 TATGGATACC TGTTTTAAGA TCCTTCAGCT CAAGTTCGAC CAGAAGCTGG CTAACCGTTG 6720 TATCGGACTT GCAAAACACC AATGGGGATT GATCTCTATT TTGCGACACA GACGCATTAT 6780 CAATACATCG ATGGTGCGAT CAAATACCTC AGTGGTCTCA CCGTGGATCA AATCCAGCAA 6840 TTGCTCACAG ATTAAGACTC GTCGGGAGTT TTGAGCCAAC ACCAGCAGTA ACCCATATTC 6900 ACCTTGAGTG AAATCTACAG GCTGTTGATG AGCATCAACC AGCACGTAAC GGTCCGGGAT 6960 CAAGTGTCCA GCCGTTAAAA AAACCACTCT ACTACCCTGC TCGACCTAAG CCTCGGCGTT 7020 CAGCCGCCTG AACGGGTATG GCAAGGGTGA AAAGAAACAG CATCCCCACA GTACCGACCA 7080 GACGACAGGA TGATGCTGGA ACAGAAAGCA TTCGCACCTC TCTTAGAATT AGACAGTGCG 7140 TACAGGATAC GTAAGACAGG GTGACGGGGC GGCGATAAAC TCTATTTACA AAGCTGAAAA 7200 TTTTCTGACG ATGAAAAACT ATTCAACAAG GTTATCTGAG GCGTTAAAAT AACCAGCTCG 7260 ATTAACGACT AACTTGAGGT GAATATGAAT TTAAAAAATA TAATTTTAAG TACTGTTTTA 7320 TCAATCGCTA GTTGTCATGC CCTGGCTGTA GGTAATTCTC CAAATAGCGC TATCTAACCT 7380 TCATGTGGGR AAACACCCCC AGTGGGGACS AAGGSCAATT GGTGGGGTTA 7430 (2) INFORMATION FOR SEQ ID NO: 65: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 6681 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 65: AGATTATTCT GGCTCAGATT CATTTTTCAT CAGTCGCTTT CCCCTATAAA CCGTAAGGTT 60 CCATAGTGTC GACGCTCTCG CTTAATTCCC ATATCGTCGA TAGTCTTATT AGCCGCTTCT 120 GTCAGGTCAG AAAAAGTATC ACGCTTCTTT GGGAGTTCAA GTCAGATTTC TCGCCGTCGG 180 GCGATGCGCT CAAAATGTTT GTCTGTATGG GGTCGCTTCA TCACGTCAAG CCATCGCGCT 240 GCCGCTCTCC GCCAGAGTAC AAGCTCTTCC AGTTGTTCTG CTTTTTATCT TATCTGTGGC 300 GATGCAGTAT CCTCCTCCGT TTGTGTAAAT CGTTGAGTGG TGAATCACGC AAAGGGGCTT 360 CTTTTTTCTG ATCTATCCCC ATATTCTTTA GCGTTCTGGT CGCAGCATCT CTGATGTCGC 420 AGACACTGAA CCTTTGTATT TTCCATGATC TTGTGGAGTT TTCGATACAT CTGCTCCGAT 480 GCTGGGTTAT AAAGATCCGC TCTTTATCAT CCTTGGCTTG TGTAAGCAAT TCTCCCCAAC 540 GTTCTGCTGC ACGCCGCCAT AACTCTCTTC TTTCCAGTTC CTCAGCTTTT TCATCATGTA 600 CCATTCGTGT ATCCCCGTTT ATCCAGTCTG AACCGCACCG GGTTTCCTGG AGAATGTTTT 660 CTCTGTGAAC TCAGGCTGCC AGATCATCGT TTCCGATGGA AGCATAATAA GCTTTTTCTG 720 CTTCTGCCGG ARGAATATGG CCCAGCTTTT CCAGCAATCG TCGATTGTCA TACCAGTCCA 780 CCCACGTTAG TGTGGCCAGC TCCACTTCTG TCCGTTTTTT CCAGCTCTTA CGGTTATTAC 840 CTCCGTTTTG TAAAGACCAT TGATGCTCTC CGCCATTGCG TCGTCATACG AGTCGCCTGT 900 ACTCCCTGTT GATGCCAGTA ATCCGGCTTC CTTAAGCCGT TGCGGACACA TAATGAGAGC 960 CTTTATCGCT GTAATTGTCA ACGACGGATG AAAAGTGATC CACTTATATC TCCACCAACG 1020 GCCCAATATT GATCCACCGT TTTACTCAGG ATTAGCTTCT GCTATAACCC CGGCCTTTCG 1080 TTTCTGTCTG AGTCGATAGC TTTCTCCTTT GATTTGAACG ACATGTGAGT GGTGTAAGAT 1140 ACGGTCCAGC ATCGCTGAGG TCAGTGCTGC ATCACCGGCG AACGTTTGAT CCCACTGCCC 1200 GAACGGCAGA TTGGATGTCA GGATCATTGC GCTCTTTTCG TAACGTTTAG CGATGACCTG 1260 GAAGAACAGC TTTGCTTCTT CCTGACTGAA CGGCAGATAG CCTATTTCAT CAATGATGAG 1320 CAGGCGGGGG GCCATTACTC CACGCTGAAG CGTCGTTTTA TAACGGCCCT GACGTTGTGC 1380 CGTAGATAAC TGAAGTAACA GATCTGCTGC TGTTGTGAAG CGAACTTTGA TACCTGCACG 1440 GACTGCTTCA TAGCCCATCG CTATTGCCAG ATGGGTTTTC CCCACACCTG ATGGCCCCAG 1500 TAATACGATA TTTTCATTAC GTTCTATGAA GCTGAGTGAG CGTAACGACT GGAGTTGCTT 1560 CTGCGGTGCT CCGGTGGCGA ATGTGAAGTC ATACTCTTCG AACGTTTTCA CCGCCGGGAA 1620 GGCTGCCATT CGGGTATACA TCGCCTGTTT ACGTTGATGA CGTGCCAGTT TTTCTTCATG 1680 AAGCAGATGC TCCAGGAAGT CCATATAACT CCATTCCTGG TCTACTGCCT GTTGTGACAG 1740 CGCAGGCGCT GCGCTTATAA GGCTTTCCAG TTGCAACTGC CCGGCGAGCG CCATCAGTCG 1800 TTGATGTTGC AGTTCCATCA TCACGCCACT CCTCTGCAGA ATGAGTCGTA GATGGAGAGT 1860 GGATGATGCA GGGGGTGTTT GTCGAAGTTC ACCAGATTTT CATCAAGATG CACGTCATAC 1920 TCTTTTTTCT CCGGAGCAGT GCCAGCATGG ACTGCTGTCT TCGAGCCAGC GATCGCAGGG 1980 ACGGGCCTGG ATTGTTTCAT GCTTTCGTTG GTTAGCGACA TCGTGCAGCC AGCGCAGACC 2040 GTGGCGGTTG GCTGTTTCAA CATCGACAGT GATCCCCATC GGGCGCAGGC GAGTCATTAG 2100 TGGGATGTAA AAACTGTTAC GGGTGTACTG CACCATCCGT TCCACCTTAC CTTTAGTCTG 2160 TGCCCTGAAG GGGCGACACA GTCGGGGAGA GAAGCCCATC TCCTTGCCGA ACTGCCACAG 2220 CGAAGGATGG AACCGGTGCT GACCGGTCTG ATATGCGTCA CGTTGCAGAA CCACAGTTTT 2280 CATATTGTCA TACAACACTT CGCGCGGCAC ACCACCAAAG AAGCGGAACG CATTACGATG 2340 GCAGGTCTCC AGCGTGTCAT AACGCATATT GTCAGTGAAT TCGATGTACA GCATTCGGCT 2400 GTATCCGAGA ACAGCAACGA ACACGTGAAG CGGTGAGCGA CCATTACGCA TAGTGCCCCA 2460 GTCAACCTGC ATCTGTCGTC CGGGTTCAGT TTCGAACCGA ACGGCAGGCT CCTGCTCCTG 2520 AGGAACCGAG AGAGAACGAA TGAATGCCCT GAGAATGGTC ATTCCGCCAC GATATCCCTG 2580 GTCTCTGATC TCGCGAGCGA TTACCGTTGC CGGGATTTTG TAAGGATGAG CATCGGCGAT 2640 GCGTTGACGA ATATAATCCC GGTATTCATC CAGGAGTGAA GCAACAGCAG GTCGCGGCGT 2700 ATATTTTGGC GGCTCAGATT TTGCCTGCAA ATAACGTTTA ACCGTATTGC GGGAGATCCC 2760 CAGTTCTCTG GCAATCGCCC GGCTACTCAT TCCCTGCTTG TGCAGGATTT TAATTTCCAT 2820 AACTGTCTCA AAAGTGACCA TAAACTCTCC TGAATCAGGA GAGCAGATTA CCCCCTGGAT 2880 CTGATTTCAG GCGTTGGGTG TGGATCACTA TTGCACCGTT CGTGACAGTA ATGGATTGTG 2940 TCAGACGGAC GACGGGCCCA TAACGCCTGC TCCAGTGCAT CCAGCACGAA TGTTGTTTCC 3000 ATGGACGATG AGACTCGCCA TCCCACGATG TATCCGGCGA ACACATCAAT GATGAACGCC 3060 ACATAAACAA AGCCCCGCCA TGTGCTTATC CCGGTAAAAT CAGCTACCCA CAACTGGTCC 3120 GGGCGTTCTG CGATGAACTG ACGGTTTACA CCGTTGCATG CGGCAACAGC TTTCCGGCTG 3180 ATTGTCATGC GAACCTTTTG CAAACCCCAT ATATTTCAGA CGATACCGTT CAACGGTAGT 3240 GAACCCACCA TCACCGCTCC CGGTATCCCG CTCATGCTGG TATACCCAGA CATGCAGGGG 3300 TTCCAGCGTA CAGCCAATCT TTGGGGCAAT GGAACAAATT GACGCCCACT ACGAGTCATA 3360 CGACTTTCCA GAACAATACG GAGCGCCCGC TGACGGACCA CCAAAGAGCC GCCATTATTC 3420 TTATTACCTT TAACTAATAA TGCCAATTCA GACCCAAACA CGGCATCATT CGCTTCAGCC 3480 TCTGCGCCAT TAATTAATGC CAGGACTTGG TCAAGAAAGC GTTGCGCTTC GTTTACATCT 3540 GTTGCTTGTC GCAGGTAATA AGGTATTCGT TCAACAAACT CGGAACGTGA TAAAGGCTGA 3600 TGCTCCAGCA AAACCTCAAG CATTGCGGGC CGCAACAAAC GACGCTCAGC ATCAACATTG 3660 GGAAACTTAA CCTCAATGGC ATATGTGGCA AAATACTTAA GTTGCTCCTT AAGCCCCAAA 3720 TTAGGCATAA GAGAATCAAT TGAGCCAGAC GCCACTGCAG CGCTTGATTC AATTGTTTCT 3780 ACATACTCGT AGGAAGGTAC AACAACATCT GGAGCCAATG TTTTAAGCTC ATGGAGTTGA 3840 CGGATAATCG GGGATAGAAC CTCATCAGGA TTACTGAACC AATCAGTGGA CCAAATACGG 3900 CTAATTCTCC ACCCCAAACG CTCCAAAACC TCTTGACGCA AACGATCACG GGCAGATTTA 3960 GCTGAATGAT AAGCCGCACC ATCGCACTCT ATACCCATTA AGTAACAACC CGGATCTTCT 4020 ACCGACAGAT CAATAAAGAA TCCTGCAACC CCACCTGAGG TTCACACTCA AACCCAGCGT 4080 GATTGAGTGC TTCCATTATA GCAACCTCAA AGTCACTATC CGGAGCCCTG CCCGTATACG 4140 TCGTGAGGGA ATCTAATTTG CCACTTTCGG CAAACTGTAA AAAACCTTTC AACGAAATAA 4200 CACCAAATTT ACTGGTTTCA CTCGTCAATA CATCTTCAGA ACGCATTGAA CTAAACACAT 4260 GCATCCGTTT CTTTGATCGA GTTAAAAGCA CATTCAAGCG GCGCCAGCMA ACATCGGAAT 4320 TGACAGGCCC AAAGCGTTAA TAAACCTTTC CACCATGCTC AGAAGGTCCA CAGGTAAAGG 4380 AAATAAAGAT TACATCACGC TCATCACCTT GAACGTTCTC AAGTTTTTTC ACAAAAAGTG 4440 GCTCTTCCAT GGCATATAAG CCATCAATTG CATCGTTAAA TTCAGTGCGA TTTCGGCGCA 4500 ATTCATCAAT AGCGCGCTCA ATCTGATCGC GTTGCCTGGA ACTCATGGCC ACTACCCCAA 4560 GAGATTCATC CAGCCGGTGT TGCGCATGAT GAAGTACAGC CTCAGCAACT GCTTGGGCTT 4620 CTTCAATATT GTGTTGATTA GAGCAACGAC CTTTTGATAC ATAAGTAAAT TTGATTCCAT 4680 ACTCTGGAGA CTCAGCATTT GGAGAAGGGA ATATCACCAA ATCACTGTTA TAAAAATGGC 4740 GGTTAGAGTA TGCAATTAAC TTTTCGTGTC GTGAACGATA GTGCCAATGC AAACGTCTCA 4800 TAGGAAACAG TGGCAAAGCA GCATCCAAAA TGCCGTCAGT ATCACTTAAA GCCGCGACAT 4860 CATCGTCATC TTCTCCGGCG GAACTTCGAT CTGAAGTGGC ACACTGAATT TGGCCACCTG 4920 AACAGAGGTG ATATGCTCAC CTCAGAACAA CACAGGTGCT CCAATGAAAA AAAGGAATTT 4980 CAGCGCAGAG TTTAAACGCG AATCCGCTCA ACTGGTTGTT GACCAGAACT ACACGGTGGC 5040 AGATGCCGCC AAAGCTATGG ATATCGGCCT TTCCACAATG ACAAGATGGG TCAAACAACT 5100 GCGTGATGAG CGTCAGGGCA AAACACCAAA AGCCTCTCCG ATAACACCAG AACAAATCGA 5160 AATACGTGAG CTGAGGAAAA AGCTACAACG CATTGAAATG GAGAATGAAA TATTAAAAAA 5220 GGCTACCGCG CTCTTGATGT CAGACTCCCT GAACAGTTCT CGATAATCGG GAAACTCAGA 5280 GCGCATTATC CTGTGGTCAC ACTCTGCCAT GTGTTCGGGG TTCATCGCAG CAGCTACAGA 5340 TACTGGAAAA ACCGTCCTGA AAAACCAGAC GGCAGACGGG CTGTATTACG CAGTCAGGTA 5400 CTTGAGTTGC ATAACATCAG CCATGGTTCT GCCGGGGCAA GAAGCATCGC CACAATGGCA 5460 ACCCGGAGAG GCTACCAGAT GGGGCGCTGG CTTGCCGGCA GGCTCATGAA AGAACTGGGA 5520 CTGGTCAGTT GCCAGCAGCC TGCGCACCGT TATAAACGAG GTGGTCGTGA ACATGTCACT 5580 ATCCCGAATC ACCTTGGGCG GCAGTTCGCA GTGACAGAGC CAAATCAGGT ATGGTGCGGC 5640 GACGTGACGT ACATCTGGAC GGGGAAACGT TGGGCATACC TTGCCGTTGT TCTCGACCTG 5700 TTTGCAAGGA AACCGGTAGG TTGGGCAATG TCGTTCTCTC CGGACAGCAG ACTGACCATC 5760 AAAGCGCTGA AAATGGCCTA GGAAATCCGC AGTAAACCAG CCGGGGTAAT GTTCCACAGC 5820 GATAGTAATA ATGCCGGTAT CAGTTTTTAT CATCACTCTG TTTGCTGTTT AACCAGACTG 5880 GTGTGATTAC TGATGCAGTG AAGACCTTCC CGCATCCTGA CTCACACAGC GATCGACCCT 5940 TTGTGTCCTG CCCTGGACCT GTCGGTTGCC GGAAGCGCCT TCATGCGAGG CGTCTCCTCA 6000 CCGATGCGCG TGACTCAAGA AGGGCCTGAC GGTTTGTCTC GTTACTGTCC TGTCCGGGTT 6060 ATCTGTCTGG AGATTCAACT CTGTTTCCTC ACAGGAGCTC TGTTATGGCA GGTAAAGTTA 6120 CGGAAACCGC TGTTGTGGGT GGCGTGGATA CACATAAAGA TCTGCACGTT GCCGCTGTCG 6180 TAGATCAGAA CAATAAAGTT CTGGGGACCC AGTTTTTCTC CACAATACGG CAAGGTTACC 6240 GGCAGATGCT GGCATGGATG ACTTCGTTTG GGGCATTAAA GCGAATTGGT GTTGAGTGTA 6300 CTGGCACCTA TGGATCAGGT CTGCTTCGCT ATTTACAGAA TGCCGGGTTA GACGTTCTTG 6360 AGGTGACTGC GCCAGATCGG ATGGAGCGAC GCAAACGGGG TAAAAGTGAC ACGATTGATG 6420 CTGAATGTGC CGCTCACGCC GCATTCTCCC GAATAAGAAC CGTCACACCC AAAACGCGCA 6480 ATGGCATGAT TGAGTCTCTG CGGGTATTAA AAACTTGCCG AAAAACAGCA ATATCAGCCC 6540 GCAGAGTCGC TCTCCAGATT ATCCATTCCA ATATTATCTC TGCCCCGGAT GAATTACGTG 6600 AACAGCTCAG AAATATGACG CGCATGCAGC TCATCAGGAC TCTGGGATCC TGGCGGCCTG 6660 ATGCCAGTGA ATACCGCAAT G 6681 (2) INFORMATION FOR SEQ ID NO: 66: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1342 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 66: TATTCGCGCA TACGCGTTGC ACATGTTCTT TTGGCGAACG ATCATCGGCA ATACAGAGTT 60 CCCAATGGGG ATAGCTTTGA GCCAGGACAG AATCCAGACA GGCACGCAMG TAGATCTCCG 120 CTGGATTATA AACAGGAATC ACAATAGATA TAACTGGAGG GTGAGTCATA CTGGCAAGCA 180 TCAGACTCAC CWCTTCKTTG CCAGGCAACG AAGGTAATTC CACCGTTTCT ATCCATTCCT 240 CATAACCGAC AGAAGACGGG GTAACGCTGA ACGTYTCGTT ATAGAATGCT TGCAGGCGCT 300 CTATTGACAT ATCGCCATTG TSCATCAATA TGGATTTTWT GATTTTTTCT AGCGGCATGT 360 CACGATAGCT TTGGTGTTCT TTTTGAATGC GAGCCAATAG TGCAGACTCG ACTACTTTCA 420 CATCAACAGC CGCTATTTCA AACTGATTAA TTGCAAATTT TGCTGCCTGT TCTAATGGAT 480 CAAATCGTAA TGCACAAGAG GCGATTCCAG ATAGAACAAC GACTGACGCT GACCGCTCGT 540 TTATATGGCA ACGTTACTGT TTCAAACTCA TTGAACCCTT TACCTGTATC CAAATRTAAC 600 TTAGCTAATC CTTGCTTTGG TTGGGCAATT AATAGAGATA TTAAATTGAT ACCATCCCTT 660 GCTAATATTT GAGAGCTGCT CCAAATCAAT AATGAAAAAT GGATCATTTC CCTCTGCAAC 720 CCAACTTTGT GAATTATCTA TATCTATCGA GAGCTGATTT GTTGCCAGAT AGGGCAGCAC 780 AACTGTATTT TGCATTTTAC TCACTGCAGG AGAAACGTCC CATGCTTCGC ATGGTTTCCT 840 ACCAAGTAAC ATCCCATAAC GCTTAAAATG TTCTCTTGCT GACAACCCGG TCTGTTTCAC 900 ATCCAAATAG TTATGCAGAT ACCAATGTTC ATCAAAGTGA GCTAGCAACT CGTCTTGGTG 960 ATTTTTAACC ATCACTTTTA TTCTCCCTTA TTGACAGGCA GGCAACTGCG CTGCTCAAAC 1020 TTCCCATACA TAATGTAATG AAGCAGCGGA TTAATGCCTC CTTGGGCCAC ATCCGGATAG 1080 GTTTGCAAAT ACCAGCGAGT ATCAAACTGC TCACTAGGGC TATAACCTTT ATCCGCCCCC 1140 ACGCTAATAA AATGCTCAAG AGCTGAGAGC CCAGTGTCTG CAACCTCTGG GTAGCGATGT 1200 TGATACCAGA GTTCATCAAA CAATCCTGAA GCGGCAANTA CTCCGCGGCA CTCTCTGTAG 1260 CTGTTGTTCT GGATGGAGTC TCCTCCTTAA ATGTTCTGCC AAGAGCACGA ACTGGGGCTG 1320 TAATCTTCCA AGAGACGGTT CT 1342 (2) INFORMATION FOR SEQ ID NO: 67: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1580 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 67: CGAAGGAAGC AGTNTGCNGC CTGCGCTGGC GGAGTTGCGC CTGTTCCCAC CGATGATGCT 60 GTACATGAAT CCTCCGGCGA ACAGAGCGGT GAACTGGAAA CCATGCTTGA ACAGGCCGCG 120 GTCAATCAGG AACGGGAATT TGATACCCAG GTGGGGCTGG CGTTAGGGCT GTTTGAGCCG 180 GCGCTGGTGG TGATGATGGC GGGCGTGGTG CTGTTTATCG TCATCGCCAT CCTCGAGCCG 240 ATGCTGCAAC TGAACAATAT GGTTGGAATG TAATTTACGG AGTTATCACA TGAATTCGTT 300 ATCCCGCACA CAAAAACCAC GGGCAGGTTT TACCCTGCTG GAAGTGATGG TGGTGATTGT 360 TATTCTTGGC GTCCTGGCAA GTCTGGTGGT GCCTAACCTG TTGGGCAACA AAGAGAAARC 420 CGATCGGCAA AAAGCCATCA GCGATATCGT GGCGCTGGAG AATGCGCTGG ATATGTACCG 480 ACTGGATAAC GGGCGTTATC CGACCACTGA GCAGGGGCTT GAGGCGCTGA TCCAGCAACC 540 GGCCAATATG GCGGATTCCC GTAACTACCG TACCGGTGGA TACATTAAAC GACTGCCAAA 600 GGATCCGTGG GGCAATGATT ATCAGTATCT CAGCCCGGGT GAAAAAGGGC TGTTTGATGT 660 TTATACCCTG GGGGCAGATG GTCAGGAAAA TGGGGAGGGC GCTGGCGCAG ATATCGGTAA 720 CTGGAATTTG CAGGAGTTTC AGTAATCAGT GCCTGAACGC GGATTCACAC TTCTGGAAAT 780 CATGCTGGTG ATTTTCCTTA TCGGCCTTGC CAGTGCGGGC GTGATACAGA CGTTTGCGAC 840 CGCTTCAGAG CCGCCTGCGA AAAAAGCGGC GCAGGATTTT CTGACTCGCT TTGCGCAGTT 900 TAAGGACAGG GCAGTGATCG AAGGGCAAAC ACTCGGTGTG CTAATCGACC CGCCTGGCTA 960 TCAGTTTATG CAGCGTCGTC ACGGACAGTG GCTACCCGTT TCTGCGACCC GCTTATCGAC 1020 ACAGGTTACG GTGCCAAAAC AGGTGCAGAT GCTGTTACAA CCCGGCAGTG ATATCTGGCA 1080 GAAGGAGTAT GCGCTGGAGC TGCAACGTCG TCGCCTGACG CTGCACGATA TTGAACTGGA 1140 GTTGCAAAAA GAGGCGAAAA AGAAGACGCC ACAGATCCGT TTTTCGCCTT TTGAACCCGC 1200 CACGCCGTTT ACGCTGCGCT TCTACTCAGC GGCGCAAAAC GCATGTTGGG CGGTAAAACT 1260 GGCACACGAT GGCGCGTTAT CCCTCAGTCA ATGTGATGAG AGGATGCCAT GAAGCGTGGA 1320 TTTACCTTGC TGGAAGTGAT GCTCGCGCTG GCGATTTTTG CGCTGGCTGC CACGGCGGTG 1380 TTACAGATTG CCAGCGGCGC GCTGAGTAAT CAGCACGTTC TTGAGGAAAA AACGGTAGCG 1440 GGCTGGGTAG CTGAAAACCA GACCGCACTG CTCTACCTGA TGACCCGCGA ACAACGGGCG 1500 GTCAGGCACC AGGGCGAGAG CGATATGGCA GGAAGCCGCT GGKTCTGGCG AACCACACCA 1560 CTGAATACCG GTAATGCGCT 1580 (2) INFORMATION FOR SEQ ID NO: 68: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 3241 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi ) SEQUENCE DESCRIPTION: SEQ ID NO: 68: CTTAACCATT ACCCAGCATT TGGTAGTTAA ATAGTCGTTA AAAGCATAAA ACATGGACAT 60 TGTGCCATCC CAGCTAAAGC ATCCATTACC GCCTGACAGG GATAAAAATA AAAAAGCAGG 120 GAACCATTTT TTCATCAGAA ATCACTTCCG TAATTACAGT TATTCATTTA GGTATGACTC 180 AGTTATAAAT CATGCTCATA CTGGCCGTGG TCTGGRAATC CCCGCCATTC AGTATCCCGC 240 TGCCATTACG AAAGGGCACT GAAGTAAAGG TGAACGTTGA ACGTGCTGTG TCCAGACCTG 300 CTGTCACTCC GTAACCATTT CCTGAACCAT TACCTAATAT AAGAGGTGTT GACATTCCTT 360 TTCCCTGATA CAGCGCTATA CCAAAATGAG TTATATTTGT TGCCAGTACA TTATTCTGAC 420 CTCCTCCCAT AGTATTTCCC GTAACTTTTA TCCAGAGAGA GCCACTCTTA TACGGACAGG 480 ATATGCTTAT GGTTTTTGTG ACTTCACCAC GTGAGTTGTC CACGTGCTCA GGATTAATAT 540 TCCCAAAATC AACAACAATA TTCTGCCCGT TATTAATGGT GCATGGGGGG ATATAAACAT 600 TCCCCCTGAT GTTAATCTGC ACATCAGCCA GTACAGCGAC CGATGTCAGA AGCAACGATA 660 TAAATAATGA TAAACGAATC ATTCCCCTCC GGAGAGCGGT ACAGAAAACA TTTTATTTTA 720 CGAGATATAA AATTAACGTA TTTTAGTTGA TACTATTACG AATATGATGC AACCAGCGTT 780 GCTGTTGCAG AGAAAGGACC GGCTATCAAA TTCTGCATAT TCCCTTTATA TCCAAGTTTG 840 GCATGAAGTG ATATAGTTTT ATCTGCATTA TTACCTGTGA TTTTTCCGGG CGTAAATGGA 900 GTCCCTAAAG TTATCGCAGT CCCAATATTT CCTGCATTAC TGTTATAAAG ATAAACGAGT 960 AACCCATCAG AAGATGTGTT TGATGTATTC TGAACTAAAA TAGCATTGTT ATAAGTGTTT 1020 GTTGCCGTTA TCGTAACCTT CATTGTTCCC AGATTATAGG GACACCGCAT ATTCACAGTA 1080 AACTCTTTTT CGTGATTTCC ATTTTGACTC AGGGTCTGAA TCTCTACATC CTGCCAGTCA 1140 ACAGTTGTGT TGCTTACAGT ACAGGCAGGA ATAATCAGTT TTCCTCTGAA GGTCAGATTA 1200 TCAACTGCAT GTACATGCTG AGACATTAAC ACTGCCCCCA GCATTACCGG AAGACACAAA 1260 CCTCTTATCT TTTTCATCTG AAATATCCTG TACAAAAATT TTGCTAACGA TATGTCAATT 1320 CAAACGTGGC TGTTGCTTCA TAATCACCGG GTACCACACT CTTCGTCCGC AGGCTTCCGG 1380 CGTTGCCACA ACATACGCGC CGAAAGGAAG CTCAAGACTG TTTCCGGTAA CCTTTTCCCC 1440 CTGGCCTTTG TTATGGGAGG TGCCGGGTTT CAGCAGACTG CTGCCATCGG TGTCCAGCAG 1500 TGCAATGCCT AACCGGCCAG CATTCACTCC GGTTACCTTC AGATGGCCCG GGAGGGCGCC 1560 TCTTCCGTCC CCTTAAAGGT CAGGGTCACA ATTTTGCCAA CTGCTGTTGC ATGGCAGTTT 1620 TCCAGCCTGA TGACAAACGA CTCTGTCGGC GAACGTCCGG GCGGATACCA GAAATCCCTG 1680 GACGCCCGGG TTTTGAAGAC GACATGTTTA TTCAGACTGT CACCGGACAC ATGGCAGGGT 1740 CTGTCAAGCA GATTACCCCT GAATGCCACA TCTGAGGCTA TTGCCTGTCC GGCAGACAGT 1800 GCGGCAAACA GTAAAAGAGC GCCTGTGCTT TTTATCATCA CATTCCCTTA CTCATATTTT 1860 ATGCTCAGAC GCAGCATGGC CGGATTGCTC CTGGCATCAG AATACTCACC CTCCTGTGTC 1920 GCCCTTTTCC TCCAGGCGGC CAGCATCTCC TCCTGCCGCC GGTCAGGCCG GCACAGTAAA 1980 AAGGTATCAC CATCGTGTAT AACAAGATGG TCACAGCCGG ATAGCTTACG GTCAGGAAGT 2040 AAAGCACTTC CGCTTCCGGG ACCGGTTACC AGTGAGCCGG AGACTGTCAT CGCAACGCCC 2100 CGTTTTCCGG GCTGAAGTGC ACCACCGTCC CCACATCCTG CCAGCCTCAG CATCAGAGGT 2160 GCTCCGGCTG CCGCAGAGTG ATTTTCCGGC CGGAGGYTTA ACGGCACCTC ATTACTCACC 2220 AGCGTGCAGG GTGAGGACAG CAGTGCACCA CTGACGGTCA GGCTTCCGGT GCGTCCCCCC 2280 CGTTCATTTA TCCGGTAATG ACGCAACTCA TCTGCAGTAA AGACGTCATC GTATATACCC 2340 CGCTCTTCAG CCCGCAGGAA AGTATGGATG AAACCACTCA GCGACAGTGC AATAAGATAC 2400 AGTACTGCTG TTGTTTTATT CACAACCATA ATATCCCACC CGCATTTAAC CGTTATTGCG 2460 GTACATTATT TCTCTTTTTT CACAGAGCAA CGGCTACCAT TACAGATAAA CGACAGTACC 2520 GGGCGACCAC CATAGTCATT AATATAAGAC AGATAAGGGG TATTATAATT TGCCGATTTT 2580 ACTGTCTGCT CTGAACGGGG AGACAGCATC ACGGTTTCAA ACTCACCTTC CTCTGCCTGC 2640 TTTTCACTTC CTCCCAGACC AATAACAGTG ACATAATAGG GCGTTGGGTT TTCAATACGA 2700 TACCCACCGC TGACTTTGTT CAGAATTAAC TGGTCCTGCC ATACTTCATT TGGTCTGGTT 2760 TTAATTGCTG CCGGGCGATA AAAAAGCTTT ATTTTGGTCT GTAAGGCTAT CTGCAGTACA 2820 TTGGCCTTTT CACTCCTCGG CGGTATTTCC CTGAGATTAA AATAAAACAG TGATTCCCTG 2880 TCCTGAGGAA GTTTACTGAT ATCCGGTGTG GTACTCAGCC TGACCATGCT TTTCGCACCC 2940 GGCTCAAGGC GCTGAACCGG AGGGGTGGCA ATAACCGGCC CTGTAATAAT TTTTTCCTGA 3000 TTTTCATTTT CTATCCATGC CTGAGCAAGA TAGGGCAGTT GTTTGTTATC ATTGGAGATA 3060 TCAAGCGTCA TTGACTTCTC ACTCCCGTCA AACACCGCGC GGGTTCTGTC CAGCGAAACA 3120 GCAGCGTCTG CCCCGGATAT AACAAACAGG GGGATGGCAG CCATCAGAAT CTTTTTTCGA 3180 ATCATACTTA ATTTCCACAT TCTGTAATTT CACCTGGTCC GGAAAATGGC ATAACCGCAT 3240 T 3241 (2) INFORMATION FOR SEQ ID NO: 69: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 398 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 69: AACGTGGATC TCCAGCTGAT CGGTGCCGTA TTCCAGGTCG TAAGTTTCAC TGATGGTTTC 60 ACGCGGCAGT TTGCCCGGTT TACGGACCGG TACAAAGCCA ACGCCCAGAC CCAGAGCTAC 120 CGGAGCGCCA AACAAGAAGC CACGCGCTTC GGTGCCGACA ACTTTGGTAA TGCCCGCATT 180 TTTGTAACGC TCAACCAGCA AGTCGATGCT GAGAGCGTAA TTTTCGGGTC TTCCAGTAAG 240 CTGGTGACAT CGCGGAAAAG AATGCCGGGT TTTGGGTAGT CCTGAATGCT TTTGATGCTA 300 TTTTTGAGAT ACTCAAGCTG CTGTGCATCG CGGGKCATAA GTGTATGCCT GCTTGTTACG 360 GTGGTACTCA CGGCGCGTTT TTAAACGTAT CAAAAGTT 398 (2) INFORMATION FOR SEQ ID NO: 70: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 17710 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 70: CAGTTNCNGT TCTCATAGAC AGATTGATAA AATCGTAAAC AGCCCCTAGC ATTCCCGTTT 60 CCTTTGCACA CATATTCAGG CACGGGGATA AAGTATAAAG AATGTCGTAC TGCTGCTACC 120 AGAGCAATAT TCCCCCCTGA TGGCCGTATC AGAGATAGTA TGCCGGTATT TTGCGGGTGG 180 TTCCCGTCAG GTTATCGTGT ACCTCCACGG TCGTAGTCAC CACCGGCATT CCGGCYTTTC 240 TCAGCCTCAA AACATCAGCT GCAATACGCT GACTGCCGAA CCAGAACAGG CCGTCCAGTG 300 CAGTCACCAG CAACCCCGCC TCCAGCGCAT GCTTCAGCCG TTCACGGGGC GCTTTCACTT 360 CCCGGGCAAT CTGCTGGTAT GGCGATGATG TGTTTTCATT CCCAATCACC CGGCGAATAC 420 GATGAGACAG ATGATACCGG TATGTATCCG GCACACCGGA AAGGCTGGCC TTCAGGCTGT 480 ACACGCAGCC AAATCGTTTA TCATTGAACA CCACATTTTT CTGGCTGATG CCCCATTCTT 540 CACGCAGCGC GGCAATCAGT TGTGGTGTAC GGGTAAGCAA CAAGCGAAAA GGCAGTTCAA 600 AACTGGTGAC ATAATCCACA TTCAACAGGG CAATGCGAAG TCGTTCTTCT GGTCCGGCTT 660 CTGTCTGCCG GCACTCCTCC AGGACATCCT GCCACTGCAG GCGAAGACGG GAAGACTCAT 720 TCAGTTCTGT AAAGCAGTAT TTATCCGCCA GATAGTCAAT TCGTGTATGC ATACTGAAGA 780 GTATTCCGTA TAAAGATTCA GCTGGCAAAA CTTTATCAGT CTGTAAAAAC TAACGGAAGA 840 GTCGATATTT CTCCCGACAA TCACCGGATG ATTGTTGCAA TACCTCGTGG CATCAGAGAC 900 TGAACAGCAG TTTTTAACGC AACGTATTGC TCTGATGTAT CAGGCCGGAC AACCCGAAAA 960 CAGCCTTCCA CCCGGCATTG TCCGCCAGCG CTTATCACCG GCCAGGTCTG TTGCAGTAAA 1020 TCCGCCACTT GCGAACATGC TTCATCAACT GTGACACTGG CCCGCGGATG GCAAATGCTC 1080 GTCTGGCTGA GCAGCAACAG GCATCGCATT GTTGCTCCTC TATGTTGTTC CCGCAACCAG 1140 CGTAATACCA CCGGCGAGGA TGGACAGGCA GTGTGATTAC GCTCCGTAAT ACGTTCGTGC 1200 ACCCGTCGGT GAAAGGAACT ACAGAATGTC TGAATCTGTT GCCCGTTGAT GTATCCTTCT 1260 GTCGAATGAA GTGTGAAGTG GATTGCCAGC AGATGCGGCC AGTGATCCAC CGCCTGCTGA 1320 ACAAAACGCC GGATTTCCCC CGGCTCTGAA AGTAAGGCTT CGGTTATTTG CACTATTTTA 1380 TCTCTGTTGA ATTTGGTTAA GTCGGTGCAG ACGCATCAAC ACAAGTACGG TTCGATGCAA 1440 ACAGCTGTGA CTGGCAATAT GAAAGGAATG ATGAATCAGT CAGGATGACA AAGTGCCGGC 1500 TGACCGGAGG GGACGCAGGA AGATTCACGG GGGGACCAGC ACCAGGGAAC AGCGCCACAA 1560 TACCAGCGCT GACACGTTGA ACATTGCCAG CGTACCGGTA TCACAACACG TTTCATACTT 1620 CTGCCCCCGT GATTCTTCGA TTCGTTACTG TATCTACTGT GACACTTCGC TTTTATACCT 1680 GCGGCTGGAT CGGCCCGGCT TGATGAATCT TCACTGATCA GCTTATAAAA CCCTCTGTCG 1740 GTCATACCGG TGAAACTGGT GATATAGTTC ATGTCAATCA GGGAATTATC GGCACGCAGA 1800 AATACGCTGT CGTGGCTTGT TGTAGTCAAC ATGGTCAGAA TGTCCTCTGT GAGATTTATG 1860 AAGATTGTGC GAATGCGGGG AATCTACTGA GCTGTGCTTT CAGAACTGGC CTGTTACGGG 1920 AKRSCAGGGA TTACCGGCGG GGTAACGGGC TTCCGGATCA TACACACCAC GATTATCGCG 1980 GACAAAATCA CTGAACGCCC AT TCACCTC TTTAAGTATG TCTTCGCAGC CCGGTACATG 2040 ACGATCCAGC GCCACATCCC GAGTGGTACT ACTTTGATGC GCCCGGTGAC ACAAAGCCCG 2100 GATTGTTCCA GACATCCTGA ATCAAACGCC CCAGATTAGG GGCGTCGAAA TATGCCTCTC 2160 TGACCATTAT ATTCCGGTGT ACAGGTAGCA GGTCAGAAGT GACAATGCGT CACCTGACGT 2220 TAAAAGTCAC TACACCCAAG ATGACGTTCA ACAGCACCAT GCGATTCAAT GTAAGCCCGG 2280 GCTGTCTGTT CCAGTACACC AGGCTCAGCG TTGTATGTGT TAGCTGCATC AAATACCAAC 2340 GACAGCACTT CAGGATACAC AACCAGATGT GTAATGGAGT TATCTTCACC CAATACTTTT 2400 CCCCACGCCT GCTCAATCAG ATTTCTGAGA ACCACCACCT CACGACTCTT ACACCAGACA 2460 TCGTTATTAA GTAGCAGCAC CATAAGATAA GGAGTGGTAT CGTTAGTCAC AGCCTCCCTA 2520 CTCCAGAGAT AATATAAAGG GGTGGGCTCA ACAGATTTAT CTTTACGTCG CTTACACTGC 2580 AAATATTCAG AAATGAGTCT ATGCAGTTCA CCAGTAAAAT CCGCCATCAG AGAGGGAATG 2640 GCCTTATTAA TACCAGGGCA AGGTATTAAT TTAAATTGTA ATAATTTAAT TTCAGGATGT 2700 GTGGCTGCAG CCCGATACAG AGTTGCAAGG ACACACTTTT GCCAGAGGGC GTTACTGGAA 2760 AGCTTAACGT TTGATTCTGT ATACATAATA AATCACCTTA CAGTTACAAC AGGTCAAAAA 2820 CCGCTGTAGC CAGAGTTACG CTGGCCTGAT GCTTTAGTAC CGGGCTTCGT CAGATAATCC 2880 AGACGCTCCA ATAAGCGCTG ATACTGCTCA GGGAAATCAG GATCATGAAT ATCCTGGATG 2940 TCACGTCCAT TAGCAGGGAA ATGAATAACG CAGCCCCCTG GATTAACAAT GCAGAAATCG 3000 TCCTGAGGTA CTGATCAATA CGGAGAGGAC TCTCGCGTGT GGTTTATTGA CACCACAGTG 3060 CAGATTCGGC GAATCCGCGA TCACGGTGCG ATTTCGTTCC ACAGCACACA ATCATGACCC 3120 CGGGTTTTAT TCAGGTAAGC AGGATTGCGG ATATCCGGTG TCGCGCCTTT CTGTCACGAA 3180 CGGGGTAGGT GCGAAACACC GGATAAAATG CAGGCTGGCA ATACCTCTGA ACGCCCTGCG 3240 CAGAGCGGAT ATTTTGGATT AAGTACTCGC ACCTCCGCAG TCCTGAAACA AGTCTGGCTG 3300 GTAGCTGTAA ACAGACTTCG TACATGTTGC TCTGGAATAG ATCCCCGTGC CACAGGCTTC 3360 GCAGAACTTT TTCCCGGGAA AATGCTGCCC GCACATCACA CAATGCCACT CCAGCACGAC 3420 CGGTAATGGC GATAGAAACA TCGCCATATC CTCAATGTAA GGGTGGGACT TTTCCGGATT 3480 CAGCACCACG CAGGCCGCCT TCTGTTGCGC GCTCAGGGCA TGTAAATCGT GCTCAAACCA 3540 CGCCCCCTGA GCATCTGTCT GCAAAATCAA CCGACCACGA CAGGAAAGGC AGAAACAATG 3600 CCTGATATTT CTGCTAAGGC TGAGGCCGCA CTGATAATGT GTTCACCCGG CGTGATCCCC 3660 AGCCCCGTTT TTATACCGTT CATTCAGCCA CTCCCTCCTC ACTGAAGTGC CCTGTATGGC 3720 AGTGAGTGCA GTACCGCTCC CCATAATAAT CGTGGTGACA TTGTCTGCAG TGCCAGCTGG 3780 CTTTACGCAC CACGGGTAAG GCATCCGGTA CGAATTTCTG CAGACGCTTA ATCAGTTGTA 3840 TTTCTCTGCG CTCCGGTCTG ACATAAGGGC ACTGTTGACC GTGCTCCGTC AGCCCGTCGT 3900 CAGTGTGTTC AAACCAGGGA AGTTCAGTGT CGTATTGCGG ATGGTATCTG AGCGCACTGC 3960 CGCAAAGGTG GCAGGTGTAG CGGTCGTAAG GTGCAGTCTG TGCGGTACGG GCAGCGGTCA 4020 GACGTCCGTT GCCATCAAAT GCGAGAAAAG ATTTTGCGTA CATAGTATAT GTTCCTTACC 4080 GCCAGACGAC ACGCAGGCGT CAGCGTCCCT TTACGGGCAG CGTGGGCAGG GTGTGAATGG 4140 CGGTACAGTT AAGGGGGGGG TGGAAAATGG GCGGGCTGTT GTTACAGCAC TGTGGATGTC 4200 ACATCATGGC GTACCAACGT AAAAAATAAT CAGCAGGCCC GGATACATCG TTGTCGCCGG 4260 ACATCAGCCC GTCCTGCTGG TTTTGCCGGG CTCAGCCCCG ACTGCAGCCG AAATTACGCT 4320 CACCAGTGGC GTGAGCTTTG GTATGTTCCT TCGCCAGATA GTCAGCACGT TCCAGCACCT 4380 GCTGAAAGCC AGTGTCATCA CCGCGTTCCA GCCACACCGC CGGCGTGTCA GGAAAATGCG 4440 CCAACGTGGC ATAAGGCCCG GCATCCACCC CCAGGGCACT GCACCAGGCN TGWTTAATCA 4500 TCCCGGCCAG TGACCCCGGA TCGCGGTAAT CGCCGGCACG ACACCAGGTA TCCCGGTTGA 4560 CCAGCAGCAG GAGGTGATAG TGTTTTTTGC CCCTGAGTAC CCCGAACTCC CGGGCCCAGG 4620 CGTAATGCAG GGTGGTGGGA TGCACGCGTT TACCTTCACG NCGTTACGCT TCTGGTAAGC 4680 GTCGATTCGG GCTTTCAGGG CATTGATGAA GCGGGATATC ACAGCCGCGT CCGTAGCTGC 4740 CGGTACATCC GGGAGACGCA GATCAACCCG AAGTGCCGTC AGGCGGGGAT GAACATTCAG 4800 TGCGTGCCGC ACCGTCTCAC GAATACGTTG CTGCCAGAAG GGGTTGTATT TGTAGGTCAT 4860 GGTTAAATCT CCGTATGGTT CATACGGAAT AGCCACGTCG TAAAAAATGC GCAGAGCCCC 4920 TGACGTGGCC ACCGACAGAA CACGGCCTCA GGCGCGTTGT GATAACCCAG CTATCGTTTC 4980 CGGACTGACG GTTGAATTTC CTGCGTTGTT TTCTTAATGT AAAAAACCTG CTACGGGTAA 5040 GGCTGTGAGG AGGAAGTGAT GGTGATACGC AAAAAGAAGT GCAGGGACTG CGGAGAAGCG 5100 ACAGAGCATA ACACGGTATG TTGCCCACAC TGCGGTTCTG TCGATCCCTT CGGCTATTAC 5160 CGCAATACAG ACAGAATATT CACCCTCCTG ATGGTCCTGC TGGTTGTGGT TCTGCTGATG 5220 ACGGCTGCGG TCAGCGTGTA TGTGCTGTGG TAGTCGGAGG GGCAGGGAGC AGACGATGAC 5280 GTAAAATATC TCCGGTGCTC AGATATCACG GCCGGTCAGA CCGCAAACCA ACGGTTAATC 5340 GTAACCGGAT CAGGCAAATG TGTGATTAGC CCCCTGGCGC TCATACCCGC ACCGCAGACC 5400 ACCTTAAGTA CTTCCCGCCC GACACCATTC CCTGCTCCCG GATAATTTGT TGTCGCTATA 5460 CCGCTTAACA TCACCGATAC CACACCGGCG CAGATAGCAC CGGATTCATT GTAGAGATGA 5520 CTTAAGGTTC AGGTAACATA TTTCCAGACA GAAGCGGGAA CACGATCGTA AAGTTTGTTC 5580 ATGGTCAGTT CTGCCAGCCG GTGATCAACC GCAGAGTTGA AATTTTCCAG CTCCGCCGGG 5640 GTGAGTTTAT ACCGTGCGTG GGAAATCACT TTTTCCAGTG TCTCCCGGGA TGAACAACGA 5700 CGGAACTGAT ACAGCCAGTC TTCTTTGGTT TTTACTTCCA TTCGTCTCTC GTTACTTTAT 5760 GCTGCGGTTA ACAGGATGCC GTCAGTATAC CGCATGCAGA CACTCTCCCG CTCCCCCGCT 5820 TGCTGCGATA CAACTTAACG TTTCAGGAAT CCAGTCATCG CACCGGGAAA GGCTTTCTGG 5880 TGACAGGAAA CGTCAGGAAC AGGAGTTTCT CAGACTCCCA CTCATCGGAT CAGGCTCAGA 5940 CAGGATTATT AATACGCTCA GTTCATGTGT CATATACAGG GCATCGGGGA TGAATATATG 6000 GGTATAACTC AGAGCCTGTA CTACAGCTTT CACTGCTGAC TGATTTTACG TATCAGCGTT 6060 CATGTATCTG CACTCTGATA TAGAATACTT CTACCGGAGC TACTCTTACG TTAGCTCACT 6120 CTCACATCAG GCAACATCAC TTATTCAGCT CACTTACCTC TTACCACTCA CTACTTCTTT 6180 ATATTTATAA TATCAATCAG ACAGCCTTAT CCCCCCGGTA ATATCTGTTG CCTTCCCGCC 6240 AGCCACAGGC TTATTCACCA CAACCACCTC CGATAACAAC TCTGCAATTA TCAGAACGCC 6300 TGCTTCTCTC CCTGTCCTCA CGAAAACTAT CCCCTCTTTA TCGCGCGTGC GTGCGGAAGC 6360 ATCTTTTCGC AACAACCACC CGGGATTCCG CTACGGCTCT GCCATCGCAA TCCCCCCGTT 6420 TATCTCCGGA CAGCCACATT CCCGATTATT TTTTACGTTT CTCCCCGGTT GTTATGCCGG 6480 TGAAGGTGGT GCGTCGTTTT CATCACCACA CCGGTTGCGA TTAACAACAT CCGGAGGAAC 6540 ATTCTCATGA CCACACCCTT TTCACTGATG GATGACCAGA TGGTCGACAT GGCGTTTATC 6600 ACTCAACTGA CCGGCCTGAG CGATAAGTGG TTTTACAAAC TCATCCAGGA CGGAGCCTTT 6660 CCGGCCCCCA TCAAACTGGG CCGCAGCTCC CGCTGGCTGA AAAGTGAAGT GGAAGCCTGG 6720 CTGCAGGCGC GTATTACACA GTCCCGTCCG TAATTTCTGC CCCTTATCCG TTCACCCGCA 6780 GCAGACGCCT CCCCGGCCTG CCGTTGACAT TCTGCTGCCT GTTTTATCCC CGTGAGGAAT 6840 ATGAAAATGA AACAACAGTA CCAGACCCGC TACGAATGGC TCCACGAAAG CTACCAGAAA 6900 TGGCTGACCG GCTTCAMCCG GCACGCCGTA TCCTGGGGCG TGTGTCATCC GAATATCTAC 6960 TATTTCCATA ATCTGACGCC CGGGTGGGTG TCATTCAACG GCGAACAGTC GGAGATTGCC 7020 ATTGTTCCCG GCAGTCTGCA CCGGCTGATT TATGGTCATG ACAAACGGGC CATGCCGCCC 7080 CTGGATGATG ATCTGGTGGT GAATTTATGC ACCAGTGAGA ATCTGCTGGT TCATCATCCG 7140 ATGCTGGAAG GCATTCTGCT GTCTGAGTGC ACGCGCCTGC ATAAAAAATC ACTGGCGAAC 7200 AAACTGATCA GTATATTCCG TCAGTTTGAC GGCACGGAGC TGCGTCTCAA ACTGGTCTGG 7260 CTTTGCTGGT TTGATTTAAT GACCGGAAAC TGCCTTGACG ACTGGACGGA GAACCTGNAA 7320 CGGAAATCAG AAAAAGAGCT GGAGAAATGG ATCATTGAGC GCCAGAACCG GAACGCACCG 7380 CTGACGAATC TGATGGATCA GTACGTGCTC CTGGCATTCC GCACAACGGT TGACGATAGC 7440 CGCAACTGAT GTCTGCATGC TGCCSGCTGA AGCCATATTC ACGGGGCAGG GACGCCCCTG 7500 CTTCCGCAAC AATCCGGGGT AATGGCGACG TACGCCTGCA GAGTGTGTTC ATCGTTGTCA 7560 CAGCCGGACA AGGTGAATAC CGTTGATGAT GCGGGGATGA ACCTGCTGGT CCACCGCGCT 7620 GTCACTCAGA CGCGTCAGCG TGTATGGACG CCCCGATCGA ATGGTTCTTC CGCCAGAGTG 7680 CACAGAAATG AGGCACGGAA CGTTACCTGA AGGGTGACCG GCACGGACTG CAACTTGTTG 7740 CCATTGATGG CGCACAAGTC ACATACAGCA GAATGTCGTG ACCGCACCTT ACCGGTGAAG 7800 CGAAACGGTG CTGCCCCACT CCACCACCAT CCCGGATAAC GCCATTACGC TGTCTGATAA 7860 GCGCTTTTAC AGCGCAAATC TGGTGCAGAA AAGCGTAAAG CTGACCTGCC GGAGCAGGAT 7920 GTGGGCATGT TGCGGGCTTA CAACCTGATA CGGCATGAGG CACTAAAAGC AGCATCAGAA 7980 ATCAGCCTGA GTTCGCGTTC CGGTTTATCC CGACAGAGAG GACAGTGCCG GGCAACACGG 8040 TGTCACCGGG GAGCATCCCG AAACGACCGG AGCATCTGCG GGATGCTCTG TAAGTGGTGT 8100 TAAGGTGGGC GGTTAAGGTA TCAAAAAAAT CGTTATCCTG TGAAAGACAG TGCGCTCTGC 8160 TGAAGTGAAC GTCACTGCCG GGAAGCATCG GGTTTCGCTA CCGGACAGTC GCGGTAACGC 8220 GTTTACCGGC ATCTGTCTGT GTGGCAGGGA TGGCTGATAT TGTCGGTTAT ACCAGCGGCA 8280 GGTGCGTCCT GTTATCTGTA AAATCAGGGC GTGCCGGTAC ACAACGCCTC GTTGATGCCG 8340 GTCACTGAAC GAATCATCCT CTGACGAAAA CAACCGTCGA TACAACGCCG GCGTAAAAAG 8400 AAAACCGGAA ACCATCTTGT GCACGACAGG TACTCAGGGG GGTATAACGC CTGCGCACCA 8460 TCACATCCGG GAACAGGGCT GCTCCTCAGT GTCTTCGTGT GGCGAAGCAT CTGCAACCGG 8520 ACGGTACTGC CCTCAGAGCA ATCTCCCTGC TGCAGTGCAC AGAGTAAGCC GGAAAGCTGG 8580 TGAATGCCGC CATGACACAC TGCGACGTGG AGAAACAAAC GACACACTCC GTCCGCAGTA 8640 ACACTGAAGG TAGTCCCGCA AACCTCAGAC TTCTTCCTGC ACGTTATCAG CGGACTGAAC 8700 CCCGGTCAGC CACTTAAACC TGCTAATCGT GTTGCTGCAT ACCCGCCCGG CCGGAAGGTG 8760 TTATGAAGCC CGCCACCGGA GCGCTTCTGC AAATATCCGG GGAGATAAAA TTTTCGTGAC 8820 AGGATGACGG TCGTGCTGCA GACGTAAAGC CGCAGGAGCG GACACGACAG ACAGTGTTCA 8880 CTGTGGCGTC CTTTGCCGTC GGTATCGTGC TCACGCTGAG GTCCCGGGGG TACACCTGAC 8940 GACAAATACC TGCGATTCCC GGGACGGTCT GTTCTCCGTA AAATAAAGAA AATGCGGGAT 9000 GCCTCCCGGA CTGCAGAGAA GAGGGATTGA CAGACAGTGT ATATTGCGTA CGATTACAGG 9060 GGAAAAACAC AGTAAATATG GAGGTCAGGT CCGAAAACAA CCTACGAAAT TTCTATGAAA 9120 AACGATTGAA AAAATCATCA AATTCAGTTC GTTTTTCTAT GGTAATTTTT AAACACTCCC 9180 GATGATAACC TGTTGTATGT GCATGTGGGG AACGCACCGA AAACATCAGA ATCATCTGAA 9240 AAAAACAACG AACACACCAG AAAAACAGGA GCAACCATAA CGAAGCAACA TATTGATTTT 9300 AAACAGAATT TAAGGTTAAC AGACAAAAAA CACTTTCAAC TGAAGGAGAA ATATACACTG 9360 GCGACAGTGC AGGGTTTTTC ATGCAAAAAA AATGAGCTTT TATCTCCGGC GCATACTGAC 9420 CGGGATGCAG CCATGACAGA GCAAAAACCA TTAAATATCA GGAGGTTAAA CACACAAAAA 9480 GCTGACATGC ATCAGGGAGC AATCCCTCAC AACAGAGGCT GAGCGGCAAC GCTTCCTCAC 9540 AGGACGGCAT TCCTGAAAGG ACAGGCAGCC ACGGCTTTTT ACTGCCCGTA TCCGGTATAT 9600 TTATCTGCCG TGACGTGCAG AGGATTTTGT GTTTCCGGAA ATCAGGAAAA CAGGAGAACC 9660 GCGGGAGATA TGATGGAAAA AGAACCGGAT GATATCTGCG CAGACTGTCC GAATATTGAT 9720 GCAATAAAAC GGCACAAACA ACAGGCCGGA GCCATCAGGG AATACACTGA GTGGTTAAAA 9780 AAACAACCGC GTGCTTCTTA CTTTTTTCTC TTCCGGTTGT ACGCATACCT TCAGAATGAA 9840 GTGATATCCC GAAAACAAAA ACATTCGCTC ACCAGCGATA ACAGCCATCC CCCGGAATCT 9900 GATGTCACCC CTCCGGATTT AACCCTTCCC CGTCGCTACT ACTGTGATTA CGGTTACACG 9960 CCCTACCCCA TGATGGGCGG ACAGATGTCT GTTTTTGCCA CAACGTCAGA AACCACCAGT 10020 TCGACGAATG CAGTCCCCGG AAACGCAGTT ACCGGGAATG AGACTGAAAA GCATGAAAAC 10080 GCGGTACCGG CGACATTCCC CGTCAGCCGT TCTGCAATGC CCCCGGAACC TCTGCGGTTT 10140 GCCACGGGTT TTCCATCGCA ACCACTGCTT GCCGGTCCCC GGGAAAAGCC GATGCGCACC 10200 GTGCATCCTG ACATCCACAG CGAAATTATA TGGTTCTGCT CCACTTACCT GCTGAAATCC 10260 GGACCACAGA TTACGAAGAC GATTATCAAC TCAGTATTCT CTGAATGGGC CCGCATCAGC 10320 AATGATTACC CCTCCCCCTT TTCGTGGGTG GACAGCAGGG ACAGTGAACA GTGTGACTGG 10380 TTATGGAACG CCATGCAGCT CCGGTGTGTG GGAACCCCGC TGAATCCCCT TACCCCGGAG 10440 CAGAAATACT GGTTTGCCTG CGCCACGTTT GATAACTGGG AGGGCTGGAA TGAGCAACAG 10500 ATACAGTTTT TACTGAAAAG TAATCCCAGA CGAAACAGAG CGAAGTTTAC GGTCACCTTC 10560 GGCCCTCCCT GGATTCAGCA TAAAGCCATT CTTCTTGATG AGCTGAAGAG TGCCCGGGAG 10620 CAACAAAAAA GGCGCGATGA ACGCGCTGAT GGTTCCGTCC CGCTGAAACT GTCCGGAAAA 10680 ATCCACAAAC ACCTTGAAAG TATTGCCCGG AGTCGTGGTA TCCCCCCAAA AAAACTGCTG 10740 AATGAAATGA TTGAGCAGGC GTACCAGGAC TCAGTGGTGA ACAGCCGGAA TAAACCACTG 10800 ATTTAAAATA ATTTCAGACA GATATTATCT CCGTGAATCC CCCGCCACCT TTCCGGTGCG 10860 CGGGGTTTTG TCTTTTTTCA CCGGGAATAC ATGTATGAAT CCGTCTGATG CCATTGAGGC 10920 AATTGAAAAA CCGCTCTCCT CCCTGCCTTA CTCGCTTTCC CGTCACATCC TGGAACATCT 10980 GCGCAAACTC ACCCGTCACG AACCCGTGAT TGGCATTATG GGTAAAAGCG GGGCCGGTAA 11040 ATCCTCACTC TGTAATGCAC TGTTTCAGGG GGAGGTCACC CCGGTCAGTG ATGTTCACGC 11100 CGGCACCCGG GAAGTGCGGC GCTTCCGTCT GAGTGGCCAT GGTCACAACA TGGTTATCAC 11160 TGACCTGCCC GGGGTGGGCG AGAGCNGGGA CAGGGATGCA GAGTATGAAG CCCTGTACCG 11220 TGACATTCTG CCTGAACTGG ACCTGGTACT GTGGCTGATT AAAGCCGATG ACCGTGCCCT 11280 GTCTGTGGAT GAGTATTTCT GGCGACACAT CCTGCAACGC GGACATCAGC AGGTGCTGTT 11340 TGTGGTGACG CAGGCCGACA AAACGGAGCC CTGCCATGAA TGGGATATGG CCGGCATTCA 11400 GCCCTCTCCC GCACAGGCAC AGAACATTCG CGAAAAAACG GAGGCGGTAT TCCGTCTGTT 11460 CCGGCCTGTA CATCCGGTTG TGGCCGTATC GGCCCGCACC GGCTGGGAAC TGGATACGCT 11520 GGTCAGTGCA CTCATGACAG CGCTTCCCGA CCATGCCGCC AGTCCCCTGA TGACCCGACT 11580 GCAGGACGAG CTGCGCACGG AGTCTGTCCG CGCTCAGGCC CGTGAACAGT TTACCGGTGC 11640 GGTGGACCGG ATATTTGACA CAGCGGAGAG CGTCTGTGTT GCCTCTGTTG TCCGTACGGC 11700 CCTGCGCGCT GTTCGTGACA CCGTGGTCTC TGTTGCCCGC GCGGTATGGA ACTGGATCTT 11760 CTTCTGAACC TGTTGTGGAT GATGTCCTCC CTGCCTCTGA GTCTGCTCAC AAAAGCGCTG 11820 TTTTCGTTAC TGTCTCTCTT GTCCGTGCAA TAGCTCAATA ATAGAATAAA GCGATCGATA 11880 ACTATTTCAT CGATCGTTTA TATCGATCGA TATGCTAATA ATAACCTTTA TTACCAACAT 11940 GCGCAGATAC GCACAGACAG ACATTCAGGG GACGACAGAA CAACACTTCA GAAACTCCCG 12000 TCAGCCGGAC CTCCGGCACT GTAACCCTTT ACCTGCCGGT ATCCACATCT GTGGATACCG 12060 GCTTTTTTAT TCACCCTCAC TCTGATTAAG GAAATGCTGA TGAAACGACA TCTGAATACC 12120 TGCTACAGGC TGGTATGGAA TCACATTACG GGCGCTTTCG TGGTTGCCTC CGAACTGGCC 12180 CGCGCACGGG GTAAACGTGG CGGTGTGGCG GTTGCACTGT CTCTTGCCGC GGTCACGTCA 12240 CTCCCGGTGC TGGCTGCTGA CATCGTTGTG CACCCGGGTG AAACAGTGAA TGGCGGAACA 12300 CTGGTAAACC ATGACAACCA GTTTGTATCC GGAACAGCTG ATGGCGTGAC TGTCAGTACC 12360 GGGCTTGAGC TGGGGCCGGA CAGTGACGAA AACACCGGCG GGCAATGGAT AAAAGCGGGT 12420 GGCACAGGCA GAAACACCAC TGTCACCGCA AATGGTCGTC AGATTGTGCA GGCAGGAGGA 12480 ACTGCCAGTG ATACGGTTAT TCGTGATGGC GGAGGGCAGA GCCTTAACGG ACTGGCGGTG 12540 AACACCACGC TGGATAACAG AGGTGAGCAG TGGGTACACG GGGGAGGGAA AGCAGACGGT 12600 ACAATTATTA ACCAGGATGG TTACCAGACC ATAAAACATG GCGGACTGGC AACCGGAACC 12660 ATCGTCAACA CCGGTGCAGA AGGTGGTCCG GAGTCTGAAA ATGTGTCCAG CGGTCAGATG 12720 GTCGGAGGGA CGGCTGAATC CACCACCATC AACAAAAATG GCCGGCAGGT TATCTGGTCT 12780 TCGGGGATGG CACGGGACAC CCTCATTTGC GCTGGTGGTG ACCAGACGGT ACACGGAGAG 12840 GCACATAACA CCCGACTGGA GGGAGGTAAC CAGTATGTAC ACAACGGTGG CACGGCAACA 12900 GAGACGCTGA TAAACCGTGA TGGCTGGCAG GTGATTAAGG AAGGAGGAAC TGCCGCGCAT 12960 ACCACCATCA ACCAGAAAGG AAAGCTGCAG GTGAATGCCG GCGGTAAAGC GTCTGATGTC 13020 ACCCAGAACA CGGGCGGAGC ACTGGTTACC AGCACTGCTG CAACCGTCAC CGGCACAAAC 13080 CGCCTGGGAG CATTCTCTGT TGTGGAGGGT AAAGCTGATA ATGTCGTACT GGAAAATGGC 13140 GGCCGTCTGG ATGTGCTGAC CGGACACACA GCCACCAGAA CCCGTGTGGA TGATGGCGGA 13200 ACGCTGGATG TCCGCAACGG TGGCACCGCC ACCACCGTAT CCATGGGGGA TGGCGGTATA 13260 CTGCTGGCCG ATTCCGGTGC CGCTGTCAGT GGTACCCGGA GCGACGGAAC GGCATTCCGT 13320 ATCGGGGGCG GTCAGGCGGA TGCCCTGATG CTGGGAAAAG GCAGTTCATT CACGCTGAAC 13380 GCCGGTGATA CGGCCACGGA TACCACGGTA AATGGCGGAC TGTTCACCGC CAGAGGGGGC 13440 ACGCTGGCGG GCACCACCAC ACTGAATAAC GGTGCCACGC TTACCCTTTC CGGGAAAACG 13500 GTGAATAACG ATACCCTGAC CATCCGTGAA GGTGATGCAC TCCTGCAGGG AGGCGCTCTT 13560 ACCGGTAACG GCAGGGTGGA AAAATCAGGA AGTGGCACAC TCACTGTCAG CAACACCACA 13620 CTCACCCAGA AAACCGTCAA CCTGAATGAA GGCACGCTGA CGCTGAACGA CAGTACCGTC 13680 ACCACGGATA TCATCGCTCA TCGCGGCACG GCCCTGAAGC TGACCGGCAG CACCGTGCTG 13740 AACGGTGCCA TTGACCCCAC GAATGTCACC CTCGCCTCCG GTGCCATCTG GAATATCCCC 13800 GATAACGCCC CGGTTCAGTC AGTAGTGGAT GACCTCAGCC ATGCCGGACA GATTCATTTC 13860 ACCTCCGCCC GCACAGGGAA GTTCGTACCG GCAACTCTGC AGGTGAAAAA CCTGAACGGA 13920 CAGAATGGCA CCATCAGCCT GCGTGTACGC CCGGATATGG CGCAGAACAA TGCTGACAGA 13980 CTGGTCATTG ACGGTGGCAG GGCAACCGGA AAAACCATCC TGAATCTGGT GAACGCCGGC 14040 AACAGTGCGT CGGGGCTGGC GACCACCGGT AAGGGGATTC AGGTGGTTGA AGCCATTAAC 14100 GGTGCCACCA CGGAGGAAGG GGCCTTTGTC CAGGGGAATA TGCTGCAGGC CGGGGCCTTT 14160 AACTACACCC TCAACCGGGA CAGTGATGAG AGCTGGTATC TGCGCAGTGA AGAACGTTAT 14220 CGTGCTGAAG TCCCCCTGTA TGCCTCCATG CTGACACAGG CAATGGACTA TGACCGGATT 14280 CTGGCAGGCT CCCGCAGCCA TCAGACCGGT GTAAGCGGTG AAAATAACAG CGTCCGTCTC 14340 AGCATTCAGG GCGGTCATCT CGGGCACGAT AACAACGGTG GTATTGCCCG TGGGGCCACG 14400 CCGGAAAGCA GCGGCAGCTA TGGCTTCGTC CGTCTGGAGG GTGACCTGCT CAGAACAGAG 14460 GTTGCCGGTA TGTCTGTGAC CGCGGGGGTA TATGGTGCTG CTGGCCATTC TTCCGTTGAT 14520 GTTAAGGATT ATGACGGTTC CCGCGCCGGC ACGGTCCGGG ATGATGCCGG CAGCCTGGGC 14580 GGATACCTGA ATCTGGTACA CACCTCCTCC GGCCTGTGGG CTGACATTGT GGCACAGGGA 14640 ACCCGCCACA GTATGAAAGC GTCATCGGAC AATAACGACT TCCGCGCACG GGGCCGGGGC 14700 TGGCTGGGCT CACTGGAAAC CGGTCTGCCC TTCAGTATCA CTGACAATCT GATGCTGGAG 14760 CCACGACTGC AGTACACCTG GCAGGGGCTC TCCCTGGATG ACGGTAAGGA CAACGCCGGT 14820 TATGTGAAGT TCGGGCATGG CAGTGCACAA CATGTGCGTG CCGGTTTCCG TCTGGGCAGC 14880 CACAACGATA TGACCTTTGG TGAAGGCACC TCATCCCGTG ACACCCTGCG TGACAGTGCA 14940 AAACACAGTG TGCGTGAACT GCCGGTGAAC GGGTGGGTAC AGCCTTCTGT TATCCGCACC 15000 TTCAGCTCCC GGGGAGACAT GAGCATGGGT ACAGCCGCAG CCGGCAGTAA CATGACGTTC 15060 TCACCGTCCC GGAATGGCAC GTCACTGGAG CTGCAGGCCG GACTGGAAGC CCGTGTCCGG 15120 GAAAATATCA CCCTGGGCGT TCAGGCCGGT TATGCCCACA GCGTCAGCGG CAGCAGCGCT 15180 GAAGGTTATA ACGGCCAAGC CACACTGAAT GTGACCTTCT GATAATTCGG CATTGTCTCT 15240 CTGTGGTCCC GGTCATCATG ACCGGGACCC GGACAGGTGC AAACGCTTCA GTGCCACATT 15300 CACTGGCATT CACAATAACA TGATATTCAT CACGGAGTGA CTATGTTACA GATAGTCGGT 15360 GCGCTGATTC TGCTGATCGC AGGATTTGCC ATTCTTCGCC TTTTGTTCAG AGCATTAACC 15420 AGCACAGCGT CTGCGCTGGC AGGGTTCATA TTGCTGTGTC TGTTCGGCCC GGCTTTACTG 15480 GCTGGCTATA TCACTGAACG CATAACCCGG TTATTCCATA TTCGCTGGCT GGCAGGCGTA 15540 TTTCTGACGA TTGCCGGAAT GGTCATCAGC TTCATGTGGG GACTTGATGG TAAACATATC 15600 GCACTGGAGG CTCATACCTT TGACTCTGTA AAATTTATTC TGACCACCGC TCTCGCCGCT 15660 GGTCTGCTGG CTCTTCCCGT GCAGATAAGA ACCATTCAGC AGAACGGGCT CACACCAGAA 15720 GATATCAGCA AGGAAATTAA CGGGTATTAC TGCTGTTTTT ATACTGCTTT TTTCCTTATG 15780 GCGTGTTCTG CATACGCACC ATTGATCGCA TTGCAGTTCG ATATTTCACC CTCACTGATG 15840 TGGTGGGGCG GGTTGTTGTA CTGGCTGGCT GCATTAGTGA CGCTGCTATG GGCGGCCAGC 15900 CAGATCCAGG CGCTGAAAAA ACTGACCAGT GCCATCAGCC AGACACTGGA AGAACAACCG 15960 GTGCTCAACA GTAAATCGTG GCTGACCAGT TTGCAAAACG ATTACAGCCT TCCTGACTCA 16020 CTGACGGAGC GCATCTGGCT CACGCTCATT TCACAACGGA TTTCCCGGGG AGAACTGAGG 16080 GAATTTGAAC TGGCAGACGG AAACTGGCTA CTGGACAATG CCTGGTATGA AAGAAACATG 16140 GCGGGTTTCA ACGAAAAGCT GAGAGAGAGC CTGTCATTTA CCCCTGATGA ACTGAAAACC 16200 CTCTTCCGGA ACCGCCTGAA TTTATCACCG GAAGCGAATG ACGATTTTCT CGATCGTTGC 16260 CTGGACGGCG GTGACTGGTA CCCCTTTTCA GAAGGCCGCC GTTTTGTATC ATTCCACCAC 16320 GTGGATGAGC TTCGTATCTG TGCCTCCTGC GGGCTGACAG AAGTACATCA TGCCCCGGAA 16380 AATCATAAGC CGGATCCGGA ATGGTACTGC TCCTCTCTTT GTCGCGAAAC AGAAACACTG 16440 TGTCAGGACA TTTATGAACG TTCTTACACC GGTTTTATTT CCGATGCAAC GGCGAATGGT 16500 CTGATTCTCA TGAAACTGCC GGAAACCTGG AGTACAAATG AGAAAATGTT TGCTTCCGGA 16560 GGGCAGGGAC ATGGGTTTGC CGCTGAACGG GGAAACCATA TTGTCGACAG AGTCCGTCTG 16620 AAAAACGCAC GGATCCTCGG TGATAATAAT GCCAAAAATG GAGCAGACAG ACTGGTCAGC 16680 GGAACAGAAA TCCAGACGAA ATATTGTTCA ACTGCAGCCC GTAGCGTCGG TGCGGCATTC 16740 GACGGACAGA ACGGACAGTA TCGTTACATG GGAAATCATG GTCCCATGCA ACTGGAAGTC 16800 CCCGTGATCA GTATGCCGGC GCTGTGGAAA CCATGAAGAA TAAGATCCGC GAAGGTAAAG 16860 TACCCGGTGT AACCGATCCC GAAGAAGCGT CCCGGCTGAT TCGTCGGGGA CATCTGACTT 16920 ATACCCAGGC CCGTAATATC ACCCGGTTCG GGACCATCGA ATCGGTCACT TATGATATTG 16980 CCGAGGGGTC GGTTGTCAGT CTGGCGGCCG GAGGGATCAG TTTTGCCCTG ACGGCATCGG 17040 TCTTCTGGCT CAGCACCGGC GATCGCGATG CTGCCCTGCA GACAGCTGCT GTCCAGGCAG 17100 GAAAAACCTT CACCCGCACA CTGGCTGTCT ACGTCACAAC CCAGCAACTT CACCGGCTCA 17160 GTGTTGTTCA GGGTATGCTG AAGCATATTG ATTTTTCGAC GGCCAGCCCG ACTGTCCGGC 17220 AGGCGCTTCA GAAGGGGACC GGTGCAGGAA ATATCAGTGC CCTGAACAAA GTGATGAAGG 17280 GGTCGCTGGT GACATCTCTG GCACTGGTAG CTGTCACAAC CGGCCCTGAC ATGATCAAAA 17340 TGTTGCGGGG ACGGATCTCC GGTGCGCAGT TCATCAGGAA TCTTGCCGTG GCATCTTCCT 17400 GTGTGGCAGG TGGTGCTGTC GGGTCAGTGG CGGGCGGGAT ATTGTTCAGT CCACTGGGAC 17460 CATTTGGTGC ACTGACAGGG CGTGTGGTTG GCGGTGTTCT GGGGGGAATG ATTGCCTCCG 17520 CTGTATCAGG AAAAATTGCC GGAGCGCTGG TTGAAGAAGA TCGCGTCAAA ATTCTGGCAA 17580 TGATTCAGGA GCAGGTGACA TGGCTTGCCG GCAGTTTCCT GCTGACCGGA CATGAGATTG 17640 AAAATCTGAA CGCGAATCTG GCCCGTGTTA TCGATCAGAA TGCTNCTGGA GATCATTTTC 17700 GCCGCCGGTA 17710 (2) INFORMATION FOR SEQ ID NO: 71: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1803 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 71: AATAACCAAT AGATGCTTAA GTTTACGATA TGCCTCAACC CGCGTCTGCT CTAAGCTGAT 60 AAGGCCAGTT TTGTAGAGAT CCGCTGCCAA GGTTGCCTGC GTTTGCACAT CCATGTAACC 120 GGCGGTGATT TCATTCATGG CATCGTTATC TTGACCAGTC AGCTTAGCAC GCTCCTGTTC 180 AAGCTGCTTG GTTAGGGCGT CAACTCGGCT CTGTAATGAG ACTACGGCCG GTGCGGTTTC 240 CTTCATATAG CTGCGCAGTT GTTTTAGCTC CGCCTGTTGA CGCACCAGCT CTCCTTCAAT 300 CTGGCTGACC ACTCCCAAGC GTGCGCTGCT GGTAGATTCA GGGCTGAGAA GTTGGTGGCT 360 ATTCTGAAAT GCTAATACTT TAGCTTTTTC ATCCTGTAAG CGTTGATATG CTCTATTTAC 420 TTCTTTTTCA ACAAAGGCCA ATTGTTCGAG CGCAACCTGA TGACCTAATT TGTTAATAAA 480 ACGCTCCGAT TCTTTGAGCA TTAACTCAAC AACTCGCTGA CCGTATTGGG GATCAAATGT 540 CTGCAACTCA ACGGTAAGTA CTCCTGATAA TTCATCAAGG TGTAACGTCA AATGTTTGCG 600 GTAATAATCA AGAAAATCTT CCCTACTGAC TCCCTTATGC AACCGCGAGA AATAATCTGC 660 ACTATCACTC TGGAAATGTG CTTTAAGTGC AAGTTCTTTG TCCAACTTGG CCAGCATATC 720 CCATGACTTC ATATAATCCT GAACGAGTAA TATATCCTGA TGATTACTAC CACCTATCCC 780 TAACATTGAT AACGCATCAG GCAACATTTT AACTTGATCG GCTTGTTTAA TCATTAATTC 840 AGCCCGGSTC ACATAACGAT CGGAAGCAAT GAAGCCAAAA TAGAGCACTG CGATAGAAAA 900 GCAGATAACT ACCCAAAGAA AACTGCCTAG CTGTAAACTT TTCTTCCACG AGCGGTGTAC 960 AATTTGATAT CCTCTCGAAT CAATCAAAAA TAGTTTTGGA TTATTGCTCA GTTTTCTTAA 1020 CTTTCGCGTA AGGCGAGATA TTGAGGATGA AGAATTCGGA GATGTCATAA TCAGTTGCTG 1080 CTCAAAGTGA CTGGTAAATT TTGATGGCAT CATCAATATT ATCAAAAACT TCTAATTTAC 1140 CATCACGTAA CAAGATGCCC ATATCGCATT GTTGTCGTAG ATTTTTCATA TCATGCGAAA 1200 CCATAATCAA ACTAGCTGTT TCTCGCTTTT TGTTAAATAC ATCAATACAT TTTTGTTTAA 1260 AACGTGCATC ACCTACTGAG GTAATTTCAT CGGTAAGATA TATATCAAAA TCAAAAGCCA 1320 TACTAACAGC AAAAGAAAAT TTTGATTTCA TGCCGCTAGA GTATGTTTTA ATAGGCAGCT 1380 CATAATGTTG TCCAATTTCA GAAAACTCTT TAACCCACTC TTCTACGGGG CTTGTATCGC 1440 GTACACCATG AATGCGGCAA ACAAATCGCG TGTTTTCACG ACCAGTCATA CTACCTTGAA 1500 ATCCCCCAGC TAGTGCTAGA GGCCAAGATA CTCGGCAGAG ACGAGTTACT TTCCCCCTGT 1560 TAGGCGTATC CATCCCTCCT AACAAACGTA ACAAAGTAGA TTTYCCKGCT CCATKGATAC 1620 CTAGAATACC TATATTACGG TCCCTTGGTA GCTCAATATT TACATTCCTC AGGACATAAT 1680 TTCGTCCAAA TTTAGTTGGA TAATATTTTG ATACATTATC AAGAATAATC ATTTTTCTTA 1740 ACGCTAACTA GCAATCAATT GGCGATGCCG TAATCGGTAA CAACTCATAG CAAAAGTGAG 1800 CAA 1803 (2) INFORMATION FOR SEQ ID NO: 72: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1283 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (Xx) SEQUENCE DESCRIPTION: SEQ ID NO: 72: NGGACCCAAG GTAAAAACNG GTAAAAAAAA CMATTGACCG ATTAAACTTT ATTTCTCTGC 60 CCGCATTAGT CTGGAGAGAG GATGGATGTC ATTTTAATTT NACTAAAGTC AGTAAAGAAG 120 CAAACAGATA TCTTATTTTT GATCTGGAGC AGCGAAATCC CCGTGTTCTC GAACAGTCTG 180 AGTTTGAGGC GTTATATCAG GGGCATATTA TTCTTATTGC TTCCCGTTCT TCTGTTACCG 240 GGAAACTGGC AAAATTTGAC TTTACCTGGT TTATTCCTGC CATTATAAAA TACAGGAAAA 300 TATTTATTGA AACCCTTGTT GTATCTGTTT TTTTACAATT ATTTGCATTA ATAACCCCCC 360 TTTTTTTTCA GGTGGTTATG GACAAAGTAT TAGTACACAG GGGGTTTTCA ACCCTTAATG 420 TTATTACTGT CGCATTATCT GTTGTGGTGG TGTTTGAGAT TATACTCAGC GGTTTAAGAA 480 CTTACATTTT TGCACATAGT ACAAGTCGGA TTGATGTTGA GTTGGGTGCC AAACTCTTCC 540 GGCATTTACT GGCGCTACCG ATCTCTTATT TTGAGAGTCG TCGTGTTGGT GATACTGTTG 600 CCAGGGTAAG AGAATTAGAC CAGATCCGTA ATTTCCTGAC AGGACAGGCA TTAACATCTG 660 TTCTGGACTT ATTATTTTCA TTCATATTTT TTGCGGTAAT GTGGTATTAC AGCCCAAAGC 720 TTACTCTGGT GATCTTATTT TCGCTGCCCT GTTATGCTGC ATGGTCTGTT TTTATTAGCC 780 CCATTTTGCG ACGTCGCCTT GATGATAAGT TTTCACGGAA TGCGGATAAT CAATCTTTCC 840 TGGTGGAATC AGTCACGGCG ATTAACACTA TAAAAGCTAT GGCAGTCTCA CCTCAGATGA 900 CGAACATATG GGACAAACAA TTGGCAGGAT ATGTTGCTGC AGGCTTTAAA GTGACAGTAT 960 TAGCCACCAT TGGTCAACAA GGAATACAGT TAATACAAAA GACTGTTATG ATCATCAACC 1020 TGTGGGTTGG GGTGCACACC TGGTTATTTC CGGGGATTTA AGTATTGGTC AGTTAATTGC 1080 TTTTAATATG CTTGCAGGTC AGATTGTTGC ACCGGTTATT CGCCTTGCAC AAATCTGGCA 1140 GGATTTCCAG CAGGTTGGTA TATCAGTTAC CCGCCTTGGT GATGTGCTTA ACTCTCCAAC 1200 TGAARTTCAT CATGGGAAAC TGGSATTACC GGRAATTAAW GGTGATATCA CTTTTCGTAA 1260 TATCCGGTTT CGCTATAAGC CTG 1283 (2) INFORMATION FOR SEQ ID NO: 73: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 6836 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 73: TCAACCTGAC CAACCACTAG AATCAACTCA CGTCCGTCGT TAGGGGGCTC ATATTCTTGT 60 GTACTCCCCA CATTGTATTT ACTGACTCGT GATGATTGTA ATTGCGCTAA TAATGACTCT 120 GCGCGTGCTT CTTCTTTCGC ATCTAAAACG TACGTAGTGA GTAACTGCTC AAGCTTACTC 180 GGACGGCGGC TATCAAAATA GATTCCAACG GGGTCAATCG AGAGTGATGA AGGTCGACAT 240 AAATTAGACC CCAATCCGTT GGAGCGGATA AAACCATCTT CAATCCGGAT CACTGATTGC 300 AGTTCAGGAT AACGGTTTCC CCACACCAAC ACCTGTTCAT CATCTTTTAA CTGTGAGGGC 360 ACAGTACGAA CAAAACAAAG TTCATCTGCC AAATACGCAC AAAATGTGCG TATAAAAGCA 420 CGCTTCCACA GAGAAAAACC AACGAGATAA AGACGACGCC AAGGTTTGGG CTCTACCTGC 480 TGCTGAGCCA AAATCGCTAC AACATCTTCT ACCTCACAAC GTTTTCCCAA TATAGGATCT 540 AAATAACGCG GATAACGGAT CAACGCCGCC GCAACTAAGC GGGGCAATGA AATAGATGAA 600 ACGCCTTCGG CTGACATTGC TTCTTCACGG CGTATACAAC GTTTACTGTC ATGCGTTAAC 660 CCCCACCCAG CATAAAATGG CATACCGAAG CAATATACAG GTTTGCCCAA CAGCAACGCT 720 TCCAAAGCCA ACCTGCGATG AAACTGTGTA CACCGCATCC ACCATACGAA TTATTCTATG 780 CGGATGGCAA GTTCACTCAC CACCTCAACA TCAGCCAGTC GAGGATCACG CCCCACTAAA 840 CGTGCTAACA CGCCGCTTTT TTTGCTAAAG CGTGTATCTG GGTGTGTTCG CAACAATAGA 900 CGCGCATTAG GGTGATTACG GCGAGCCTCG ACCACCATAG AAACAAAATC AGCTTCGCAA 960 GCAAGAGCCC CAGAAATTGA CAAGTCTCCC GCTACTTGAT CCACAAGCAA AATACGCGGT 1020 CTTGGATCAT CCAGTAAACG TGCTAAGTTT GAATGAGCCG TGAGGTGAAT AACTCAGGTT 1080 GTATATGTGT CGGTAAATCT AAAGAAGGCC CGTCAGTAGC ACGGGACAGA GCCATTAAAT 1140 GTATGCTCAG TGCTATTGGG TATAGCAGTT ATACTTGGTG ATTCCTAAAC GCAAAATATC 1200 MGAGATCAGA TGCTCCAGCG CGCGCAAAGT AAAGCCGTAT CCAACAGGTT CCAATAATAA 1260 GCTGTTCTAA TTGACTCGTC TGATGTGCAT CATAATATAT CCCCAGAGGG TCAGCAATAA 1320 GAGAAACCGC CTTTCCTCCT TTTGCTGGGT GCCCGATATA GCCAATAAAA CCATCTTCAA 1380 GTTGCCAATA AGATATTCCT AACTCTTGAG CTTTCTGTTT AATCTGCTTA GTATTAGATT 1440 TTTTTCCCCA GCCAACTAAA ACGTCATTTT TAGAAAAAGC CTCGTCTCCT TTCATATAAA 1500 GCAATGGGTG ACCAAGCATA GGCTCAATAT TATTTTYTCT GGCAAGAATC CCTTTCGATC 1560 CCGTATATAA ATACATGTTG TCTCTGTGAA CTGAAGATTC TCTACAATGG TGTATAAAGT 1620 GTGATTTAGA TGAACAGCTC TGCGCTCTCT AATGACTTTG CAATACTATC TTTTGCTGAA 1680 GTGAGAATGT CCGCCTTTAA CTCGGGCCAC CTAATACCAA TTGTAGGATC ATTCCATGCA 1740 ATGCCTCTAT CACTGGCAGG GGCATAATAA TTAGTTGTTT TATACAAAAA TTCGGCCGAT 1800 TCAGTCAGTG TTACAAAACC ATGGGCAAAT CCTTCCGGAA TCCATAATGT CGTTTGTTTT 1860 CCCCTGAAAG ATGAACGCCA ACCCATTGTC CGRAGCTCGG TGAGCTTTTG CGAATATCTA 1920 CCGCAACATC AAACACTTCA CCGGCTACAC AACGCACTAA CTTGCCCTGG GCATGGGGAG 1980 GTAACTGATA GTGCAAGCCA CGCAGTACCC CTTTAGAAGA TTTTGAGTGA TTATCCTGCA 2040 CAAAGGTAAC TGGATATCCT ACAGCCTCTT CAAACAACTT GTGATTAAAA CTCTCAAAGA 2100 AAAAACCACG CTCATCTCCA AATACTTTTG GCTCAAAAAT AAGCACACCA GGAATTGCTG 2160 TCTTGATTAC ATTCATCTAT ATGCCCACAT TTAATTAAAT ATTTTTAGGG GAAGCATATT 2220 CCCTCCCCCT TCTCAATTAC ATCACGCCTT ATCAATCATT TTTAATAAAT ATTGCCCATA 2280 GGCGTTTTTT GCCAACGGAG CAGCAAGYTC ACGAACCTGG TCGGCACTAA TAAACTTCTG 2340 GCGATAAGCA ATCTCTTCCG GACAAGCCAC TTTCAATCCC TGACGCGTCT CGATGGTCTG 2400 AATAAAGTTA CTCGCTTCAA TTAGGCTTTC GTGGGTACCG GTATCAAGCC AGGCATAACC 2460 ACGCCCCATC ATTGCCACCG ATAGATTGCC TTGCTCCAGG TAAATACGGT TCACATCGGT 2520 GATTTCCAAC TCACCACGCG GCGATGGCTT GAGACCCTTG GCAACGTCCA CAACGCTGTT 2580 GTCGTAGAAA TAGAGGCCGG TGACTGCGTA STACTCTTAG GCTCCAGTGG TTTTTCTTCC 2640 AGTGAAATAG CGGTACCTTG ATTATCAAAT TCGACCACTC CATAACGTTC CGGGTCGTGC 2700 ACATGATAGG CAAATACAGT AGCACCGGTC TCTTTGGCCG CGGCTGCCTC CAACTGTTTC 2760 TGTAGGTCAT GACCGTAGAA GATGTTATCC CCCAGCACCA GTGCACACGG GGCTGAACCA 2820 ATGAATTCTT CACCTAGAAT AAAAGCTTGT GCCAACCCGT CTGGGCTTGG CTGAACCTCA 2880 TATTGTAAAT TCAGTCCCCA GTGGCTGCCA TCACCCAGCA ATCGCTGAAA GGANGGAGTA 2940 TCTTGTGGAG TGCTAATGAT CAAAATATCG CGAATTCCAG CCAGCATCAG GGTGCTCAGC 3000 GGCCGCAGTA CTGGATCATC GGCTTGTCAT AGATGGGCAA CAACTGCTTG CTCACCGCCA 3060 TAGTAACCGG ATAGAGACGT GTACCAGATC CACCGGCCAG AATAATACCT TTACGTTTAG 3120 TCATGATGCT TGTTTCTTAT TTTTAAATTA CATAAGAATA AAGTGGCTTG AGCCGCGCCT 3180 TTCTGTTTTA TCCTCACCTG TGGTTTACTT CCCCATGATC TCAGTCAACA TCCGCTCAAC 3240 ACCGACTGAC CAGTCCGGCA AAACCAGATC AAATGTACGC TGGAATTTTT TAGTATCAAG 3300 TCGGGAATTA TGAGGGCGTT TCGCCGGGGT CGGAAAGGCG CCTGTCGGCA CTGCATTAAG 3360 CTGTGTGACT GCCAGTTCAA CTCCTGCGTC TCTGGCTTTG TCAAACACCA ACCGGGCGTA 3420 GTCAAACCAA GTGGTAGTAC CGGAGGCAGC CAAATGGTAC AGCCCGGCAA CGTCGGGTTT 3480 GCTCTGTGCA ACTCGGATTG CATGGGCGGT ACAATCGGCC AGCAACTCAG CTCCAGTTGG 3540 AGCGCCAAAC TGATCATTAA TGACCGATAT CTCGCGACGC TCTTTGCCAA GACGCAGCAT 3600 AGTTTTGGCG AAGTTGGCAC CGCGCGCAGC ATAAACCCAA CTGGTACGAA AGATAAGGTG 3660 ACGTGAGCAG AGTGCCGCAC CGTGTTCCCC TGCCAGCTTG GTTTCGCCAT AGACGTTGAG 3720 CGGGGAAATC ACATCGGTTT CCACCCAAGG ACGTTCACCA CTTCCATCGA AAACATAGTC 3780 GGTGGAATAA TGTACTAGCC ACGCACCTAA TGCTTCAGCT TCTTTGGCAA TAACCGCCAC 3840 ACTAGTTGCA TTGAGTAACT CGGCAAATTC CCGCTCACTC TCCGCTTTGT CGACTGCAGT 3900 ATGGGCCGCT GCGTTAACAA TCACATCCGG CTTGACGAGA CGTACCGTTT CAGCCACCCC 3960 TGCAGAATTG CTAAAATCAC CGCAATAGTC GGTGGAGTCA AAATCAACGG CAGTGATGTG 4020 CCCCAGAGGC GCCAATGCAC GCTGCAGCCC CCATCCACTT TCTGGCCACA CCAGACTCGC 4080 CAGCAAAAAA GTGAGTGCTG TCAATAACTC AACCAGCGGA TAACGCTTGC TGATTTTCGC 4140 CTGACAGTCG CGGCAGCGCC CTTTGAGCAT CAACCATGAG AGCAGCGGAA TATTGTCACG 4200 AACGCGGATG GTCTGCTGGC AATGCGGACA GTGCGAACGC GGTAGCGCAA GGCTTATTTT 4260 TGACTGCGCA CTCGGCATTT CACCATGAAA CTCCGCCATT TGTTGGCGCA GCATGATGGG 4320 GTAACGCCAA ATCACCACAT TCAAAAAACT GCCGATGATC AATCCTCCGA CGGTTGCCAG 4380 TATGGGCATC GCCGCGGGGT ATTGCTGAAA AACATCAAAA AGCATGGTTA AAGGTTATTT 4440 GTTGTAACTT GCCGGATGCG GGCCTGCGGG TGTATGCCAT ACGGCTTTCC TTCAGGCCCG 4500 ATGCGCCTTA TTTCATGCCG GATGCGGCGC GAGCGCCTTA TCCGGCATAC AGGCTTACTC 4560 AGCTGACATC TTATGCTCGG TAACCTGATT AATGGTTTCC GGCCCTTGCT GCGGTTTCGG 4620 CAGATTAAGC GCCGCCAGTG TCTCGTAAGC CGACTGGCTC ACACCGCCCT CGAAGTTCAT 4680 CTCGCTCGCT CCCGGCAACT GGTAAGCATT CGCGCCCGGA TTCCATTTCT TAAAGAACTC 4740 CGAAAGATCC GTCTGGGCGA CCCAGGATGC ACACAGCATC AGCTTGTCGG CAGCGTTACC 4800 GTTGGATTCG GCACAGTAAT TTCTTTCGCC AAACTTGGTT TTGCCAACCT CATCGCCGCG 4860 TGCTTTACGG TGCATCAACT GGAACAGGTT CCAGCCTTTC ATCCCTTCAC GATCGCTGTA 4920 GAACTTAGGC AGGTCACCTT CTGGATACCA CTGTTTGATA TCAAAGTTTT TCTCTGCCCA 4980 CTCTTTCAGC TGTGCGTACA TCAGCAGACG GTCACCCGCA CCGCCGCGCG CCCATGCCTG 5040 ACCGTTGCTC TCCTCCAGAT ATTCCGGCGC GACGGTAATG TCGTCAGCGA CACGGTTCAT 5100 CTTGCCGAGA TAGCGATCCT GCATGTACAG CGCCAGCACG TTGTTCGCTA CTTCAGTTGC 5160 GCCAGGAACA GTCAGCGGCG TTTCGGCGGC GTTGTGACCA ACTTCGTGCC AGATCAGCCA 5220 GTCGTTCAGC GGCGTCGTCG GCAGCGTGGT GCTGTTCGTC GAGAAGCTGC TGTTCATTAC 5280 CGGATAACCA GAGTGCGCAT CACCGATGGA GATCTGCACA TCGTTGGTGA AACGATGCTT 5340 GTGGCCCGTC AAGTTTTTAT AGGTAAACAT CCGGTGCTTA CCGTCTTCAT CATTACGACC 5400 GTAGAAGTCA TTCATCGAGC TGGCAAAGGT ATCCAGATCT TTAGCGAATT CTGCTACGCC 5460 ACCAGTGAAA TTGCTGGCCT CAAGGTTCTT CTTCGGCGTG GTGTAGACGA AAGCGTCTGA 5520 CTCCAGCTCG CCCAACGGCG CAGGGGAGTT CAGAGCGTTT TTCCATGCGC CATCTTTATA 5580 GAACGGCGCT TTCACCACAC CAGTAAAGGT GAATTCGGCT GACTCATTCT GTGGGCTGTT 5640 GCCCTTGATA TAAATCAGAC CACCGTAAGG AACCGTAAAC TTCACCTCAC CATTGGCTTT 5700 CAGCTCATAG GTTTTCGTCA CTTTTGGCGG ACGGTTCAGA GCGACTTCAT GCTTCTCACG 5760 TCCGGTAAGG TCGTCGGCCA GCGCCACGGT GACAGTCACA GGAACTGATG CAGAAGACTC 5820 AATGGTGACC TCTTTCTGAG CCGGAGCCCA CAGGCCAGTA GACTGCATGT TACCCGCAAA 5880 CCATTTGGTC GGATTCGAGT ACAGGCTGAT GGTTTCAGTA ACCTTCTCAC CTTCTGCCGA 5940 TACCGCTCCC GGATACTTCT CGACATCAAC TTTGATGTTC AGATCCCACC AGGAACGACC 6000 CAGCATCAGG CGCGTCAGCG GTTTTTCCAT ATAGTTGAGC GGATAGCTCG GGTTCATCAT 6060 GCCCGCTTTA TTAACGCTCT TCTCGCCGTA GATCATGTTG TTATCGACCA GCGATTTTTT 6120 CAGCTCATCA GAAACACTGC GTGCCGCCAG TATAGGCATC GTTGGCGTAG CAGTTCAGGA 6180 ACTCGGTGAA CGTTTTAAAG CCCAGCTCGT CATCCTTGTC GTTTTCATAG CGATATTCAA 6240 TTTTATTCCA CAGCCAGACC GACATGTTCT GGTACAGACG TTCCAGATCG ACGCTGCTCA 6300 GACGCTCACC TTTGCGACCA TTGGTCCGGA AGTAGAGCTC ATGCTGATAC AGACGCTGAA 6360 TGTTGGTGCC TAAATCCGCA GCCTGCACCA TCGCTTTTGC CGTGTCGGCG TTAAGGCTTA 6420 GTTGCGTATA CTGTGGAACA TACATGCCAC CAGTAACCGG AACCCCCGTG CCAGGACGAT 6480 ATTCCAGACA GTTGACCTCG TAGTGGTAAG TTGGGTCCTT ACACTCCTTT AATCCAGGAA 6540 ACTTCTCAAA GATTTTTGCC TTCGCAGCCT TCAGAGAATC CTCTGTTTTA TGATCGGCCT 6600 CATCAATAAA GGCATAACGC GTTTCCTGTT TGCCATCTAC ATCTTCCAGC CAGCTGGCAA 6660 CTTCCAGCTT CGGTTTGTCA TCAGGTTTGT TTTCTACCTG ATATTTCCAC TTAACTTCCC 6720 CTGTCTTACT ATCGATGGTG TACGGCAGCG CACCATCTAC GGCAGGATAA CGTTCATAGA 6780 CCCAAATGCC CGTTGCGCGC TGCTGACGAA CGCGGTTCGG ATACCCTTGC GGATCC 6836 (2) INFORMATION FOR SEQ ID NO: 74: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1332 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 74: GGAAAAACNC GCCGTATATT AGCCCGCGCG GAAAAAGCCC CGTNACGGGC AAACGCAGCA 60 AGGTTTTATC CCAGCGCAGG CGCATGGCAG GATTTTTGAG TAGCCGTTGC CCCAGCACCA 120 GAAGCCCCAG CAATCCCGCC AGCCAGTAAA CGCCGCTGGT CTGTAACGTG TCGCTCATGG 180 CGATGAGCGT GCGGGTGGAG GCGGGCAGCG CGTGTCCGAG ATGATCAAAC TGTTCGATGA 240 TTTTTGGCAC CACTGCCGTC AGCAAAATAG TGACCACGCC CGTTGCCACC ACCAGCAGTA 300 CCAGCGGGTA GAGCATGGCC TGCAGCAGGC GTGAATTTCC AGNACCTGCC GCTGTTACGG 360 TGTAACCCGC CAGGCGATTG AGCACCACGT CGAGATGTCC GGATTTTTCT CCGGCAGCAA 420 CCATCGAACA AAACAGGGAA TCAAAGACGC GGGGATGTTC GCGCAGGCTG TCCGACAGGK 480 TGTAACYTTC CTGAATCCGC TGCGCAGCGC CATTCCGAGG CTTTTTACAT GCAGTTTTTC 540 ACTTTGCTCA CTGACCGCCT GTAAGCAGGT TTCCAGCGGC ATTGCTGCCT GTACCAGCGT 600 TGCCAGTTGG CGCGTGAACA GCGCAAGATC TGCCGCCGCC ACGCGACGAT GTGCGTGCCG 660 CCGACGCTGC AACATCCCCC CTGACGAAGT ATTCATCCGG GCTTCAATAT GCACGGGGAT 720 AAGCTCTTTA CCGCGCAACA ACTGGCGGGC ATGACGCGCG GAATCCGCCT CAATCATACC 780 TTTGGTTTTG CGACCATTAC GCTCCAGCGC CTGATAGTAA AACAGTGCCA TTACGCCTCC 840 ATGGTTACCC GCAGAACTTC ATCGAGAGAG GTTTCTCCGG CGAGCACTTT CTCAATGCCG 900 TTGCTGCGGA TACCCGCAGA GTGTTGTCGG ACATAACGTT CCAGCTCCAG CTCCCCGGCC 960 TGACGGTGGA TCAAATCACG CAATGTGGCA TCCACCACGA TCAGCTCATG GATGGCAGTC 1020 CGTCCGCGAA AACCTTTGTG ATTACAGGCG GGACAGCCCT GTGGATGGTA CAGAGTGACG 1080 GTACGGGCGT CGGTAATTCC CAGCAGGCGT TTTTCTTCGT CGGTGGCAGG CGCGGCCTGA 1140 CGGCAGTCGG AGCACAGCGT GCGGACCAGT CGCTGCGCCA TCACGCCCGT CAGACTGGAA 1200 GAGAGCAGGA AAGGCTCCAC GCCCATATCC TGCAAACGTG TGATCGCCCC CACCGCTGTG 1260 TTGGTATGCA GCGTGGAAAG TACCAGGTGT CCGGTCAGTG AAGCCTGAAC AGCGATTTCT 1320 GCGGTTTCGG TA 1332 (2) INFORMATION FOR SEQ ID NO: 75: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 4407 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 75: CCCAACGTTT ATCGTATTTC ATTAAAGTCC CTTGCCCGAT GCTATCTCGA GTTACATGAC 60 GAAATCGCTG ATTTGGATGT CATGATTGCG GCAATTGTCG ATGARCTGGC GCCTGAACTG 120 ATTAAACGTA ATGCTATTGG ATACGAAAGC STTCGCAGTT GCTGATCACG GCAGGAGACA 180 ATCCCCAACG ATTAAGATCA GAATCAGGTT TTGCGGCACT GTGTGGTGTC AGCCCTGTTC 240 CCGTATCTTC AGGAAAAACG AATCGTTATC GACTTAACCG GGGTGGAGAT CGTGCTGCAA 300 ATAGTGCACT TCACATCATT GCCATCGGAC GTTTGCGAAC TGACGATAAA ACGAAGGAAT 360 ATGTCGCCAG ACGAGTAGCG GAAGGGCATA CAAAAATGGA AGCAATACGC TGCCTGAAGC 420 GCTATATCTC ACGCGAAGTT TATACATTAC TGCGTAATCA AAACAGGCAG CTCAACAGCA 480 TCCCGATAAC GGCTTGACTC TTAGAAGGGC GTCCAGGGCA GCCACTATAC AAGCAGGCAG 540 TTCCGGCAGT TACTGTGGCG TTACCAGATC AAACAGAGTC TGAGTCGACG AGGAAATTGC 600 TGGGATAACA GCCCGATGGA GCGCTTCTTC AGGAGTCTGA AAAACGAGTG GATACCGGTG 660 ACGGGTTACA TGAACTTCAG CGATGCTGCC CATGAAATAA CGGACTATAT CGTTGGGTAT 720 TACAACGCGC TCAGGCCGCA CGAATATAAC GGTGGGTTGC CACCAAATGA ATCGGAAAAC 780 CGATACTGGA AAAACTCTAA AGCGGTGGCC AGTTTTTGTT GACCACTACA TTTAGTGCGA 840 CACGGGAAGC GCGATATGAA CGATACGATA CATCAATGGT TTATTGCGGT GATAACCTGA 900 AGGGTGAGAT TGAGGCTATT TAT ATAGTC TTGAGAGGCG TCAGGTTTAG AGCAGGAATG 960 CTGAGTAGCC ATCTTATCGA TTGTTTTCGA GCGTAAGATG GCTGAATGGA ATGGCTATTA 1020 TTGCACAGTC CTTAATTATA ACATTCATAC CGACATGATT ATCTTCTGTC CGGAAGAATC 1080 AGAGGCTGCG GTTTCAGACT GTCTGCCGGT ACATTCCTCT CTCCGTTAAA AACCATAACG 1140 GGTTCATTAT CTTCGTCTGT CAGCAGATTG AATGGCGGTA TATTTTCAGT ACGAATGCCG 1200 GTCAGCCACT GAAAAATACC TGCGAAATGA CGGGCACTGA TTTTTCTGCT GACGGACTGA 1260 TGAGACGTGA TGTCACTGGC GGTAATAATC AGGGGAACGC TGTAGCCTCC CTGCACATGA 1320 CCATCATGAT GAACAGGATT AGCACTGTCG CTGACCGACA GACCATGGTC AGAAAAGTAA 1380 AGCATGGCAA AATGACGGGA ATGCCGGCGA AGGATACCAT CAAGCTGCCC GAGAAAGTTA 1440 TCCCAGTTTA CTGATGCTGG CGAGGTAACA GGCAATTTTT CGGGGATACT GCCCCAGGTA 1500 ATGATTCGGC CAGGAGTTAA GCCGGTCACA CGGGTTCGGA TGAGACCCCA TCATGTGCAG 1560 GAATATCACT TCGGAGAGGA TTTATCCGCC AGTGCACGTT CTGTTTCCTG TAACAACAAC 1620 ATGTCATCCG TTTTACGGGA AGCAAAGCTG CCTTTCTTGA GGAAAACGGT ATGCTCCGCA 1680 TCAGAAGCAA TAACAGAGAT GCGTGTATCA TGCTCCCCCA GCTTTCCCTG ATTGGATATC 1740 CACCATGTGC TGTATCCTGC TTTTGCTGCC AGCGCCACCA CGTTGTTGCC GGAGTCAGGG 1800 TTCTGCTCAT AGTCATAAAT CAGTGTCCGG CTCAGGGAAG GTACGGTACT GGCTGCTGCC 1860 GATGTATAGC CGTCAATAAA TAAACCGGGA GCAGTATTCA GCCACGGTGT GGTTGGCACG 1920 GGATAGCCAT ATACCGACAT ATAATCCCTG CGCACACTCT CACCAGTGAC GATAACAATC 1980 GTGTCATACA ACGGTACACC CGGCAGGATT TTCCAGTTGT CAGCCCCGTG CTGATTCAGT 2040 TGTTTATAAC GCTGCATTTC ACGCAATGTG TCAGTTGTCC CCACAACAGT TCCTTTAACC 2100 ATCCGCAACG GCCAGCTGTT TACTGAGCAT AATACGAACA GCAGCAGTGC CAGCCAGTTA 2160 CGGTGACCGC GGTGGTGTGT TCGCCAGAAA ATCACCATGA ATACCAGAAT CGCGGCACTG 2220 ACCAGAAAAT GATAAACAGG AATCATCCCG GTAAACTCCG CTGCCTCATC AGTTGTGGTC 2280 TGCAGCAACG CAACAATAAA ACTGTTGTTG ATTTTACCGT ACGTCATACC GGCAGGCGCA 2340 TACAGTGCAC AACAGAACAG AAATAACAGC GCTGTAATGG ATGTGAGGGT ATTTCTGTGT 2400 GCAAGAAGCA GAAGAAAGAA CAGCAGCAAC ACATTCCCGG TGGTATTCTT CTCAGTGTAT 2460 CCGCATGCAA TTGTGGTTAT GACAGAAACA ACAAAAAAGA ATAAAAACAA TATAATCCTG 2520 AGAGTGTTGC CCGGACAAAA CAGTTTTCTG ATATTCATCG GAGTATATCG ACAACATTAT 2580 TATGAAGAGA ACAGGATAAT AAAAATCAGA AGTTATCTGT GAAACAGATA ACAGACANCC 2640 CTGCAGTATA ATATTACTGC AGGGTGTTCC TTTTTAATTA CAGAAATACG TAATTATCTT 2700 AATTGCAGAA ATATGCGCAA TTATCGTTCA GAAGCAGTGT CGTCAGAAGT TATAAGTCAC 2760 ACCAAGCAGG ATGTCATGAC TTTTAACATC AACCTCTGAT TTATATTTAT CCCCTTCTGT 2820 ATCCTTGTAA TACAGGGAGG ATTTACCAGC ATCCAGATAG CGATAGCTGA GGTCAAGAGC 2880 GATATCCGGG GTTACGTCAT AGCGAACACC GGCCCCAATG CTCCATGCGA AGTTGTCAGC 2940 AGAGCCTGAG CGTGATATAG AATAACGCAC TCGCTCACCG TAGCCATAAT CCCAACTACC 3000 GCTACCTGTT GATTCCTGAT GAATTCTGGC GTAACCAATT CCGGCAGACA CCCATGGCGT 3060 AAATGCACTG TCGTTTCTGA AATCATAGTA CGCATTCAGC ATCAGGCTGT TGACTGACAC 3120 CTCATTCTTC AGGTCACTAT GTCCCGCGTG GTCCTTATAG AGGTTGTATG TTGTGTCAGC 3180 TTTTCCACGG GCGTAAAACT CCAGTTCTGT ACGCACAGGA ATACTGAACT GCGGATGCAA 3240 GTCATAACCA AACGCTATAC CTCCACTGAA TACCGTGTTA TGGCCATCCC CCCCCTATAC 3300 TTTGATGTTT CCTCTTTATT TTCGGACAGG AAACTCTGGT CAGAAAGAGA TACTGCTGAA 3360 GTACCTGCTT TACCGGTCAG ATAAAAACCG CTTTTACCTT CCTCAGCACC CGCATTTGCT 3420 GCAANCATAC AGGCAGCGGT AACTGCTGAA ACAGCAAAAA CTTTTTTCAT TTCAATTAAC 3480 TCCATTATTT CACTATTTTT GTAAATAGCA CTCCTAATAT TTTAAAACCA GTCAAAAGAT 3540 AGTATCAAGC AAATTATTCA TGTCTAATGA ACAGATAAAA TCGACTATGT GTCGGCAAGA 3600 CTCTGCTCCA CCGATATTCC TCTTATTTCC GCCTCGATGA AATACCCCCG TTACCTTATT 3660 TGTACCCCTT ATAATGGGAT GTTGGCCAGC CAGACCCGGC ATGATTAGTT CTCCCTGTCG 3720 ACTATGCTCC GGGAGGGATG TCACCGGGTC TGGTGAGGCG CGGATAACCG CTAATAGGGG 3780 AAGGTCAGGT ATTTTACACC GGGACCGTCA GGGCAAGATA ACGAAAGCCA GCTCCCCGCA 3840 TGAACTGACG CCAGATAGTT TCTGTCCATT GCTGCTTTTC TCATCTTACG TCTTAACCCT 3900 GCCTTGAATA CCTTATCTCT CGTCAAAATA TTAATAGCGA TATGCCGTAT CCCTGAAAAT 3960 AATCCCGCTG CGTTTCCTCT TCTTACTTGC AGTCGTCTTC ATTCATTACC ACGTCCAGAC 4020 GCCATGCAGC TTATTCTCCA CGTGCCAGTG ATTTCGGATC GCTGTGACGA ACTTCTCTGC 4080 GGTTAAATCA GCAGAACTGA TATAATATCT GACCATTATT TCTGACTCTT GCTTTTGTTC 4140 TGCTATTATT GACCGAAAGG AGACTGCCAG GCATATTTTT TCAGCCCTTT CCATTCAAAC 4200 GTGAATTCAA TCAGCTCATC AGGGACNTCG CCAAACCATA TGAAGACGGG ATCCTNCTCT 4260 GCCGTGACTC TTGTCACTAA TTGCGTAACA GTCATGCTCN GGGATAATTA AATCTTTCAG 4320 CGGAAATAAA AAGATTATCA GATATGGGGA TGACACCACA GCACCGCTGA GGCCAGTATG 4380 GATAAACCAT GTACCTTATT AACCAAA 4407 (2) INFORMATION FOR SEQ ID NO: 76: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 824 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 76: TTTTTTGCAA GAGAATTTCC CTGAACCTGA AGCTCATCAT CGCCATCTCC GCCGTTCAGG 60 TAATTATTAC CTGCTCCCCC AATTAACTTA TCGTTGCCAT CACCGCCATA GAGCTGGTCA 120 TCTCCGTTTC CACCACTCAG TGTGTCATTA CCTTTATCAC CATATAAGCG GTCATTCCCG 180 TCATTTCCTT CTATATGGTC ATCACCATCC GCGCCATGGA AGATATCAGC AAATTTACTG 240 CCAAAAAACT TGTCGGCACG CGTGGTCCCA ATAAGTTCTT CCACGGAATA TAAGTTATCA 300 GTCTCTGTTA AATTTTTACC ATTGATATGA GTGAATTCAT AACTCCGATA TTGCGTTTTT 360 TCAGTTCTTT TTCCAACTGA AACCTCCTGC TCCTTCACAA CTTCCTGTAA AACCTTAACA 420 TCACCACCAA GTACACGTGT TACCGTGTAA TTACCCGCTT CGGTTGCTTT TGTGCCATCA 480 ATGGTCAGAT AACCGGTGTC TGTTTTATCA TAATAAACAA CATCATGTCC TTTACCTGCG 540 TAGATATTGG CTGAGCCGGC AGATAAAAAG ACCTTATCAT CCCCGTCTCC CAGGTGTGAC 600 TCAATACGAA TTTCCCGATA CTGGTTATTA CCGACTGATG CATGCTGAAT CAGGTTAGAG 660 TAATCATATA CAGACCCCTT GTCCTGNAAC CCCCTTCACC GTCCATTTAT CAACACCCTT 720 GACTAATAAC TCGGTAATAT ATTCATATTT TCCGGACTGC CTCCTTTCAC GAATTTCCTC 780 ACCGGGAGTT TAACAATGGG CGTAACNAAT TTGCAATAAC GTGG 824 (2) INFORMATION FOR SEQ ID NO: 77: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 550 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 77: GNGGCCGCAG TACTGGATCA TCACCGAAGT TTCGCGCGGA AAAGCGTTAG AGAAAGATCT 60 AATGCTTCAT GATGGTGATG GACTTTTCCT GATGGTGAAA TCCAGCGGGA AATGCTCTGG 120 CGTTTCCGTT ATCAACATTC GACAACAAAG CAGCGGACAA TGATGGGACT CGGTGTCTTT 180 TCCACACTTT CACTTGCTGA TACCCGAGGG CTAAGAGTGG ATTATATTTC CTTATTAGCC 240 AACAGAATCG ACCCGCAAAT TCAAGCTAAA GCCGTAGACG AAGAGCAATA TTTGAAAAGG 300 TGGGCACCTA CGTTACCAAT ACTGGCTTAA TGGCTACATA CGGCGGTCAG GGTCAGTTTA 360 CGCTTACAAA ATATAAAACA ATTTGATACA AAATATTCCT CTTATTCTAA ATAAAAGTAT 420 CTTGAAAACC TTCCAACTGG AAGGTAGATT GAATTTATGC TAAACATAAA GAGGAATTGC 480 TTATGAATTA CGTTATCCGC ACTACCACCG TCGTCTTTAG TCTCATGCTG GGCAGGTTAC 540 GCAACTGCTG 550 (2) INFORMATION FOR SEQ ID NO: 78: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 382 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 78: CACTAAAGGC CCTGGATGTT TTTCGCTCAT TAGTAGACAT CTCGCTGATA ACGGCGCTCT 60 ACGCGCACTC ACTTAAAAAT TCATCCGCCG CTTCGGTGTC CATGCCACCA AATTCGGCAA 120 TCACTTCCAG AAGTGCCTGC TCAACGTCTT TCGCCATGCG ATTAGCGTCG CCGCAGACAT 180 AAATGTGGGC ACCATCATTG ATCCAGCGCC ACAGCTCCGC GCCCTGTTCG CGCAGTTTGT 240 CTTGTACGTA AACTTTTTCT TTTTGATCGC GCGACCAGGC AAGATCGATA CGTGTCAGCA 300 CGCCATCTTT GACGTAGCGC TGCCAMTCCA MCTGGTACAG GAAGTCTTCC GTAAAGTGCG 360 GATTACCAAA GAACAGCCAG TT 382 (2) INFORMATION FOR SEQ ID NO: 79: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 3576 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 79: TAAATCAGCA GAACTGATAT AATATCTGAC CATTATTTCT GACTCTTGCT TTTGTTCTGC 60 TATTATTGAC CGAAAGGAGA CTGCCAGGCA TATTTTTTCA GCCCTTTCCA TTCAAACGTG 120 AATTCAATCA GCTCATCAGG AACATCGCAA ACAATATGAA GACGGATTTC TTCTCTGCCG 180 TGACTCTTGT CACTAATTGC GTAACAGTCA TGCTCTGGAT TATTTAATTC TTTCAGCGAA 240 AATAAAAGAT TATCAGATAT GGGATGACAC ACAGCACCGC TGAGCAAGTA TGTATAACCA 300 TGTACTTATA ACAAAAGGAG ACGTAAGAAG GGGAACGGGT ATCAGAGGGC CAATCAAAGC 360 AGGTATAATG AACGCCAGTA TAATTGTCCG CAACCCAGAA ATATATTATT GAACTGGTTA 420 TCTCCTGCGA ATGCATATAC TGCAACGGCC GTTAAAATAG CATTATATCC ATAAAGCCCG 480 GCAGAGATTT TATCAGGAGA AAGCTCAGGA ATACAGAATG ATACCACCAC ACTCAGAAAC 540 GAAGCGACAA CCGTAATCAT CAGTAGTTTC CGGCTCCCTG CAAGTAGTCC CAGCATAACA 600 AGAATACCGC CGACAGCATC AGGAAACATA AAAATCTCCA TAAAGCTACC AGACAATGCC 660 ACCGGATAGT TTTTCAGCAA AACAGAACCT GCACTTCGCC CGAAGGTACT GACATATCAT 720 GAGGCATTAT TCCGGAATGT AATAACCACG TAGCGATAAT AAAGGGGGCG GTCAATACGG 780 GTAACCCTCT GAGCACTGAC GACAACAGGG GAGTAAACAA AACAATACCA AGAGTTCCGA 840 CGATAAGTAC AGCAATTCCG GAGACTGACA CAGGGACAAG CATGCCACAG GCTATGCCAT 900 ACAGAACAGC ATTATATCCC CATATACCTT CATTAATCTC CTCATCAGGA TACCGCAAAC 960 ACCAGGCAAA GAACGGAGAA AGTGCTGCAC TGATGGCTGA GAAATACAGT ATTTCGGGGT 1020 GCCCCATATT AAAAGAGGCT ATTCCAGTCG CCAAAAAAAA GAACAAGCCA GAAACAACAT 1080 TGTTCTGTAA TAATACCTGT GAATACCCCT TACTAAAGGC GGTTATCACC TGTTTTACTC 1140 TCATGTAAAA TGTCACACAC ACCTCATACA TAAACCATTC TCCGCTTCTG CGGGACAGTA 1200 CCGCCCCTGA CTCCACCTCA CAGCGGATTG TGTATTTTTA AACAATCACA GTCTTCTCAT 1260 ATACTTTCCA TTCTGAAGCT TATCTCTTCC TCCGTGATAA GCTTCCGTCG CGGGATGTGT 1320 TATACGCCCT GTAAGACAGT TATAAAGGAC ATCAATGCCA TAGTTAATGA YTACCGAATT 1380 CCGGTGGATA GTCAGTACTG GTTTGCCACA AAACAGTGCA GTCACACATG ACAGGAGAAG 1440 ATATGAGCCG GATACCGCTG CTCTGAGACT TAACGCTCAT GTAAACTTTC TGTTACAGAT 1500 TCTTCCAGGG ACTAAGAAGA TAACTGANTT ACGTTCGCAT TCCAGTSTTT ATTTCTGCAG 1560 TGACAGCCAT ACCCGAGCTT AATGGAATGT GCTTATTCCC GGTTGACAAA TCATTCTCTT 1620 CAACAGAAAC AATGACATTA AAAACGAGTC CCAGTTTCTG GTCTTCTATT GCATCTAAAT 1680 TTATATTTTT TACCTTACCC ACCAGATAAC CATATCGGGT GTAAGGAAAA GCCTCCACTT 1740 TAATGATGGC ATTCTGCCCG ACGTTAATAA AACCAATATC TTTATTTTGT ACCAGAGCAG 1800 TAACCTCCAG CGTGTCATCT TCCGGAACGA TGACCATCAG TGTTTCCGCT GTTGTAACAA 1860 CCCCACCTTC AGTATGAACC TTCAGTTGCT GAACTTTTCC CGAAACAGGG GCCCTGATTA 1920 CTGAAGCCTG TTGACGCTCT TCATTTTTCT CTAACTCCAG AGTTAATAAC TCAATGCTGT 1980 CTGTTGTTTG TCTTAGCTTG TCTAAAATTT CATTTTTAAA AAGCTGCGTG ACAAGCTGAT 2040 ATTCTTCTTT TGCAGACAAT ATCTCACTCT CAATTTGCTC CAGTTGCGAT TTATAAACCC 2100 GTAATTCATT TGCTGCCTCA ACATATTTAT TCTCCTGCTC AAGTACAGCA TGTTTTGCAA 2160 TTGCCTGTTT ATGCAACAGG CTCCTGAAAT CATCCAGACG GCTTTTTTCA ACCCTCGATA 2220 CATTTTCATA ACGGTTTATA CGGGCAAGTA TTGTTAAWCG CTCTGCTCTT TTCTTATCCA 2280 GATTCAGTTC TTTTTGATAC TTCTGATTTT GCCATGTGGA AAACTGTTCT TTTATCAAAG 2340 AAGTTAAACG CAGTACTTCC TCTTCAGATA CATTCTGAAA ATAAGGCTCA TCAGGAAGTT 2400 TCAGTTCAGG AAGTTTATTT AATTCAATTG ACCGGCTCAG AATTTGATAC CGAATTTGTT 2460 CCAGCCTGGC CTGTAACAGT GATGACTGCG TTTTTAACGT ATCAGCTTCA GCTCCCAGCG 2520 CTGTAAGCTT TAATAACACA TCCCCTTTCC GGACTGACTC TCCTTCTTTT ACGAYAATTT 2580 CTTTAACTAT CGAGTTTTCA ATAGGTTTAA TTTCTTTNTA CGCCCACTGA GTGTTAATTT 2640 CCCATTTGCA GTGGCAACAA TTTCCACCTG GCCTAAAACA GATAAAATGA AAGCAATAAC 2700 CAGAAACCCC ATAATAAAAT AAGCAACCAG ACGCGGCCGT CTGGATACCG GCGTTTCAAT 2760 TAATTCCAGA TGAGCGGGTA AGAATTCATT TTCGTCCTTT TCACGTACCG GAGTATCTAA 2820 CTGCTTCCGG ATTTTCCATG TTTCACTCCA GACAAGTTTA TAGCGCAACA GGAACTCGCT 2880 GAACCCCATT AACCATGTTT TCATATTCTT CTGTTCTTTC TGTTAGTCTG ACTGTAACTG 2940 ATATAAGTAA CTGTATAAAC TTTCCGGTTC AGAAAGCAGC TCCTTATGTT TACCCTGTTC 3000 AACAATTTTC CCTTTTTCCA TGACAATAAT GCGGTCTGCA TTTTTTACTG TAGACAGACG 3060 ATGAGCAATG ATTATAACCG TTCTGCCCTT ACATATTTTG TGCATATTGC GCATGATGAC 3120 ATGCTCCGAC TCATAATCCA GAGCACTGGT TGCTTCATCA AAGATGAGTA TTTTAGGGTT 3180 GTTCACCAGC GCCCTTGCAA TTGCGATGCG TTGACGTTGA CCTCCGGATA ATCCTGCCCC 3240 CTGTTCCCCG ACAATGGTGT TATACCCCTC ACGCAATTCA GAAATAAAAT CATGAGCACC 3300 TGSTAATTTC GCTGCATAAA TAACTTTTTC GACGGACATG CCAGGATTAG CCAGTGAAAT 3360 ATTATCAATA ATACTGCGAT TAAGCAGCAC ATTGTCCTGC AACACAACCC CCACCTGACG 3420 ACGTAACCAG TTAGGATCGG CCAACGCAAG ATCATGTCCA TCAATTAAGA CCTGGCCATT 3480 TTCAGGAATA TAAAAACGTT GAATTAATTT AGTTAATGTG CTTTTTCCTG AACCAGAACG 3540 TCCGACAATA CCAATAACCT CCCCCTGCTT AATACT 3576 (2) INFORMATION FOR SEQ ID NO: 80: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 3541 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 80: TCAGCCCGGT GAGCGGGTTT GACAATTCCG CACTCACCAT TGGGCTAAGG GTTATCAGGT 60 GGGGTTAAGG AAATGGCAAA ACCTACCCCC GTCCAAACTC CAGTCGCTGC ACATTCACCA 120 TCCCTGGCTT CTCACCTGCG CTGACATCAA TTTGTGTCAC CCGCAGCGCA TATTTTTCAT 180 CCAGTGCTTT TAACCAGTTC AGCAGGTCAT TAAACACCAC AGGTTCTATC CAGACCTGGA 240 TATTCTCCCC GCGCTCGGCA ATCCGTTTGA TGACCACCGA GTGCGCGGAA GCTGTCACTG 300 ATGACCCGCG ATACCTGTGC TGGCGTTGTC GTGCCGGATT TTCGCGCCGC AATAATATCC 360 GGCGCGGCGC TCTTCAGTCG CGCGTTCATC GCCACCAGCT GCTGCAACAT CGTCTCCTGT 420 TGCTCAATCC GTTCGCTCAA CGGCTGCCAG ATGAGAACGT AATATCCGGC GCTAAACAGG 480 AACACTACCG CTGCCAGTAA CATGCCTTTT TCACGCGGCG AACGCCCCGC CAGGTGTTGT 540 GTCAGCCAGT GTTCGCCACG GCTTAACTGG CGTTCACGCC ATTGCTGAAA ATAGTGAATA 600 AATTTATCGC GTAACATGTT ATTTCCTCCG CAACGTTACG CCGCCGGAAA CCGCATCACC 660 CTCTTTCTGT AACGCGTCCT GTTGCACAAC ATAATCTGCC GCCAGTGCGC TACGAGTTTA 720 TCGAAGCTGG CAAAGTTCGC AGCCCGTAGC TGGAGGTGAA GCGTCTGGCG TTTTTGATCA 780 AAGGTGAAAC ACGCATTTCG ATGTCGGTAA GTGACGCTGA TTTCAGGGTA CTGGCGATCG 840 CTGACAATTC TGCGAGCAGC CGGGTATCGT CGGTCTGTGG GCGATATTTT TTCAGCGCCA 900 TCGTCACCTG AGAGCGTAAA TTCACAATCC GCTTCTGCTC CGGGAATAGC GTTAAGAACT 960 GTTTCTCCGC CTGGGTGCGG CTTTGCGCCA CCTGTTCGCT GACGCTCCAT AACGTCACGC 1020 CCCGTTCCAC TACCAGCGCA ACCAGAATCA ACAATATCGG CAGAATCATC ACCCGCCAGC 1080 GCGCCCACTG TTTTCGGTAG CTGACACGAG GCTGCCACGG CCCTGTTAGC AGGTTCCCTT 1140 CCGGTTCGCC ATAAGTGGTA ATGGCGGGCA GAGCGTAACG GTCAGCGTTC GGCGTCTGCA 1200 CCAGCCCATG CAGACAGTTC TTCCGGTGCA ATGCCGACCA CGGTTAGTGA AAGCGGTAAA 1260 TCCTGCTCAT TGAGCTGTGC TCGGAACATG ACCGGAGCCA GCGCCCGCCC GGCGCTCCAT 1320 CCCCGGCATT CATCGATGCG GMAGATAACC CGTTGCGCAT CGCCAGCCAT AAACCCACAA 1380 GGAATGGACA TCCAGTCCGG CGCGACGATA GCGCGGGTGA TGCCGTTTGC CTGCAACCAC 1440 TGCGCAATGT TGCGCATATG CTGCTGGTGA ATCACAGCTA CGGTTGCCAG TTGCTGGTCG 1500 ATTTTCAACG GGGCGAAATG CAGTTCATCG ATATCCTGGT TCAGCTCTTC TTCCAGCAAG 1560 GCGGGCAGAA TCGTCGGTAT CTGCTTGCGG GGCACATCAG GCAGTTCAAC CTGCCAGACG 1620 CTGATCCATT CGCCGGGAAT GTAGAGTCGA ATCGCATCAG TTTGCAGCCA TTGCTGGAGA 1680 CATTCATCAG CAACGTCAGG CCAGATGCCG CACTCCACGT CGGCGGTACG ACGCTGCCAA 1740 CGGATGGGAG CGGAAMGNCA AAGCGGGAAA AAAATCTCAA GCATGGAACT CACTCACTTT 1800 CTCCTGTCTG ATGCCAGAGA ACAGAAAAGT GTTGTGGGCC CATGCGGACA ATTAACGAAT 1860 TCATCGTCAG TTCAATCTCA TTCACGGTGA TATCTGAACG CAGCCAGAAG TAATTGCTGT 1920 CCACGCTCAG GACGGTTTTT AGCTGTTTTT TAGTACGCTC ATCGACGTCA GCAAGTAACG 1980 GCTGTGCAAG AAACTGATCG ACATCTTCCC AGCCCTTCGC ATGACGTTGT TGTAATAACG 2040 CTCGCGCCTG AACAGGGCTT AACCACGGGT CAAACAGCGC CTCAAGAATC ACACTTTGCG 2100 TGACGTCTAA GGTATTGATG TTGATTTGCT GGCGGGTCAT CGGCAGCGCA CAGACCAGCG 2160 GTTTCAGTTT TTGATAAAGC CCGGCGTCCA TTCCCTGCAC CACGCGCATC TCGCTGATAT 2220 CAGCCAGCGG TTGATTAGCG GCGTAAAACG GCACCGAACG GGCGAGATAC TCGCTGTCTT 2280 CACGGCCCAG ACGCGTCTGC ACGCTGCGGT CTTCGTCAAT AAACTCCCAC AGGCTTTCGG 2340 CTATCAGTTC GGCCCGATAA GCAGGCACAT CCAGGCGCGT GATCAGGGCA ATCAGTTGTT 2400 GTACCGCGAG CGGACGCGAC GCCGTCGTCG GCTGAGCGAG GGCATTCAGG TTAAAGCAAG 2460 CCTGTGCGTC ACGCAGAGTG ACGGCGATTT GCCCTGCGGC AGTGGGAAAA AACGCGGGCC 2520 GGAAGCCCNA CGTGCGCCAG ATGCACGCGC TTTTCATTTT TCAGGCTCAG ACTGAGTGCG 2580 CTCAACGCCA GGCTTTCCGC ACTGGCGCTG TACCACAGCG CCTGCTGGTA CTCCTGCTGG 2640 TGCGCGTTCG CCCAAGTTGT TTCTGCATCC GCCCGGAAAG CGTGATGGTC ACCAGCATCA 2700 TAACCGCCAG CAATACCAGC ACCACGACCA GTGCCATTCC GCGTTTTGGT GGTGAGGTGA 2760 TCATGATAAT TGCGGCCCGC GTAACAACCA GATGCGTTCA ATTTCGCCCC ATTGTGGCGA 2820 ATGCAGGGTT ATGCGTACTG CCACGGGGAT CGCCTGCACT GATGACCAGC TCTCCTGCCA 2880 GCGCGTGCCG TCGTAGAACT GCAAACGGAG CGAATCCGCC GGGATTAATT TTTGCGTTGT 2940 TGGCTTCACG CTGCCTGCCG CATCGGTCAG TGGCCAGGCT AACCGTTCGA GATAACCACC 3000 ATGAATGCGG TAACCGACGG TGAGCAGATT ACTGCGCGGC AGACGCATCA ACGGATTAAC 3060 CACGCCGCCA CGTACAAAAC GCATCCCTTC ACTCTCAGAC GCCAGCACGC CAGCGCCCGC 3120 CAGTAACGCT RGTTCACGCT GGCCCTGATC GCCTCTTACC GGACGCGGCA TCATTTGTGT 3180 CAGATCGTGG GTCAGAAAAC TCATCGTTTG CTGCATGAGG TTTAGTTTTT GATCGTGTCC 3240 GGCGACGGCG CTATTCACGC GTGTAACCCG TTTGTCACCT GCTGCGCCAT CATTGCCAGT 3300 GAGGCAAAAA TGGCTATTGC CACCAGCATT TCCAGTAACG TGAAACCAGC GCGAGTCCTT 3360 CTCACTGTTG GTCTCCCACG GCGCTAAACC ANGCGCGTCG TGACTGAATC ACTGACGAAA 3420 AGTCNTCATG AAGACTGACT TCAATATCCA CNGCATGGAG CAGCGCATTA NCGGTATTCA 3480 GTGGTGTTGG TTCGCCAGAA CCAAGCGGCT TTCCTGCCAT AATCGCTCTC GGCCCTGGGT 3540 G 3541 (2) INFORMATION FOR SEQ ID NO: 81: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1234 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 81: GTACTGGACA TCTTTGATGA ACAAGCTCCT CAGTGTAAAT TGTACGTCTC TGATCGTAAT 60 CTTCCTGAGG GCGTTGAACA TCTATCCGCT GAATTTATAC CCTATACTCC TGAGTCGGCA 120 GATTTTCTGA TTCAACGTTT TTTCTCTGAA ACTATCCATA TTGAAAGTGC AATTGTTGTT 180 ACAGCACTTA AAATTGCCAA TCAGATTGCT CTATCTCAAA ATGAGACCAA GAATGTGTAT 240 CTGCTTGGAT TTGATTTTAC GATAAAGGGG GGGTTCACTA GCAAGATCCC CTGCGCAGCC 300 TTGCATGCCG AACCAGAATA TCAAGAGCGA ATTATCAGTA GTCAAGAACA GCTATTGCAG 360 ATGCTCCTTG CAGAAAAAAC ACGCCTGAAT ATCAATATCA ATCATGTTGG TAATAAGCCT 420 TACAGCGTAT ATTCTGTTGA TGCATTTAAT CAAGTGTTCG CTGCCCGCCA TCGTGGAGTC 480 GTGCTGCCCA CACATGCCCA GATTTCCACT ACATCATCAC AAAATGGGGT GAAGGTGATC 540 GCAGAGATTA CTACTAATCA CTTTGGTGAT ATGGACCGAT TGAAGTCAAT GATTGTAGCG 600 GCCAAGCAGG CAGGGGCTGA CTATATCAAA CTGCAGAAGC GTGATGTTGA AAGTTTCTAT 660 AGCAGGGAGA AGCTGGAGTC ACCGTACAAC TCTCCTTTTG GCACCACCTT TAGGGACTAT 720 CGGCATGGCA TTGAACTCAA TGAAGAGCAA TTTTCCTTTG TCGACTCTTT CTGTAAAGAG 780 ATTGGTATCG GCTGGTTTGC TTCTATTTTA GATATGCCCT CGTATGAGTT CATTCGGCAA 840 TTTGAACCAG ATATGATCAA GCTACCATCA ACTATATCTG AACATAAAGA TTATTTGGCT 900 GCTGTTGCTT CTGATTTTAC TAAAGATGTA GTAATTTCAA CTGGTTATAC TGATGAGGCC 960 TATGAGCGTT TTAYCCTKGA TAACTTTACC AAGGTTAGAA ATATTTATCT GCTGCAATGC 1020 ACCTCGGCTT ATCCCACACC GAATGAAGAT ACCCAGCTAG GTGTGATAAG ACATTATTAT 1080 AATTTGGCGA AAAAGGATCC ACGTATTATT CCTGGTTTTT CCAGCCATGA TATTGGTAGC 1140 CTTTGTTCCA TGATGNTGTC GCAGCCGGTG CAAAAATGAT TGAAAAGCAT GTTAAATTTG 1200 GCAATGTGGC TTGGTCTCAC TTTGATGAAG TTGC 1234 (2) INFORMATION FOR SEQ ID NO: 82: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 6313 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 82: ATGGGACCTT TCTTCAATGA TGTTGCCGAG TGGTTAGAGT CATTAGGTCG TAACGCTGTG 60 AATGTTGTAT TCAATGGAGG AGATCGTTTT TACTGCCGTC ATCGACACTA TCTGGCTTAT 120 TACCAAACGC CGAAAGAATT TCCTGGTTGG TTACGAGATA TCCACCGGCA ATTTGACTTT 180 GATACCATTC TCTGTTTTGG TGACTGCCGT CCATTGCACA AAGAAGCAAA ACGTTGGGCG 240 AAGTCTAAAG GGATCCGCTT TCTGGCATTT GAAGAAGGAT ATTTACGTCC GCAATTTATT 300 ACTGTTGAAG AGGACGGTGT AAACGCGTAT TCATCGCTGC CGCGCGATCC TGACTTTTAT 360 CGTAAATTAC CAGATATGCC TGCACCACAT GTTGAGAACT TAAAACCCTC GACGATGAAA 420 CGTATTGGTC ATGCAATGTG GTATTACCTG ATGGGATGGC ATTACCGACA TGAATTCACT 480 CGCTACCGTC ATCACAAATC ATTTTCTCCT TGGTATGAGG CTCGTTGCTG GGGGCGTGCG 540 TACTGGCGTA ACTATTTTAC AAAATAATGC AACGTAATGT ATTGGCTCGG TTAGTGAATG 600 ATCTGGACCA ACGTTACTAT CTTGTTATTT TACAAGTTTA TAATGATAGC CAAATTCGTA 660 ATCACAGTAA TTATAATGAT GTGCGTGATT ATATTAACGA AGTTGTATAT TCATTTTCGC 720 ATAAGGCACC GAAAGAGAGT TATTTGGTGA TCAAACACCA TCCGATGGAT CGCGGTCACA 780 GACTCTATCG ACCATTAATT AAGCGGTTGA GTAAGGAATA TGGCTTAGGC GAGCGAGTCA 840 TATACGTACA CGATCTCCCA ATGCCGGAAT TATTACGCCA TGCAAAAGCG GTTGTGACAA 900 TTAACAGTAC AGTGGGGATC TCTGCACTGA TTCATAACAA ACCACTCAAA GTGATGGGTA 960 ATGCTCTGTA CGACATCAAG GGGTTGACGT ATCAAGGGCA TTTGCACCAA TTCTGGCAGG 1020 CCGATTTTAA ACCAGATATG AAACTGTTTA AGAAGTTTCG TGAATATTTA TTGATGAAGA 1080 CGCAAATTAA TGCTGTTTAT TATGGTGTAA AATCAAAAAG CAATAGAAGG TCCGCATTCC 1140 TAAACGGTAG CAGATGATGG TTTTCATGGG CGTTTCAGGT TACTCAATCA GCCAACAACC 1200 GCAGCGAAAA CCCTGCTTTC TCGACCAGTT CAGGCCGGTT TTACCTCCAA TGCTTTCCGT 1260 CAGAACTGAG ATTTCAGCCA GTTGCCGGAT AAGTGTGTCG ATTTGCAGCA GTATACTTTT 1320 TCGTACAGCC AGAATGTGGC AGACTGAGGT GGAATAGATA ACGTCCGTAT GCCCGCTCAC 1380 CACCTCCGGG CGGGAGTGTG TGGTATCTGA CATCATCATT TTTCCTTTCT GTTTATAAAT 1440 GAAAACGCCA GCCGTGTTCA GGCTGACGTC AGGGAAGTGA AATCGGGTGA GTGATCTTCA 1500 CTGGTTCTGG TGCAAAAGTT ACTGTTGGCG CAGGGTACGG ATACCCTCCC TGGCCTGTTC 1560 GATACAGGGC AACAGTGCTG CCGAATCTGT TTTATCCTCA TCGTTGTCGA AGATAATTCC 1620 CGATTCGCAG TCGATATTGT CCTGCAGCCA CGTAATCAGA ATATCCAGCG CTGTTTCCGT 1680 GGTTAATGAT TTCATGTTGT GAATTTCCGG ATTACCAGTC GAAAGTGGGT AAACCTGGCA 1740 GACATCTGGC ACTGGCATCC AGATGAATGA GACTGACACC ATAACGCCGG ATGAGTGTGA 1800 CGACCAGACG ACGGAACGTA ACAGATAACC GGTACCGGTA AAATGAATCC ATTCTGATTC 1860 ACCAAAGTCA CTGGTCTGGT GTAACAGCGA GTACAGCCAG GCGTTGTCCT TTTCCGTGAT 1920 ATGTGCGGTA CTGCAGCGTA TGCCGGAAAG AGTCGTAAAC GGTTGTGGAG TGCAGGTTGA 1980 CTGTTGGTCA GATTCATCCA CCACGCGGAG TGAATAACCG TTTTCAGCGA CCTTGTTAAT 2040 CAGTTCAGCG AGATTAATAC CATCGACGTC AACGACAATG CGCCCCATAT TCAGTGCCTG 2100 TACGTTAACG CTGTCGGCTT CCGGCGTCAG GGAAAGTTTC ATTGTTTCAC CTCCGGGTGC 2160 TTACCCAGGA TAATATTATT TACCGCTCTG TAATTGTCGC GGGTCATCAG GCCGGTCGCC 2220 CTGCGAGCCC GGAGGATATC GATGCTGTTT ATTAACTGAG AGCGGGTACA GGCGCTGAAT 2280 CCCGGCTGGT CGGTACGCAC CAGCGCGTAT TTTTCCACGA GAAAGTTCAC CGCATCACAC 2340 AGTGAAATGC CTGCCTCAAT ATGCTGCTCG ATCACACGTT CATCGGCAAA CGGTGTGTCA 2400 TTCAGTGTGA GGCCGTAGTG CTGGTCCAGC AGTCGGGACA GAAGTATCTG CCAGATTTCA 2460 ACAGGAGACG GGCGAGAACT GGCCGCCTGC CCGGGTAATA CAGGTAATGT TTTCATACTG 2520 AAGATTTTCC TGATATGCAG ATATAAAAAT GGGAAAGTGG CGTGGTGAAA ACACCAGGCC 2580 GTAGCAGAAG GCTATTCTGG AGAGTTAATT TTTCATTTCG GGCGTCGGAT AAACAGCCAG 2640 ATAAACGTAA CCACAACTGC TGAGGGTATC GGCTTTGCAG GTCAGCCCTT TTGCATACAG 2700 CGTGACGGTA TGCTGATGGC GGGGATTCAG TTCACCGCTG GTGAGCATGA GTTCCAGTTG 2760 TTTCATCAGC AGCGGAAAGG CCTGGTCCAG GTGGTACGCA TCTGCATTGC TGTATAGGCC 2820 TCTGATACCG GCGCGGTCGG CAAGGTAATG CAACCGGTTA CCCTCCTGCA CCAGACGTGC 2880 CCCGAAACAG GGCGTCACGG TGCAGGGCAG CCCCCACCAG GGGCGGTCGT GATTGTCGTC 2940 GGGAAGTGTT GTCCCGGGGA GTGTGTCTGA CACGATAAAA TCCCTACAGA AAATCGGCTA 3000 AGAATGCTCC GGTATTGGCG ATAATTCTGC TCATCAGAAT TCCCACTCAG TTCAGGGTGA 3060 CGCTCATCAG CCGGACATAC GGGCCAAAAC TGTCCTTACG GCGTTCAGCA AACACGGCCA 3120 GCACACCGGG AATATCCTGT ACTTCACGAC CGGTATACGC CTCAGCACTG CCGTGCCAGC 3180 GGTACTTACC GGTGCAGAAC GGAAATAGAC GGGATGCAGG ATGCTGTTGG TGAATACGCA 3240 TGGCTTCACC ACGGGTGATG ATTTTCATAA TGGGATACCT CTGAAGACAG AAGATAAAAG 3300 TGAAAACAGG TGTGATGTGG TTGTGACGGT GACGGGTTAA AGCAGACCGT GTTCCGCAAA 3360 GGAGAAAACC TGACTGCCAC CAACTATCAG ATGGTCCGGT ACCCGGATAT CCACCAGGGC 3420 CAGTGCCTGT ACCAGACGTT CCGTGATAAG GCGGTCTGCC TTACTGGGGG TGACTTCACC 3480 GGACGGGTGA TTGTGTGCCA GTACCACGGC GGCGGCATTG TGGTACAGGG CGCGTTTAAT 3540 CACTTCCCGG GGATGGACTT CCGTGCGGTT GATGGTGCCG GTGAAGAGGG TTTCACCGGC 3600 AATCAGCTGA TTCTGGTTGT TCAGATACAG TACCCGGAAC TCTTCACGCT CCAGTCCCGC 3660 CATCTTCAGA ATCAGCCATT CCCGTGCCGC ACGGGTGGAG GTGAAGGCCA CGCCGGGTTC 3720 ATGAAGATGG CGGTCCAGGG TTTTCAGGGC CCGCAGAATG AGACTGCGCT CGCCGGGCGT 3780 CATCTCTCCG GGCAGAAAGG AAAGTTGTTG CATTGTGCTT CTCTCCATTC AGTCGATGAT 3840 GCGCATAATG GCGCTGCATT CCGGATGCTG CAGGGCGTAA TCCCGCAACC GGTAATAATG 3900 GATCGTCATG GCATAACACT CCGTACGACA GGCATGATGA CTGTACGTCA TCAGACAGGC 3960 GGCAATGCCG GCGGCTTCCG GGCTCATTTC AGCGCGGTTA CCGTTCATGG CATTGAACAG 4020 TACCCAGTTT TCGTCATCAT CGTCATCCGG TTCGGGTGCC ATAAATGCCC CGCCGTTGTT 4080 CAGGGTGTAC AGATTCCAGA TACCACCGCA GTAGTCTTCG CACAGACGGT CCATCCAGCC 4140 GAAGACACGG GGCTCCAGGG TCACCCACTG TGGAATGAGG CCAAAGTGCT GCGGCCAGAA 4200 GCTGATGCGC TGTTCATCAG GGACTATGGT GGCAACCAGC TGAGGCTGGT CATTCCCTGA 4260 TGCAGCGGTT ACGGAAACAG AAGGAGTGGT GGAATTATGC AAGACGGTTG TCATGAGATT 4320 ATTCCTTATA AAAAGTAAAT GAATGGAAGA AACCCCGGGG GAAGGGACAG ACGTGAGTCA 4380 GAACTGCGCT TTCAGGGAAA CGGCATCAGC GCATACTCTC CAGCAGCGTT TCAGCCATCA 4440 CCCACAATGC GCGGTTGAGC TTAATGTCGG TGTCGATGCT GTGAATGGCA CGGGTATGGA 4500 TACGTTTTCC TCTGGCACTG CGACCGGAAA TTCCGCCTTT CAGCATATTC TCCTGAATGG 4560 TCTGATAAGC ACTCCACAGG TCCTTACCGT AATCCTCCCG GCGTCGTGGT GTCAGAATGT 4620 CGGCGGTGGT GACGGGCTGA TGTTCGTCAC CATAACGGTA AGTCAGTGCC GCCTGTGCCA 4680 GCGCCTGGCG TGCCGGTGGC GGCAGAATCA GCGACTGCAT GGCATCACGC TTTTCCTCAA 4740 TCCGGTCAAA AACCCCCACC ACCTCGTAAG CCCCTTCAAT AACTTTCTCC ACCACATTTC 4800 CCCGGTGCGG AACACGCACT TCCCCCAGAG ACTGACCACA GACGCATCCG TTCTGGCAGA 4860 CGAACCTGAA GTAACCCGGC AGCATCTGGT AGCTGGAGGT ACCGTCATGA GAGTTGAGCA 4920 GAATAATTTC AGGGACATGT TCTCCGTTTA TCTCTCCGGC CCGCCGCAGA CGCAGCATGT 4980 GTTTGGTGTA TTCCCGGCGG TCCGGGTCAC GTACGCGGGT CTGGCAGGCG AAGAATGGCT 5040 GAAAGCCTTC CCGCTGCAGG CTTTCCAGTA CGGTGATGGT GGGGATGTAC GTATAGCGTT 5100 CACTGCGGGA GGTATGCCGG TCTTCACCGA AAATACCCGG TACATGGTGC ATCAGTTCTT 5160 CGTGTGTCAG CGGACGGTCA CGGCGTATCT GGTTCGCATA ACCAAAACGA CTGGCTAGTC 5220 GCATAATTTG CTCCTTATCG GTGGTTAAGA TTTACTGGTG TAATAAATGA AAAAGCCACG 5280 TCTCCCGGAG AAGACGCGGC CTGACAGATG AAATGAATGA CGTTTATTGT CTGAGAAGCC 5340 CTTAACTGGC GAGCTGAGTA TTAAGCTGTG TTCCGGCATC ACCAGCGCAA CTGACCTTCA 5400 GCATTACGGA TAACCAGCCG GGAATATGTT CCCTGGTCAT CTTCAGTAAA CACATTGCGG 5460 TAAGCTGTTA TGACAGCAAC CGCCTGCCCG TATGAGAAAG ATCCTTCAGC CAGGACATAC 5520 TCTGTGTGTA ACCCGGCATA TCTGGTTTCT CCTGATAAAT AGCCTCTGCC ATACGTTGTG 5580 GCAGAGGCTG AAGCATGAAA CTGACTTCAG GGATCAGTTA ACATTTTTTC CGGAAACGGT 5640 AATCAGCAGT GGATGGTAGT CCTGGGGATC GAAAACCGAT AACGGCAGAC TGACACGATG 5700 GCCGTTACTT TCTTCAGTTG CTTTAATGAT TTCGGTTGTG GCGACATTTT CCACGCACTC 5760 CGTTTCCAGA AATGCGTCTG TGGTTCGCGT GGCATTACTG TCACCAAAGG CTTCCGTTTC 5820 CATTTTTCTG GTCACCAGCG TCTGACCATA TTTGTCTTTG AGTTGCAGAG TGATGGTGAG 5880 GGGGCCAAAT CCTTCATCGT TTCCGCCATT ATCCAGCCGG AACTGGTAAG CACAAATATT 5940 TCCCGGGAGC CATATCGTAT CTGTATTGCG TATACTGATG TAACGTTGAT CCTGTGCCCG 6000 GAGTGGGGCA GACCACGTTA ACCCCAGAAT GAAGGCGGTA ATCATGCAGG TTTTGAACAG 6060 GTGAATCATG GTATTTACCT CTCTGAGTCA TGACGATTAC ACTGACAAAT CAGGTGATAA 6120 AACGTAAAAG GCGCAGAATA GCCGTTATGC CGGTAACTCC GGGGGTAATG TTTCTTCCAG 6180 TCGGTTAACC ATATTGCCGA GATGGGATGC ATCATATTCC ATGACGGGGC GTTGCCTGAT 6240 GATACTGACC ACCAGTGGTT TGATTAACAT GTTGGTCGCG GCCCGTTGTT GTATACCGGC 6300 GGCGAAAATG ATC 6313 (2) INFORMATION FOR SEQ ID NO: 83: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 432 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 83: CGTTGGCCGC TTGCGCAGAT AAAAGCGCGG ATATTCAGAC GCCAGCACCG GCTGCAAATA 60 CGTCTATTTC AGCAACACAA CAACCAGCTA TCCAGCAACC GAATGTCTCC GGTACCGTCT 120 GGATCCGTCA GAAAGTCGCA CTGCCGCCTG ATGCTGTGCT GACCGTGACA CTTTCTGACG 180 CGTCGTTAGC CGATGCACCG TCAAAAGTGT GGCGCAGAAA GCGGTGCGTA CTGAAGGTAA 240 ACAGTCACCA TTCAGCTTTG TTCTGTCATT TAACCCGGCA GATGTTCAGC CGAACGCGCG 300 TATTCTGTTG AGTGCGGCGA TTACCGTGAA TGACAAACTG GTATTTATCA CCGATACCGT 360 TCAGCCGGTG ATCAACCAGG GCGGAACTAA AGCCGACCTG ACATTGGTGC CGGTACAGCA 420 AACCGCCGTG CC 432 (2) INFORMATION FOR SEQ ID NO: 84: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 3494 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi ) SEQUENCE DESCRIPTION: SEQ ID NO: 84: GGGCTGATTA CGATTTTATC AATCTGTCTA TAGAACATGA ACTGAATGAA GGAATAGCTG 60 GCAGAGAGAG GTTATGCCGG ACTGGCGGAT AACCGGAACC GGTTGGCAGA GGTGGTTACC 120 CGTAAATTGC AGGACAGCTT TTATATGAAC TTTCCTGGGA TGCGCTGAAC ACGGCATACA 180 GTGAACACCC AGAGTGGTTT TCCGGGCTTG TCTCCGGGGA TGAGAATTAA AAAGTGGATT 240 ATGCTGCTAT AGCGCGGCGT GATTTCCTGC AGGGATTTCC ATTTATAAGA ATACGCCGCT 300 TCGGGGAATC TCCGGTTCTC CTGAGAGTTA CGATTGTTTT TTTACTCAAA TCCACAACAC 360 CTGAACTGGA ACTTGTGTTG CATCCCTGAT TGTTACTCTG CAGGAAACAT CTTTTTTACC 420 ATCAAAGGAT GACTGTTTTC CTTTCTCCCC TCCGTAAAAC ACAACTTCGA TCACATTTCT 480 GACATTTTTT CCAGATTTTA CATAACAGGA TTGTTTCTGT ATGTTTTTTA TCTGGTGTAA 540 ATTTCAGCAC TGACATTCCG CTTACGTTAA TTTACACTGA ATACCCCACG AGGAGAATAT 600 GCAGCACCGG CAGGATAACT TACTGGCGAG CAGAACGTCG TTGCCTGGTA TGGTTTCCGG 660 TCAGTGCGCA TTTAAGCTCC GCACTTTCTC TCCGGTGGCA CGCTATTTTT CCCTCCTCCC 720 CTGCCTTTGT ATTCTTTCGT TTTCGTCTCC GGCAGCCATG CTGTCTCCGG GTGACCGCAG 780 TGCAATTCAG CAGCAACAGC AACAGTTGCT GGATGAAAAC CAGCGCCAGC GTGATGCGCT 840 GAAGCGCAGT GCGCCGCTGA CTGTCATACC GTCTCCGGAA ATGTCTGCCG GTACTGAAGG 900 TCCCTGCTTT ACGGTGTCAC GCATTGTTGT CCGTGGGGCC ACCCGACTGA CGTCTGCAGA 960 AACCGACAGA CTGGTGGCAC CGTGGGTGAA TCAGTGTCTG AATATCACGG GGCTGACCGC 1020 GGTCACGGAT GCCGTGACGG ACAGCTATAT ACGCCGGGGA TATATCACCA GCCGGGCCTT 1080 TCTGACAGAG CAGGACCTTT CAGGGGGCGT ACTGCACATA ACGGTCATGG AAGGCAGGCT 1140 GCAGCAAATC CGGGCGGAAG GCGCTGACCT TCCTGCCCGC ACCCTGAAGA TGGTTTTCCC 1200 GGGAATGGAG GGGAAGGTTC TGAACCTGCG GGATATTGAG CAGGGGATGG AGCAGATTAA 1260 TCGTCTGCGT ACGGAGCCGG TACAGATTGA AATATCGCCC GGTGACCGTG AGGGATGGTC 1320 GGTGGTGACA CTGACGGCAT TGCCGGAATG GCCTGTCACA GGGAGTGTGG GCATCGACAA 1380 CAGCGGGCAG AAGAATACCG GTACGGGGCA GTTAAATGGT GTCCTTTCCT TTAATAATCC 1440 TCTGGGGCTG GCTGACAACT GGTTTGTCAG CGGGGGACGG AGCAGTGACT TTTCGGTGTC 1500 ACATGATGCG AGGAATTTTG CCGCCGGTGT CAGTCTGCCG TATGGCTATA CCCTGGTGGA 1560 TTACACGTAT TCATGGAGTG ACTATCTCAG CACCATTGAT AACCGGGGCT GGCGGTGGCG 1620 TTCCACGGGA GACCTGCAGA CTCACCGGCT GGGACTGTCG CATGTCCTGT TCCGTAACGG 1680 GGACATGAAG ACAGCACTGA CCGGAGCTGC AGCACCGCAT TATTCACAAT TATCTGGATG 1740 ATGTTCTGCT TCAGGGCAGC AGCCGTAAAC TCACTTCATT TTCTGTCGGG CTGAATCACA 1800 CACACAAGTT TCTGGGGGGT GTCGGAACAC TGAATCCGGT ATTCACACGG GGGATGCCCT 1860 GGTTCGGCGC AGAAAGCGAC CACGGGAAAA GGGGAGACCT GCCCGTAAAT CAGTTCCGGA 1920 AATGGTCGGT GAGTGCCAGT TTTCAGCGCC CCGTCACGGA CAGGGTGTGG TGGCTGACCA 1980 GCGCTTATGC CCAGTGGTCA CCGGACCGTC TTCATGGTGT GGAACAACTG AGCCTCGGGG 2040 GCGAGAGTTC AGTGCGTGGC TTTAAGGAGC AGTATATCTC CGGTAATAAC GGTGGTTATC 2100 TGCGAAATGA GCTGTCCTGG TCTCTGTTCT CCCTGCCATA TGTGGGAACT GTCCGTGCAG 2160 TGACTGCACT GGACGGTGGC TGGCTGCACT CTGACAGAGA TGACCCGTAC TCGTCCGGCA 2220 CGCTGTGGGG TGCTGCTGCC GGGCTCAGCA CCACCAGTGG CCATGTTTCC GGTTCGTTCA 2280 CTGCCGGACT GCCTCTTGTT TACCCGGACT GGCTTGCCCC TGACCATCTC ACGGTTTACT 2340 GGCGCGTTGC CGTCGCGTTT TAAGGGATTA TTACCATGCA TCAGCCTCCC GTTCGCTTCA 2400 CTTACCGCCT GCTGAGTTAC CTTATCAGTA CGATTATCGC CGGGCAGCCG TTGTTACCGG 2460 CTGTGGGGGC CGTCATCACC CCACAAAACG GGGCCGGAAT GGATAAAGCG GCAAATGGTG 2520 TGCCGGTCGT GAACATTGCC ACGCCGAACG GGGCCGGGAT TTCGCATAAC CGGTTTACGG 2580 ATTACAACGT CGGGAAGGAA GGGCTGATTC TCAATAATGC CACCGGTAAG CTTAATCCGA 2640 CGCAGCTTGG TGGACTGATA CAGAATAACC CGAACCTGAA AGCGGGCGGG GAAGCGAAGG 2700 GTATCATCAA CGAAGTGACC GGCGGTAACC GTTCACTGCT GCAGGGCTAT ACGGAAGTGG 2760 CCGGCAAAGC GGCGAATGTG ATGGTTGCCA ACCCGTATGG TATCACCTGT GACGGCTGTG 2820 GTTTTATCAA CACGCCGCAC GCGACGCTCA CCACAGGCAG ACCTGTGATG AATGCCGACG 2880 GCAGCCTGCA GGCGCTGGAG GTGACTGAAG GCAGTATCAC CATCAATGGC GCGGGCCTGG 2940 ACGGCACCCG GAGCGATGCC GTATCCATTA TTGCCCGTGC AACGGAAGTG AATGCCGCGC 3000 TTCATGCGAA GGATTTAACT GTCACTGCAG GCGCTAACCG GATAACTGCA GATGGTCGCG 3060 TCAGTGCCCT GAAGGGCGAA GGTGATGTGC CGAAAGTTGC CGTTGATACC GGCGCGCTCG 3120 GTGGAATGTA CGCCAGGCGT ATTCATCTGA CCTCCACTGA AAGTGGTGTC GGGGTTAATC 3180 TTGGTAACCT TTATGCCCGC GATGGCGATA TCACCCTGGA TGCCAGCGGC AGACTGACTG 3240 TCAACAACAG TCTCGCCACG GGGGCCGTCA CTGCAAAAGG TCAGGGCGTC ACCTTAACCG 3300 GCGACCATAA AGCGGGAGGT AACCTGAGCG TCACAGCCGG AGCGATATCG TTCTCAGCAA 3360 TGGAACGCTT AACAGCGACA AGGACCTCAG CCTNGACCGC CGGCGGCAGA AATTCACTCA 3420 ACAGAATGAA AAACTGACTG CCGGCCGGGA TGTAACGCTT GCCGCGAAAA AACATCACAC 3480 AGGGTTACCG GCCA 3494 (2) INFORMATION FOR SEQ ID NO: 85: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 9319 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 85: GNCCCAAGCT TAGGTTCGCG GCCGCAGTAC TGGATCTATT GCCAGCTTCA CCGCCAGACT 60 GTCAGTCAGT ACATCACCGT ATTTCTGCTG GCAGGTTGCC GGGCGGCTGC ACAGTCACTG 120 ATCAGTTGCT TCTGCTGTGC CGTACTCAAC TCTTCGTACT TTTTGATAAT ACCGCCGCAG 180 TCACCGCCTT TCGCCTGACA GGACTTCATT TCAGCAGAGC AGGCATCTAT CTGCTTATTG 240 CTCAGGTAGT TATTCTCAAC AACAACCACA GGGGATTAGA AGCCTTTTAG CCTGAAATAT 300 TTTGCGAGAG CACATCCAAT ACCAATAAAT GAGCCAATCA CACATCCGAT AAACAAAACA 360 TGCCGAATCT CTTTCAAACT AATATTTAAA TTACCTGTTA TCAACCACTC CACCAAAGAA 420 AAAAACACAT CAATACATAG GAATGACACC ACTATAGAAA GAAATGCGAT TATAAAAATA 480 ATAAACAATT CTGATAAGTG CTGAGAATTG CCGCTCATTT TTTCACCTCC GGAATGTAAG 540 ACTCAATCTT TTTACCTTCA TACTCAGAAG CAAAAGAAGC CGACACATCC CCAGCTATAC 600 CAGGAATCCT ACTGGGTGTC ATTTCTTTTG ATAGCCCCAA TTCTCCTTTA ATATCGGTAT 660 ATTTTTGAAG TGTTGGATTA AATTTCGGGT CCCAGCCGTC TTTTAACCAG TTAGCACCAC 720 TATTAATGCC CCATGAAAGG CCTTTACCAA TGCCATATCC AATAGCAGAA CCAGCACCAT 780 TGATCAACGC ACCAGATGTT GGGGCTTTTC CTTCGAGCCA GTTTCCTAAT GCTCCTCCAG 840 TTGCATTCCA GCCAACTGTG CCTACAACTC CATTCCCTGC ACTAATCACA TTAACCCAAC 900 CACCGATAAT CGCTGTTGTA GGATCTATAG TTCCATCCGT CAGATAGCTA ACACCTGCAT 960 TAGCTCCTGC CCCTAATCCC CACATGGCCT GAGCACCGCC AGTAAGAGAG CTACACTACC 1020 AGTGGCCAAC GCTCCGGCAT ACGCTTTATT GACTGCTTCT CCTCGCTTAC AGGCTTCACC 1080 GCCTGGGGCA TCGTTACAGG AAAGTACATC TGCGCCATGC GTCTGAGCAG CTTTGCTCTG 1140 CTCGGACTCT GTGCCACCAA CCAGGTTATT CTCAGCAATG TTCTTCCCGA CACCAGCCCC 1200 AGCAGCCGCG CCAGCCACAT CGCCACTGGC AATGCCGCCA GCCATACCCG CTGACAGCGT 1260 TGCCAGCGTG CTTACGGTTT GCTTCTGATC TTCTGTCAGT TTCGACGGAT CTACGTCCGG 1320 ATAGAGGCTT TTCGCAATGG CTGACGAGAT CACTTCACCA GTACCCGCAC CAATTGCGCC 1380 TGCTGCCGCA CTGTTGCCCT GAAGGGCTGC TGTCACACCA CCGAGAATGG CATGGGCAAT 1440 GGCTTTTGCC GCTGTATTGT CATCAATACC CGCGTGATGA CCGATGATGT TCGCCAGCTC 1500 CGGCGCCGAA GCTCCGGCCA GAGCACCTGC TAAATTACCC CCCGCCAGCC CCTGAAGTGC 1560 AGCCGTTGCA GCCTGGATAC CGCGCTGCAT ATCGCTGCCG GTACCATACT TTTCCTGTTC 1620 CTTTTTGTAT TCCGGCGTAT CACGCAGTTT TGCCAGATAT GCCTGCCGCT GTTCTTCCGT 1680 CGCATCCGCC GGAACAGGCC CATATTTATC CTGCGCAGCT TCAACGCATT CAGTTCCCCC 1740 TGCGTCCGCG CAATATCCGC CACCTGACTG CCTATGTCAC TGATAAGCCC CACTGTCTGC 1800 AGACGCCTCT GCTCCTTCTC CTTGTCAAAT ATCGGGCTGA TACTGTCATT AGCGTGCGCA 1860 GGGTCACGGC TCAGGTTCGC CAGATTCTGC TTCTGATTGC CCCTGTCCCG GATGGTGATA 1920 GTGCCTTCTG CCACTGCGGC CTGAGTCGTT CCTTCCGCAT GTCCGCTGTG ACCTCCGGCG 1980 GATATCATGC CACCCGGCAT GTTACCCTGA AATTTATCCC CGAAGCTGCC ACCACCGCTC 2040 AGACTGATTC CACTGTGACT GACTTTATAA TCCGCTTCGT TGTGAAGGTC ACTGAACCCC 2100 AGCGTTCCGG TATCCAGGTG GTTTTTATCC GGTGTGGCAG TGGAGGCAAT CACCGCACCA 2160 TCCAGTTGGG TATGTTTACC CACTGTGATG TCGAAGCCGC CGTCACCGGC AAACATTCCG 2220 GTTTGTTCAG CAACGGAGTC AAAGCGGCTC TTCATCTTAT CCCGGGAGGC AGCGATGTAA 2280 CCTGAGCCGG TCATGGAGCC AAAGGTAAAA CTGCCGCCGG CASCCACGCT GGTCTGTTTA 2340 CTGTCGTACT TACTGGTGTC CTGCTGGCTG CTTATCAGCA GGTCGTGGCC CACATCGGCG 2400 ATAATCCTGT TGCCGTTGAC CTGAGCACCG TTCAGTACCG TATCCCGACC ACTGTTGATG 2460 GTGACGGTTT TACCGCTGTC TGTTGTGGTT TCAGTCCACT CAGTACCGTT ACCTTTCTCG 2520 CTGCCTTTTG CCGCATTAAC GCTGGCAAAG ACACTGATAC CGGCACCTTT ACCTGCACCG 2580 ATACTGACAC CCACGCCACC GCCACTGCTG CTGTTCCTGC CCGTTGTTTT TTGTGTGTTT 2640 GCCGCGCCAC TCAACAGAAC ATCATTCGCA GCATCCAGGT TTGTGTTACC ACCGGCCTTA 2700 AGCTGGCTTC CGGCAATCAC AATATCTCCG CGGTTATCGC CCCTGTTTTT ACCGGTTGCG 2760 ACAACAGACA GATTATTCCC GGCATTCAGC GTACTGCCGG ATACTGTGTC ACTTTCAGAA 2820 TGTTGTTGTG ATTTCGATTT CTGGGTGGTG AGCGACAGGC TGACTCCCGT CGCATTCGGG 2880 TCACCGGTTG CGGAGGCCAT TGCCGCAGCC TGTCCGGCCT GCACACCAGA CAGCGCTGTC 2940 TTTGTAGCCT GCAGGGTTTT CAGACGGCTG TCACTGCTCT CCTTCGTCTC CTGTGCACTG 3000 GTGACCGCAT TATTGATGGC ACTGCCCACT GTGCCGGAAA GGGCAACCGT CAGCCCGCTT 3060 TTCTTCTGCT CAAATTTTTC GTCCACAGTA CGACGGTCAT GCCCCGGGTC AACCACCACA 3120 CTGTCACCGG TAATGCTGAT ATCCCGGTTC GCAATCACAT CCGAACCGCT GATATGAGCC 3180 TGTTTGCCCG CGGTAATACT GACATTACCG GCAGTGGAGC CGATGGTACT GGCACTCTGA 3240 CTCTGCGTTG TCCCGGCCTC GCGGCGGTCG TGCGTTGTCT TACTGCTGCC AATGGTGAAG 3300 CCAATACCGC CGGTACCCAT CAGACCGGAT TTCTTCGTTT CCTTAAAGCG CCAGGACGTA 3360 TCTGTACTGG TGGCAGCAAG AACATCAACA TGGTTACCCG CCGCCAGTGA CACATCCCGG 3420 TCAGCCACCA CATCCGAACC CTCTACCGTC AGGTTATCAC CGGCGTTAAC GGTCACGCGG 3480 TTCCCCGACA GCAGGGAACC TGYTTCACGG GAGGCACTGT CCTCACTGAT GGTGTGGGTG 3540 GTTTTCTTAC TGAGAAAACC TCCGCTTTTT TTCTTCGTTT CCAGATAGTG ATAGTCACTT 3600 TCTGTCGCCG TGGTCAGGGC AACATCACGA CCGGCATTCA CGCTGATATT GCCGGTTGCG 3660 GTAACGGATG ACGCAACAGC GGTGATATCC CGTCCTGCGG TGACGGTGGT GTCACCACCK 3720 CTGGCGATTT CCGTTCCCTG CTGACGGACT GTCTCGTTAA TCTCTTTCTT TTTCTTCGAC 3780 GTATAGCTGT CGCCTGCGCC GGCAGACTCT GCCACCAGGT TCACATCACG TCCGCCCCGG 3840 ATGACCACGT TATTTTCCGC AGCCATACCG GCAGCCTGAC TGGCAATATC ACGACCGGCA 3900 ACAAGGAGGA GGTTATCGCC CGCCGTCACC GTGGACACAG CTGCGTGGCT TTCATGACTT 3960 TCTGACCTGC CGTTGCGACT GTTTTTGCTT TCCCTGACTG CATTCAGACT CAGGTCGTTA 4020 CCTGCAGAAA GCAGGGCGCT GTGCCCGGCA GAAACAGAGG ATGCTGTGAC ATCCAGATTA 4080 TGGCCTGCAG CCATCGCCAG GTTACCGCCG GCGCTGATGC TGCTGCCCTG TGAGGTGGTG 4140 GATGATGAAC TGTTGTCATC AGTGTGCCAG AAACCGGACT GACTTTTGCT CCCGCTTATC 4200 AGGTTTACGG CAATGTTGAT GTCATTACCC GCAGACATTC CAAGGTCTCC ACCGGACGAG 4260 ACCGTTGCCC CGGTAATATC AATGTTTTTC CCTGCATCCA GTGAAAGTGA ATCAGTGCCT 4320 TTAATGGTCG CAACCGGACC GGTGTCCGTA CCGCTGAGAT GCACACCACC ATATCGGCTG 4380 TCACTGCCCG CATTCCATTG CTGACGCCGG GTGATATTGC TGATGTTGCC ACTCACGCTT 4440 TCCAGTTGTA CGGTTTTACC GCTGATGACT GAGCTGATAT TGCTGATATC CCCGATGGCG 4500 CTCAGGTCCA GGCTACCGCC CGCGCTTATC AGCCCTGCAT TCAGGTTGTC GATATAGCCG 4560 GTACTGTCGA GCGAAAGGTC GTTCTGTGCG TTGATGCTGC CGCCGCTGTT GGTGATATTG 4620 CCGTCCGCAA GCTGCACGTT GTTCCCGCTG ATAACGCTGC CGTTATGCAG GGTGATATCT 4680 TCCGGCGACA GATACAGTTT CGGGACCATG ACTGTCTGTC CGTTGATGGT GACTGACTCC 4740 CACCACAGCA TGCTGCCGTC AAGCTGAGCA ATCTGTTCAG CTGTCAGCGC CACACCAAAC 4800 TCTAATCCCA GTCCTTTCTG TTGTCTGGCC GCGTTATCCA TCAGATACCG CATCTGTTCC 4860 GTGTCTGAAC CCAGTCCGTT GAGATAACGT GAACCCGTCC GGCTCAGCAC CGCGTTACTG 4920 ACATACCGGG TATCAAAGAC CGCATCCCCC AGGAAACGAT AATCTTTTTC CGGTTTCAGC 4980 CCGAGGCGGT CAAGAAAATA CGATGAGCCC AGAAACTGTT TTTCATCGGT ATACGACGGA 5040 GCCGTTTCAC GTGGCGCCTG ACCCGGTTTC GCTCCAAGAA GCTCATACAG TCCGGCAAAC 5100 AAATGGCTGT CCACCTGTCC GAGACCATCC AGTTTCGGGT TCACCGTAAT CAGATACGGA 5160 CTGTCCGGGT CCGTGGACGG AACCAGGTAT CCATTGTTGC CGGAAGGCAG TGGCCAGTCA 5220 TCACTGATAC CGGTCTGACC GGTCAGTGGC GAACCTCCGG CAATATTTTT CAGGGCACCT 5280 GCCAGTTCAT CGTGCCATTG CGGAGAGCCA ACCACCACCG GCTCATACTG CTGCAGCGCT 5340 GTCTGTGTCA GACTGTCTCC GCCGGTCTGC TGACTTAACG TATTCAGTAC AGGTGCAGAG 5400 ACCACCGGAC TGACACTACC TGCATGTGCA GTGGTTGTTC CGTTATTGAT ACTGCTGGTA 5460 AAACGGGTCT TAACATCCCC GCCCGCCTGA ATAACGGAAT AATACGTCTT ACCGGGCGTG 5520 TAATCTTTTT CCCGGCCATC CAGTGAAAAT CTGATGGTAT TGTTTTCAAA TTCCGGTGAC 5580 AGCAGGGGCA GTTTATCCAG AGAGCCTGTT GCATAGCTAC CGTAAAACGT TTTCGGGTCG 5640 TAGCGGTATA CCAGATATTC ATTCTCTGTC CCCGTCTGCC AGCTCTGATT GCTTAACTCT 5700 CTGCCCGAGA GTGCGATATC CCCATTCGCC AGGATAAATG ACGCCCGGTT TTCCAGTCGT 5760 TCAGCCTCAG CAGAAAGATT ACGCCCTGAC GCAATGCGGC CTGCCGGATT ATCAGCACCG 5820 GTTACTGTTG TGATGTTCTG GCTGCTGAGA AAGCGCTGTG TGGCACTGTC AGCAAACGGA 5880 GCGTAATAAT AAAGCGTATC CATTGTGATA TTGCATGCCC CGTGCCCGTT GCAGGGCGTA 5940 CCGTGCTGAT TTTCAACTTC ACGGGTGAAA TAGCCATAGC TGCCGTCAGG AAGAAGGGAA 6000 AGGGGAATAT CAACCAGAGC ATTTCCCATT CCCTGAATGG ATGAGGGGTT AGTCCGGGTT 6060 GTTGTTGTGG CAGAAAATCC CTCCCGCTGG TTCAGAAGAT GCCCGGTTCT TACAACAATA 6120 TCGCCCTGAT GCGTCTCAAT ATTCCCGGAA GTATTGATAA TCTCTGTGTT TGCACCGCCG 6180 GAAGCATCCT TCTGTACCCA CAGACTGTTG CCGGCCAGGA TATCACCATG CTGGTTATGC 6240 AGACGGTCTG TAAACAGCTT CAGGTTATTC CCCGCATAAA TCAGCGCACT GTTCAGCAGG 6300 GTACCGGCCA CATTCATTGT CAGACTGCCT GCCGTGCCGG TAAAACCACT GATGGTGATA 6360 TCACTCCGGC TGTTCAGACT CACATCGCCA CCGGCCTGAA GTGAACCCGG TGCGTTAAGG 6420 AAAAGACGCT GTGCGCTGAA AACACTGTTG CCTTTACCGG CAGTCAGCGT TCCATTGTTG 6480 GTGAATGCCT CTCCGGCACC GAGCACCATG GCATCACCCT GCATGACACC GCCGTTGGTG 6540 ATGGCATTTT GCGACGTGAC GGAAAGGGTT TTCCCTGCGG CCAGGGTACC GTAATTCGTG 6600 AGGGCAGCAA TCAGTTTCAG TGTGACATCA CCGGTGGCCA CCACCTGCCC CTGACCACTG 6660 AAGTCCTGAG CGTCAAGCAG CAGGTTGCCT GCACTGTACA GCCGCCCTGT ACCATTTTGC 6720 AGCAGTGAAC TGCCCTTGAC GCCAAGCCCG GAGGTTCCCA GCAGGGTACC GCTGTTGCTG 6780 AATGTGTGGT AATTCACCAG CAGGTCCGCA CCCTGAAGCG TACCGGTATT ATTCAGCGTG 6840 GTTCCTTTAA CGTCGGCACT GCCGGTGGCA AGTACGCGTC CGCCGTTGAC AGTATTCACC 6900 ACATCCAGCA GCAGGGTGGC AGCCTGTACC AGTCCGCTGC CGGTGTTCGC CAGCACCTGC 6960 GCCGTCAGCG TGAGGTTACT GCCGGAGAGG ATTTTGCCGT CGTTCTGCAG ACGGTCAGTG 7020 GCGTTCAGGG AAACCCCGCC ACCACCCTGT ATCGTGCCCT GGTTACTCAG GGTCGCAGTA 7080 CTGACATTCA GTGCATTCCG GCTCATCAGA ACACCACCGG AACGGTTGTT CACGCCACCG 7140 GAGGCGGCCA GCGTCAGCGT TTCGCCCTGC AGATGCCCGC CGTTTGTGAG TTGTCCTGCC 7200 GTGATGGTGG TGGCATTTCC CTGTAATTGC CCGTCGTTTG TGACACTGTC TGCCTTCAGC 7260 GTCAGCACAC CTGCACTGAG CAGTTTTCCG CTCGCGTGAT TGTGCAGCGT CTGATTCACC 7320 GTGAGCGTGA GAGCATCCAC ACCGGTGATG TCACCCGCAC TGGTCAGTGA GTTCGCCTTC 7380 AGGGTCAGAT TTTTTGCAAT CCATTGTCCG CTGTTGCTTA AATTCAGTGC ACTGAGCGCC 7440 ATTTCACCGT TCGAGGTGAC TTTGCTGCCT GCTGTGCTGA CGAGCTCACC CGTCAGACGT 7500 GCAGTCAGGC TGTCAGCCGC CTGGATCGCC CCGCTGTTTG CCAGACTGTC TGCGGTGATC 7560 AGCACCCGTT TGCCCTGCCA GTGTCCGGAA CTGGTAATAC TGCCTGCGGT GATTGTCAGA 7620 TCGCCGCTGG TCAGCAATGA ACCTCCGTTA TTCATCAGCG CAGGTTGAGG GGATGCCATA 7680 CGGGCGGCAA GCGTCAGCGC GGCTATCCCG GTGAGCGTGC CACTGTTGGT GACACTGTTC 7740 TGGCGAATCG TGACATGGTT ACCCTGGACA GTGCCGCTGT TATCCAGTGA GTTTCCATCA 7800 AGGGAGAGCG TGCCGGCCGA AAGCAGACTG CCCCGGTTGT CCATGGTGGC TGCTTTCAGC 7860 GTGGTGTCAC CCTGGCTCAT GATATCGCCG GTACTGGTCA ACTGACCGGT TGCCGAAGCA 7920 GTAAGGTTAC CGGTTGCCAG CACGGAACCA CTGTTCGCCC AGTTGTCCCG CYTGCACGGT 7980 GAGATTCTGT CCCTGCGTGG TCCTGCGGTA TGCAGTGTTT TACCCCGGAG GGTGAGGTCG 8040 CCCGCCGTCA GCCAGCGCCC GTTACTACCC TGTGAGAGGG TGTCGCCAGC AAGCGCCAGT 8100 GCACCGGCGC CCTGCAACAG GCCGTCACCA TCCAGCGTGG TCGCCCTGAC GCTCAGCGTG 8160 TCAGCGATGA TTTTTCCCGG ATTGCTGAGG GAGACAGCAT TTAACATTAA ACCATTATCA 8220 CCGGTGATAA GCCCGCTGTT GCGGATGTCC GGTATATCCA GCGTCAGGTC TGCAGCACTG 8280 TACAGCGTGC CGTTCTGCTG ATTATCAAGC CTCTGTGTGT TAACGGTAAG TGAGGCCTCC 8340 CCCTGCAACA GACCGCTGTT GGTCAGGGTC TGTGACTGTG TATTCAGGGC GGAACCAACA 8400 AGTACGCCGC TGCTGGTCAG TTCCGGCGCA CTGAGGCTGA GCGACGGGGC ACTGCTTTTC 8460 CCGCTGTGGG TGAGCTTTTC ACTGGCGTTC ACCACCATGG TCTGTTGTGC TGCCTGCGTA 8520 CCTGCAAGAC GTGCATCTCT GGCGTTGATG CTGAGATTTT TACCGCTCTG AAGCTGTGCG 8580 CCCGCTGCGG TACTCAGTTT GTCTGCCTGA ACCCGGAGGG TGTCACCGGC ACTGTTTTCC 8640 CCGTCCAGCG CCACTGTTGT CACATTCAGC GTCATCGCAG CATCGCTGTG GGTGACCGAT 8700 TTTTTACCGG AGCTCAGCGC CTGCGCACTG ACCGTCAGCC CTTTGCCGCC GGACAGCACA 8760 CCGTTCTGTG TCACATCCTG CGCCTTCAGC ACCAGTACAT CATCGCTCAC CAGCGAACCT 8820 GTACTGGTCA GTTTCCCACT GGCCGTGATA TCCACTTTGC CCTTCGCGCC AGTGCGGCCG 8880 CTCTGGGTAA AGTCGCGGGT ATTCACGGTC AGGGGACCGC CACTGAGCAG GGAGCCACTG 8940 TTGCTGAGCG TTGTACTGCC GAGCGTCAGG GAAGCCCCCT GAACAGCACC ACTGTTATTC 9000 AGCGTGCCGG CATCGAGTCC CGCATGACCT TTCGCCAGCA ATATTCCGTC CTGTGTCAGC 9060 GTGGTGGCGC TGGCCGTGAG ATTCTGCCCG GCGGTTATCT GTCCCTGTGT TGTCAGCGTG 9120 TCACTGGCGA CAGTCACGAT ATCGCGGGCC GCGTTAATCT GGCTGGCGGT ATCCTGTGTG 9180 ATGTTTTTCG CGGCAAGCGT TACATCCCGG CCGGCAGTCA GTTTTTCATT CTGTTGAGTG 9240 ATTCTGCCGC CGGCGGTCAG GCTGAGGTCC TTGTCGCTGT TAAGCGTTCC ATTGCTGAGA 9300 ACGATAATCG CTCCGGGCT 9319 (2) INFORMATION FOR SEQ ID NO: 86: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 551 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 86: ATGAGGCGAT TAAAGCAACA TTGGGCAGTG ATAATGCCCC CACCCAGCCA CCTAACGCAG 60 CGAAGAGTAA TACATCGCCC ATGCCTAATG CTTCTTTACG CAGAACTATT CCGGCTATCC 120 AGCGSAGGGA GTAAAAAGTG ATAAATCCCA CCAGTACGCC GGTAACTGCG TCTTGTAGCG 180 TTAACGGACT CTGTTGCGCC CATGCTGCAA TCAGCCCGGT CCACAATACG CCCTGAGTAA 240 AAACATCGGG CAGCCATTGG TTGTCGAGGT CAATGACGCT CGCGGCAATC AGCCAGGCGG 300 ATAATATCAT CACCGCCAGC CCCCATCCAC TTTCTGGCCA CACCAGACTC GCCAGCAAAA 360 AAGTGAGTGC TGTCAATAAC TCAACCAGCG GATAACGTTG CTGATTTTCG CCTGACAGTC 420 GCGGCAGCCC TTTGAGCATC AACCATGAGA GCAGCGGAAT ATTGTCACGA ACGCGGATGG 480 TCTGCTGGCA ATGCGGGACA GTTGCGAACC GGGTTAGCCA AGGGCTTTAT TTTTTGGACT 540 GCGGCACTCG G 551 (2) INFORMATION FOR SEQ ID NO: 87: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 595 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 87: CATTTACCAA ACCCCGTTCG AATATCTTAT CTATTGCCCA TCTCATATTA AATATAACCG 60 ATAATTTGGT GGATACTAAT AGTAATTACC TTGTTATTGA AAATATAATT ATTGTTATTT 120 TTAGCCTCAT TAATTAAATT GAAAAATCCT CTCTAATTTT TGTCAGATTA GGGCTGTAGA 180 AAGGATCGAG TTCAAGATGT TTACCCCATT TGCTTTTCAT AAAGTCCACT TCCCTGGCAA 240 ATCTGGCTAG TTTCTCCGGT GAATCTTCGG CTCCTCGACT AATCGATTCA TAGTGGTAAA 300 GCTCGGCATA AGGTGTCCAG AGATTACGAT ACCCCGCTTC GNGTACTTTC AGACAGAAGT 360 CCACATCATT AAAAGCAACA TGCAGATTCT CTTCATCCAA CCCGGCAACT TCCTCATAAA 420 TATCTTTGCG AATAAGCAGG CAAGCCGCCG TGACGGCCGA GAGAGTTTGT GTCAACAACA 480 AACGGCTGAA ATAGCCCGGA TGGTGGCGAG GATAATGTTT ATGGGAGTGT CCAGCTACAC 540 CACCAATACC GAGAATCACT CCGCCATGTT GTAAAAGTAT CATTACTGTN ATAGG 595 (2) INFORMATION FOR SEQ ID NO: 88: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 399 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 88: TGGCAGTTGA ACAGATTTTC ACATCAGCAA CAGATTAGCG AACGGGACTT GGCATTAGCC 60 GAGCGTTTTA GTGAANGTTT AGCTCTAACA CGTCTATTAG AAGAGCGCAC GCAGNATTAT 120 CACTGAACTA GAGATTGAAA AACAATTGCT TACCACCAAG TTGTCTGGCG TAGAGCAGCA 180 GTTAAGGGCT GAGCAAGAGT CGCTTCAGCA GGCCCAGTCT GCATTGCTCT CAGCAGCAAA 240 AGAAAAGCAA CATCAACTTG ATGAGTTGGA ATCGGTGCTC AATGAGCGGT ACAGTGAGAT 300 TGCAACCTTA ACCCGTTGGC TGGAAGAACG TGATCAGGCA CTCCTTAGTG CAGCAAGTGA 360 ACAACAACAG ACCAATGANA CCATATAGAG CTCAGCCAG 399 (2) INFORMATION FOR SEQ ID NO: 89: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1013 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 89: ATACTCTGCT TGTTGAGCAG CCATTACGTC GCTTTGTGAC GCAATATTAG ACTCGTGCAC 60 TGCTATTAGT TGAGTCAGTT CATCACATTG TTTAGAAGCC GCAGCCAAAG CAAGAGTTTG 120 CTCATCTATG CTTTGCTGCA ATGTTTGTTG CACAAGTTGC CCTTCTTCCA GCTGTTGCTG 180 TAGATTTGCA CTTACCTTTT TCAGTGCATC ATATTCCAAG CCTAACGTAT CGTGCTGTGC 240 TTCCAGTAAT CCATAAGCAT GCTGCAACTG GTTTTTAGTT TGCTGCTCAC CGTCAAGCTG 300 TTGCTGCAAT GCATTAGCCT GCTGTTGCAA CAAGTTCACC ATATTGTCTC GCTCGGCCAG 360 TGTACGAACC TGTGTATCCT GGATATGTAG CGCTTGTTCC AACTGAAGCT GTAATTCGGT 420 AATTTGCCGC GAATGTTCGC TCAATGCTCT GTTGCTCTTG CTGAGCGCGA GAGTAAGGTG 480 AGATGCACGC TGTGTTTCTT CACTCAATTG TAACGTCAGG GTATTGACCT GTTGCTCCAG 540 TTGATGGCGA GCTTGCTCCT GGCTCGTGAT GCGACTCTGT TGCTGCTCTA GTTGATGCAG 600 AGCTGTATGC AACTCATCGT TGGCTTGTAT TCGCTCCTGC GACCATACAC TCAAGTTTGT 660 TTGGGCCTCA TTGAGCTGTT CTTGCAATAA TGCCACCTCA GATGTCAGCG AATTGATATG 720 TTGCTGGGCA AAAGATAGCT CATCAGATTG CACTTGAGCA TGTGCAAGCT GCTTTTCCAT 780 TTCTAATATG CTGTTATGTT GTGCAGTAAT GCGCTCGGCA AGACGCCCCC TTTCCAATGC 840 CTGCTGTTCT ACCAATAGCT GCCGTTCAGC CTGAATGTCA TCTTGTTGTG TAGACAACTG 900 ACGTTTTAAC TGGGAATTCT CCCAACTCTC GCTACAAGAT TTNCCCAAAC GACAAAAGAT 960 GTCTTGGACT TGTNTGGGTT ACACGAGCAT TTTCTGAGGA TTTTATACCA ATN 1013 (2) INFORMATION FOR SEQ ID NO: 90: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 689 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 90: GATATCCACA TCGAGACGTT TGAAAAGAGT CTGGTGATCC GTTTTCGTGT TGACGGCACA 60 TTACATGAAA TGCTGCGTCC GGGGCGCAAA CTGGCCTCGC TGCTGGTGTC GCGTATCAAG 120 GTGATGGCGC GGCTGGACAT TGCCGAAAAG CGCGTGCCGC AGSATGGACG TATTGCGCTG 180 TTGCTGGGCG GCCGGGCGAT TGACGTGCGT GTATCAACCA TGCCTTCCGC CTGGGGGGAA 240 CGGGTGGTGC TGCGACTGCT GGACAAAAAC CAGGCTCGCC TGACGCTGGA GCGTCTGGGT 300 TTAAGTCTCG AACTGACTGC GCAGTTGCGC CACTGTTACA CAAACCGCAC GGCATTTTTC 360 TGGTGACGGG GCCGACCGGT TCCGGCAAAA GCACCACGCT GTACGCTGGA TTGCAGGAGC 420 TGAACAACCA CTCGCGTAAC ATTCTCACGG TTGAAGACCC TATCGAATAC ATGATTGAAG 480 GGATCGGTCA GACGCAGGTT AACACCCGCG TCGGCATGAC ATTCGCCCGT GGCCTGCGCG 540 CAATTTTGCG TCAGGACCCG GATGTGGTGA TGGTCSGTGA AATCCGCGAT ACCGAAACCG 600 CAGAAATCGC TGTTCAGGCT TCAACTGGAC CGGACACCTG GGNACTTTCN ACGCTGGNAT 660 ACCAAAAAAA AGGGGTGGGG GGATTATAC 689 (2) INFORMATION FOR SEQ ID NO: 91: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1281 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 91: CTCAGCAGAA CCGAGATCTT CCATCAGCTG GCGGGCCTCG GAAGANTCCC GCTGCCAGAC 60 CGCATTCAGC CGCTGTTCAA ATTCGGCCTC GTCGATTTGC CTCAGCGTAA AGGGCGCGTT 120 CAGCCCCCGT TGCAGCTCCT GCAAAACAGA GAGCGACAAC GGATGCACAT GGAGGATCTC 180 CAGCGACGCT TCGCACCATG CCACCAGGCT AAACCGACGG CTGAAACTAT AGGGCAGACG 240 CACGGTGTTA GCGGTGGTTT CCTGTGCTAC AGGCACCATT AACGCGTTCT CCCGGCATTA 300 AGGAACGCAC GAACTTCTGG CGGTAAGGCC TGATTTTGCG CAGGCAATAT CGCTGCGCAG 360 TGTGCGGCAT CAGGCTTAAG CCCTGCTCAT CGCGGTAGAT TTGCTCGGCG CGCATGTAGT 420 TATATTTGCG CTGCGACACA CCGTCTGCCG CCATACCGTC ACGCAGAATG GTCGGGCGGA 480 TAAACACCAT CAGGTTACGT TTTTCTTTTT TATCCGCCGT CGATTTAAAC AGGTTACCAA 540 TCAACGGGAT ATCGCCCAGC AGCGGCACTT CTCGCCACGC TTTCTCCCGC CTGGTCGTCC 600 ATCAGACCGC CAAGCACAAT TAGCTCACCA TCGTTAGCCA ACACGGTGGT TTTCAGTTTG 660 CGCTCACCAA ACACCACGTC GAGGCTGGTC TGTCCTTCCA CCTTCGACAC TTCCTGCTCA 720 ATCACCATCT GTACCGCGTT TCCTTCGTTA ATCTGCGGCG TGACTTTCAG CATGATGCCG 780 ACTTTTTTCC TCTCTACCGT GTTGAAAGGA TTGCTGTTAT TGGAGCCAAC GGTAGATCCA 840 GTTAATACCG GAACGTCCTG GCCCACCATG AAGAAGGCTT CCTGGTTGTC CAGCGTGGTG 900 ATGCTCGGCG TGGAGAGCAC GTTCGAGCTG GAGTCGTTTT TGACCGCCTG TACCAGCGCC 960 ATCCAGTCGC CTTTCAMCAC GCCAACCGCC GTACCGCTAA AGCCAGAAAG AAGCTGAGCA 1020 AGCGTGGAGA GATCGCCGTT AGTATCCGGA TTTATGGTGG TAGCGCCGTT TTCACTGATC 1080 ACCGTGGAGC CTTTCTGCGG TTTTGCYTGA GAAATCGTGC GCCCAGCGTA CCAATAGGGA 1140 TCTGCGTACC GTTAGCAAAC TGCATTAATC CGGCATCTTT CGACGCCCAC TGCACGCCGA 1200 AATTGATAAT TCACCTTCGG CAACTTCCAC GATCAACGCC TCGACATGTA CCTGAGCACG 1260 GCGAATATCC AGTTGTTCAA T 1281 (2) INFORMATION FOR SEQ ID NO: 92: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 421 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 92: CAATATTAGC GCACGGCACC AAAGGTGATG AATGAGCAGG CTGRAATATT ATTTTCCCGC 60 GGTGCAGAAA TCCTTGTTCT TGGTTGTACA GAAATTCCGG TTATTCTGGC GCAACGTTAA 120 AGAGCAGCCT TCCCGCTATA TTGACTCACG GCGTCACTCG TTCGTGCCGG AATAAAATGG 180 TACGAAAATC GTGTCGGTAA ACATTATCTT TTAACCCAAT AATCATTTAA ATCGCAGCCA 240 GAAAGTTATT CGCTTTTAAC TGAATTATAT TTATAACGGA GAACATTATG GTTTGGCTGG 300 AAATTATCGT AGTACTTGGT GCAATAKTTT TTGGTATTCG CCAGGGGGGA ATCGGTATTG 360 GTTTATGTGG CGGGCTTGGG CTTGCCATTC TGACTCTGGG ACTTGGTCTG CCTATGGGGG 420 G 421 (2) INFORMATION FOR SEQ ID NO: 93: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1018 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi ) SEQUENCE DESCRIPTION: SEQ ID NO: 93: GTTAACAATG GCGTAACAAA TTTCAATAAC GTAGAAGATT TGCTGTCAGA AAGGTCAATA 60 TTTCCTTTCA ATGGGTCAAA GACTTGCTTC TGGAATTCAT CCGGTTTTTT CTCCAGACGT 120 TTTCCTTCTT CATAATAGTC AATATAACTT TTACCACTGA GTGTTTTGKC YCCATTTCTG 180 GTGACACCAG CTAACTCACC TATCAGCGTA TCCCMATGTT GCTGGGTAAT GAGGACTGAT 240 CTTTCAACAG AATACTCTTT ATTATACTGA GATAATATTT TAAAGTTATC TTCTAAAAAT 300 GCAGCATGGC GGGCATCATA TCCCATTTTC AAAGTAATTT TTGCCGTGTT TTTTCTCCCA 360 TTCAGCAATA ACATCGGCCA TTTTACTGGC GACATGTTCA AACATTGCCT GTTTTGAAGC 420 CTCAAGGATG CCTGAAATTA TCCCCGTAAC AGCCCCTACC AGCGCGCTTA CCGGTGCACC 480 AACCAGAGAT GTCGTTGCAG CAGCACTAAT ACCTGAAGAT ACTGAAGCCA GAACAGTGCT 540 TATCGTTGTT AACGATGCAT CAATAGCTCC TGTTTCTTTG TGGAAAGCAG CAAGTAAACT 600 GTCACCATCG TATCCAAGTT TTTTGAATCG TTGTGAATAC TCCTCTATTT TATTGGCACG 660 TTTAAACTTA TCGGCAATGG ACAGGAATGA GAGGGGACTA ATTGCCAGTG TCACAACAGA 720 AGCAATTAAA CCGGCAGCAG CAGCAGATGT AGATAACCCC TGTGCTGCAC GCTGTGCGAY 780 NAATATATTG AGAAATACCT TTTCCAACAT TACCCAGTAC TTTCGTTGTT AATTCAACAC 840 CTGCTGCAGC TTTAGTTCCG GTATCTGCAT CTGCATTGCT CAGAATGAAA CTTGCTGAAA 900 TCGCAGATAA AATACCCGAT ACAGTATCTA ACCCTGCACC GATATTATCA AGGTTAGGTA 960 AATTCTGTAA CTTATTACCA ACACCGTTCN GGNCTGTTGG TATTGGGATA ATACACTT 1018 (2) INFORMATION FOR SEQ ID NO: 94: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 400 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 94: GGCAATGTTC AAATCGATAT TGTGCAGCAC CTGGGTTGGG CCAAAGTGCT TGGAGACGTT 60 TTTAAATTCA ATCACAGGAT TTTCATCCTT CTTTCCAGAC GACGCAGAAT AAAGCTCAGC 120 ACCAGGGTAA TAATCAGATA GAACACCGCC ACGGCGCTCC AGATCTCAAG GGCGCGGAAG 180 TTACCGGCAA TAATTTCTTG CCCCTGACGG GTCAGTTCCG CCACGCCGAT CACAATAAAC 240 AGCGAGGTGT CTTTAATGCT GATGATCCAC TGGTTACCCA GCGGCGGCAG CATACGACGC 300 GTGCCAGCGG TAAAATGACG TAGCGAATGG TTTCCCMACG TGAAAGACCG AGCGCCAGTC 360 CTGCTTCACG AAAACCTTTG TGGATAGACA GCACCGCACC 400 (2) INFORMATION FOR SEQ ID NO: 95: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1857 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 95: CGTGTTCCCC TGGCCNGCTT GGTTTCGCCA TAGACGTTGA GCGGGGAAAT CACATCGGTT 60 TCCACCCAAG GACGTTCACC ACTTCCATCG AAAACATAGT CGGTGGAATA ATGTACTAGC 120 CACGCACCTA ATGCTTCAGC TTCTTTGGCA ATAACCGCCA CACTAGTTGC ATTGAGTAAC 180 TCGGCAAATT CCCGCTCACT CTCCGCTTTG TCGACTGCAG TATGGGCCGC TGCGTTAACA 240 ATCACATCCG GCTTGACGAG ACGTACCGTT TCAGCCACCC CTGCAGAATT GCTAAAATCA 300 CCGCAATAGT CGGTGGAGTC AAAATCAACG GCAGTGATGT GCCCCAGAGG CGCCAATGCA 360 CGCTGCAGCT CCCATCCTAC CTGACCATTT TTGCCAAACA ACAGAATATG CATCAGGTAC 420 GCTCCCTATA GTTTTGTTCA ATCCAGGATT GGTAGGCACC ACTCTTGACG TTGTTAATCC 480 ATTGTTGATT ATCCAGATAC CACTGCACGG TCTTGCGAAT ACCAGACTCA AAAGTCTCCT 540 CTGGCTGCCA ATCCAACGCA GCGCTCATCT TGCAAGCATC AATCGCATAT CGGCGATCGT 600 GTCCGGGGCG ATCCGCCACA TAAGTAATTT GATCGCGATA AGAGCCAGCT TTCGGTACCA 660 TCTCGTCAAG CAGATCACAA ATAGTATGTA CTACATCCAG GTTCTGCTTC TCGTTGTGAC 720 CGCCTATGTT ATAAGTCTCC CCGACCAAGC CAGTGGTCAC TACCTTGTAG AGTGCTCGTG 780 CATGATCTTC CACATACAAC CAGTCACGAA TTTGGTCACC TTTACCATAA ACCGGCAGCG 840 GCTTGCCATC CAGCGCATTG AGGATCACTA GCGGGATCAG CTTCTCGGGA AAGTGGTAAG 900 GGCCATAGTT GTTGGAGCAG TTAGTGACAA TGGTTGGCAG GCCGTACGTA CGGTACCAAG 960 CACGCACCAG ATGATCGCTG GAAGCCTTGG AGGCAGAATA GGGACTGCTA GGAGCGTAGG 1020 AGGTAGTTTC GGTAAAGAGC GGCAATGCCT CACCGGAGGC TACTTCATCC GGATGGGGCA 1080 GATCGCCATA TACTTCATCG GTAGAAATAT GGTGGAAGCG AAAGGCCGCC TTGCTCAACT 1140 CGCCCAGACT GCTCCAATAG GCGCGAGCCG CTTCCAGCAA TGTATAGGTG CCTACGATAT 1200 TGGTTTCGAT AAAGTCGGCT GGCCCTGTGA TAGAACGATC AACATGGCTT TCAGCAGCCA 1260 GATGCATCAC GGCATCTGGC TGGTGCAGAG CAAACACCCG ATCCAACTCA GCACGATTAC 1320 AGATATCAAC TTGTTCAAAC GAATAACGCT CACTTGACGA TACACTGGCC AAAGATTCCA 1380 AATTGCCAGC ATAGGTGAGT TTATCCAGAT TGATAACGGA GTCTCCAGTA TCACTAATGA 1440 TATGACGCAC CACGGCAGAG CCGANAAAAC CAGCACCGCC AGTAACGAGA ATCTTCATAT 1500 ATTTCGCTCT CTTATTTTAC AATTAATAGC TATTAAAAAT AAACTTGTTG ACTCCGATAT 1560 ATTAGAAATA TCGGGATACC GAACTAAATA TTTTTATATG CTTTTGCCAA GCAGACTCTA 1620 TATCCACCCT GTATCACTAT GCTTTCTGGC ATACAATATC CCATCATTGA CACAATGATA 1680 AACATATAAA TAAAGAAAAT TTTAAATCAT ATAACCAAAT TACTTTCATT TATTATCAAT 1740 AAGTATTTTG ATAAGAATAC CTATACCACA GGGAGCCCCC TGAAACATAA TATTAGCGAA 1800 GAATGATAAC TGATAGTTAC CATCTTAGAG ATAAAAACTT ATTTGTGTGG CGGGATG 1857 (2) INFORMATION FOR SEQ ID NO: 96: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1128 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 96: AGCTCTTTCG TGTAAAATAA AATACAGCAT ATCCTATATA GCTTACAATC ATTAAATGAA 60 GTCGCCAATA TTTATATGTT TTATCAATAT CAGCTTGACT CATTGTTATT TCTTTGTCAG 120 GAGACTCTGA AAATATGGAC ATATATAACC TCTTTTATTA TGAAATATTT TCAATAATAA 180 TAATCCGTTA GTAATCCTAT CATAGGGTAA TGTCTCATCA TGTTAAAATG ATCACATTTA 240 TAATCATGTC AAAAAGAACA ACAGAAAAAA TCATATAAAA TCAATTAAAT ATAATTGCCA 300 CATATTGTTG TTATTWAAAC ATTGGTGGTG AATTTAAAGC GAGAACAGTT TGTAACAGTG 360 ACTCCTTGCA GACTAAGTTA GAGTCTCCTT CTAAAATTAG ACGGWKTTCT ATTGATGGAT 420 AATAGTAAGC GCACCGTGAA KGACGTGGGG TAAAAATTAG TTTACAGATT GAGTGACATT 480 CCAGGGCAAC AACTCTTTCA CGCGGTTGGC AGGCCAGGTG TTGATTACAC TGATCACGTG 540 GCGTACATTA CCGGACTCGA TTCCGTTAAG TTTGCAGCTA CCGATCAGGC TGTACATCAC 600 TGCCGCACTC TCGCCTCCAC CATCAGAGCC GAAGAACATG TAGTTACGCC GCCCCAGTGC 660 AATACCCGGA GGCGTTTTCA CACAGGTTAT TGTCGATCTC CACCCAGCCA TTGCGGCAGT 720 ATTCGTTCAG AGCGTCCCAT TGCTTCAGCA GATAGGTGAA CGCTTTCGCT GTATCCGAGT 780 GGCGCGACAG TGCTCATCTG CCCCTGGAGC CACTCATACA ACGACTGCAT TAGCGGTACC 840 GTTCTGGCTT TTCTGACCGC CAGTCGCTCT TCTGCCGGAC TGCCGCGGAT CTCAGCCTCG 900 ATAGCGTACA GTTCACCGAT ACGCTGCAGG GCTTCCGTGG TGATGTCAGG TGGCGCTCTT 960 GCATGCACAT CGTGGATTTT TCTCCGGGCA TGGGCCATAC AAGCCGCTTC GGTTACCTGA 1020 CCGCTTTCGT AAAGAGCATT GTAACCCGCA TATGCATCGG CCTGCAGGAT ACCTCTGTAG 1080 TCCGCCAGAT GTTGCTGTGG GTGGATGCCT TTGCGGTCGG GAGAGTAT 1128 (2) INFORMATION FOR SEQ ID NO: 97: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 439 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 97: GTTTGCTTAC GAACCGTGAA ATATGACGGT CCCATATAAC TGCCTGATAC TTGTATATCA 60 TATACTTGTG CATGCATGTC ATCATTAAAA AGTACTTTGT CACCGTCTTT AAGTTGAAGA 120 CGTGTAAAAT CTTTATACGG CAAGTAGACG GAAAACGGGC GCTTTCCCTG TCGCCAATCA 180 CACCGACATG ACTGACTTTT GCGAGAGGAA GTGCATAATT CACCAATTCA GAGCCTAATG 240 CATTGCGCTG GGTAAGCTCA AATCGGAATG GGTTTCGAAC CTTTCCCGCA ACATTGATCA 300 TTGGACCTTG TTGCTCAACT GAAAATCACA TCTTGATCTT TTAATGCCAG CTTCGGGAGT 360 TTCCCATACC GTATGAAATC ATAAAGATCA ATTTGCKGTG NTTACTGCTA TTTTGTGCGT 420 GAACACCTTA ATTTTTGCG 439 (2) INFORMATION FOR SEQ ID NO: 98: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 906 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 98: TATTCGTAAT TAGTTATAAA CAGATGATGT AAACACCAGT TGACTAGAGT CAATCTTATA 60 CTGGCAACAT CTATGATTAA TTTGTGTGGT TATAATTTTA AATATCTTAT ATTTATGGGC 120 TATTATTGAT ATCTGTCAGA GTATCAATAA TAGAAGGTAA TTGTTTTACA TACTATCAAC 180 TTTTGGATAA CGTTTTAAAA TGCACCTTGC ACATCGTATT TTATTATTTT CACTAATCTT 240 TTTTATAACG GCCTGCGCAC ATGATCCAAA ACAAGTTGAA GCCTCTCGTC CATTGGTAAC 300 AGCGATTAAT TCTTCTTATT CTCTTATTCC TGAAGATTTG CAGGCACCAT TAAATAACCA 360 AGATCAAGGC ACGACATTCA ACAAAAATGG CGTAATTTAT ACTATTGAGG AAAGGTATAT 420 ATCGGCTTTA GGTTCTCAAT GCATAAAGTT AAGTTATGCG ATGAATAAAA ATTATTCAAA 480 GCGAAGTGTT GTATGTAAAG AGAATAACAA GTGGTATCAA GTACCTCAGT TGGAACAAAC 540 ATCAGTTAGC ACTTTGCTTA TTGAAGAATA AAGTTGAAGG TAGACGGTTA GAAAATAATG 600 AAAATTTCGC AACTTAGCAC TCTTCTCTTT CTTATTTCTG CATCAGCATT CGCCGCAATA 660 GAGCAAAATC AATCTAATGG TTCACATTTA GATTATGATC TTGCTGCCTC GACAGGAGAG 720 TCTCGGAAAA TGCTAGCAGA CATCACTGGA CAGCCTAATA CAACCTCCAC AACAGGAAGC 780 TTCACACAAC AGAATCGTAA TGGGATGTTG CTTCCAGGAG AGTCAGATGT ACGAAAATTA 840 CTGCCGCAAT CTGAAGCAGG CTTACCTCCT CCGTATGGTG CTAATTTATT TGCCGGAGGC 900 TATGAA 906 (2) INFORMATION FOR SEQ ID NO: 99: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1395 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 99: GCGGCCTGAT ATATGCCGTT ATTACAAAAA GAGGATCAAC CACACTGCCT TTTGGACCGT 60 GTTTAAGTCT GGGCGGTATA GCAACACTTT ATCTACAGGC ATTGTTTTAA TGATAACCAC 120 GTCATTATCA AAGTGACATT TTAACTCTTA TTAATAACCT TAGAGATTAT TTACCATGTC 180 GATAAAACAA ATGCCAGGGA GGGTATTAAT ATCGCTATTG TTGAGCGTTA CAGGATTATT 240 AAGTGGCTGT GCCAGCCATA ATGAAAATGC CAGTTTACTG GCGAAAAAAC AGGCGCAAAA 300 TATCAGCCAA AACCTGCCGA TTAAATCTGC GGGATATACC TTAGTGCTGG CGCAAAGTAG 360 TGGCACGACG GTAAAAATGA CCATTATCAG CGAATCGGGT ACTCAGACCA CGCAGACACC 420 TGACGCCTTT TTAACCAGCT ATCAACGACA AATGTGCGCT GACCCAACGG TGAAATTAAT 480 GATCACCGAG GGAATTAATT ACAGCATAAC GATTAATGAT ACACGTACAG GTAACCAGTA 540 TCAGCGGAAA CTGGATCGTA CCACCTGTGG AATAGTCAAA GCATAACGTC GGGTAGATAT 600 AAATTGGCGC GGGTTGTTTT TCGTGACGCA CGAATTTATC TCATTCAATG GCTGACAAAA 660 ATTCGTCACA CTCTTAACCA GAGACAATCT CTTAATACAG ACAAAGAGCA TCTGCGCAAA 720 ATTGCACGCG GGATGTTCTG GCTGATGCTG CTTATTATTT CTGCAAAAGT GGCGCATTCA 780 CTCTGGCGCT ATTTCTCCTT TTCTGCGGAA TATACGGCGG TTTCCCCATC GGCGAATAAA 840 CCGCTCCGTG CGRATGCAAA AGCGTTCGAT AAAAATGACG TGCAATTAAT CAGCCAGCAA 900 AACTGGTTTG GCAAATATCA GCCCGTCGCC ACGCCGGTAA AACAACCCGA ACCTGCACCT 960 GTGGCCGAAA CGCGTCTTRR TGTGGTGTTG CGTGGGATCG CCTTTGGTGC CAGACCCGGC 1020 GCGGTTATTG AAGAAGGTGG TAAACAGCAG GTCTATTTGC AGGGTGAACG CTTGGCTCGC 1080 ACAACGCAGT GATTGAGGAA ATCAACCGCG ACCATGTGAT NTGCGCTATC AGGGAAAAAT 1140 AGAGCGCCTG AGCCTGGCTG AAGAGGAGCG TTCCACCGTT GCCGCGACCA ACAAAAAAGC 1200 TGTCAGTGAC GAAGCAAAGC AAGCTGTTGC TGAACCTGCT GTCAGTGCGC CAGTTGAGAT 1260 CCCNGCTGCC GTGCGTCAGG CACTGGCGAA AGATCCGCAG AAAATTTTTA ACTATATCCA 1320 GCTTACGCCT GTGCGTAAGG AAGGGATTGT CGGTTATGCA GTGAAACCGG GGGCAGATCG 1380 TTCTCTGTTC GATGC 1395 (2) INFORMATION FOR SEQ ID NO: 100: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 380 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 100: CACTTGAATA AAACTGACAC CGTTTACCTC CATAATAGTG AGCATAGCCG CCATTGCGGC 60 CTGATCGGCG AACCGGAAAT CGCAACCTGC GAACGACAAC CGAACCGGCA AGCGTGCGGG 120 AAGGACGGAT ACCGGACTCT TTCGCCACTT CAGCAATCAC CGGCAGCGTG GAAAAAACAA 180 TAAACCCAGT ACCGGCCATA ATGGTCATAG ACCAGGTGAT AATCGGCGCG ATTATGTTGA 240 TATATTTCGG GTTACGCCGC ATAAAATTAC CAGCGACGGT ACCAGATAAT CCATTCCCCT 300 GCGGCCTGTA AGGCTGAGGC CGCCACAACA ACGGTCATAA TAATCAGGAT CACGTCGACT 360 GGCGGCGACC CCATAGGCAG 380 (2) INFORMATION FOR SEQ ID NO: 101: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 995 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 101: CTTTACGGTT TAATAGGGGA ANGCCGACTG GATGNAAAAA TGGAATCTGG AGCCCAGAAT 60 AAATCTGAAT TTAATGTGGA CTGGATATGC TCCAATAACC CCGGCAGGGA GTCATCTGTG 120 CGAAGATATT TGCGTTATGC TGTAATATAA TAATTCAATG TATTTCAGGA ACAGTAATAT 180 ACTACAGTTT CTACTTTCTT GTATTTAATA AATTGTTCCG CATCGCTAAA AGCAGGTCTT 240 TCAGAAGCCA CAAGAATTCT GTGGTCCCAG TATTTTTAGT TATCCTATTT TTATATCTAA 300 CTTGTAATAC TTACAGCATT TTCATTCATC CTAATGGAAG GCTGTAATAA TCTTTGAGCT 360 TAGAAACATC AAAATTATGC ATCTCATTAA TTTTGTCAGT CACACGACCT CTGGTAAAAA 420 TAAAACCCCC AGAAATATGC CATTTCTAGG GGGGGCGTAA GAATCAATAT ATTTTAGTGT 480 TGTTACATTT AGCTCTTAGC TCTTAGCTCT TAGCTCTTAG CTCTTAGCTC TTAGCGTTTG 540 TAGTTTCATC GCAATGAGTA AAAGGACAAC AAGAATAAGT GATAACGTTA AGAGAAGAGC 600 ATAGAAACCA TTCCAGTGGT ATATTTCTAT TATTTTAGAC AATGGATAGC CAGCCGCGGA 660 CGCACCAAGA TATGCGAATA AACTAACAAA ACCAGTAGAA GCACCAGATG CATATTTATG 720 TGAGTTTTCA GCAGCTGCCA TTGCGATCAG AAATTGTGGC CCAAAGATAA AGAAGCCAGT 780 GATGAAAAAT AATAACGAAA AAACATATTT ACTATCAATA GAAACCAACC ATAGACATGC 840 AGAAGCAATG ATTATACCAA TTGTATAAAT AACATTCATT TGAGAGCGAT TGCCCTTAAA 900 CAGAATATCT GATCCCCATC CAGCTACGAT AGCACCAAAA AAGCCTCCAA CCTCAAACAT 960 CATTACTGTT GCATTTGCTG TTAGCAAGTC ATATT 995 (2) INFORMATION FOR SEQ ID NO: 102: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 817 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 102: TAAAAGCGAC TCCATGTGAA ATTTCTGTTT GTCGTTTTTT CCCCGTTGTA GCGGCTCTGC 60 TCCTGGCTTC CCTGATAGTC AGCCCGCAGG CGCCAGGGCC CCAGATTCCC CCCCACAGTC 120 CCGTTATAAC TGAACTGATG AGAGTCTCCT CCCTGATAAT TACGGGAAAC CGTCCCGTTG 180 AGGTTATAAT CCAGCATCAG TCCGGGAATG CCGTCGTCCC AGCGTGAGGG AGGCAGCCAG 240 GTGGCATCAG AATACTCAAG CCAGGCCTGC GGCATATTGA TGCGTAATAC GCCCGCTCCG 300 GTATCAGGAC GAATATCCAC TCCCGGCAAC CCATGAAAAT CCGCACACTG ACCATCATGC 360 CAGTAAACAA CTTTATCCAG AGATTCTGCT GTTAACCCCA TCAGTCTGAC CATATCTGAT 420 GTCAGACAGC TGCGGCAATT TTTTTTCTGC CTTATCTCCT GACAACGCAG GTTCAACAAA 480 TGAMATCTGT AACGATGCGG GAGAAATACT TTGCCCGTTA ACAATCACAT CCAGAAGATA 540 TTGCCCCGGC AGAACATAGC CGGCTTCTGA AAAACGGGTG AAGTCAATAT TTTTCTTGTC 600 CGCTGCGTCA AGTACATCTG TATTAAACTC AACGGCACTG GCTGCGTTAC AAAACAGAGA 660 CAACAATATC ACACAGGTAA TATTGTTGAC TGCAAAAGGT ATTCTGTCTT TCATTCCACG 720 CATCACCAGA TTCACAAAAA AGATAAATAA CCGGACATCT CACCGGAGTG ACTCACTCAT 780 AATCGACCCG GAATCCCAGC ACAGCAAAAT AATTTCC 817 (2) INFORMATION FOR SEQ ID NO: 103: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 709 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 103: TTTTTGTCAG AGCGTTCACT CTCTGGCTGG ATGATTTCGG CTCGGGAAAT GCAGGCTTAA 60 TGTGGGGACT GTCGGGGATG TTTGAACGGG TAAAAATAAG TCATGAGTTT TTTCATTATG 120 TCCTGAAAAA CGGGTGTGCA ATGCCACTTC TCCGTGCTGT GGCAGACACT GTTGCCTGTC 180 ACAACAGAGG CGTGATACTC GAAGGTGTTG AAAATGAAGC GTTGTTCCGT ATTGCCAGAG 240 ACATGAATGT CCAGGGCTGT CAGGGATGGC TCTACAGGCG TGTGGGGGTT GATGAATTAT 300 CCGCGCTTAT TCAGCAGTAT GAATAATCCT TTTTCACAGA CTGGTCAGCT GTCAACATTT 360 ATGTTTTTTT ATCTGCGGGA ATTTATCCGT CTGCCTGTCG GGACTACTCT GTCATACAGA 420 AATCAGGCCA GAATAAATTG TTGTGGAAAG GTGAGATTTA CCGGATGACT GATGTGCTCT 480 TGTGCACAGG TATACAGGCA GTGTGTTTCC AGTATATGGA AAATGATTAA ATGAATAACA 540 CAGACTTATT AGAAAAAATC ATCAGGCATC AACAAAACAA AGATCCTGCA TATCCTTTCC 600 GGGAACATCT TTTGATGCAA CTCTGTATCC GTGTAAACAA AAAAATACAG AACAGTACAT 660 CTGAGTTTTT TGGTGCATAT GGTATAAATC ACTCAGTATA TATGGTTCT 709 (2) INFORMATION FOR SEQ ID NO: 104: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 485 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi ) SEQUENCE DESCRIPTION: SEQ ID NO: 104: TCATCAAGGG ACGGGGCATA TCTGGATGCG ACAGGGCAAA CCAACCACTG AGAATCCAAC 60 CTGCCAAAGC CTGACCAGGA AGTCCGACGT TAAAGAAACC AGCTCGACTG GCAACGGCAA 120 AACCAAGACC AATCAAGACC AGAGGACCCA TAGCACGGAA GATTTCTCCA ATCCCACGCA 180 GACTGCCAAA GGCTGTATAG AACAATTCTT CGTAGCCCCA AATAGCATCA TAACCGAAGA 240 TCCACATGAC AATGGCTCCG AGTAAAATTC CTAGGAATAC AGAAATCAAG GGAACCGAAA 300 TTTGTTGTAA TTTTTTAGAC ATCACTCTTC TCCTTTCCCA AGTTYCCACC AGCCATCAAG 360 ACACCAAGTT CTTGTTTATT GGTTGTTTCT GGTGATACAA TACCTTGAAT CTTACCATCG 420 TGGATAACGG CAATACGGTC TGAGACGTTT AAAATCTCAT CCAATTCAAA GCTGACNACA 480 AGGAC 485 (2) INFORMATION FOR SEQ ID NO: 105: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 459 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 105: AGCAGAATAG GCAACATCAC CACGCCGACA AACAGCGAGA AGAGAATGAC GCCAGCCGCC 60 AGGAACACCA GCTCATAGCG CGCCGGGAAG ACGTTACCAT CCGGCAAGAG CAGCGGGATA 120 GAGAGCACAC CGGCCAGAGT GATCGCCCCA CGCACCCCGG CGAAAGACGC GATCAGGATT 180 TCTCGTGTGG TCCACGAACC AAACTCCATC GGCTTCTTCT TCAGGAAGCG GTTGCTGAAC 240 TTTTTCATCG TCCACAGCCA GCCGAAACGG ACCAGCATCA GCGCCGCATA TATCAGAATA 300 ATATTGGTAA ACAGCATCCA GATTTCGACG TTAGGGTCGA TTTCTTGCTG GCCATCAGCG 360 GACGTCTTCC AGRATTACCC GGCAGCTGCA GACCTTAACA GCAGGGAACA CCATGGCCGT 420 TTTAAGGACA ATTTCNAGCA TCGGCCCANG TGCTGTTTT 459 (2) INFORMATION FOR SEQ ID NO: 106: (1) SEQUENCE CHARACTERISTICS: (A) LENGTH: 908 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 106: TTAATAGCAC TAATACTGTC CTGCTCTATT CCGCTGACAT TTTCAGTCAG CTGCTGTATG 60 GGATGGGTTA CCCAAAACCA GACCAGCATA CCTGACAAGA GACCGCATAT CACTACCAGA 120 AACAGCGACC AGTACAGTGC ATTCCATAGT GCCTTTGTCC AGGCTGTATC AGTAAGAGCA 180 TTAAGTTCCT CTCCCTGTAA AATAATATAC AGATATCCTT TCGGTTCATC ACTCTGGTAA 240 AGCGGTGCGG TACTGAAAAC TTTTTGCTTA TTTACACTTC GGGGATCATC ACCATATACG 300 GGCCAGACAC TGCCGGAGAG AAATTTTTTC AACGGTGCAA TATTGATATA CCGGCGTTTG 360 AGATGACCCG GAGGGCGGCC TCCACAAGCA GTCGCCCTTC CGGTGAAACC ATATACAGCT 420 CCACACTGGG ATTAAGCGTC ATCAGACGCT CAAACAGACT CGTTAATGTC CGGTGTTACC 480 AGACAAAACA AGCATCGCAA GACGCCACAA ACGGTGCGCT TACTTAAATA AGCCGGTTAC 540 AGGTGAAAAA TCACGTCCTG ATATTCAAAT GTTTTTTCAG GTCATATTTT AGCAGGACAC 600 TACCAGCACC TAACAGCAGC ACATCTTTTA TAACAAAACT GTCAACTTTC CCCAGTTGTG 660 GTAACAGGCT GAGCGTGGTT ATTCCTGTAA CAATAACGAT AATATCTCCC AGTACACCAG 720 CAGCAGGCCT GAAGAAACCG ATAATCAATG CCAGAAATGT GATAGTTTCC ACTATGCCGA 780 GGAAATAGCT CCCTCCATGA ATACCAAATA TAATATACAG GATATTCAGC CAGGTGGGAT 840 ATATCAGGGG CTTGAGAGCC ATAACTTCAA AATCAAACCA TTTATAAGTC CCAAAAAGCA 900 TAAATATT 908 (2) INFORMATION FOR SEQ ID NO: 107: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1057 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 107: CGGGCTAACC CAATATGCTT TATTAACCCG GGATAATTAC CCTGTTGCAT ATTGTAGTTG 60 GGCTAATTTA AGTTTAGAAA ATGAAATNAA ATATCTTAAT GATGTTACTT CATTAGTCGC 120 AGAAGACTGG ACTTCTGGTG ATCGTAAATG GTTCATTGAC TGGATTGCTC CTTTCGGGGA 180 TAACGGTGCC CTGTACAAAT ATATGCGAAA AAAATTCCCT GATGAACTAT TCAGAGCCAT 240 CAGGGTGGAT CCCAAAACTC ATGTTGGTAA AGTATCAGAA TTTCACGGAG GTAAAATTGA 300 TAAACAGTTA GCGAATAAAA TTTTTAAACA ATATCACCAC GAGTTAATAA CTGAAGTAAA 360 AAACAAGTCA GATTTCAATT TTTCATTAAC AGGTTAAGAG GTAATTAAAT GCCAACAATA 420 ACCGCTGCAC AAATTAAAAG CACACTGCAG TCTGCAAAGC AATCCGCTGC AAATAAATTG 480 CACTCAGCAG GACAAAGCAC GAAAGATGCA TTAAAAAAAG CAGCAGAGCA AACCCGCAAT 540 GCGGAAAACA GACTCATTTT ACTTATCCCT AAAGATTATA AAGGGCAGGG TTCAAGCCTT 600 AATGACCTTG TCAGGACGGC AGATGAACTG GGAATTGAAG TCCAGTATGA TGAAAAGAAT 660 GGCACGGCAA TTACTAAACA GGTATTCGGC ACAGCAGAGA AACTCATTGG CCTCACCGAA 720 CGGGGAGTGA CTATCTTTGC ACCACAATTA GACAAATTAC TGCAAAAGTA TCAAAAAGCG 780 GGTAATAAAT TAGGCGGCAG TGCTGAAAAT ATAGGTGATA ACTTAGGAAA GGCAGGCAGT 840 GTACTGTCAA CGTTTCAAAA TTTTCTGGGT ACTGCACTTT CCTCAATGAA AATAGACGAA 900 CTGATAAAGA AACAAAAATC TGGTGGCAAT GTCAGTTCTT CTGAACTGGG CAAAAGCGAG 960 TATTGAGCTA ATCAACCAAC TCGTGGGACA CAGCTGGCCA GCCTTTAATA ATAATGTTNA 1020 ACTCATTTTC TCAACAACTC AATAAGCTGG GGAAGTG 1057 (2) INFORMATION FOR SEQ ID NO: 108: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 752 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 108: TACCGGGCCC CCCCTCGAGG TCGACGGTAT CGATAAGCTT GATATCGAAT TCCTGCAGCC 60 CGGGGGATCC ACTAGTTCTA GAGCGGCCGC CACCGCGGTG GAGCTCCAGC TTTTGTTCCC 120 TTTAGTGAGG GTTAATTTCG AGCTTGGCGT AATCATGGTC ATAGCTGTTT CCTGTGTGAA 180 ATTGTTATCC GCTCACAATT CCACACAACA TACGAGCCGG AAGCATAAAG TGTAAAGCCT 240 GGGGTGCCTA ATGAGTGAGC TAACTCACAT TAATTGCGTT GCGCTCACTG CCCGCTTTCC 300 AGTCGGGAAA CCTGTCGTGC CAGCTGCATT AATGAATCGG CCAACGCGCG GGGAGAGGCG 360 GTTTGCGTAT TGGGCGCTCT TCCGCTTCCT CGCTCACTGA CTCGCTGCGC TCGGTCGTTC 420 GGCTGCGGCG AGCGGTATCA GCTCACTCAA AGGCGGTAAT ACGGTTATCC ACAGAATCAG 480 GGGATAACGC AGGAAAGAAC ATGTGAGCAA AAGGCCAGCA AAAGGCCAGG AACCGTAAAA 540 AGGCCGCGTT GCTGGCGTTT TTCCATAGGC TCCGCCCCCT GACGAGCATC ACAAAAATCG 600 ACGCTCAAGT CAGAGGTGGC GAAACCCGAC AGGACTATAA AGATACCAGG CGTTTCCCCC 660 TGGAAGCTCC CTCGTGCGCT CTCCTGTTTC CGACCCTGCC GCTTTACCGG ATANCTGTNC 720 GGCTTTCTCC CTTCGGGAAG CGTGGCGCTT TC 752 (2) INFORMATION FOR SEQ ID NO: 109: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 486 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 109: CTTGGGTAAT NGACCTCATA TCCCTCCGCC AAAAAAGGAT CTACATGCGA TTTTGCGAAG 60 CCAGCGTTGA TTGTAGGCGA GAGAATGGTT CTGTTGTTTT GGTACATTTC AGTTGTCATG 120 GATTTCACAA ATGTAGCATG ACCTTTCACC TGTCCAAGAG ACTGCAACAC CATCTGTCCA 180 AAACAATAAA TAGGAATCAA ACAGGCTACC AACATCAACA AGTATCCCAA TAAGGCTCGT 240 AGTTTAGTCC TTGACATGAC GCCCCTCCAA TTGCTTTTCT AGTCCTTTGA CAATCCGTCG 300 ATTACGATAC ACGCGATACA GCAAGAGAAG GATGACCGCC ATCGCTCCTA GTAATAACCA 360 CAACCAGAAT TGCCCACGCT CTCTCACCGC TCGATTCCGC TCTGCAATTG GTGCCGTATA 420 CGGAATCCGC TTCCCACGTA CCAACAGACG ATGACTGTTA ATCCTATACG GTGTACNAGT 480 CAACCA 486 (2) INFORMATION FOR SEQ ID NO: 110: (1) SEQUENCE CHARACTERISTICS: (A) LENGTH: 313 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 110: TTACGCNTTC AACCAGGTCT TCTGGTTTAC CAACGCCCAT CAGGTAACGC GGTTTGTCTG 60 CCGGAATTTG CGGGCATACA TGCTCCAGAA TGCGGTGCAT ATCTGCTTTC GGCTCACCCA 120 CAGCCAGACC GCCGACAGCG TACCATCAAA ACCGATATCT ACCAGACCTT TAACAGAAAT 180 ATCACGTAAA TCTTCGTAAA CGCTGCCCTG GATGATACCA AACAGCGCAT TTTTGTTTCC 240 GAGACTGTCA AAACGCTCAC GGCTACGTCG CCCAACGCAG AGACATCTCC ATGGAGCGTT 300 TTGCGTAATC CCA 313 (2) INFORMATION FOR SEQ ID NO: 111: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 1613 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 111: CGGAAATCCC AGTAATTCCA TCCTCANATA TTCCACTCAN CCTCACTGTA ACAAAGTTTC 60 TTCGAATAAT AAAAATCATG CTTTCTGTTA TCAACGGAAA GGTATTTTTA TTCTCTGTGT 120 TTGCTTTATT TGTGAAATTT AGTGAATTTG CTTTTTGTTG GCTTTATNTG ATGTGTGTCA 180 CATTTTGTGT GTTATTTTTC TGTGAAAAGA AAGTCCGTAA AAATGCATTT AGACGATCTT 240 TTATGCTGTA AATTCAATTC ACCATGATGT TTTTATCTGA GTGCATTCTT TTTGTTGGTG 300 TTTTATTCTA GTTTGATTTT GTTTTGTGGG TTAAAAGATC GTTTAAATCA ATATTTACAA 360 CATAAAAMMC TAAATTTAAC TTATTGCGTG AAGAGTATTT CCGGGCCGGA AGCATATATC 420 CAGGGGCCCG ACAGAAGGGG GAAACATGGC GCATCATGAA GTCATCAGTC GGTCAGGAAA 480 TGCGTTTTTG CTGAATATAC GCGAGAGCGT ACTGTTGCCC GGCTCTATGT CTGAAATGCA 540 TTTTTTTTTA CTGATAGGTA TTTCTTCTAT TCACAGTGAC AGGGTCATTC TGGCTATGAA 600 GGACTATCTG GTAGGTGGGC ATCCCGTAAG GAGGTCTGCG AGAAATACCA GATGAATAAT 660 GGGTATTTCA GTACAACACT GGGGAGACTT ATACGGCTGA ATGCTCTTGC AGCAAGGCTT 720 GCACCTTATT ATACAGATGA GTCGTCGGCA TTTGACTAAA TTATGGCATT CCGGAGTTTC 780 TGGAAGATAA AAAAAGAAGC CCTTATCAGA AAGCAGACAG GTTATATCAG TATTCTGTCG 840 ATAAATAACC TGCCCTGAAA ATACGAGAAT ATTATTTGTA TTGATCTGGT TATTAAAGGT 900 AATCGGGTCA TTTTAAATTG CCAGATATCT CTGGTGTGTT CAGTAATGAA AAAGAGGTTG 960 TTATTTATGA TTAAGTCGGT TATTGCCGGT GCGGTRCTAT GGCAGTGGTG TCTTTTGGTG 1020 TAAATGCTGC TCCAACTATT CCACAGGGGC AGGGTAAAGT AACTTTTAAC GGAACTGTTG 1080 TTGATGCTCC ATGCAGCATT TCTCAGAAAT CAGCTGATCA GTCTATTGAT TTTGGACAGC 1140 TTTCAAAAAG CTTCCTTGAG GCAGGAGGTG TATCCAAACC AATGGACTTA GATATTGAAT 1200 TGGTTAATTG TGATATTACT GCCTTTAAAG GTGGTAATGG CGCCAAAAAA GGGACTGTTA 1260 AGCTGGCTTT TACTGGCCCG ATAGTTAATG GACATTCTGA TGAGCTAGAT ACAAATGGTG 1320 GTACGGGCAC AGCTATCGTA GTTCAGGGGG CAGGTAAAAA CGTTGTCTTC GATGGCTCCG 1380 AAGTGATGCT AATACCCTGA AAGATGGTGA AAACGTGCTG CATTATACTG CTGTTGTTAA 1440 GAAGTCGTCA GCCGTTGGTG CCGCTGTTAC TGAAGGTGCC TTCTCAGCAG TTGCGAATTT 1500 CAACCTGACT TATCAGTAAT ACTGATAATC CGGTCGGTAA ACAGCGGAAA TATTCCGCTG 1560 TTTATTTCTC AGGGTATTTA TCATGAGACT GCGATTCTCT GTTCCACTTT TCT 1613 (2) INFORMATION FOR SEQ ID NO: 112: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 930 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 112: NTAGTCCATG GCCCCATGGA GCGAANTCCA AAGTGTGGAT ATTGTCGTTT TAATTCATCC 60 CAAAAGCTGA AATACGCCAA AACCCACGTT CCCTAACATT GGTATCATGC ATAATGACCA 120 CAGCCNTTCA GAAAGCTTTG GCAACCAGCT TTCAAAATCA TGGGTACCGC TTCAAACGTA 180 TGCAAACCAT CAATATGAAG CAGATCAATG CTACCTTGTG AAAAATGCTC TAACGCTTGG 240 TCAAATGTAC TGCGAATGAG AGTAGAAAAA CCTGAATAGT GCTGTTGATT ATATTCTGAT 300 ACTTGCCTGT AAACTTCTTC GCCATACAGC CCCGCATGTT CATCTCCCCC CCAGGTATCA 360 ACGGCAAAGC AGCATGTTTC TAAATCTAGT TTAGAGACTG CTTGGCAAAA TGAGAAATAA 420 GAACTTCCAT AATGAGTTCC CAGCTCAACA ATATTTCTTG GCCGCAGTGT GTCAACTAAC 480 CAGAAAGCAA AAGGAATGTG TTCTAGCCAA GCAGATTGTG CAAGGTATGT AGGACACCAN 540 AAAAGAGATG GTTTGAAAAT GAAATTCAAT TCCCTGCCAA TATCAGTGAT GGGATATAAC 600 TCACGATTCT CTACTAACTG ACTAATTTTT TGACTATCCA TTGAGGAAAA CTCACATGTA 660 TTTATAGAAT TAAATCAAGA AACCTGAAAA TACCTATAGT GCGGTAACTT ATTAACTAAC 720 ATTTAAATAT TAACAATACA CTTGGAAATA TTAGTTAAAA ATAAATCATT ATGATTTCTC 780 ATCAATCCTG GTGCTCACGC AAAGTTGCCA GCCCCATAAT AATAAGACCA TAGAACAAGC 840 AAAGTAATAC ACCCACAGTC GCAAGATTAT AGAATCGCCG TGGATATTCG GCATCTTCCG 900 CTAAAGTTGG TTGGGTAATA ACCAATAGAT 930 (2) INFORMATION FOR SEQ ID NO: 113: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 659 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 113: ACGATATCCC CCCTCTGCTT TTGAGAGGCA ATCTGCTTTA ATACATGATT CATCACAACA 60 CCTCTTGCTG CGCTTTGATC TTAATTTTAT ATTTTTGGGT AGGGAAAAGT AATTGCCCCT 120 GATACGGCTC ACCATTTACC AACGTTTCAC AGCTATGTTC CAGAGCTAAA TTAAGACCTG 180 GTAGAATATC CCAGCAATTC ACCCCTTTGA CATTTTCAAA GCTGTCATAA GCACCGGNNA 240 AGGGGGGGCC AACATGTTAT ACATGGAGCA GCCAATGATA CGATATTCAA AGCCCTCTTC 300 CAGTTGCATC AGATCCTGCT TGGTAASGGA GGAAGAGAGG CCACGAATAC GAGAGCGATG 360 ATGTGTAATC GGCATACCTG TGATATGAAG ATCATTCAAT TCAGGTAAGA AGATGCAGGA 420 CTCTTGATGT TTCCCCTCGG TGTAAATGCT GATACCAATG CCCCACTCTT TGAGCCCAGA 480 GACAAAGTTT TCTGTGCCAT CAATTGGATC TAGAACAATG TAAGAACCTT TGGGATTCCA 540 CTCAATATCT CCTAAAGGGG CTAATTCCTC TGAAATTAGC ACATGCCCTG GTAGATGCTT 600 TCTACAGAGT TCGAAAACTA TATCTTGAAC TTTTAGATCC AGTACTGCGG CCGCGATCC 659 (2) INFORMATION FOR SEQ ID NO: 114: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 556 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 114: CCCGGATATA CATCAGGAGA AATTGGAGCA GCAATTGGAT GCGCCATTAA TGCCTGGTTA 60 GGGATCCCCG CATGTGGGCA CGCAAATGGC TCAGAATATG ATCGACCTTC ACCAGATAAA 120 CCAAATCTGA GCGAACCATT TATCCCAAGA CCCACGTATG ACGCTTCACT TCATTCCTGG 180 CATGGCGGAT ACTGAGTAAA TCATCCTGAA TCATTATGTT CAACATCATC AATTCTCCGG 240 ACTTGTTGTC AGATGTCCGG AGAATATTAA CCTTTTCTTC AGAAACAGAW TGATCAAGAA 300 TCACACTCCT TCTTTAAGAG GATTTTATCC AGAAAACTGA CTTTCTTCTA TCAAAATMAC 360 AGTATCCTGT TTTATCAGGA ATAATCTTTA CCTCCGGTAT CATTCCCATA ATCAGATATC 420 AGAAAAATGT GCCAGTAATT TTTTACTGAT GACTTCAAAC ATTTCACATT CATCACACGT 480 CAGATTACTC CAAAGTTCTT TCAGATATGT GTTCTGCGCC AGAGTGAGTC TCTGAATAAA 540 AAACATACCT TCAGAC 556 (2) INFORMATION FOR SEQ ID NO: 115: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 503 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 115: TACCTGTTTG TGGAATTTGA CCCAGAAGTG ATTCATACCA CGACTATCAA CGCGACCCGN 60 GTGTNCAGCC ACTTCGTGCG CTTTGGCGTN CGCAGCGATA GTCCCATCGG CGGTTATTCA 120 TCAGCTATCG GTATATAAAC CGAAAGACAT TGTCGATTCC GGCAACCCCT TATCCGGGTG 180 ATAAGGTGAT TATTACCGAA GCGCGTTCGA AGGCTTTCAG GCCATTTTCA CCGAACCCGA 240 TGGTGAGGCT CGCTCCATGC TATTGCTTAA TCTTATTAAT AAAGAGATTA AGCACAGTGT 300 GAAGAATACC GAGTTCCGCA AACTCTAAAA CGCAATCCCA AACAGTGTTT TGACATTAGC 360 ATCCGTGGTG GCAGCCAGCC ATGCGGCATC TTCTCCACGC CAGTGCGCAA TACGTTGCAA 420 AATATGGGGC AGATGGGCTG GCTCGTTGCG CCGGGATGAN GGCTTTGGCG TGAGATCGCG 480 AGGGAGCAGA TACGGNGCAT CAG 503 (2) INFORMATION FOR SEQ ID NO: 116: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 433 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 116: TTTAACATCA AAATTACCTG CAGCTGAAAT GATTTTGCTG ATTTCATTAA TTAATGGATT 60 AAGATTACCC TGACTTCCAT AGGCTAATGC ATCATTCCCA TACACATAAC TTGCCTTATT 120 ATTACTCTGT TGATACTNAA GTGCCTTTTT AAGGGAATCT GGTGTGATTA CCCTGCCGTC 180 TTTATCAAAA ATCTGCTCTA TCTGGTGATT AGAGATATCA CCTGACTCTT TTTCAAACCA 240 GTTTTTAAAT GTAATACCAT TTTTGTGGCC AATGGAAAGA ACATTACCTT CAGCTTTATA 300 CATGATGAGG TCATTACCTT CTCGCCTGAA GGCCACATCC CGGAAATCAA TATCAGCCAA 360 ACTGAGTTTA TCGTCTTTCC CCCCATCATC GTCAATAATA TGATGGCCAT ATCCTGAAAG 420 ATAACGATAA ATA 433 (2) INFORMATION FOR SEQ ID NO: 117: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 302 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi ) SEQUENCE DESCRIPTION: SEQ ID NO: 117: GCGCTCTGTT CCCGTTCCTG TTCATCACCA TCGCCTGTGG TGCGGTATCT GGCTTCCACG 60 CGCTGATCTC TTCCGGTACG ACGCCAAAAC TGCTGGCTAA TGAAACCGAC GCGCGTTTCA 120 TCGGCTACGG CGCAATGCTG ATGGAGTCCT TCGTGGCGAT TATGGCGCTG GTTGCTGCGT 180 CCATCATCGA ACCGGGTCTT TACTTCGCGA TGAACACCCC GCCTGCTGGC CTTGGCATCA 240 CCATGCCTAA CCTGCATGAA ATGGGGTGGC GAGAACGCGN CGGATTCATC ATGGCGCANT 300 GA 302 (2) INFORMATION FOR SEQ ID NO: 118: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 656 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 118: AATTAATAAG CCAAATACTA CATCACGTAA TACTTGCAAA GAAGTGCGTG GAGTTTGACT 60 AATAATGGGT TTGTCCATTA ATACTTACCC AAATAATCGG CTCATTATAG CAACGAGCCT 120 CCGATTAAAA TTTAAAATAC TCAATCATTT AATAGCAACG TTAGCAGCTA CAGCGATTTG 180 ATAAATAATT TGTGTGATAT CTTTAAATGA TTGCATGGTT TTGCTATCAA CCTGAGGTAG 240 AACCAATATC TGATCCCCCG GTTGTACTTT ACCTTGCCCT TTAAATTCTA CAAGACCATT 300 TGCATGTACA ATAGCAATTC GCTTGTCGTT AGCTCGCTCA GTAAAACCTC CGGCCCATGC 360 AACATAATCA TCCAAATTAG CATCGGCATT ATATACTACT GCTTGTGGCA TCAACACTTC 420 ACCCCCCACT TGAATAAGAT CAGTCTTATT TGGAATAACT ATTTGATCGC CTTGTTCTAA 480 TTGGATAWTG GCAATAACAC CTTTATCTGC AACTACTACT TTACCAAGCG GTKGAACTTT 540 ACGAGCCTTT YCAACAAACT GCATCACTAA CTCTGCTTCT TTAGCACGTA TATTCGCCTC 600 ACCATCAGAT CGCGCGGGTG TGGTAAANTT CATACGTTCC AAGCGGTTTA GAGATT 656 (2) INFORMATION FOR SEQ ID NO: 119: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 436 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 119: ATATGTTATC TGGATCCAGA TAAAGAGCGT TCTTGACCCG CTATATCCAG ACAGGTCAGT 60 TACACCCTGT CCGGAAAAAC TGATCGGAAT AACAACAGTA TATTTTCTAA TACACTGGCA 120 AATGGTGCCG GCGGTGTGGG GATTCAGCTT CTGGATAGCG CTGGTAATGC GGTTGCTGCT 180 GGACAGAAGA AATATCTGGG ACAGGTAGGA CCATCAACAT CTCTCAATAT TGGATTAAGG 240 GCATCTTATG CACTGACCAA TGGACAGACT CCACCTACTC CCGGACGAGT TCAGGCGTTA 300 GTTGATGTTA CCTTCGAGTA TAATTAGGAA TGTCGGGGAT GGGCTATCCC CGATATTATT 360 GCAGGATTAG TCTGTGATAC AGATATACAG CCCATATGAA CAACTGTTTG CATATATAAA 420 AATGATGATA ATTTTA 436 (2) INFORMATION FOR SEQ ID NO: 120: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 559 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 120: AATAATTAAA TTTGGAGGGA TCAGTTTTCT GATAATGTTC TGTTATTAAA ACATTATCCC 60 ATGGGGCGTA GTTATATCAA TTAGCAGGAT CTTATGAGTT AACTAACATC AGTTTTGAAT 120 TTTTAATGGG GGTAATTTAT CTTTTACTAA AAATATTTTA ACTATTAATA TAGCATCATG 180 GTTGTTACGG TTTGTTTTAA TTCTATTTTA TAATGTGCTA TATATTGTAT TTTTGTGCTT 240 AGATAAATAT GTTTTTTCAT TACTTTAGTG ATGTTAATAT TTTGCGTGTA GTAAAAATCA 300 TTGTTATAAC AAATGTCACT GTTGCTATAC TTTGCTGAAC TGTTTATCGG TCATTTTGAT 360 TCAATCACTG GTTCTATATT TTTTAATAAC CGTTCTGTAG CGATTAATAT ATTGCTCTCC 420 AGAGGATACA CTATATGAAA TATATTAAAA GTCATTAATT TTNATTCAAT GTTGTTTAGA 480 GTTATGTTCA GTGTTTGGNA ATAGGATGTG TTTCTAAACC GTCTTGGGTT CTATAATAAA 540 TTCTATTCTT ANAGGTTTT 559 (2) INFORMATION FOR SEQ ID NO: 121: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 481 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 121: CATGTCCCTT CCTGAATACT GGGGAGAAGA GCACGTATGG TGGGACGGCA GGGCTGCTTT 60 TCATGGTGAG GTTGTCAGAC CTGCCTGTAC TCTGGCGATG GAAGACGCCT GGCAGATTAT 120 TGATATGGGG GAAACCCCGG TACGGATTTA CAGAATGGTT TCTCCGGACC TGAAAGAAAA 180 TTCAGCCTCC GGCTCAGGAA TTGTGAATTT AACAGTCAGG GTGGGAACCT TTTCTCTGAT 240 TCCCGGATAA GGGTGACTTT CGATGGCGTC CGGGGTGAAA CGCCGGATAA GTTTAATTTA 300 TCCGGTCAGG CAAAAGGCAT TAATCTGCAG ATAGCTGATG TCAGGGGAAA TATTGCCCGG 360 GCAGGAAAAG TAATGCCTGC AATACCATTG ACGGGTAATG AAGAAGCGCT GGATTACACC 420 CTCAGAATTG TGAGAACGGA AAAAAACTTG AAGCCGGAAA TTATTTTGCT GTCTGGGATT 480 A 481 (2) INFORMATION FOR SEQ ID NO: 122: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 535 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 122: CCATATAGTG ACTTCATTGA ACAAAATGTA AATGGAATCT TGCTGGAGAA TGACCCACAT 60 ATATGGATAA AAGCTCTTTC ATTACTTGTT AGTGCAGATC ATAAACGTAG CGAGTTGGCG 120 TTCAATGCTA AAAAATATGC TTGTAAAATT GTAGGTGTCG AGTAAAAAGA TATTTTTATT 180 TAATTGGTGC TATTGAATGT TTAAAAATCG AACTGATTGG TGTTTTAATA TTAATCATAG 240 GTTATGATGC AAAAATATAT TAGGCATTGC CTGCTTCAAT TAACTTGAGA GTGTAAGTTG 300 AATTGAAATA TGGTTATATG ATAAAGCAAT ATATGTTAAT ACATATGTCA ACCGAAAATG 360 CCATTATGTG TTTTTTACTT TATCTGTAAC GACACAATAT ATAAAATAAG GCTAATAATC 420 AAAACGCTTT TTAATTTGAT TGTTTTGAAT CAAGTGACTA AGAAATTCTC TTGCTGCAAA 480 TAACTCCCTT AGTGATTTTT TTTGAGTCTA TTTTATTCTC TGGGCATGGT CATGC 535 (2) INFORMATION FOR SEQ ID NO: 123: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 412 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 123: CCGGCCCCAT AATGATGGTT TTATTAAGGT TAGCGCCGAC GGTTTCGATG AACGATTTCA 60 GGTCGGTATC TTTAAAATTA GCGGTGAAAG TGGCTTCTTC CGCCCAGACC GGTGAACTGC 120 ATAATGCCGC TGCCAGCACC AGCGGCAGTA AACGCTTTTT TGTTTTGAGG CCAGTTGTCT 180 TCTTACGCCA GACCGACAAC GTCATATCAC GCCAAAACAC GATGAATGAT TCTCCTGGAT 240 TAAATGCGGT TAGCGCAGCG CGATGGAAAT GTCGTGGCGC GCACCCTTGC GTAAAACCGT 300 AAGTTGAATG GAATCCATTG AAGGTAACTG CCGCATCAGA GCAATCATTG CTCGTGGATC 360 AGTGAAATCC TGCTGATTTA GCGCAAATGC GATATCGCCT TCCTTAAAAC CG 412 (2) INFORMATION FOR SEQ ID NO: 124: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 576 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 124: TAGCCTGTTC AGCGTATATT TGGGATGAGA AGCCAAAGTG GCTTTGGTGG TGTCCCAGCC 60 CAGGTTTTTA TTACTGCTGG TTATTTACCT TTCATGTTTT TCAATAAAGT TGTGACTCAG 120 TTGAAATCTG CTGTCAATGC TAATATGGGA CTTTTTTGTT ATAGACAAGT GACTCCTTTT 180 GCAACTTTTA TAGCACGTTT TATGCTAGAA ACAATGGTGG GCATGATTGT CGGTATAATC 240 CTAGTACTAG GATTATTGTG GTTTGGCTTT GATGCAATAC CTGCGGATCC ATTGCAAGTG 300 ATCCTTGGTT ATTCTCTTCT GATGCTGTTT TCTTTTTCTC TTGGTATTGT ATTTTGTGTT 360 ATTTGTAATT KRGCGARAGA GGCAGATAAA TTTCTTAGCT TGTTAATGAT GCCTTTGATG 420 TTTATCTCTT GTGTTATGTT TCCTCTTGCT ACTATTCCCC CTCAATATCA GCATTGGGTT 480 TTTATGGAAT CCACTTGTGC ATGCTGTAGA ACTAATCCGA AGGGCATGGG ATATCTGGGT 540 TATCGTAGTC CTGATGTAAG TTGGGCGTAT CTGTCG 576 (2) INFORMATION FOR SEQ ID NO: 125: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 132 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 125: TTACCAAGCA GGATCTGATG CAACTGGAAG AAGGCTTTGA ATATCGTATC ATTGGCTGCT 60 CCATGTATAA CATGTTGGCC GCCGTACGCG GTGCCTATGA CAGCTTTGAA AATGTCAAAG 120 GGGTGAATTG CT 132 (2) INFORMATION FOR SEQ ID NO: 126: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 542 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 126: GATTAGGGGT CACTCAGGAT TATAAAAAAG CGGCAGAATA CTATAAAAAA GGTGATAAAA 60 ATAATGATAT TACAGCACAA TACCGTCTGG CAAAACTTTA TGAACAAGGT AACGGTGTAA 120 AACGTGATTA TCAACAAGCG ATAAACCTTT ACCTTAAACA TATCAACAGA ATGGATCACA 180 TCACTGCCCC CAGTTTTGTG GCTCTGGGTG ATATCTATTC TCTGGGATTS GGGGTAGAGA 240 AAAACCCACA ACTGGCTGAA AAATGGTATC AAAAAGCGAT AGATGCAGCT AATACACAAC 300 ATAACCAGGA AATAAATCAT TAAACGACAA CACTTAATAC CATATTGTGA AGATGTTCAG 360 ACATGGCGGA ATTCCCCTAT TCTTTGTTGG CGCTTACAAC AGACTATATT CCGCCATATC 420 TGTCTTTATT GTGTATAAAC CATCGATACT GATGTTTGAT AGTGCTAAAT AATCATTGGC 480 GCAATCACAA AGCCTAATGC CACTCCAGCA ATAATTCCCC CCAACCCAGG CAGCATAAAT 540 GG 542 (2) INFORMATION FOR SEQ ID NO: 127: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 382 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 127: GAACCACTTA GCGGCAGCTA TCGGGAATCG CCTGCTGAAA GACGGTCAGA CAGTGATTGT 60 GGTTACCGTG GCTGATGTTA TGAGTGCCCT GCACGCCAGC TATGACGATG GGCAGTCAGG 120 CGAAAAATTT TTGCGGGAAC TGTGCGAAGT GGATCTGCTG GTTCTTGATG AAATTGGCAT 180 TCAGCGCGAG ACGAAAAACG AAGCAGGTGG TACTGCACCA GATTGTTGAT CGCCGGACAG 240 CGTCGATGCG CACGTGGGGA TRCTGACAAA CCTGAACTAT GAGGCCATGA AAACATTGCT 300 CGGCGARCGG ATTATGGATC RCATGACCAT GAACGGCGGG CGATGGGTGA ATTTTAACTG 360 GGAGACTGGC GTCCGAATGT CG 382 (2) INFORMATION FOR SEQ ID NO: 128: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 126 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi ) SEQUENCE DESCRIPTION: SEQ ID NO: 128: CGTCCCGCAC CCGGAAATGG TCAGCGAACC AATCAGCAGG GTCATCGCTA GAAATCATCC 60 TTAGCGAAAG CTAAGGATTT TTTTTATCTG AATTCTAGCC AGATCCCCGC TGATTTATGC 120 TGGTTA 126 (2) INFORMATION FOR SEQ ID NO: 129: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 258 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 129: ACCCCCAGCC TAGCTGGGGG TTTTCTGTGC ACAAAAAATC CCGGCATAAT GGCCGGGATT 60 TGCGAGCTTT CCCACTATTT CTTGATTCCT AAACGGAACA TATCAGTTGG GAATAAAGGT 120 TGTATTATCA CTTCATCATT ANAAATGAAT AATTTGGGCG ATAAAGCTGT TACGTCATAG 180 ATATTTTCAG CGATTAATCT TAGANTTGAC CTAAAAACTG GAATACTTGC ATCATCTGCA 240 AAGACAAACA TGTCATCG 258 (2) INFORMATION FOR SEQ ID NO: 130: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 399 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 130: AACCAGCGGT TCGCATCATC TCATCCCACT GACTCTCCGC TTTTGACAGA TCTGCATATC 60 CTCGGGCCAA CTTATCCAGT ACTCCGTAGT TTGCCGATTT ATTCACCCGC CAGAACACCG 120 CCTCACCTGC ATCGGCAAGC CGGGGGGAAA ACTGATACCC CAGTAGCCAG AACAGACCGA 180 AAATAATATC GCTGCTACCC GCAGTGTCTG TCATGATTTC AACTGGATTC AGCCCTGTCT 240 GCTGCTCAAG AAGTCCTTCC AGTACAAAAA TCGAATCCCG TAATGTACCG GGTACCACAA 300 TGCCATGGAA CCCAGAGTAC TGATCAGATA CGAATTATAC CAGGTGATGC CTCGTCCAGA 360 ACCAAAATAT TTTCTGTTAG ATCCTGAGTT GATGGTCTT 399 (2) INFORMATION FOR SEQ ID NO: 131: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 745 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 131: AAATAACATC AACATACATT TGACTCGCGG GGGAAACGTT TACGGAGTCT TCATACTGGC 60 ACTTTTTTAT GCTGCTGACT ACTCTTCGTC ATCGCCATCA ACATGCGCAC GAATCAGCGC 120 CATAAACGGT TTGCCAAAGC GTTCCAGCTT GCGCATCCCA ACGCCGTTAA CGCTGAGCAT 180 TTCGCTGGCG GTGATCGGCA TCTGTTCAGC CATCTCAATC AAGGTTGCGT CGTTAAACAC 240 CACGTACGGC GGGACATTAC TTTCATCGGC TATCGATTTA CGCAGTTTGC GTAATTNGGC 300 GAACAGTTTG CGATCATAGT TGNCGCCGAN CGATNTCTGC ATCGCTTTCG GTTTGAGCGC 360 CACGATACGC GGCACGGCAA TTGCAAAGAG GATTCGCCGC GCAGCACCGG GCGCGCGGCC 420 TCTGTCAGTT GTAGGGCAGA ATGCTGGGCA ATATTTTGCG TCACCAGGCC GAGGTGAATC 480 AGCTGGCGGA TCACGCTCAC CCAATGTTCA TGGCTTTTAT CACGGCCCAT GCCATAGACT 540 TTCAGTTTGT CATGACCATA GTCGCGGATA CGCTGGTTAT TAGCACCACG AATCACTTCC 600 ACCACATAAC CCATCCCAAA CCGCTGATTC ACACGACCAA TGGTGGAAAG GGCAATCTGA 660 GCATCGGTTG AACCGTCGTA CTGTTTCGGC GGATCGAGGC AGATATCGCA GTTCNCCGCA 720 CGGCTCCTGA CGCCCTTCGC CAAAA 745 (2) INFORMATION FOR SEQ ID NO: 132 : (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 439 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 132: AGAATGGCGG CTTCTTGCCC CCCTTTGCCC CGGTCCTGAC TAGCATGGCT GGAGTCCAGT 60 GTCCAGGCCA CGACCATGCT CATCATGGAA GCAGCTTTTG TAGTACANTC GCAGCTTATT 120 TTCCTGGAAC GAAATGTCTG GCATCGTGGT GCATAACATA ACCCCCAATG CCCAGCAGAT 180 GCACAGAAGG TTCTAGAATC GCCCACTGAT ATCCCATACA AAATTTACCA AAACGTGTTC 240 GTATTTCTCG TATAAATAAT GTCTCTATGG TGACGTTCTA GACTTCAAAC CCACTTTTTG 300 AATTTGATGA TGTGCTCCTA ATCTCTTCAG GAATGTAACG CCCTTGGTTT ACAGCTACCA 360 ATACACTGGA GGTATACTTA TCTGCAACTG GATGAACTAG ATGTACTTGA GCAAACATTT 420 CATAAGCTCG ACGACAGTT 439 (2) INFORMATION FOR SEQ ID NO: 133: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 350 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 133: CTGGAAAGCG ACGTTGATGG ATTAATGCAG TCGGTAAAAC TGAACGCTGC TCAGGCAAGG 60 CAGCAACTTC CTGATGACGC GACGCTGCGC CACCAANTCA TGGAACGTTT GATCATGGAT 120 CAAMTCATCC TGCAGATGGG GCAGAAAATG GGAGTGAAAA TCTCCGATGA GCAGCTGGAT 180 CAGGCGATTG CTAACATCGC GAAACAGNAC AACATGACGC TGGATCAGAT GCGCACCGTC 240 TGGCTTACGA TGGACTGAAC TACAACACCT ATCGTAACCA GATCCGCAAA GAGATGATTA 300 TCTCTGAAGT GCGTAACAAC GAGGTGCGTC GTCGNATCAC CATCCTGCCG 350 (2) INFORMATION FOR SEQ ID NO: 134: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 400 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 134: CCCCAAGATT GCTAACAAAT GCGCGTTGTT CATGCCGGAT GCGGCGTGAC CGCCTTATCC 60 GGCCTACGAA ACCGCAAGAA TTCAATATAT TGCAGGAGCG GTGTAGGCCT GATAAGCGTA 120 GCGAWTCAGG CAGTTTTGCG TTTGCCCGCA ACCTTAGGGG ACATTTAGCG ACCCCATTTA 180 TTTCTCACTT TTCCGCCTCA TCATCGCGCG TTAATTTCTT TCATGAATCA CGCTTTACAA 240 TATCCAGCGC GCGCANAACG GTACTGGCAG GGATCTGAAT TTTCCTCCAG CAGCACAATC 300 AAATCGACAG CCAGTTTGAC ATCGTCAAGG GGCATTTTCC CAGTGACATA ATCTCTCCAT 360 TGCTAAGCGG GTTAAAACGC GCTAACCTGT TTCGATTTTT 400 (2) INFORMATION FOR SEQ ID NO: 135: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 463 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 135: CTATCCTTAT GACCACCCAA CTACNTCATT TACACCCAAA CCAGCGATCT GAATAAAGAA 60 GCGATTGCCC AGTTACGACT GGGCGGAAAA TGCGCGTAAG GATGAAGTAA AGTTTCAGTT 120 GAGCCTGGCA TTTCCCTGTG GCGTGGGATT TTAGGCCCGA ACTCGGTGTT GGGTGCGTCT 180 TATACGCAAA AATCCTGGTG GCAACTGTCC AATAGCGAAG AGTCTTCACC GTTTCGTGAA 240 ACCAACTACG AACCGCAATT GTTCCTCGGT TTTGCCACCG ATTACCGTTT TGCAGGTTGG 300 ACTGCGCGAT GTGGAGATGG GGTATAACCA CGACTCTAAA CGGGCGTTCC GACCCGACCT 360 CCCGCAGCTG GAACCGCCTT TATACTCGCC TGATGGCAGA AAACGGTAAC TGGCTGGTAG 420 AAGTGAAGCC GNGGTATGTG GTGGGTAATA CTGACGATAA CCC 463 (2) INFORMATION FOR SEQ ID NO: 136: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 584 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 136: TTGGTCAGCC GTACCTGAAT GGGGGCTGAT GCCCGGCTGG TTAATGGCAG GTGGTCTGAT 60 CGCCTGGTTT GTCGGTTGGC GCAAAACACG CTGATTTTTT CATCGCTCAA GGCGGGCCGT 120 GTAACGTATA ATGCGGCTTT GTTTAATCAT CATCTACCAC AGAGGAACAT GTATGGGTGG 180 TATCAGTATT TGGCAGTTAT TGATTATTGC CGTCATCGTT GTACTGCTTT TTGGCACCAA 240 AAAGCTCGGC TCCATCGGTT CCGATCTTGG TGCGTCGATC AAAGGCTTTA AAAAAGCAAT 300 GAGCGATGAT GAACCAAAGC AGGATAAAAC CAGTCAGGAT GCTGATTTTA CTGCGAAAAC 360 TATCGCCGAT AAGCAGGCGG ATACGAATCA GGAACAGGCT AAAACAGAAG ACGCGAAGCC 420 TACGNTAAAG AGCAGGTGTA ATCCGTGTTT GATATCGGTT TTAGCGNACT GCTATTGGTG 480 TTCATCATCG GCCTCGTCGT TCTGGGGGCG CAACGACTGC CTGTGGCGGT AAAAACGGTA 540 GCGGGCTGGA TTCGCGCGTT GCGTTCACTG GCGACAACGG TGCA 584 (2) INFORMATION FOR SEQ ID NO: 137: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 527 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 137: GCAGGCAGGA GGAACTGCCC AGTGATACGG TTATTCGTGA TGGCGGAGGG CAGAGCCTTA 60 ACGGACTGGC GTTGAACACC ACGCTGGATA ACAGAGTTGA GCATTGGNTA CACGGGGGAG 120 GGAAAGCAGA CGTTACAATT ATTAACCAGG ATGTTTACCC AGACCATAAA ACATGGCGGA 180 TTGGCAACCG NAACCATCGT CAACACCGTT GCAGAAGKTG GTCCGGAGTC TGAAAATGTG 240 TCCAGCGGTC AGATGGTCGG AGGGACGGCT GAATCCACCA CCATCAACAA AAATGGCCGG 300 CAGTTATCTG GTCTTCGGGG ATGGCACGGG ACACCCTCAT TTGCGCTGGT GGTGACCAGA 360 CGGTACACGG AGAGGCACAT AACACCCGAC TGGAGGGAGG TTAACCAGTA TGTACACAAC 420 GGTGGCACGG CAACAGAGAC GCTGATAAAC CGTGATGGCT GGCAGGTGAT TAAGGAAGGA 480 GGGAACTGCC GGCGCATTAC CACCATCAAN CCNGAAAAGG GAAANCT 527 (2) INFORMATION FOR SEQ ID NO: 138: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 441 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 138: GTCAGTCTCT GGGGGAAGTG CGTGTTCCGA CCGGGGAAAT GTGCTGGAGA AAGTTATTGA 60 AGGGGCTTAC GAGGTGGTGG GGGTTTTTGA CCGGATTGAG GAAAAGCGTG ATGCCATGCA 120 GTCGCTGATT CTGCCGCCAC CGGACGCCAG GCGCTGGCAC AGGCGGCACT GACTTACCGT 180 TATGGTGACG AACMTCARCC CGTCACCACC GCCGACATTC TGACACCACG ACGCCGGGAR 240 GATTACGGTA AGGACCTGTG GAGTGCTTAT CAGACCATTC AGGAGAATAT GCTGAAAGGC 300 GGAATTTCCG GTCGCAGTGC CAGAGGAAAA CGTATCCATA CCCGTGCCAT TCACAGCATC 360 GACACCGACA TTAAGCTCAA CCGCGCATTG TGGGTGATGG CTGAAACGCT GCTGGAGAGT 420 ATGCGCTGAT GCCGTTTCCN T 441 (2) INFORMATION FOR SEQ ID NO: 139: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 398 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 139: CGAGCGAGAT GAACTTCGAG GGCGGTGTGA GCCAGTCGGC TTACGAGACA CTGGCGGCGC 60 TTAATCTGCC GAAACCGCAG CAAGGGCCGG AAACCATTAA TCAGGTTACC GAGCATAAGA 120 TGTCAGCTGA GTAAGCCTGT ATGCCGGATA AGGCGCTCGC GCCNATTCCG ATGAAATAAG 180 GCGCATCGGG CCTGAAGGAA AGCCGTATGN ATACACCCGC AGCCCGCATC CGGCAAGTTA 240 CAACAAATAA CCTTTAACCA TGCTTTTTGA TGTTTTTCAG CAATACCCCG CGGCGATGCC 300 CATACTGGCA ACCGTCGGGA GGGATTGATC ATCGGCAGTT TTTTGAATGT GGTGATTTGG 360 GCGTTACCCC ATCATGCTGC GCCAACAAAT GGCGGAGT 398 (2) INFORMATION FOR SEQ ID NO: 140: (i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 580 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 140: GCCGAACAGA CACAGCAATA TGAACCCTGC CAGCGCAGAC GCTTGCTGAT TAATGCTCTG 60 AACAAAAGGC GAAGAATGGC AAATCCTGCG ATCAGCAAAG TCAGCGCACC GACTATCTGT 120 AACATAGTCA CTCCGTGATG AATATCATGT GTATTGTGAA TGCCAGTGAA TGTGGCACTG 180 AAGCGTTTGC ACCTGTCCGG GTCCCGGTCA TGATGACCGS AACAGAGAGA CAATGCCGAA 240 TTATCAGAAG GTCACATTCA GTGTGGCTTG GCCGTTATAA CCTTCAGCGC TGCTGCCGCT 300 GACGCTGTGG GCATAACCGG CCTGAACGCC CAGGGTGATA TTTTCCCGGA CACGGGCTTC 360 CAGTCCGGCC TGCAGCTCCA GTGACGTGCC ATTCCGGGAC GGTGAGAACG TCATGTTACT 420 GCCGGCTGCG GCTGTACCCA TGCTCATGTC TCCCCGGGAG CTGAAGGTGC GGATAACAGA 480 AGGCTGTACC CACCCGTTCA CCGGCAGTTC ACGCACACTG TGTTTTGCAC TGTCACGCAA 540 GGTGTCACGG GATGAGGTGC CTTCANCAAA AGGTCATATT 580 (2) INFORMATION FOR SEQ ID NO: 141: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 446 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 141: TGCGGACATC CAGCGTTCCG CCATCATCCA CACGGGTTCT GGTGGCTGTG TGTCCGGTCA 60 GCACATCCAG ACGGCCGCCA TTTTCCAGTA CGACATTATC AGCTTTACCC TCCACAACAG 120 AGAATGCTCC CAGGCGGTTT GTGCCGGTGA CGGTTGCAGC AGTGCTGGTA ACCAGTGCTC 180 CGCCCGTGTT CTGGGTGACA TCAGACGCTT TACCGCCGGC ATTCACCTGC AGCTTTCCTT 240 TCTGGTTGAT GGTGGTATGC GCGGCAGTTC CTCCTTCCTT AATCAMCTGC CAGCCATCAC 300 GGTTTATCAG CGTCTCTGTT GCCGTGCCAA CGTTGTGTAC ATACTGGTTA MCTCCCTCCA 360 GTCGGGTGTT AWGTGSCTCT CCGTGTANCG TCTGGTCANC AACAACGCAA ATGANGGTGT 420 CCCGTGCCAT CCCCGAAGAC CAGTAA 446 (2) INFORMATION FOR SEQ ID NO: 142: (l) SEQUENCE CHARACTERISTICS: (A) LENGTH: 327 base pairs (B) TYPE: nucleic acid (C) STRANDEDNESS: double (D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 142: TGAATACGTT AAGTCAGCAG ACCGGCGGAG ACAGTCTGAC ACAGACAGCG CTGCAGCAGT 60 ATGAGCCGGT GGTGGTTGGC TCTCCGCAAT GGCACGATGA ACTGGCAGGT GCCCTGAATA 120 ATATTGCCGG AGTTCGCCAC TGACCGGTCA GACCGGTATC AGTGATGACT GGCCACTGCC 180 TTCCGTCAAC AATGGATACC TGGTTCCGTC CACGGACCCG GACAGTCCGT ATCTGATTAC 240 GGTGAACCCG AAACTGGATR GTCTCGGACA GGTGGACAGC CATTTGTTTN CCGGACTGTA 300 TGAGCTTCTT GGAGCGAAAC CGGGTCA 327 INDICATIONS RELATING TO A DEPOSITED MICROORGANISM (PCT Rule I3bis) A. The indications made below relate to the microorganism referred to in the description on page 5 , line § B. IDENTIFICATION OF DEPOSIT Further deposits are identified on an additional sheet [X I Name of depositary institution American Type Culture Collection (ATCC) Address of depositary institution (including postal code and country) 12301 Par lawn Drive Rockville, Maryland 20852 United States of America Date of deposit Accession Number September 23, 1996 97726 C. ADDITIONAL INDICATIONS (leave blank if not applicable) This information is continued on an additional sheet | | DNA plasmid PAI-1 D. DESIGNATED STATES FOR WHICH INDICATIONS ARE MADE (if the indications are not for all designated States) E. SEPARATE FURNISHING OF INDICATIONS (leave blank if not applicable) The indications listed below will be submitted to the International Bureau later (specify the general nature of the indications eg., "Accession Number of Deposit") For receiving Office use only For International Bureau use only I j This sheet was received with the international application I j This sheet was received by the International Bureau on: Authorized officer Authorized officer Form PCT RO/134 (July 1992) INDICATIONS RELATING TO A DEPOSITED MICROORGANISM (PCT Rule Ubis) The indications made below relate to the microorganism referred to in the description on page 5 , line 8 B. IDENTIFICATION OF DEPOSIT Further deposits are identified on an additional sheet | X | Name of depositary institution American Type Culture Collection (ATCC) Address of depositary institution (including postal code and country) 12301 Parklawn Drive Rockville, Maryland 20852 United States of America Date of deposit Accession Number September 23, 1996 97727 C. ADDITIONAL INDICATIONS (leave blank if not applicable) This information is continued on an additional sheet \ | DNA plasmid PAI- 2 D. DESIGNATED STATES FOR WHICH INDICATIONS ARE MADE (if the indications are not for all designated States) E. SEPARATE FURNISHING OF INDICATIONS (leave blank if not applicable) The indications listedbelow will be submitted to the International Bureau later (specify the general nature of ' theindicationscg., "Accession Number of Deposit") Form I , CT R INDICATIONS RELATING TO A DEPOSITED MICROORGANISM (PCT Rule Ubis)

Claims: Whatls Claimed Is: 1. An isolated nucleic acid molecule, comprising a polynucleotide having a nucleotide sequence at least 95% identical to a sequence selected from the group consisting of: (a) a nucleotide sequence of an open reading frame depicted in one of Tables 1 through 4; (b) a nucleotide sequence beginning with the first initiation codon encountered reading 5' to 3' in an open reading frame depicted in one of Tables 1 through 4, and ending with the 3' terminal stop codon; (c) a nucleotide sequence beginning with the first initiation codon encounter reading 5' to 3' in an open reading frame depicted in one of Tables 1 through 4, and ending with the nucleotide preceeding the 3' terminal stop codon; (d) a nucleotide sequence of (a) excluding codons for amino acids eliminated during processing of the putative protein identified in one of Tables 1 through 4; or (e) a nucleotide sequence that is complementary to any of the nucleotide sequences in (a), (b), (c), or (d). 2. An isolated nucleic acid molecule of claim 1, wherein said nucleotide sequence is 100% identical to the nucleotide sequence of an open reading frame depicted in Tables 1 through 4, or a complement thereof. 3. An isolated nucleic acid molecule, comprising a polynucleotide that hybridizes under stringent hybridization conditions to a nucleic acid molecule of claim 2. 4. An isolated nucleic acid molecule, comprising a polynucleotide that encodes the amino acid sequence of an epitope-bearing portion of an E. coli J96 PAI protein encoded by an open reading frame depicted in one of Tables 1 through 4. 5. A method of making a recombinant vector, comprising inserting an isolated nucleic acid molecule of claim 1 into a vector. 6. A recombinant vector produced by the method of claim 5. 7. A method of making a recombinant host cell, comprising introducing a recombinant vector of claim 6 into a host cell. 8. A recombinant host cell produced by the method of claim 7. 9. A recombinant method for producing an E. coli J96 PAI polypeptide, comprising culturing a recombinant host cell of claim 8 under conditions such that said polypeptide is expressed and recovering said polypeptide. 10. An isolated polypeptide of an E. coli J96 PAI IV or PAI V protein encoded by a polynucleotide of claim 1. 11. An isolated polypeptide of an E. coli J96 PAI IV or PAI V protein encoded by a polynucleotide of claim 2. 12. An isolated polypeptide comprising an immunogenic epitope of an E. coli J96 PAI IV or PAI V protein encoded for by an open reading frame depicted in one of Tables 1, 2, 3 or 4. 13. A vaccine, in dosage form, comprising (a) a pharmaceutically acceptable diluent, carrier, or excipient, and (b) an antigen selected from the group consisting of: (i) a polypeptide having an amino acid sequence at least 95% identical to an amino acid sequence encoded by a uropathogenic E. coli J96 PAI IV or PAI V open reading frame depicted in Tables 1, 2, 3 or 4, and (ii) a polypeptide comprising an immunogenic epitope of an E. coli J96 PAI IV or PAI V protein encoded for by an open reading frame depicted in one of Tables 1, 2, 3 or 4; wherein said antigen is present in an amount effective to elicit protective immune responses in an animal to pathogenic E. coli. 14. An isolated antibody that binds specifically to a polypeptide of claim 10 or 11. 15. An antibody having binding affinity to a polypeptide according to claim 12. 16. A method of detecting a pathogenic E. coli antigen in a sample, comprising: (a) contacting said sample with an antibody according to claim 14 or 15 under conditions such that immunocomplexes form, and (b) detecting the presence of said antibody bound to said antigen. 17. A diagnostic kit comprising: (a) a first container means containing an antibody according to claim 14 or 15 and (b) second container means containing a conjugate comprising a binding partner of said antibody and a label. 18. A hybridoma which produces an antibody according to claim 14 or 15. 19. A method of detecting the presence of antibodies to pathogenic E. coli in a sample, comprising: (a) contacting said sample with a polypeptide according to one of claims 10, 11 or 12 under conditions such that immunocomplexes form, and (b) detecting the presence of said antibody bound to said antigen. 20. A kit for detecting the presence of antibodies to pathogenic E. coli in a sample comprising at least one container means having disposed therein a polypeptide according to one of claims 10, 11 or 12. 21. Computer readable medium having recorded thereon one or more nucleotide sequences depicted in SEQ ID NOs: 1 through 142, or nucleotide sequences at least 99.9% identical thereto. 22. Computer readable medium having recorded thereon a nucleotide sequence of at least one uropathogenic E. coli J96 pathogenicity island open reading frame depicted in Tables 1 through 4, or a complement thereof. 23. The computer readable medium of claim 21 , wherein said medium is selected from the group consisting of a floppy disc, a hard disc, random access memory (RAM), read only memory (ROM), and CD-ROM. 24. The computer readable medium of claim 22, wherein said medium is selected from the group consisting of a floppy disc, a hard disc, random access memory (RAM), read only memory (ROM), and CD-ROM. 25. A computer-based system for identifying fragments of uropathogenic E. coli J96 pathogenicity islands PAI IV and PAI V that are homologous to target nucleotide sequences, comprising: a) a data storage means comprising a nucleotide sequence of SEQ ID NOs: 1 through 142, or a nucleotide sequence at least 99.9% identical thereto; b) a search means for comparing a target sequence to said nucleotide sequence of said data storage means of step (a) to identify a homologous sequence, and c) a retrieval means for obtaining said homologous sequence of step (b).

Inventors: CHOI GIL H, DILLON PATRICK J, WELCH RODNEY A, CHOI, GIL, H., DILLON, PATRICK, J., WELCH, RODNEY, A.
Applicants: CHOI GIL H, DILLON PATRICK J, HUMAN GENOME SCIENCES INC, UNIV WISCONSIN, WELCH RODNEY A, CHOI, GIL, H., DILLON, PATRICK, J., HUMAN GENOME SCIENCES, INC., UNIVERSITY OF WISCONSIN, WELCH, RODNEY, A.
Application year: 1997
Main classification: C12N9
IPC codes: A61K39, A61P31, C07K14, C07K16, C12N1, C12N5, C12N15, C12P21, C12R1, G01N33